iso4217:EUR959800201400050266202021-12-31959800201400050266202020-12-31959800201400050266202019-12-31ifrs-full:IssuedCapitalMember959800201400050266202019-12-31959800201400050266202020-01-012020-12-31ifrs-full:IssuedCapitalMember959800201400050266202020-01-012020-12-31959800201400050266202020-12-31ifrs-full:IssuedCapitalMember959800201400050266202020-12-31959800201400050266202021-01-012021-12-31ifrs-full:IssuedCapitalMember959800201400050266202021-01-012021-12-31959800201400050266202021-12-31ifrs-full:IssuedCapitalMember959800201400050266202021-12-31
2024 ANNUAL FINANCIAL
REPORT FLUIDRA S.A.
Leading today, shaping tomorrow
Contents        2024 Annual Financial Report
Annual Accounts Fluidra S.A.
  2024
Leading today, shaping tomorrow
logo fluidra.svg
Inform INDI Eng_Página_1.jpg
Inform INDI Eng_Página_2.jpg
Inform INDI Eng_Página_3.jpg
Inform INDI Eng_Página_4.jpg
Inform INDI Eng_Página_5.jpg
Inform INDI Eng_Página_6.jpg
2024 Annual Financial Report        10
Contents
Annual Accounts
2024 Annual Financial Report        11
Fluidra, S.A.
Statement of financial position
31 December 2024 and 2023
(Expressed in thousands of euros)
Assets
Notes
31/12/2024
31/12/2023
Intangible assets
4
12,584
9,143
Property, plant and equipment
5
9,711
7,161
Equity instruments of Group companies
7
1,455,588
1,453,014
Non-current investments
8
214
164
Other financial assets
214
164
Deferred tax assets
21
14,780
11,196
          Total non-current assets
1,492,877
1,480,678
Trade and other receivables
9
69,986
7,459
Current loans to Group companies
7
44,213
71,872
Current accruals
9,835
13,112
Cash and cash equivalents
33
38
          Total current assets
124,067
92,481
          Total assets
1,616,944
1,573,159
Equity
Capital and reserves
10
1,537,304
1,492,164
Capital
192,129
192,129
Share premium
1,148,591
1,148,591
Reserves
102,780
(9,693)
Profit/(loss) for the year
144,211
203,292
Own shares and equity holdings
(50,407)
(42,155)
Grants, donations and bequests received
1,048
1,048
        Total equity
1,538,352
1,493,212
Liabilities
Non-current provisions
11
14,901
13,794
Deferred tax liabilities
21
        Total non-current liabilities
14,901
13,794
Current debt
24,741
Other marketable securities
12
24,741
Current debt with Group companies and associates
13
27,026
9,685
Trade and other payables
14
36,665
31,727
        Total current liabilities
63,691
66,153
        Total liabilities
78,592
79,947
        Total equity and liabilities
1,616,944
1,573,159
The accompanying notes are an integral part of the annual accounts for the year ended 31 December 2024.
2024 Annual Financial Report        12
Fluidra, S.A.
Income statement
31 December 2024 and 2023
(Expressed in thousands of euros)
Notes
31/12/2024
31/12/2023
Revenue
18
261,222
298,417
Dividend income
179,346
252,000
Services rendered
81,876
46,417
Self-constructed assets
942
466
Other operating income
9,657
8,944
Non-trading and other operating income
9,658
9,062
Capital grants released to income during the year
Profit on sales of fixed assets
(1)
(118)
Personnel expense
16
(49,535)
(46,511)
Salaries and wages
(40,405)
(38,777)
Employee benefits expense
(9,130)
(7,734)
Other operating expenses
(78,757)
(60,236)
External services
(78,498)
(60,114)
Taxes
(164)
(124)
(Charges) /Reversals due to impairment of non-current assets
(95)
2
Amortisation and depreciation
4 and 5
(4,670)
(4,113)
Impairment and gains/(losses) on disposal of fixed assets
Results from operating activities
138,859
196,967
Finance income
1,695
216
Group companies and associates
1,693
216
Other
2
Finance cost
(3,472)
(5,888)
Debt with Group companies and associates
(1,962)
(2,937)
Debt with others
(1,510)
(2,951)
Change in fair value of financial instruments
Derivative financial instruments
Exchange gains / (losses)
418
(43)
Financial result
(1,359)
(5,715)
Profit/(loss) before tax
137,500
191,252
Income tax
21
6,711
12,040
Profit/(loss) for the year from continuing operations
144,211
203,292
The accompanying notes are an integral part of the annual accounts for the year ended 31 December 2024.
2024 Annual Financial Report        13
Fluidra, S.A.
Statement of comprehensive income for the years ended 31 December 2024 and 2023
(Expressed in thousands of euros)
31/12/2024
31/12/2023
Profit/(loss) for the year
144,211
203,292
Income and expense recognised directly in equity
Grants, donations and bequests received
Tax effect
Total income and expense recognised directly in equity
Total recognised income and expense
144,211
203,292
The accompanying notes are an integral part of the annual accounts for the year ended 31 December 2024.
2024 Annual Financial Report        14
Fluidra, S.A.
Statement of changes in equity for the years ended 31 December 2024 and 2023
(Expressed in thousands of euros)
Equity attributable to equity holders of the parent
Share
Legal
Other
Interim
Profit/(loss)
Treasury
Grants,
donations and
Share capital
premium
reserve
reserves
dividend
for the year
shares
bequests
received
Total
Balance at 1 January 2023
192,129
1,148,591
39,126
54,562
129,978
(112,692)
1,048
1,452,742
Net profit/(loss) recognised directly in equity
Profit/(loss) for the year
203,292
203,292
Total recognised income and expense in the year
203,292
203,292
Capital increase
Transactions with own shares or holdings (net)
(70,952)
70,537
(415)
Distribution of dividends
(132,885)
(132,885)
Equity-based payments
(29,522)
(29,522)
Other changes in equity
129,978
(129,978)
Balance at 31 December 2023
192,129
1,148,591
39,126
(48,819)
203,292
(42,155)
1,048
1,493,212
Net profit/(loss) recognised directly in equity
Profit/(loss) for the year
144,211
144,211
Total recognised income and expense in the year
144,211
144,211
Capital increase
Transactions with own shares or holdings (net)
8,603
(8,252)
351
Distribution of dividends
(104,408)
(104,408)
Equity-based payments
4,986
4,986
Other changes in equity
98,884
(98,884)
Balance at 31 December 2024
192,129
1,148,591
39,126
63,654
144,211
(50,407)
1,048
1,538,352
The accompanying notes are an integral part of the annual accounts for the year ended 31 December 2024.
2024 Annual Financial Report        15
Fluidra, S.A.
Statement of cash flows for the years ended 31 December 2024 and 2023
(Expressed in thousands of euros)
Notes
2024
2023
Cash flows from operating activities
Profit /(loss)for the year before tax
137,500
191,252
Adjustments for:
Amortisation and depreciation
4 and 5
4,670
4,113
Impairment allowances
7 and 8
(Profit)/loss on the sale of property, plant and equipment
118
Finance income
(1,695)
(216)
Finance cost
3,472
5,888
Change in provisions
(879)
(2)
Grants recognised in profit and loss
Expenses for share-based payments
2,412
(33,622)
Exchange (gains)/losses
(418)
43
Changes in operating assets and liabilities:
Trade and other receivables
(37,820)
8,030
Trade and other payables
6,061
(344)
Cash flows from/(used in) operating activities
Interest received
1,666
214
Interest paid
(3,068)
(4,043)
Income tax received/(paid)
(1,017)
4,613
Cash flows from/(used in) operating activities
110,884
176,044
Cash flows from/(used in) investing activities
Payments for investments in property, plant and equipment
5
(3,770)
(1,863)
Payments for the acquisition of intangible assets
4 and 13
(6,954)
(2,717)
Payments for investments in financial assets
7 and 8
(50)
(1)
Payments for the transfer of assets
Proceeds from the sale of intangible assets
62
134
Proceeds from the sale of property, plant and equipment
0
8
Proceeds from the sale of investments in financial assets
0
20
Cash flows from/(used in) investing activities
(10,712)
(4,419)
Cash flows from/(used in) financing activities
Acquisition of own equity instruments
(108,868)
(152,044)
Disposal of equity instruments
109,219
151,627
Issue of bank borrowings and other marketable securities
121,300
342,000
Net proceeds/(payments) on debt with Group companies and associates
28,880
(15,722)
Redemption and repayment of bank borrowing and other marketable securities
(146,300)
(364,600)
Dividends paid
(104,408)
(132,885)
Cash flows from/(used in) financing activities
(100,177)
(171,624)
Increase /(decrease) in cash and cash equivalents
Disposal of own equity instruments
(5)
1
Effect of currency translation differences on cash flows
38
37
Cash and cash equivalents at year end
33
38
The accompanying notes are an integral part of the annual accounts for the year ended 31 December 2024.
2024 Annual Financial Report        16
1. Nature, principle activities
and composition of the Group
Fluidra, S.A. (hereinafter the Company) was incorporated as a
limited liability company under Spanish law for an indefinite
period in Girona, Spain, on 3 October 2002 under the name
Aquaria de Inv. Corp., S.L., and changed to its current name on
17 September 2007.
The Company’s corporate purpose and activity consists of the
holding and use of equity shares, securities and other stock, and
advising, managing and administering the companies in which
the Company holds an ownership interest.
The Company’s registered address is located in the municipal
area of Sant Cugat del Vallès (Avda. Alcalde Barnils 69, 08174
Sant Cugat del Vallès, Barcelona, Spain).
The Company is the parent of a group of companies. The
Group’s activity consists of the manufacture and marketing of
specific accessories and machinery for swimming-
pools, irrigation and water treatment and purification. The
Group operates globally with a particular presence in EMEA
(Europe, the Middle East and Africa) and in North America.
Fluidra, S.A. is the parent company of the Group comprising the
subsidiaries detailed in accompanying Appendix I (hereinafter
Fluidra Group or the Group). Additionally, the Group holds
ownership interests in other entities as detailed in Appendix I
also.
Share capital is represented by 192,129,070 ordinary shares
with a par value of €1 each, fully subscribed and paid up.
2024 Annual Financial Report        17
2. Basis of presentation
a) True and fair view
The annual accounts at 31 December 2024 have been prepared
on the basis of the accounting records of the Company and in
accordance with prevailing legislation and the Spanish General
Chart of Accounts, to give a true and fair view of the equity and
financial position at 31 December 2024 and results of
operations, changes in equity, and cash flows for the year then
ended.
The Company's directors expect these 2024 annual accounts to
be approved by shareholders at their general meeting without
significant modification.
The annual accounts are presented in thousands of euros
rounded to the nearest thousand. The euro is the Company's
functional and presentation currency.
b) Comparative information
For comparative purposes, the annual accounts include the
2024 figures in addition to those of the prior year for each item
of the balance sheet, the income statement, the statement of
changes in equity, the statement of cash flows and the notes
thereto, which were part of the 2023 annual accounts, approved
by shareholders at their general meeting on 8 May 2024.
c) Group companies
As mentioned in note 7, the Company has a stake in
subsidiaries. As a result, the Company is the parent of a Group
of companies in accordance with current legislation. In addition
to these individual annual accounts, on 25 March 2025 the
directors authorised for issue the consolidated annual accounts
of Fluidra, S.A. and subsidiaries at December 2024, in
accordance with International Financial Reporting Standards
adopted by the European Union (IFRS-EU), which show profit
attributable to equity holders of the Parent of €138,068
thousand (profit of €113,827 thousand in 2023) and equity of
€1,657,194 thousand (€1,576,569 thousand in 2023). The
consolidated annual accounts will be filed at the Barcelona
Companies Registry.
d) Critical issues regarding the
valuation and estimation of
relevant uncertainties and
judgements used when applying
accounting principles
Relevant accounting estimates and judgements and other
estimates and assumptions have to be made when applying the
Company’s accounting principles to prepare the annual
accounts. A summary of the items requiring a greater degree of
judgement or which are more complex, or where the
assumptions and estimates made are significant to the
preparation of the annual accounts, is as follows:
Significant accounting estimates and key assumptions and
judgements when applying accounting policies
In the Company's 2024 and 2023 annual accounts, estimates
were used by management in order to quantify certain assets,
liabilities, income, expenses and commitments reported
therein. These estimates basically refer to:
Impairment of investments in Group
companies and associates:
An impairment analysis of investments in Group companies and
associates includes an analysis of their recoverable amount,
which is understood to be the higher of the fair value less costs
to sell and the present value of the cash flows expected to be
received. This recoverable amount is calculated using cash flow
projections based on past results and trend expectations for
each of the markets (see note 3 e). The calculation of the
recoverable amount requires the use of estimates by
management. The key assumptions used to determine fair value
less costs to sell and the value in use include the growth rates,
profitability, the discount rate and tax rates. The estimates,
including the methodology used, could have a significant impact
on values and impairment loss. In addition, the capitalisation
value is used as a reference.
The fair value of the commitment to the Company's
management team to acquire an ownership interest in the
Company's share capital (see note 19 a).
Reasons that justify the classification of income from
dividends and impairment losses on non-current assets within
operating results (see note 3 e) vii) and note 16).
Changes in accounting estimates
Although estimates are calculated by the Company's directors
based on the best information available at 31 December 2024
and 2023, future events may require changes to these estimates
in subsequent years. Any effect on the annual accounts of
adjustments made in future reporting periods is recognised
prospectively.
2024 Annual Financial Report        18
3. Significant accounting policies
The accounting principles and measurement criteria contained
in the Spanish General Chart of Accounts have been used to
prepare the annual accounts at 31 December 2024 and 2023.
The most significant principles are summarised as follows:
a) Foreign currency transactions,
balances and cash flows
Foreign currency transactions have been translated into euros
using the exchange rate prevailing at the transaction date.
Monetary assets and liabilities denominated in foreign currency
are translated to euros at the closing exchange rate, while non-
monetary items measured at historical cost are translated at the
exchange rate prevailing at the transaction date.
In the cash flow statement, cash flows from foreign currency
transactions have been translated into euros at the exchange
rates at the dates the cash flows occur.
The effect of exchange rate fluctuations on cash and cash
equivalents denominated in foreign currency is presented under
a separate caption in the statement of cash flows as Effect of
exchange rate fluctuations.
Exchange gains and losses arising on the settlement of foreign
currency transactions and on the translation into euros of
monetary assets and liabilities denominated in foreign
currencies are recognised in profit or loss.
b) Intangible assets
Intangible assets are measured at cost of acquisition or
production. The production cost of inventories includes the
acquisition cost of the asset, other consumables and the costs
directly related to the units produced and a systematically
calculated portion of either the variable or fixed indirect costs
incurred during the transformation process.
Production costs are capitalised in the income statement under
Self-constructed assets. Intangible assets are presented in the
balance sheet at cost, less any accumulated amortisation and
impairment allowances.
Subsequent costs incurred in intangible assets are recorded as
expenses, unless they increase the future economic benefits
expected from the assets.
i) Computer software
Computer software acquired and produced by the Company,
including website development costs, is recognised when it
meets the conditions for consideration as development costs.
Payments made to develop a website for promotional purposes
or to advertise the Company's products or services are
recognised as an expense when incurred.
Computer software maintenance costs are charged as expenses
when incurred.
ii) Research and development
Expenses related to research activities are recognised as an
expense in the income statement when incurred.
The Company capitalises the development costs incurred in
specific and individualised projects that meet the following
conditions:
Payments attributable to the performance of the project can
be measured reliably.
The allocation, assignment and timing of costs for each
project are clearly defined.
There is evidence of the project's technical success, in terms
of direct operation or sale to a third party of the results
thereof once completed and if a market exists.
The economic and commercial feasibility of the project is
reasonably assured.
Financing to develop the project, the availability of adequate
technical and other resources to complete the development
and to use or sell the resulting intangible asset are reasonably
assured.
There is an intention to complete the intangible asset for its
use or sale.
If the Company is unable to distinguish the research stage from
the development stage, the costs incurred are recognised as
research expenses.
Costs recognised in profit or loss in previous years cannot
subsequently be capitalised when they meet these conditions.
Upon registration in the corresponding Public Registry,
development expenses are reclassified to the caption Patents,
licences, trademarks and other similar items.
iii) Useful life and amortisation
The Company assesses the intangible asset's useful life to be
either finite or indefinite. An intangible asset is deemed to have
an indefinite useful life when there is no foreseeable limit to
when it will generate net cash flows.
2024 Annual Financial Report        19
Intangible assets with finite useful lives are amortised by
systematically allocating the amortisable amount over their
useful lives using the following criteria:
Amortisation
method
Estimated years of
useful life
Patents and brands
Straight-line basis
5-10
Computer software
Straight-line basis
4-5
To this end, amortisable amount is understood as acquisition
cost less residual value, if applicable.
The Company deems the residual value of assets to be zero,
unless:
a) There is a commitment from a third part to purchase the
asset at the end of its useful life.
b) There is an active market for the intangible asset and:
i. Residual value can be determined using this market; and
ii. It is likely that this market subsists at the end of the
useful life of the asset.
The Company reviews the residual value, useful life and
amortisation method of intangible assets at the end of each
reporting period. Changes to initially established criteria are
accounted for as a change in accounting estimates.
In accordance with Royal Decree 602/2016 of 2 December,
modifying the General Chart of Accounts, goodwill and
intangible assets with an indefinite useful life will be amortised
over a maximum period of 10 years. No goodwill or intangible
assets with indefinite useful life are included on the Company's
balance sheet.
iv) Impairment
The Company measures and determines valuation allowances
for impairment of intangible assets and any reversals thereof in
accordance with the criteria described in the section on
property, plant and equipment.
c) Property, plant and equipment
i) Initial recognition
Property, plant and equipment are measured at cost of
acquisition or production. The production cost of inventories
includes the acquisition cost of the asset, other consumables
and the costs directly related to the units produced and a
systematically calculated portion of either the variable or fixed
indirect costs incurred during the production process.
Production costs are capitalised in the income statement under
Self-constructed assets. Property, plant and equipment are
presented in the balance sheet at cost, less any accumulated
amortisation and impairment allowances.
ii) Depreciation
Property, plant and equipment items are depreciated by
allocating their depreciable amount on a systematic basis over
their useful lives. To this end, depreciable amount is understood
as acquisition cost less residual value. The Company determines
the depreciation charge separately for each component of an
item of property, plant and equipment with a cost that is
significant in relation to the total cost of the asset and with a
useful life that differs from the remainder of the asset.
Property, plant and equipment are depreciated using the
following criteria:
Depreciation
method
Estimated years
of useful life
Other installations,
equipment and furniture
Straight-line basis
5-12
Other property, plant and
equipment
Straight-line basis
4-8
The Company reviews the residual value, useful life and
depreciation method of property, plant and equipment at the
end of each reporting period. Changes to initially established
criteria are accounted for as a change in accounting estimates.
iii) Subsequent costs
Subsequent to initial recognition of the asset, only the costs
incurred which increase capacity or productivity or which
lengthen the useful life of the asset are capitalised. The carrying
amount of parts that are replaced is derecognised. Costs of
servicing are recognised in profit and loss as incurred.
Replacements of property, plant and equipment which meet the
requirements for capitalisation are recognised together with a
reduction of the carrying amount of the items replaced. In those
cases in which the cost of the replaced items has not been
depreciated separately and it is not practicable to determine the
carrying amount thereof, the cost of the replacement is used as
an indication of the cost of the replaced item at the date it was
acquired or constructed.
Impairment of non-financial assets subject to
amortisation or depreciation
The Company evaluates whether there are indications of
possible impairment losses to verify whether the carrying
amount of these assets exceeds the recoverable amount. The
recoverable amount is the higher of the fair value less costs to
sell and the value in use. Additionally, and regardless of the
existence of any indication of impairment, the Company tests
intangible assets not yet ready to be put to use for potential
impairment at least annually.
The calculation of an asset's value in use reflects an estimate of
the future cash flows expected to derive from the asset,
expectations about possible variations in the amount or timing
of those future cash flows, the time value of money, the price
for bearing uncertainty inherent in the asset and other factors
that market participants would reflect in pricing the future cash
flows expected to derive from the asset. Impairment losses are
recognised in the income statement and are only reversed if
there has been a change in the estimates used to calculate the
asset's recoverable amount.
2024 Annual Financial Report        20
Where the Company has reasonable doubts as to the technical
success or financial and commercial feasibility of in-progress
research and development projects, the amounts in the balance
sheet are recognised directly in losses on the disposal of
intangible assets in the income statement and may not be
reversed.
Recoverable amount is determined for an individual asset,
unless the asset does not generate cash inflows that are largely
independent of those from other assets or groups of assets. If
this is the case, recoverable amount is determined for CGU to
which the asset belongs.
Any reversals of impairment losses are charged to the income
statement. The increased carrying amount of an asset
attributable to a reversal of an impairment loss cannot exceed
the carrying amount that would have been determined (net of
amortisation or depreciation) had no impairment loss been
recognised for the asset. After an impairment loss or reversal of
an impairment loss is recognised, the depreciation
(amortisation) charge for the asset is adjusted in future periods
based on its new carrying amount.
d) Leases
i) Lessee accounting
The Company has the right to use certain assets under lease
agreements.
Leases in which, at the start of the agreement, the Company
assumes substantially all the risks and rewards incidental to
ownership of the leased asset are classified as finance leases; all
other leases are classified as operating leases.
Operating leases
Lease payments under an operating lease, net of incentives
received, are recognized as an expense on a straight-line basis
over the lease term, unless another systematic basis is more
representative of the time pattern of the lease's benefit.
Contingent rents are recognised as an expense when it is
probable that they will be incurred.
e) Financial instruments
i) Classification and separation of financial
instruments
A financial instrument is classified upon initial recognition as a
financial asset, a financial liability or an equity instrument, when
it becomes party to the contract or legal transaction, in
accordance with the terms set out therein, either as issuer or
investor or buyer thereof.
Furthermore, for measurement purposes financial instruments
are classified into financial assets and liabilities at fair value
through profit or loss, loans and receivables, debt and payables,
investments in the equity of Group companies, joint ventures
and associates and financial liabilities. They are classified under
the categories above in accordance with the characteristics of
the instrument and the purpose that influenced their purchase.
Regular purchases and sales of financial assets are recognized
on the trade date; i.e. the date on which the Company commits
to purchase or sell the asset.
ii) Offsetting principles
A financial asset and a financial liability are offset only when the
Company has a legally enforceable right to offset the recognised
amounts and intends either to settle on a net basis, or to realise
the asset and settle the liability simultaneously.
iii) Financial assets and liabilities at fair value
through profit or loss
This heading includes derivative financial instruments that have
not been designated as hedging instruments.
Equity instruments that are not listed on an active market and
whose fair value cannot be reliably measured are not classified
into this category.
Financial assets and liabilities at fair value through profit or loss
are initially recognised at fair value. Transaction costs directly
attributable to the purchase or issue are recognised as an
expense in the income statement as incurred.
After initial recognition, they are recorded at fair value through
profit or loss. Fair value is not reduced by transaction costs
incurred on sale or disposal. Accrual interest and dividends are
recognised separately.
iv) Loans and receivables
Loans and receivables comprise trade and non-trade receivables
with fixed or determinable payments that are not quoted in an
active market other than those classified in other financial asset
categories. Financial assets included in this category are initially
measured at fair value, including transaction costs, and are
subsequently measured at amortised cost using the effective
interest rate method.
v) Investments in the equity of Group
companies, joint ventures and associates
The investments included in this category are initially measured
at cost, which equals the fair value of the consideration paid
plus the directly attributable transaction costs. That is to say,
inherent transaction costs are capitalised.
Group companies are those over which the Company, either
directly, or indirectly through subsidiaries, exercises control as
defined in article 42 of the Spanish Code of Commerce, or when
the companies are controlled by one or more individuals or
entities acting jointly or under the same management through
agreements or statutory clauses.
Control is the power to govern the financial and operating
policies of an entity or business so as to obtain benefits from its
activities. In assessing control, potential voting rights held by the
Company or other entities that are exercisable or convertible at
the end of each reporting period are considered.
Associates are defined as the entities over which the Company
has significant influence, either directly or through other
2024 Annual Financial Report        21
subsidiaries. Significant influence is the power to participate in
the financial and operating policy decisions of a company but no
control or joint control over it is held. The existence of potential
voting rights that are exercisable or convertible at the end of
each reporting period, including potential voting rights held by
the Company or other companies, are considered when
assessing whether an entity has significant influence.
After initial recognition, they are measured at cost less any
accumulated impairment, if applicable.
If an investment no longer meets the conditions for
classification in this category, it is reclassified to available for
sale investments and it is measured as such from the date of
reclassification.
At least at year end, the necessary value adjustments are carried
out provided there is objective evidence that the carrying value
of an investment will not be recoverable. Impairment loss is
measured as the difference between the carrying amount and
the recoverable amount, the latter of which is understood to be
the higher of the fair value less costs to sell and the present
value of estimated future cash flows from the investment (see
section ix).
vi) Interest and dividends
Interest is recognised using the effective interest rate method.
Dividends from investments in equity instruments are
recognised when the Company is entitled to receive them and
they are recorded under revenue given the Company's business
activity. If the dividends are clearly derived from profits
generated prior to the acquisition date because amounts higher
than the profits generated by the investment since acquisition
have been distributed, the carrying amount of the investment is
reduced.
vii) Fair value
Fair value is the amount for which an asset could be exchanged
or a liability settled between knowledgeable, willing buyers and
sellers on an arm's length basis. The Company generally applies
the following systematic hierarchy to determine the fair value of
financial assets and financial liabilities:
Firstly, the Company applies the quoted prices of the most
advantageous active market to which it has immediate access,
adjusted where necessary to reflect any difference in credit
risk between the instruments commonly traded and the
instrument being measured. For this purpose, the bid price is
used for assets purchased or liabilities to be issued and the
offer price for assets to be purchased or liabilities issued. If
the Company has assets and liabilities that offset market risks
against each other, average market prices are used for the
offset risk positions, applying the appropriate price to the net
position.
If there are no market prices available, the prices of recent
transactions are used, adjusted for conditions.
Otherwise, the Company applies generally accepted valuation
techniques using, insofar as is possible, market data and, to a
lesser extent, specific Company data.
viii) Amortised cost
The amortised cost of a financial asset or liability is the amount
for which it was initially measured less repayment of the
principal, plus or less the gradual accumulated allocation or
repayment, using the effective interest rate method, of any
difference existing between the initial value and the repayment
value at maturity, less any decrease due to impairment loss or
default.
Additionally, the effective interest rate is the rate that exactly
discounts estimated future cash payments or receipts through
the expected life of the financial instrument, or shorter where
appropriate, to the carrying amount of the financial asset or
liability. For financial instruments in which the variable to which
commissions, basis points, transactions costs, discounts and
premiums are related is reviewed at market rates before
expected maturity, the amortisation period is that until the next
review of conditions.
Cash flows are estimated considering all contractual conditions of
the financial instrument, excluding future credit losses. The
calculation includes the commissions and basis points of interest
paid or received by the parties to the contract, as well as the
transaction costs and any other premium or discount. In the event
that the Company cannot reliably estimate cash flows or the
expected life of a financial instrument, contractual cash flows over
the whole contractual period are used.
ix) Impairment of financial assets
A financial asset or a group of financial assets is impaired and
impairment losses are incurred only if there is objective
evidence of impairment as a result of one or more events that
occurred after initial recognition of the asset and that event (or
events) has an impact on the estimated future cash flows of the
financial asset or group of financial assets that can be reliably
estimated.
Impairment of financial assets measured at
amortized cost
At least at year end, the Company analyses whether there is
objective evidence of impairment of a financial asset or a group
of financial assets with similar risk characteristics assessed
collectively, as a result of one or more events occurring after
their initial recognition causing a reduction or delay in estimated
future cash flows, which may be due to debtor insolvency.
Should this evidence exist, the impairment loss is calculated as
the difference between the carrying value and the current value
of the future cash flows, including, if applicable, cash flows from
collateral and personal guarantees expected to be generated,
discounted at the effective interest rate calculated upon initial
recognition. For variable rate financial assets, the effective
interest rate corresponding to the closing date of the annual
accounts under the contractual conditions is used. The
2024 Annual Financial Report        22
Company uses formula-based approaches or statistical methods
to determine impairment losses in a group of financial assets.
Impairment adjustments, and the reversal thereof when the
amount of the loss decreases due to causes relating to a
subsequent event, are recognised as expenses or income,
respectively, in the income statement. Impairment reversal is
limited to the carrying amount at which the asset would be
recognised at the reversal date had the impairment not been
recorded.
In substitution of the present value of the future cash flows, the
Company uses the market value of the instrument, provided it is
reliable enough to be deemed representative of the value the
Company may recover.
Investments in Group companies, associates and
joint ventures and equity instruments carried at
cost
Impairment is calculated by comparing the carrying amount of
the investment with its recoverable amount. The recoverable
amount is the higher of value in use and fair value less costs to
sell.
Value in use is calculated based on the Company’s share of the
present value of future cash flows expected to be derived from
ordinary activities and from the disposal of the asset, or the
estimated cash flows expected to be received from the
distribution of dividends and the final disposal of the
investment.
Nonetheless, and in certain cases, unless better evidence of the
recoverable amount of the investment is available, when
estimating impairment of these types of assets, the investee’s
equity is taken into consideration, adjusted, where appropriate,
to generally accepted accounting principles and standards in
Spain, corrected for any net unrealised gains existing at the
measurement date.
In subsequent years, reversals of impairment losses in the form
of increases in the recoverable amount are recognised, up to
the limit of the carrying amount that would have been
determined for the investment if no impairment loss had been
recognised.
The recognition or reversal of an impairment loss is recorded in
the income statement.
Impairment of an investment is limited to the amount of the
investment, except when contractual, legal or constructive
obligations have been assumed by the Company or payments
have been made on behalf of the companies. In this last
circumstance, a provision is recognised.
x) Financial liabilities at amortised cost
The financial liabilities included in this category are initially
measured at fair value, which, unless evidence exists to the
contrary, is considered to be the transaction price, which is
equivalent to the fair value of the consideration received, less
the transaction costs directly attributable thereto. That is to say,
inherent transaction costs are capitalised.
For subsequent measurement, the amortised cost method is
used. Interest accrued are expensed in the income statement
(finance cost), using the effective interest method.
The Company derecognises all or part of a financial liability
when it either discharges the liability by paying the creditor, or is
legally released from primary responsibility for the liability
either by process of law or by the creditor.
f) Cash and cash equivalents
Cash and cash equivalents includes cash on hand and demand
deposits at banks. This caption also includes other short-term
highly-liquid investments readily convertible into specific
amounts of cash that do not mature beyond three months.
The Company recognises cash payments and receipts for
financial assets and financial liabilities in which turnover is quick
on a net basis in the statement of cash flows. Turnover is
considered to be quick when the period between the date of
acquisition and maturity does not exceed six months.
The Company classifies cash flows corresponding to interest
earned and interest paid as an operating activity. Dividends
received from subsidiaries are classified as operating activities
and dividends paid by the Company, as financing activities.
g) Grants, donations and bequests
Grants, donations and bequests are recorded in recognised
income and expense when, where applicable, they have been
officially awarded, the conditions attached to them have been
met or there is reasonable assurance that they will be received.
Financial liabilities comprising implicit assistance in the form of
below-market interest rates are initially recognised at fair value.
The difference between this value, adjusted where necessary for
the issue costs of the financial liability and the amount received,
is recognised as a government grant based on the nature of the
grant awarded.
h) Own equity instruments held by
the Company
The acquisition by the Company of equity instruments is
presented separately at acquisition cost as a decrease in
shareholders' equity in the balance sheet. In the transactions
entered into with own equity instruments no profit or loss is
recognised in the income statement.
Transaction costs related to own equity instruments, including
issue costs related to a business combination, are recorded as a
decrease in reserves, net of any tax effect.
Dividends related to equity instruments are recorded as a
reduction in equity when they are approved by the shareholders
in general meeting.
2024 Annual Financial Report        23
i) Classification of current and
non-current assets and liabilities
The Company classifies assets and liabilities in the balance sheet
as current and non-current. For these purposes, assets and
liabilities are classified as current in accordance with the
following criteria:
Assets are classified as current when they are expected to be
realised or are intended for sale or consumption in the
Company's normal operating cycle, they are held primarily for
trading, they are expected to be realized within twelve months
from the reporting date, or are cash or cash equivalents,
unless they are restricted from being exchanged or used to
settle a liability for at least twelve months after the reporting
date.
Liabilities are classified as current when they are expected to
be settled in the Company's normal operating cycle, they are
held primarily for the purpose of trading, they are due to be
settled within twelve months after the reporting period, or the
Company does not have an unconditional right to defer
settlement of the liability for at least twelve months after the
reporting period.
Financial liabilities are classified as current liabilities when
they are due to be settled within twelve months after the
reporting date, even if the original term was for a period
longer than twelve months, and an agreement to refinance, or
to reschedule payments, on a long-term basis is completed
after the reporting period and before the financial statements
are authorised for issue.
Deferred tax assets and deferred tax liabilities are recognised
in the balance sheet as non-current assets and non-current
liabilities, irrespective of the expected date of recovery or
settlement.
j) Termination benefits
Unless otherwise justified, the Company is obliged to
compensate its employees when it terminates their services.
Termination benefits are recognised as a liability when the
Company has a detailed formal plan for the termination and
there is a valid expectation among the affected employees that
termination will arise either because the plan has already
started to be implemented or because its main characteristics
have been published.
Termination benefits for voluntary redundancy are recognised
when the scheme is announced and there is no realistic
likelihood of the offer being withdrawn. These payments are
measured based on the best estimate of the group of
employees to be included in the plan.
k) Obligations with employees
In accordance with the agreements signed with executives, in
the event of permanent invalidity, a percentage of the previously
earned remuneration is paid yearly until death. At 31 the
December 2024 and 2023, there is no liability under this
heading, as the obligation has been outsourced.
l) Share-based payment
transactions
The Company recognises a personnel expense for all employee
services received in share-based payment transactions upon
receipt of said services, and the corresponding increase in
equity if the transaction is settled with equity instruments or the
corresponding liability if the transaction is paid with an amount
based on the value of equity instruments.
The Company recognises equity-settled share-based payments,
including non-monetary contributions to capital increases and
the corresponding increase in equity, at the fair value of the
goods or services received, unless fair value cannot be
estimated reliably, in which case value is determined by
reference to the fair value of the equity instruments granted.
The delivery of equity instruments as consideration for the
services performed by the employees of the Company or third
parties providing similar services are measured by reference to
the fair value of the equity instruments granted.
Employee benefits paid in the form of equity instruments are
recognised by applying the following criteria:
If the equity instruments granted vest immediately on the
grant date, the services received are recognised with a charge
to the income statement, with a corresponding increase under
Other equity instruments;
If the equity instruments granted vest when the employees
complete a specified service period, those services are
accounted for during the vesting period, with a credit to Other
equity instruments.
The Company measures the fair value of the instruments
granted to employees at the grant date.
Market-related vesting conditions are taken into account when
calculating the fair value of the equity instruments granted.
Vesting conditions, other than market conditions, are taken into
account by adjusting the number of equity instruments included
in the measurement of the transaction amount so that,
ultimately, the amount recognised for services received is based
on the number of equity instruments that eventually vest.
Consequently, the Company recognises an amount for the
services received during the vesting period based on the best
available estimate of the number of equity instruments
expected to vest, revising this estimate if the number of equity
instruments expected to vest differs from previous estimates.
2024 Annual Financial Report        24
Once the services received and the corresponding increase in
equity have been recognised in Other equity instruments, no
additional adjustments to equity are made after the vesting
date, without prejudice to making the corresponding
reclassifications in equity.
m)   Provisions
Provisions are recognised when the Company has a present
obligation (legal, contractual, constructive or tacit) as a result of
a past event; it is probable that an outflow of resources
embodying economic benefits will be required to settle the
obligation; and a reliable estimate can be made of the amount
of the obligation.
The amount recognised as a provision in the balance sheet is the
best estimate of the expenditure required to settle the present
obligation at the end of the reporting period, taking into account all
risks and uncertainties surrounding the amount to be recognised as
a provision and, where the time value of money is material, the
financial effect of discounting provided that the expenditure to be
made each period can be reliably estimated. The discount rate is a
pre-tax rate that reflects the time value of money and the specific
risks for which future cash flows associated with the provision have
not been adjusted at each reporting date.
Single obligations are measured using the individual most likely
outcome. If the obligation involves a large population of
homogeneous items, it is measured by weighting the possible
outcomes by probability. If there is a continuous range of
possible outcomes and each point on the range has the same
probability as the others, the obligation is measured at the
average amount.
Where the Company has subcontracted the hedged risk to a
third party through a legal or contractual agreement, the
provision is recognised only for the portion of the risk assumed.
If it is no longer probable that an outflow of resources will be
required to settle an obligation, the provision is reversed.
n) Revenue from the rendering of
services
Revenue from the rendering of services is recognised at the fair
value of the consideration received or receivable. Volume
rebates, prompt payment and any other discounts, as well as
the interest added to the nominal amount of the consideration
are recognised as a reduction in the consideration.
However, the Company includes interest on trade receivables
maturing in less than a year that do not specify a contractual
interest rate when the result of upgrading the cash flows is
insignificant.
Discounts given to customers are recognised as a reduction in
sales revenue when it is probable that the discount conditions
will be met.
Revenues associated with the rendering of services are
recognised in the income statement by reference to the stage of
completion at the reporting date when revenues, the stage of
completion, the costs incurred and the costs to complete the
transaction can be estimated reliably and it is probable that the
economic benefits derived from the transaction will flow to the
Company.
The company recognises revenue on ordinary activities when
control of the goods or services committed to customers is
transferred.
The company accounts for this revenue using the following
successive stages:
1. Identify the contract with the customer.
2. Identify the performance obligations.
3. Determine the transaction price or contract
consideration.
4. Allocate the transaction price to the performance
obligations.
5. Recognise the revenue on ordinary activities when the
company meets each performance obligation.
Generally speaking, the Company has concluded that there is
ordinarily a single performance obligation allocated to the
transaction price and therefore no impacts from regulatory
adoption are identified.
o) Income tax
Tax expense (income) comprises current tax and deferred tax.
Current tax assets or liabilities are measured at the amount
expected to be paid to or recovered from the tax authorities,
using the tax rates and tax laws that have been enacted or
substantially enacted at the reporting date.
Current and deferred income tax is recognised in profit or loss,
except to the extent that the tax arises from a transaction or
event which is recognised, in the same or a different period,
outside profit or loss, directly in equity or a business
combination.
Deductions and other income tax relief granted by public
administrations as a decrease in the amount payable for this tax
are recognised as a decrease in the corporate income tax
expense in the year in which they are accrued.
The Company and other Group companies are taxed under the
consolidated tax regime. Fluidra, S.A. is the parent of this
consolidated tax group and is responsible for making the
relevant payments to the tax authorities (see note 21).
In addition to the factors to be considered for individual taxation
set out previously, the following factors are taken into account
when determining the accrued income tax expense for the
companies forming the consolidated tax group:
Temporary and permanent differences arising from the
elimination of profits and losses on transactions between
2024 Annual Financial Report        25
Group companies, derived from the process of determining
consolidated taxable income.
Deductions and credits corresponding to each company
forming the consolidated tax group. For these purposes,
deductions and credits are allocated to the company that
carried out the activity or obtained the profit necessary to
obtain the right to the deduction or tax credit.
Temporary differences arising from the elimination of profits
and losses on transactions between tax group companies are
allocated to the company which recognised the profit/loss and
are valued using the tax rate of that company.
A reciprocal credit and debit arises between the companies that
contribute tax losses to the consolidated Group and the rest of
the companies that offset those losses. If there is a tax loss that
cannot be offset by the other companies in the consolidated
Group, these tax loss carryforwards are recognised as deferred
tax assets, in accordance with the criteria established for their
recognition, considering the tax group as the taxpayer.
The Parent of the group records the total consolidated income
tax payable (recoverable) with a debit (credit) to receivables
(payables) from/to Group companies and associates.
The debt relating to the subsidiaries is recognised with a credit
(debit) to payables (receivables) to/from Group companies.
Recognition of taxable temporary differences
Deferred tax liabilities deriving from taxable temporary
differences are recognised in all cases except where they arise
from the initial recognition of goodwill or an asset or liability in a
transaction that is not a business combination and, at the time
of the transaction, affects neither accounting profit nor taxable
income.
Recognition of deductible temporary
differences
Deferred tax assets arising on deductible temporary differences
are recognised provided that it is probable that sufficient
taxable income will be available against which the deductible
temporary differences can be utilised. Assets that arise from the
initial recognition of an asset or liability in a transaction that is
not a business combination and, at the time of the transaction,
affects neither accounting profit nor taxable income are not
recognised.
Tax planning opportunities are only considered for the purpose
of assessing the recoverability of deferred tax assets if the
Company intends to use them or it is probable that it will use
them.
Measurement
Deferred tax assets and liabilities are measured at the tax rates
that are expected to apply in the periods in which the asset is
realised or the liability is settled, based on tax rates (and tax
laws) that have been enacted or substantively enacted by the
end of the reporting period and factoring in the tax
consequences that would follow from the manner in which the
Company expects to recover its assets.
p) Transactions between Group
companies
Transactions between Group companies are recognised at the
fair value of the consideration given or received. The difference
between this value and the amount agreed, if applicable, is
recognised in line with the underlying economic substance of
the transaction.
2024 Annual Financial Report        26
4. Intangible assets
Details of the investment property accounts and movement
during 2024 and 2023 are as follows:
Thousands of euros
Balances at
31.12.23
Additions
Disposals
Transfers
Impairment
Balances at
31.12.24
Cost
Patents, licences, trademarks and other
similar rights
1,059
8
1,067
Computer software
41,710
4,921
(214)
46,417
Under construction
2,200
2,200
42,769
7,129
(214)
49,684
Accumulated amortisation
Patents, licences, trademarks and other
similar rights
(939)
(196)
151
(984)
Computer software
(32,687)
(3,429)
(36,116)
(33,626)
(3,625)
151
(37,100)
Carrying amount
9,143
3,504
(63)
12,584
Thousands of euros
Balances at
31.12.22
Additions
Disposals
Transfers
Impairment
Balances at
31.12.23
Cost
Patents, licences, trademarks and other
similar rights
1,059
1,059
Computer software
39,131
2,717
(256)
118
41,710
Under construction
118
(118)
40,308
2,717
(256)
42,769
Accumulated amortisation
Patents, licences, trademarks and other
similar rights
(916)
(23)
(939)
Computer software
(29,563)
(3,128)
4
(32,687)
(30,479)
(3,151)
4
(33,626)
Carrying amount
9,829
(434)
(252)
9,143
a) Computer software
Capitalised expenses relate to the cost of software licences
acquired, external expenses relating to development of the
corporate ERP and personnel expenses for company staff
involved in the development, which are capitalised under Self-
constructed assets. In 2024, €942 thousand of computer
software was capitalised (€466 thousand in 2023). The most
notable additions in the year relate to the project to centralise
the group’s servers, totalling €2,120 thousand and the project to
integrate supply chain processes in a single space, which
amounts to €718 thousand.
b) Fully amortised assets
The cost of fully amortised intangible assets still in use at 31
December is as follows:
Thousands of euros
2024
2023
Patents, licences, trademarks and
other similar rights
384
359
Computer software
27,288
25,479
27,672
25,838
2024 Annual Financial Report        27
5. Property, plant and equipment
Details of property, plant and equipment and movement during
2024 and 2023 are as follows:
Thousands of euros
Balances at
31.12.23
Additions
Disposals
Transfers
Balances at
31.12.24
Cost
Other installations, equipment and furniture
4,853
2,622
2,281
9,756
Other PPE
3,618
782
(1,124)
130
3,406
Under construction
2,435
366
(2,411)
390
10,906
3,770
(1,124)
13,552
Accumulated depreciation
Other installations, equipment and furniture
(1,233)
(572)
(1,805)
Other PPE
(2,512)
(648)
1,124
(2,036)
(3,745)
(1,220)
1,124
(3,841)
Carrying amount
7,161
2,550
9,711
Thousands of euros
Balances at
31.12.22
Additions
Disposals
Transfers
Balances at
31.12.23
Cost
Other installations, equipment and furniture
4,761
92
4,853
Other PPE
3,226
406
(14)
3,618
Under construction
1,070
1,365
2,435
9,057
1,863
(14)
10,906
Other installations, tools and furniture
(830)
(403)
(1,233)
Other PPE
(1,959)
(559)
6
(2,512)
(2,789)
(962)
6
(3,745)
Carrying amount
6,268
901
(8)
7,161
a)Fully depreciated assets
The cost of fully depreciated property, plant and equipment
items still in use at 31 December 2024 and 2023 is as follows:
Thousands of euros
2024
2023
Other installations, equipment and
furniture
118
112
Other property, plant and
equipment
1,068
1,504
1,186
1,616
b) Insurance
The Company has taken out several insurance policies to cover
the risks to which its property, plant and equipment items are
exposed. The coverage of these policies is considered sufficient.
2024 Annual Financial Report        28
6. Operating leases
- lessee
The Company has leased from third parties several floors in
office buildings and parking spaces, as well as several vehicles
and other assets under operating leases.
The most significant lease contracts are as follows:
Office building in calle Alcalde Barnils, 69 in Sant Cugat del
Vallés, floors 1, 2, 3 and 4, where the Fluidra Group’s
headquarters are located. This agreement came into force on
1 January 2021 for a renewable 5-year term (plus a 5-year
extension) with a 5-month grace period.
On 31 July 2024, the previous agreement was extended to
include the 1st floor at number 71 in Sant Cugat del Vallés.
Offices located in carretera Sentmenat, 46 – 48, warehouse 6
in Polinyà. This agreement entered into force on 1 May 2022
for an automatically renewable 1-year term.
A storage unit in Polinyà (Barcelona) also, located at calle
Santiago Russinyol 14. This agreement came into force on 1
November 2021 and has a 5-year term.
Operating lease payments recognised as an expense for the
year are as follows:
Thousands of euros
2024
2023
Leased offices and parking spaces
498
489
Leased vehicles
444
360
Other assets under lease
230
252
1,172
1,101
The future minimum lease payments under non-cancellable
operating leases are as follows:
Thousands of euros
2024
2023
Under one year
1,819
1,325
From one to five years
4,032
3,409
Over five years
725
1,330
6,576
6,064
2024 Annual Financial Report        29
7. Equity instruments and loans
to Group companies
a) Equity instruments of Group
companies
Movement in the equity instruments of Group companies
heading in 2024 and 2023 is as follows:
Thousands of euros
Balances at
Balances at
31.12.23
Additions
Disposals
Transfers
31.12.24
Equity instruments
1,453,004
2,574
1,455,578
Carrying amount
1,453,004
2,574
1,455,578
Thousands of euros
Balances at
Balances at
31.12.22
Additions
Disposals
Transfers
31.12.23
Equity instruments
1,448,904
4,100
1,453,004
Carrying amount
1,448,904
4,100
1,453,004
The company’s investment relates to its sole subsidiary, Fluidra
Commercial, S.A.U. (formerly Fluidra Finco, S.L.U.),
Information relating to remaining interests in Group companies
and associates is presented in Appendix I.
In 2024, the Company made the following changes in interests in
Group companies:
The Company increased its interest in the subsidiary Fluidra
Commercial, S.A.U. (formerly Fluidra Finco, S.L.U.) as a result
of the long-term variable remuneration plan aimed at Fluidra,
S.A.'s executive directors and management team and the
subsidiaries that make up the consolidated group, with share-
based equity instruments for a total amount of €2,574
thousand.
In 2023, the Company made the following changes in interests in
Group companies:
The Company increased its interest in the subsidiary, Fluidra
Commercial, S.A.U. (formerly Fluidra Finco, S.L.U.), as a result
of the long-term remuneration plan aimed at Fluidra, S.A.’s
executive directors and management team and the
subsidiaries that make up the consolidated group, with share-
based equity instruments for a total amount of €4,100
thousand.
None of the Group companies in which the Company has
holdings are listed on the stock exchange.
In accordance with article 13.1 of the rewritten text of the
Spanish Companies Act, Group companies that are single
shareholder companies are entered as such on the Companies
Register.
The recoverable amount of the groups and companies in which
the Company has interests is determined on the basis of the
higher of fair value less costs of disposal and value in continuing
use. These calculations use cash flow projections based on
finance budgets and/or strategic plans, approved by
management, for the cash-generating units to which goodwill
has been allocated and cover a period of five years. These
projections are adjusted based on the degree of compliance
with the strategic plans and/or financial budgets in prior years.
The estimated long-term growth rate is between 1.92% and
2.99% (between 1.91% and 3.03% in 2023) and does not exceed
the medium to long-term growth rate for the markets in which
the CGUs operate. The discount rates after taxes used range
between 8.21% and 12.94% (between 8.18% and 12.90% in
2023). However, this recoverable value is analysed from an
individual perspective for each of the directly and indirectly held
subsidiaries of the Company, based on the forecast evolution of
each subsidiary in line with the average projections and discount
rates used for the CGUs, taking into account their borrowings.
The Group’s market capitalisation at 31 December 2024
amounts to €4,519 million (€3,622 million at 31 December 2023).
The Company has not recorded any valuation adjustments in
2024 or 2023.
2024 Annual Financial Report        30
b) Loans to Group companies
Non-current
At 31 December 2024 and 2023, no loans have been granted to
Group companies, except a security deposit for €10 thousand.
Current
Details of current investments in Group companies and
associates at 31 December 2024 and 2023 are as follows:
Thousands of euros
2024
2023
Receivables from Group companies
under the consolidated tax regime
5,112
14,169
Cash-pooling receivables (Fluidra
Commercial, S.A.U)
39,065
57,590
Interest on cash-pooling receivables
(Fluidra Commercial, S.A.U)
36
Receivables from Group companies
for current loans
113
44,213
71,872
The company and other Group companies are taxed under the
consolidated tax regime. Fluidra, S.A. is the parent of this
consolidated tax group and responsible for making the relevant
payments to the tax authorities (see note 21).
Balances receivable under this heading from several Group
companies subject to the consolidated tax regime are recorded
under Receivables from Group companies under the
consolidated tax regime (see note 13).
Cash-pooling debts reflect the company's debtor and creditor
balances in the Group's centralised cash pooling accounts, the
head of which is Fluidra Commercial, S.A.U. (formerly Fluidra
Finco, S.L.U).
2024 Annual Financial Report        31
8. Non-current investments
Details of non-current investments and movement in 2024 and
2023 are as follows:
Thousands of euros
Balances at
Additions
Disposals
Transfers
Balances at
31.12.23
31.12.24
Other financial assets
164
50
214
Carrying amount
164
50
214
Thousands of euros
Balances at
Additions
Disposals
Transfers
Balances at
31.12.22
31.12.23
Other financial assets
1,301
(1,137)
164
Carrying amount
1,301
(1,137)
164
Other non-current financial assets and loans to Group
companies, current investments in Group companies (see note
7) and trade and other receivables (see note 9) are classified
under loans and receivables. There are no significant differences
between the fair values and the carrying amounts of these
categories.
Other financial assets essentially includes non-current security
deposits.
2024 Annual Financial Report        32
9. Trade and other
receivables
Details of trade and other receivables are as follows:
Thousands of euros
2024
2023
Receivables, Group companies
40,597
7,214
Other receivables
198
114
Provisions for uncollectibility
(829)
(736)
Current income tax assets (see note 21)
24,661
Public entities
5,359
867
69,986
7,459
In 2024, the overdue receivable from Fluidra Maroc, S.A.R.L., for
an amount of €94 thousand, was impaired due to the
impossibility of collection as a result of exchange controls in that
country.
In 2023, the overdue receivable was impaired for €29 thousand,
due to the impossibility of collection.
2024 Annual Financial Report        33
10. Equity
Share capital
At 31 December 2024, Fluidra, S.A.'s share capital consists of
192,129,070 ordinary shares with a par value of €1 each, fully
subscribed.
The shares are represented by book entries and are established
as such by being recorded in the corresponding accounting
record. The shares bear the same political and financial rights.
The Company only knows the identity of its shareholders
through the information that they provide voluntarily or in
compliance with applicable regulations. In accordance with the
Company's information, the structure of significant ownership
interests at 31 December 2024 and 2023 is as follows:
Ownership percentage
31.12.24
31.12.23
Rhône Capital L.L.C.
11.67%
11.67%
Boyser, S.R.L.
7.80%
7.80%
Schwarzsee 2018, S.L.
7.41%
7.00%
Dispur, S.L.
7.33%
7.33%
Edrem, S.L.
6.93%
6.93%
Aniol, S.L.
6.23%
6.23%
G3T, S.L.
5.73%
5.73%
Capital Research and Management
Company
5.31%
5.31%
Other shareholders
41.59%
42.00%
100.00%
100.00%
Share premium
This reserve can be freely distributed, except for the situations
stipulated in section c).
Reserves
The breakdown of this heading is as follows:
Thousands of euros
Balances at
Balances at
31.12.24
31.12.23
Legal reserve
39,125
39,125
Amortised capital reserve
3,500
3,500
Voluntary reserve
60,155
Negative reserves
(52,318)
102,780
(9,693)
a) Legal reserve
Pursuant to article 274 of the Spanish Companies Act, 10% of
profit for each year must be transferred to the legal reserve
until the balance of this reserve reaches at least 20% of the
share capital.
This reserve can be used to increase capital by the amount
exceeding 10% of the new capital after the increase. Otherwise,
until it exceeds 20% of share capital and provided there are no
sufficient available reserves, the legal reserve may only be used
to offset losses.
At 31 December 2024 and 2023, the legal reserve is fully funded.
b) Amortised capital reserve
As a result of the aforementioned capital reduction in 2022, a
restricted reserve for amortised capital has been allocated for
an amount equal to the nominal amount of amortised shares,
i.e. €3,500 thousand.
c) Negative reserves
The share premium and profit/(loss) for the year are freely
available, but are subject to the legal limitations on their
distribution contained in article 273 of the consolidated text of
the Spanish Companies Act of Royal Decree 1/2010 of 2 July.
Dividends
According to the minutes of the Company’s ordinary general
shareholders’ meeting held on 8 May 2024, agreement was
made to pay a cash dividend charged to freely available
voluntary reserves of €0.55 gross per eligible Company share,
resulting in a total dividend of €104,412,175 if the distribution
were to be made on all of the Company's ordinary shares. This
dividend was paid out in two payments on 3 July 2024 and 3
December 2024.
According to the minutes of the Company’s ordinary general
shareholders’ meeting held on 10 May 2023, agreement was
made to pay a cash dividend charged to freely available
voluntary reserves of €0,70  gross per eligible Company share,
resulting in a maximum total dividend of €132,893,869  if the
distribution were to be made on all of the Company's ordinary
shares. Effective payment of this dividend took place on 5 July
2023 and 3 December 2023.
2024 Annual Financial Report        34
Treasury shares
Movement in treasury shares in 2024 and 2023 is as follows:
Euros
Average
acquisition/
disposal price
Number
Face value
Balances at 1.1.23
5,792,658
5,792,658
19.4544
Acquisitions
8,826,554
8,826,554
17.2257
Disposals
(12,310,447)
(12,310,447)
(17.7380)
Balances at 31.12.23
2,308,765
2,308,765
18.2587
Acquisitions
5,007,687
5,007,687
21.7402
Disposals
(5,030,840)
(5,030,840)
(21.7098)
Balances at 31.12.24
2,285,612
2,285,612
22.0541
The time and maximum percentage limits of treasury shares
meet the statutory limits.
No Group company owns shares in the Parent.
Proposed distribution
of results
The allocation of the Company's results for the year ended 31
December 2023, approved by shareholders at their general
meeting on 8 May 2024, and the proposed distribution of the
Company's 2024 results are as follows:
Euros
2024
2023
Basis of allocation:
Profit/(loss) for the year
144,210,876.80
203,291,821.12
Distribution:
To legal reserves
To voluntary reserves
30,304,801.80
46,572,748.20
To negative reserves
52,317,905.17
Interim dividend
To prior years' losses
Dividends
113,906,075.00
104,401,167.75
Total
144,210,876.80
203,291,821.12
The board of directors of Fluidra, S.A. shall propose a dividend
of €0.60 per share to the general shareholders’ meeting,
charged to profit/(loss).
2024 Annual Financial Report        35
11. Provisions
A breakdown of other provisions is as follows:
Thousands of euros
2024
2023
Provisions for taxes
14,159
13,185
Provisions for obligations with
employees
737
604
Litigation and other liabilities
5
5
Total
14,901
13,794
Non-current provisions are broken down into three headings:
Provisions for taxes to cover potential risks related to tax
obligations; Provisions for obligations to employees recorded in
accordance with employment legislation to cover potential
future employee compensation and benefits; and Provisions for
litigation and other liabilities, which includes provisions
recorded in connection with contingencies arisen as a result of
the Company's activities.
Movement during 2024 and 2023 is as follows:
Thousands of euros
Provision for
employee
obligations
Litigation
and other
liabilities
Provision for
taxes
Total
At 1 January 2023
772
5
13,185
13,962
Allocation
Amount utilised
(168)
(168)
At 31 December 2023
604
5
13,185
13,794
Allocation
133
1,256
1,389
Amount utilised
(282)
(282)
At 31 December 2024
737
5
14,159
14,901
2024 Annual Financial Report        36
12. Other marketable
securities
In order to reduce finance costs and diversify sources of
financing, Fluidra, S.A. set into action a promissory notes
scheme on the Alternative Fixed Income Market (MARF). On 28
June 2024, the scheme was renewed for a further year for €200
million, with no amount outstanding at 31 December 2024
(€24.7 million at 31 December 2023, with an interest rate linked
to existing issues of between 2.80% and 4.80%).
2024 Annual Financial Report        37
13. Debt with Group companies
and associates
The breakdown of this heading is as follows:
Thousands of euros
Balances at
Balances at
31.12.24
31.12.23
Debt with Group companies
2,391
5,334
Payables to Group companies under
the consolidated income tax regime
24,635
4,351
27,026
9,685
The Company and other Group companies are taxed under the
consolidated tax regime. Fluidra, S.A. is the parent of this
consolidated tax group and is responsible for making the
relevant payments to the tax authorities.
Balances payable under this heading from Group companies
subject to the consolidated tax regime are recorded under
Payables to Group companies under the consolidated tax
regime (see note 21).
2024 Annual Financial Report        38
14. Trade and other
payables
A breakdown of this caption in the consolidated statement of
financial position is as follows:
Thousands of euros
2024
2023
Payables
23,973
17,315
Public entities
5,192
7,468
Salaries payable
6,709
6,434
Current income tax liabilities
791
510
36,665
31,727
2024 Annual Financial Report        39
15. Risk management policy
The Company's activities are exposed to various financial risks:
market risk (currency risk, fair value interest rate risk and price
risk), credit risk, liquidity risk, and cash flow interest rate risk.
The Company focuses its risk management on uncertainty in the
financial markets and aims to minimise potential adverse effects
on the Company's profits. The Company uses derivatives to
mitigate certain risks.
Market, liquidity, foreign exchange and interest rate risk
management is monitored by the Group's Central Finance
Department in accordance with the policies defined by the
Group. This department identifies, evaluates, and covers
financial risks in close collaboration with the Group's operating
units.
Credit risk is managed centrally by the Company in accordance
with the parameters set out in Group policies.
a) Credit risk
Credit risk exists when a potential loss may arise from Fluidra,
S.A.'s counterparties not meeting their contractual obligations,
that is, due to not collecting the financial assets according to the
established amounts and time frame.
The accompanying table shows the ageing analysis of Trade and
other receivables which are past due but not impaired at 31
December 2024 and 2023, as they are mainly debts with Group
companies.
2024
2023
Not due
39,426
6,343
Past due
540
249
0 - 90 days
385
87
90 - 120 days
24
48
More than 120 days
131
114
b) Liquidity risk
Liquidity risk is the possibility that Fluidra, S.A. will not have
sufficient funds or access to sufficient funds at an acceptable
cost to meet its payment obligations at all times.
The Company applies a prudent policy to cover its liquidity risks
based on having sufficient cash and marketable securities, as
well as sufficient financing through credit facilities, to settle
market positions. Due to the dynamic nature of the underlying
businesses, the Group's finance department aims to maintain
sufficient headroom on its undrawn committed borrowing
facilities.
During the next few months, and based on its cash flow
forecasts, the Company does not expect any difficulties in terms
of liquidity.
c) Foreign currency risk
The Company is not significantly exposed to foreign currency
risk.
d) Cash flow interest rate risk
The income and cash flows from operating activities are not
significantly affected by fluctuations in market interest rates.
There are no significant cash flow interest rate risks.
The Company manages cash flow interest rates in coordination
with the Group.
e) Market risk
The Company is not exposed to significant market risk.
2024 Annual Financial Report        40
16. Income and expense
a) Revenue
Revenue in 2024 and 2023 relates to services rendered to Group
companies and dividends (see note 18).
b) Personnel expense
Details of the personnel expense in 2024 and 2023 are as
follows:
Thousands of euros
31.12.24
31.12.23
Salaries, wages and indemnities
37,739
34,734
Social Security payable by the
company
8,235
7,001
Payments to personnel in equity
instruments
2,666
4,043
Other employee benefits expense
895
733
49,535
46,511
2024 Annual Financial Report        41
17. Employee information
The average headcount in 2024 and 2023 of the Company's
personnel and directors, distributed by category, is as follows:
31.12.24
31.12.23
Directors (*)
14
13
Executives
18
18
Managers
51
48
Professional workers
146
139
Technicians
259
219
Administrative and support staff
58
58
546
495
(*) The Directors category includes two senior managers in 2024 and one in
2023.
At year end, the distribution by gender of personnel and
directors is as follows:
31.12.24
31.12.23
Men
Women
Men
Women
Directors (*)
10
4
10
3
Executives
17
3
12
3
Managers
37
16
33
15
Professional workers
99
50
95
45
Technicians
179
113
134
93
Administrative and
support staff
28
36
24
32
370
222
308
191
(*) The Directors category includes two senior managers in 2024 and 2023.
The average number of employees with a disability equal to or
greater than 33% during 2024 is 4, with 3 from the “Professional
workers” category and 1 from the “Technicians” category. The
average number of employees with a disability equal to or
greater than 33% during 2023 is 5, with one from the
“Executives” category, 1 from the “Technicians” category and 3
from the “Professional workers” category.
2024 Annual Financial Report        42
18. Transactions with Group companies
and associates
Details of the most important transactions with Group
companies and associates are as follows:
Thousands of euros
31.12.24
31.12.23
Income
Dividends
179,346
252,000
Services rendered
81,876
46,417
Non-trading income
8,905
7,006
Interest income
1,695
216
Total income
271,822
305,639
Expenses
Expenses for services received
6,178
8,529
Interest expense
1,962
2,937
Total costs
8,140
11,466
Details of the dividends recorded in 2024 and 2023 are as
follows:
Thousands of euros
31.12.24
31.12.23
Fluidra Commercial, S.A.U.
179,346
252,000
179,346
252,000
The Company only receives dividends from the
subsidiary Fluidra Commercial, S.A.U. (formerly Fluidra Finco,
S.L.U.).
The income caption Services rendered includes necessary
recurrent services rendered by Fluidra, SA. to the Group
companies in the area of management and administration. The
main services included fall under the following areas:
Chairperson, Board of Directors and CEO, General Director of
Operations, Internal Auditing, Finance, Investor Relations, Legal
Services, Tax, Investments and Acquisitions, Human Resources,
Supply Chain, IT Systems, Communication and Marketing, Lean
Management, Procurement, E-Business, Planning and Analysis,
General Division Management, General Services (telephony,
travel and insurance) and Technical Office and Sales Support.
Expenses for services received includes the services rendered by
Group companies, specifically Zodiac Pool Solutions LLC, to 
provide the services rendered by Fluidra, S.A. described in
previous paragraphs.
2024 Annual Financial Report        43
19. Information on the directors
a) Remuneration and balances with
the Company's directors and
senior management
No advances or loans have been granted to key senior
management personnel or directors.
The pay earned by key management personnel and directors of
the Company is as follows:
Thousands of euros
2024
2023
Total key management personnel
3,833
2,787
Total directors of the Company (*)
4,709
4,309
(*) At 31 December 2024, a portion of the pay under the Total directors of the
Company heading (€4,709 thousand) is paid by the Parent company (€4,309
thousand in 2023).
Members of the Company’s board of directors have earned a
total of €1,591 thousand in 2024 (€1,489 thousand in 2023) from
the consolidated companies where they are directors. Similarly,
the members of the board of directors have received €157
thousand in compensation for travel expenses in 2024 (€133
thousand in 2023).
Additionally, for their executive duties, they have received a total
of €2,960 thousand in 2024 (€2,692 thousand in 2023). The
executive function includes remuneration in kind relating to the
share plan, a vehicle and life insurance.
In the year ended 31 December 2024, the Company has taken
out life insurance policies and has recognised an expense of €55
thousand (€50 thousand in 2023) to cover survival, death and
temporary and permanent incapacity contingencies.
Furthermore, the Company has made contributions to benefit
plans of €91 thousand (€66 thousand in 2023).
During the year ended 31 December 2024, the company paid
the annual civil liability insurance premiums for directors and
executives of the Group for possible damages and/or claims
from third parties during the exercise of their duties amounting
to €147 thousand (€152 thousand in 2023), with all Group
directors and executives, including those of the company, being
covered by these policies.
In addition to the above, the Group has no pension plan or life
insurance policies for former or current members of the board
of directors or key management personnel, nor has it given any
guarantees on their behalf.
The Group’s key management includes the executives that
answer directly to the board of directors or senior
management, as well as the internal auditor.
On 9 June 2022, the general meeting of shareholders approved
a new long-term variable remuneration plan for executive
directors and the management team of Fluidra, S.A. and the
subsidiaries comprising the consolidated group, including the
delivery of Fluidra, S.A. shares.
The 2022-2026 plan covers a five year period from 1 January
2022, with effect from the date of approval of the plan by the
general shareholders' meeting, until 31 December 2026, without
prejudice to the effective settlement of the plan’s last cycle
which will take place during June 2027.
The 2022-2026 plan entails the concession of a certain number
of PSUs (Performance Share Units) which will be taken as a
reference to determine the final number of shares to be
delivered to the beneficiaries after a certain period of time,
provided that certain strategic objectives of the Fluidra Group
are met and the requirements set forth in the regulations are
fulfilled.
The plan is divided into three independent cycles and will have
three grant dates for the target incentive to be received in the
event of 100% compliance with the targets to which it is linked,
each of which will take place in 2022, 2023 and 2024,
respectively.
Each cycle shall have a target measurement period of three
years, starting on 1 January of the year in which the cycle starts
and ending three years after the start date of the cycle
measurement period, i.e. 31 December of the year in which the
cycle measurement period ends.
After the end of each cycle’s measurement period, the incentive
linked to each cycle will be decided and each beneficiary will be
entitled to receive the incentive depending on the degree of
fulfilment with the objectives set for the relevant cycle.
The incentive linked to each plan cycle will be settled in June of
the financial year subsequent to the end of the measurement
period, following approval of the annual accounts for the year in
which the measurement period of the relevant cycle ends.
In order for the beneficiary to consolidate the right to receive
the incentive corresponding to each cycle of the 2022-2026 plan,
he/she must remain in the Fluidra Group until the end date of
the cycle's measurement period, notwithstanding the special
cases of disengagement set out in the regulations, and the
objectives to which each cycle of the 2022-2026 plan is linked
must be met.
In particular, the plan’s three cycles are linked to the meeting of
the following strategic targets;
a) Evolution of the “Total Shareholder Return” (TSR), in absolute
terms;
2024 Annual Financial Report        44
b) Evolution of the Fluidra Group’s EBITDA;
c) S&P rating linked to ESG objectives (Environment, Social and
Governance).
For the purposes of measuring the evolution of TSR, the initial
value shall be taken as the weighted average of Fluidra's share
price at the close of the stock market sessions on the thirty days
prior to the start date of the first cycle’s measurement period,
and the final value shall be taken as the weighted average of
Fluidra's share price at the close of the stock market sessions on
the thirty days prior to the end date of each cycle’s
measurement period.
The maximum amount earmarked for the plan’s three cycles as
a whole in the event of 100% compliance with the targets to
which it is linked is fixed at €55 million. The maximum number
of shares included in the plan shall be the result of dividing the
maximum amount allocated to each cycle by the weighted
average share price at the close of the stock market sessions on
the thirty days prior to the starting date of the relevant cycle’s
measurement period.
If the maximum number of shares allocated to the plan
authorised by the general shareholders' meeting is not sufficient
to settle the incentive in shares corresponding to the
beneficiaries under each cycle of the plan, Fluidra shall pay in
cash the excess incentive that cannot be settled in shares.
At 31 December 2024, the best estimate of the fair value of the
plan’s total amount comes to approximately €27,602 thousand
(€30,536 thousand at 31 December 2023), which will be settled
in full in equity instruments. At 31 December 2024, an equity
increase was recorded in this respect for the amount of €4,987
thousand (€8,142 thousand at 31 December 2023).
b) Transactions other than
ordinary business or under
terms differing from market
conditions carried out by the
directors of the Company
During 2024 and 2023, the directors of the Company have not
carried out any transactions with the Company or with group
companies other than those conducted on an arm's length basis
in the normal course of business.
c) Conflicts of interest concerning
the directors of the Company
Neither the Company's directors nor any persons related to
them were party to any conflicts of interest requiring disclosure
in these notes pursuant to the provisions of article 229 of the
consolidated text of the Spanish Companies Act.
2024 Annual Financial Report        45
20.   Other commitments
  and contingencies
At 31 December 2024 and 2023, the Group has not presented
any mortgage guarantees.
At 31 December 2024, the Group has presented guarantees to
banks and other companies for €80 thousand (€80 thousand in
2023).
The agreement that includes the Group’s long-term loans in
both the US dollar (750 million) and euros (450 million) tranches,
and the revolving credit facility (€450 million) is signed by the
borrowers, Fluidra North America, LLC (formerly Zodiac Pool
Solutions LLC), Fluidra Commercial S.A.U. (Formerly Fluidra Finco
S.L.U.) and Fluidra Holdings Australia Pty Ltd (Borrowers), as well
as by Fluidra S.A. in its capacity as parent company of the Group
(Holdings), who are severally liable for the obligations of said
agreement. The following Group companies also act as
guarantors (Guarantors), jointly and severally liable if the
borrowers breach the agreement: Zodiac Pool Systems LLC, SR
Smith LLC, Custom Molded Products LLC, Cover-Pools LLC, Trace
Logistics S.A.U., Sacopa S.A.U., Manufacturas Gre S.A.U., I.D.
Electroquímica S.L.U, Inquide S.A.U., Fluidra Global Distribution
S.L.U., Fluidra Export S.A.U, Fluidra Comercial España S.A.U.,
Cepex S.A.U., Fluidra Group Australia Pty Ltd, Fluidra
Commercial France S.A.S., Zodiac Pool Care Europe S.A.S.,
Fluidra Industry France S.A.S, Poolweb SAS and ZPES Holdings
S.A.S.. As is customary in this type of syndicated financing and in
order to meet the personal obligations assumed, the
Guarantors have created a collateral package for some of their
assets in the four jurisdictions in which they operate, namely
Spain, the US, France and Australia, consisting mainly of pledges
on shares, intellectual property and certain receivables.
Under Spanish, US and French law, pledges have been signed on
certain shares as guarantees in rem to ensure compliance with
the financial obligations assumed in the credit agreement.
Specifically, senior pledges have been established on shares in
the companies mentioned above with registered addresses in
Spain, the US and France in favour of the lenders. The pledges
established in the US include collection rights to borrowed
money and the rights to dividends and other rights linked to
these shares.
Under US law, a guarantee in rem agreement has also been
signed on intellectual property assets.
Lastly, a security trust deed was signed on the shares in Fluidra
Holdings Australia Pty Ltd and Fluidra Group Australia Pty Ltd,
and on all current and future goods of any kind at these
companies, including all their intellectual property assets.
Appendix I includes details of the carrying amount and capital
and reserves of the aforementioned shares that jointly and
severally guarantee the long-term loan.
In terms of the intellectual property subject to guarantee, the
only carrying amount related to the guarantees granted, as
mentioned above, arises from the fair value of the brands
identified in the business combination with Zodiac in 2018, and
amounts to USD 137,588 thousand.
2024 Annual Financial Report        46
21. Deferred taxes and Income tax
During 2024, the Company continues to be taxed under the
consolidated tax regime. Fluidra, S.A. is the parent of this
consolidated tax group and is responsible for making the
relevant payments to the tax authorities. The companies that
make up this tax group at the reporting date are: Fluidra Export,
S.A., Cepex, S.A.U., Fluidra Commercial, S.A.U., Fluidra Comercial
España, S.A.U., I.D.Electroquímica, S.L., Inquide, S.A.U., Poltank,
S.A.U., Fluidra Global Distribution, S.L.U., Sacopa, S.A.U., Talleres
del Agua, S.L.U., Trace Logistics, S.A.U., Unistral Recambios,
S.A.U, Innodrip, S.L.U. and Manufacturas Gre, S.A.U., S.L.U.
Profits determined in accordance with tax legislation are subject
to a rate of 25% on the taxable income of companies located in
areas of Spain not subject to a regional tax agreement.
In 2023, the consolidation scope included Fluidra Export, S.A.,
Cepex, S.A.U., Fluidra Commercial, S.A.U., Fluidra Comercial
España, S.A.U., I.D.Electroquímica, S.L., Inquide, S.A.U., Poltank,
S.A.U., Fluidra Global Distribution, S.L.U., Sacopa, S.A.U., Talleres
del Agua, S.L.U., Trace Logistics, S.A.U., Unistral Recambios,
S.A.U, Innodrip, S.L.U. and Fluidra Finco, S.L.U.
A reconciliation of net income and expenses for the year with
taxable income at 31 December 2024 and 2023 is as follows:
Thousands of euros
2024
Income statement
Income and expense recognised in
equity
Increases
Decreases
Net
Increases
Decreases
Net
Total
Income and expense for the period
144,211
144,211
Corporate income tax
6,711
6,711
Profit/(loss) before tax
137,500
137,500
Permanent differences - ind. company
913
(170,378)
(169,465)
(169,465)
Permanent differences - consolidated tax
group
Temporary differences - ind. company
17,724
(3,528)
14,196
14,196
Originating in this year
17,724
17,724
17,724
Originating in prior years
(3,528)
(3,528)
(3,528)
Temporary differences - consolidated tax
group
Offsetting of tax loss carryforwards
Taxable income
(17,769)
(17,769)
2024 Annual Financial Report        47
Thousands of euros
2023
Income statement
Income and expense recognised in
equity
Increases
Decreases
Net
Increases
Decreases
Net
Total
Income and expense for the period
203,292
203,292
Corporate income tax
12,040
12,040
Profit/(loss) before tax
191,252
191,252
Permanent differences - ind. company
831
(239,400)
(238,569)
(238,569)
Permanent differences - consolidated tax
group
Temporary differences - ind. company
37,614
(24,426)
13,188
13,188
Originating in this year
37,614
37,614
37,614
Originating in prior years
(24,426)
(24,426)
(24,426)
Temporary differences - consolidated tax
group
Offsetting of tax loss carryforwards
Taxable income
(34,129)
(34,129)
The individual company's permanent differences relate mainly
to the elimination of dividends and other non-deductible
expenses.
The temporary differences of the individual company relate
mainly to non-tax-deductible provisions, the 50% limit on tax
losses (see details below) and the reversal of restrictions on the
deductibility of depreciation and amortisation in 2013 and 2014.
Details of deferred tax assets and liabilities by type are as
follows:
Thousands of euros
Assets
Liabilities
Net
2024
2023
2024
2023
2024
2023
50% limit on offsetting of tax losses (additional
provision 19, corporate income tax law)
11,219
8,407
11,219
8,407
Provision for employee obligations
3,219
2,589
3,219
2,589
Other items
342
200
342
200
Total
14,780
11,196
14,780
11,196
Taking effect in 2023, 2024 and 2025, additional provision
number 19 of the Spanish corporate income tax law (Law
27/2014) limits the offsetting of individual tax losses of each
company within a Spanish tax group to 50%. As a result of this
measure, the Company has capitalised €3,595 thousand (€8,407
thousand in the previous year) which, in accordance with the
regulatory text, will be reversed on a straight-line basis over the
next 10 years.
2024 Annual Financial Report        48
The breakdown of changes by type of deferred tax asset and
liability is as follows:
Thousands of euros
31.12.23
Losses and
gains
Equity
Other
31.12.24
50% limit on offsetting of tax losses (additional provision 19,
corporate income tax law)
8,407
2,748
64
11,219
Provision for employee obligations
2,589
636
(6)
3,219
Other items
200
142
342
Total
11,196
3,526
58
14,780
Thousands of euros
31.12.22
Losses and
gains
Equity
Other
31.12.23
Deferred gains
(1,138)
1,138
Tax credit for unused tax loss carryforwards and deductions
Limit on deductibility of amortisation/depreciation
2
(2)
50% limit on offsetting of tax losses (additional provision 19,
corporate income tax law)
8,407
8,407
Provision for employee obligations
7,498
(4,909)
2,589
Other items
2,034
(1,834)
200
Total
8,396
1,664
1,136
11,196
At 31 December 2024, deferred tax assets of €1,338 thousand
are expected to be reversed in the coming 12 months. At 31
December 2023, €863 thousand were expected.
The breakdown of corporate income tax income is as follows:
Thousands of euros
2024
2023
Current tax
for the year
(4,442)
(9,755)
Tax deductions
(696)
447
Prior years' adjustments
17
(1,194)
Other
1,936
126
Deferred taxes
Source and reversal of temporary differences
(3,526)
(1,664)
(6,711)
(12,040)
2024 Annual Financial Report        49
The reconciliation of current tax with current net income tax
liabilities / (assets) is as follows:
Thousands of euros
2024
2023
Current tax
5,138
(9,308)
Liabilities of Group companies
under the consolidated tax regime
19,523
9,818
Current income tax (assets)/
liabilities (see note 9)
24,661
510
The relationship between income tax expense and profit from
continuing operations is as follows:
Thousands of euros
2024
2023
Profit for the year before tax from
continuing operations
137,500
191,252
Profit at 25%
34,375
47,813
Dividend exemption
(42,595)
(59,850)
Permanent differences
252
208
Tax deductions
(696)
Other
1,953
(211)
Income tax expense/(income)
(6,711)
(12,040)
The company has not recognised a deduction of €21 thousand
applicable until 2041 as a deferred tax asset.
Likewise, at 31 December 2024 and 2023, there are no
unrecognised tax loss carryforwards pending offset or unused
deductions.
The years open to inspection are:
Tax
Open tax periods
Corporate income tax
From 2020 to 2024
Value added tax
From 2021 to 2024
Personal income tax
From 2021 to 2024
Tax on Economic Activities
From 2021 to 2024
Tax returns cannot be considered definitive until they have been
inspected by the tax authorities or the inspection period of four
years has elapsed. Due to different possible interpretations of
current fiscal legislation, additional tax liabilities could arise in
the event of an inspection. In any case, the Company's directors
consider that in the event of additional tax inspections, the
possibility that contingent liabilities arise is remote and the
additional tax payable, if any, that may derive would not have a
significant impact on the Company's annual accounts.
There are no inspections in progress at 31 December 2024 for
the company nor for the tax group of which the company is
parent.
Pilar 2 - Global minimum tax
On 20 September 2022, the European Union approved Directive
(EU) 2022/2523 setting out standards to ensure a global
minimum level of taxation of 15% for multinational enterprise
groups and large-scale domestic groups with annual
consolidated income equal to or higher than €750 million, also
called Pilar 2.
In Spain, this Directive has been transposed through Law 7/2024
of 20 December, setting out a top-up tax to ensure a global
minimum taxation level, among other things, applicable to years
beginning on or after 1 January 2024.
The Group has assessed the potential impact of adopting this
standard on its consolidated financial statements. As a result,
the Group has recorded a provision of €790 thousand for
estimated top-up tax in the United Arab Emirates, China and
Bulgaria jurisdictions. In the other jurisdictions in which the
Group operates, no tax is expected to be paid as they fall under
the transitional safe harbour rules provided for in the fourth
transitional provision of Law 7/2024.
These transitional safe harbour rules seek to simplify adaptation
to the Pilar 2 regulations by stipulating that the top-up tax will
be zero when one of three conditions are met. 
In accordance with the temporary exemption included in IAS 12,
the Group has not recognised deferred tax assets or liabilities
relating to the top-up tax arising from application of Law 7/2024.
2024 Annual Financial Report        50
22. Information on late payment
to suppliers
According to Law 31/2014 of 3 December establishing measures
on combating late payment in commercial transactions, the
information on late payment to suppliers in Spain is as follows:
2024
2023
Days
Days
Average payment period to
suppliers
55.60
46.74
Transactions paid ratio
58.17
48.89
Transactions payable ratio
44.46
34.67
Amount
(thousands
of euros)
Amount
(thousands
of euros)
Total payments made
85,980
77,949
Total payments outstanding
19,855
13,853
Monetary amount of invoices paid
within the maximum period set out
in late payment legislation
44,638
58,169
Payments made within the
maximum period as a percentage of
total payments made
51.92%
75.00%
Amount
(number of
invoices)
Amount
(number of
invoices)
Invoices paid within the maximum
period set out in late payment
legislation
3,948
3,446
Percentage of total invoices
66.50%
69.00%
2024 Annual Financial Report        51
23. Auditors' and their Group companies'
or related parties’ fees
Ernst & Young, S.L. have invoiced the following net fees for
professional services during the year ended 31 December 2024
and 2023:
Thousands of euros
31.12.24
31.12.23
Audit services
139
139
Other assurance services
146
104
Total
285
243
Other assurance services for 2024 and 2023 includes: the report
on the system of internal control over financial reporting (SCIIF),
the review report on non-financial information and
sustainability report and the review of the integrated report.
The amounts presented in the table above include all of the fees
related to the services rendered in 2024 and 2023, regardless of
when they were invoiced.
No other company affiliated with EY, S.L. has invoiced fees
for professional services to the Group during the years
ended 31 December 2024 or 2023.
2024 Annual Financial Report        52
24. Environment
Given the company's business activities, at 31 December 2024
and 2023 there are no significant assets for the protection or
improvement of the environment and it has not incurred any
major expenses of an environmental nature during either year.
The Company's board of directors considers that there are no
significant contingencies in connection with the protection and
improvement of the environment and that it is not necessary to
recognise any provisions for environmental liabilities and
charges at year end.
2024 Annual Financial Report        53
25. Subsequent events
On 9 January 2025, the purchase of 100% of BAC pool systems
Holding AG, BAC pool systems AG, and BAC pool systems GmbH
("BAC") was finalised. BAC is a well-known manufacturer and
designer of automatic, manual and safety covers for residential
and commercial pools and operates in Germany and
Switzerland. BAC has around 60 employees and expects sales
and adjusted EBITDA in 2024 of around €13 million and €2.5
million, respectively. This acquisition helps Fluidra strengthen its
standing in pool covers in central Europe. This is a sustainable
product that is increasingly in demand on the market as the
covers significantly reduce water evaporation and loss of heat
from swimming-pools, leading to savings in water replacement
and energy.
On 6 March 2025, the Company received notification from the
tax authorities informing it of the start of a general tax
inspection covering 2020 to 2023 corporate income tax, VAT for
the February 2021 to January 2025 period, withholdings and
payments on account for income earned and income from
professional services, and withholdings and payment on
account for non-residents and dividends for the February 2021
to January 2025 period.
At the date of authorisation for issue of these annual accounts,
the Company does not have enough information to estimate the
possible financial impact of this inspection. The directors believe
however that the Company has rigorously complied with its tax
obligations, in accordance with current legislation and that, as a
result, they do not expect this inspection to have a significant
impact on the Company.
2024 Annual Financial Report        54
Appendix I
Fluidra, S.A.
Information on Group companies
31 December 2024
Name
% of interest
Euros
Capital and
share premium
Reserves
Profit/(loss) for
the year
Interim
dividend
Total
shareholders'
equity
Carrying
amount
Details of subsidiaries
Direct
Ind
FLUIDRA COMMERCIAL, S.A.U.
100%
142,690,173
1,439,620,919
240,153,269
(179,345,624)
1,643,118,737
1,455,578,283
                    AO ASTRAL SNG
90%
194,936
1,658,179
1,002,179
2,855,294
823,516
                              ASTRAL AQUADESIGN LIMITED LIABILITY COMPANY
58,50%
11,873
621,744
410,270
1,043,887
5,702
                    ASTRAL BAZENOVE PRISLUSENTSVI, S.R.O.
100%
71,395
2,379,670
343,688
2,794,753
1,229,641
                    FLUIDRA INDIA PRIVATE LIMITED
100%
360,201
1,080,116
1,654,552
3,094,869
965,501
                    ASTRALPOOL CYPRUS, LTD
100%
1,000
1,892,097
765,102
2,658,199
1,045,000
                    ASTRALPOOL HONGKONG, CO., LIMITED
100%
994
697,907
4,154
703,055
994
                    FLUIDRA SWITZERLAND, S.A.
100%
922,085
112,316
(356,120)
678,281
1,034,841
                    ASTRALPOOL UK LIMITED
100%
51,603
2,176,229
1,001,470
3,229,302
4,522,264
                    CEPEX MEXICO, S.A. DE C.V.
100%
633,090
100,964
(159,440)
574,614
555,778
                    CERTIKIN INTERNATIONAL, LIMITED
100%
1,500,003
10,947,200
1,841,365
14,288,568
17,225,862
                              FLUIDRA INDIA PRIVATE LIMITED
100%
360,201
1,080,116
1,654,552
3,094,869
1,612
                    FLUIDRA ADRIATIC D.O.O.
100%
10,060
1,059,361
479,439
1,548,860
1,495,952
                    FLUIDRA BALKANS JSC
61,16%
216,354
1,407,481
2,806,373
4,430,208
719,114
                    FLUIDRA BRASIL INDÚSTRIA E COMÉRCIO LTDA
100%
20,414,607
(8,120,206)
1,368,362
13,662,763
18,848,599
                              VEICO.COM.BR INDÚSTRIA E COMÉRCIO LTDA
100%
794,821
(1,019,295)
91,051
(133,423)
                    FLUIDRA CHILE, S.A.
100%
2,746,065
(906,431)
157,623
1,997,257
3,007,192
                    FLUIDRA COLOMBIA, S.A.S
100%
1,743,492
(436,790)
(108,767)
1,197,935
1,643,864
                    FLUIDRA COMERCIAL ESPAÑA, S.A.U.
100%
1,202,072
28,147,343
10,272,773
39,622,188
38,723,524
                    FLUIDRA EGYPT, EGYPTIAN LIMITED LIABILITY COMPANY
100%
70,757
3,131,023
1,401,571
4,603,351
3,211,203
                              W.I.T. EGYPT, EGYPTIAN LIMITED LIABILITY COMPANY
100%
1,045,059
(1,013,797)
106,966
138,228
996,554
2024 Annual Financial Report        55
Name
% of interest
Euros
Capital and
share premium
Reserves
Profit/(loss) for
the year
Interim
dividend
Total
shareholders'
equity
Carrying
amount
Details of subsidiaries
Direct
Ind
                    FLUIDRA EXPORT, S.A.U.
100%
601,000
3,605,064
2,021,242
6,227,306
820,950
                              ASTRALPOOL (THAILAND) CO., LTD
100%
580,680
2,362,495
524,320
3,467,495
288,378
                              FLUIDRA INDONESIA PT.
100%
1,870,547
1,179,105
(282,556)
2,767,096
1,877,901
                              FLUIDRA TUNISIE, S.A.R.L.
100%
67,016
47,794
21,416
136,226
63,522
                    FLUIDRA GLOBAL DISTRIBUTION, S.L.U.
100%
(7)
1,753,100
12,316,372
(2,870,088)
11,199,384
31,585,434
                    FLUIDRA HELLAS, S.A.
96,96%
3,768,050
1,270,926
2,850,151
7,889,127
4,188,271
                    FLUIDRA HOLDINGS SOUTH AFRICA PTY LTD
100%
25,633,166
7,253,752
(14,404)
32,872,514
26,417,215
                              FLUIDRA WATERLINX PTY, LTD
100%
25,073,684
(5,711,702)
4,325,806
23,687,788
35,049,863
                    FLUIDRA INDONESIA PT.
100%
1,870,547
1,179,105
(252,536)
2,797,116
98,262
                    FLUIDRA KAZAKHSTAN LIMITED LIABILITY COMPANY
70%
47,250
1,273,194
138,617
1,459,061
872,628
                    FLUIDRA MAGYARORSZÁG KFT.
95%
156,561
(376,960)
(1,186,140)
(1,406,539)
1,116,177
                    FLUIDRA MALAYSIA SDN.BHD.
100%
364,620
379,480
150,458
894,558
620,887
                    FLUIDRA MAROC, S.A.R.L.
100%
311,143
3,826,215
1,913,637
6,050,995
2,911,292
                    FLUIDRA MEXICO, S.A. DE C.V.
100%
3,358,504
1,775,598
(2,342)
5,131,760
3,303,436
                    FLUIDRA MIDDLE EAST FZE
100%
211,231
17,684,469
6,851,633
24,747,333
599,294
                    FLUIDRA MONTENEGRO DOO
60%
10,000
419,026
126,936
555,962
6,000
                    FLUIDRA ÖSTERREICH GMBH "SSA"
98,50%
1,158,434
7,131,741
1,554,515
9,844,690
6,942,991
                    FLUIDRA POLSKA, SP. Z.O.O.
100%
95,376
1,136,447
415,937
1,647,760
236,997
                    FLUIDRA COMERCIAL PORTUGAL UNIPESSOAL, LDA
100%
1,375,641
6,907,682
2,697,130
10,980,453
7,457,938
                    FLUIDRA ROMANIA S.A.
66,66%
50,000
262,545
426,114
738,659
33,330
                    FLUIDRA SERBICA, D.O.O. BEOGRAD
60%
10,000
296,492
687,760
994,252
6,000
                    FLUIDRA COMMERCIALE ITALIA, S.P.A.
100%
1,060,000
10,417,541
6,546,286
18,023,827
16,610,888
                    FLUIDRA SINGAPORE, PTE LTD
100%
238,473
1,678,232
135,410
2,052,115
882,821
                    FLUIDRA NORDIC AB
100%
5,768
36,918
181,742
224,428
5,563
                    ASTRALPOOL (THAILAND) CO., LTD
100%
580,680
2,362,495
524,320
3,467,495
130,400
                    FLUIDRA TR SU VE HAVUZ EKIPMANLARI AS
51%
169,192
2,789,701
2,249,487
5,208,380
73,481
                    FLUIDRA VIETNAM LTD
100%
119,209
354,433
63,473
537,115
119,208
                    SIBO FLUIDRA NETHERLANDS B.V.
100%
(2)
323,528
12,934,717
1,380,479
14,638,724
16,787,551
                    YA SHI TU SWIMMING POOL EQUIPMENT (SHANGAI) CO, LTD
100%
85,183
578,483
(542,650)
121,016
85,183
                    FLUIDRA DEUTSCHLAND GMBH
100%
(6)
3,962,512
62,165
33,869
4,058,546
56,494,489
                    FLUIDRA HOLDINGS AUSTRALIA PTY LTD
100%
131,949,901
(96,019,640)
18,332,425
(21,410,656)
32,852,030
118,796,524
                              SRS AUSTRALIA PTY LTD
100%
186,763
(1,121,486)
216,177
(718,546)
3,162,050
2024 Annual Financial Report        56
Name
% of interest
Euros
Capital and
share premium
Reserves
Profit/(loss) for
the year
Interim
dividend
Total
shareholders'
equity
Carrying
amount
Details of subsidiaries
Direct
Ind
                              SUNBATHER PTY LTD
100%
4,380
3,487,692
(532,860)
2,959,212
8,841,644
                              FLUIDRA GROUP AUSTRALIA PTY LTD
100%
20,509,253
23,285,886
10,633,679
54,428,818
26,754,778
                                    FABTRONICS AUSTRALIA PTY LTD
100%
62
(62)
7,023,384
                                    FLUIDRA (N.Z.) LIMITED
100%
59
1,267,421
(95,190)
1,172,290
110
                    FLUIDRA TUNISIE, S.A.R.L.
100%
67,016
47,794
21,416
136,226
642
                    FLUIDRA BH D.O.O. BIJELJINA
60%
10,035
378,132
370,283
758,450
6,009
                    CEPEX S.A.U.
100%
11,037,930
22,021,803
4,866,628
37,926,361
88,818,379
                    SACOPA, S.A.U.
100%
(9)
601,000
39,124,125
13,826,828
53,551,953
224,858,078
                    I.D. ELECTROQUÍMICA, S.L.U.
100%
5,022
6,249,292
4,636,394
10,890,708
61,987,757
                    INQUIDE, S.A.U.
100%
10,293,709
21,593,680
6,397,793
38,285,182
105,977,657
                    FLUIDRA SI D.O.O.
60%
30,000
133,640
30,102
193,742
18,000
                    SWIM & FUN SCANDINAVIA Aps
100%
16,792
3,577,801
1,059,367
4,653,960
18,005,891
                    AQUACONTROL, GESELLSCHAFT FÜR MEß-, REGEL- UND
                    STEUERUNGSTECHNIK ZUR WASSERAUFBEREITUNG GMBH
100%
66,600
1,603,467
(185,569)
1,484,498
1,539,304
                    NINGBO DONGCHUAN SWIMMING POOL EQUIPMENT CO., LTD
70%
905,369
6,969,451
2,846,359
10,721,179
633,758
                    TALLERES DEL AGUA, S.L.U.
100%
2,203,753
(645,388)
(367,776)
1,190,589
1,549,796
                    MANUFACTURAS GRE, S.A.U.
100%
445,343
20,265,697
1,603,828
22,314,868
27,587,523
                    TRACE LOGISTICS, S.A.U.
100%
4,509,000
970,211
394,459
5,873,670
3,347,690
                              TRACE LOGISTICS NORTH BV
100%
30,000
(190,687)
87,318
(73,369)
                    INNODRIP, S.L.U.
100%
760,000
3,329,684
(1,562,742)
2,526,942
150,000
                    FLUIDRA NORTH AMERICA LLC
100%
(10)
295,454,402
(296,928,298)
126,169,876
(138,991,846)
(14,295,866)
1,077,536,765
                              ZODIAC POOL SYSTEMS CANADA, INC.
100%
4,377,616
1,278,506
421,206
6,077,328
855,350
                              ZODIAC POOL SYSTEMS LLC
100%
79,255,428
(45,805,733)
187,159,783
220,609,478
172,778,020
                                    COVER-POOLS INCORPORATED
100%
470,118
39,847,233
6,658,624
46,975,975
23,267,490
                              FLUIDRA LATAM EXPORT LLC
100%
178,659
1,864,530
1,250,501
3,293,690
189,358
                              FLUIDRA USA, LLC
100%
4,955,885
(5,950,634)
(716,211)
(1,710,960)
6,873,913
                              CUSTOM MOLDED PRODUCTS LLC
100%
52,630,268
(37,289,955)
(1,380,382)
13,959,931
223,235,330
                                    CUSTOM MOLDED PRODUCTS SHANGAI INC.
100%
5,777,424
(177,913)
3,067,279
8,666,790
10,682,276
                              S.R. SMITH, LLC
100%
36,769,324
7,518,695
44,288,019
216,908,438
                              TAYLOR WATER TECHNOLOGIES LLC
100%
(1,254,940)
9,703,989
10,628,244
19,077,293
72,561,015
                    ZPES HOLDING SAS
100%
320,403,565
57,931,946
24,778,607
403,114,118
320,898,864
                              ZODIAC POOL CARE EUROPE SAS
100%
6,884,265
38,040,324
6,158,157
51,082,746
230,948,628
2024 Annual Financial Report        57
Name
% of interest
Euros
Capital and
share premium
Reserves
Profit/(loss) for
the year
Interim
dividend
Total
shareholders'
equity
Carrying
amount
Details of subsidiaries
Direct
Ind
                                    ZODIAC SWIMMING POOL EQUIPMENT (SHENZHEN)
                                    CO., LTD.
100%
77,200
743,807
86,067
907,074
                              FLUIDRA COMMERCIAL FRANCE, S.A.S.
100%
13,307,294
5,821,191
6,000,010
25,128,495
70,638,053
                                    FLUIDRA BELGIQUE, S.R.L.
100%
162,920
1,425,270
44,195
1,632,385
4,819,600
                                    POOLWEB SAS
100%
37,000
333,995
871,959
1,242,954
125,225
                              FLUIDRA INDUSTRY FRANCE, S.A.S.
100%
2,050,000
6,831,557
2,415,849
11,297,406
4,019,800
                              PISCINES TECHNIQUES 2000, S.A.S.
100%
1,062,169
544,928
25,485
1,632,582
1,000,001
                    NCWG, SISTEMAS DE GESTAO DE AGUA, LDA
100%
(3)
                    DINI & LULIO, LDA
100%
(3)
                    ECOHÍDRICA, TECNOLOGIAS DA ÁGUA LDA.
100%
(3)
                    KREATIVE TECHK, LDA
100%
(3)
List of associates consolidated using the equity method
                  ASTRAL NIGERIA, LTD
25%
(1)
                  ASPIRE POLYMERS PTY. LTD
50%
                  BLUE FACTORY S.R.L.
17%
List of companies consolidated at cost
                  DISCOVERPOOLS COM, INC.
11%
(1)
                  SWIM-TEC GmbH
25%
(4)
(1) Companies belonging to the Fluidra Commercial, S.A. and subsidiaries subgroup.
(2) Sibo Fluidra Netherlands, B.V. owns 100% of the share capital of the German company SIBO Gmbh.
(3) Companies acquired during the current year
(4) 25% of the company owned by Fluidra Deutschland, GmbH.
(5) Absorbing company of Zodiac International SAS
(6) Absorbing company of Meranus Haan and Meranus Lauchhammer.
(7) Absorbing company of Unistral Recambios, S.A.U.
(8) Absorbing company of Fluidra Finco S.L.U.
(9) Absorbing company of Poltank, S.A.U.
(10) Company previously called Zodiac Pool Solutions LLC,
(11) Company previously called Cover-Pools Incorporated.
(12) In the year ended 31 December 2024, the following companies have been wound up: Cmp Pool & Spa (Shanghai) Co, Ltd, Turcat Polyester Sanayi Ve Ticaret A.S., Certikin International (Ireland) Limited, Fluidra Australia PTY LTD,  Cepex Mexico, 
Astralpool Australia PTY  LTD and Hurlcon Staffing PTY LTD
2024 Annual Financial Report        58
Fluidra, S.A. and Subsidiaries
Details of the corporate name and purpose of the subsidiaries, associates
and joint ventures directly or indirectly owned
Subsidiaries accounted for using the full
consolidation method
AO Astral SNG, domiciled in Moscow (Russia),
is mainly engaged in the marketing of swimming-pool
materials.
Aquacontrol, Gesellschaft für meß-, regel- und
steuerungstechnik zur wasseraufbereitung gmbh,
domiciled in Haan (Germany), is mainly engaged in the
production and distribution of measuring, control and
regulation equipment for pools, water systems and waste
water of all kinds.
Astral Aqua Design Limited Liability Company, domiciled in
Moscow (Russia), is mainly engaged in the distribution, design,
installation and project management of fountains and ponds.
Astral Bazénové Prislusentsvi, S.R.O., domiciled in
Modletice - Doubravice (Czech Republic), is mainly engaged in
the production and sale of chemical substances and other
chemical products classified as toxic and very toxic.
Astralpool Cyprus, LTD, domiciled in Limassol (Cyprus), is
mainly engaged in the distribution of pool-related products.
Astralpool Hongkong, CO., Limited, domiciled in Wang Chai
(Hong Kong), is mainly engaged in the marketing of pool,
water treatment and irrigation products.
Astralpool (Thailand) Co., Ltd, domiciled in Samuth Prakarn
(Thailand), is mainly engaged in the marketing of pool, spa
and irrigation products.
Astralpool UK , Limited., domiciled in Fareham (England), is
engaged in the manufacture, purchase and
sale, distribution, marketing, export and import of all types of
swimming-pool products.
Cepex S.A.U., domiciled in La Garriga (Barcelona, Spain), is
mainly engaged in the manufacture and distribution of plastic
material by injection systems or similar and, in
particular, plastic parts for valves and the manufacture of
plastic injection molds.
Certikin International, Limited, domiciled in Witney Oxford
(England), is engaged in the marketing of swimming-pool
products.
Cover-Pools LLC. (formerly Cover Pools Incorporated),
domiciled in West Valley City (USA), is mainly engaged in the
manufacture and distribution of automatic pool covers.
Custom Molded Products, LLC, domiciled in Newnan,
Georgia (United States), is engaged in taking part in any legal
act or activity whereby limited liability companies may be
created under the Law and to engage in any and all activities
required or incidental thereto.
Custom Molded Products Shanghái, Inc., domiciled in
Shanghai (China), is essentially engaged in the sale of
bathroom equipment, plastic products, rubber products,
electronic products and metal materials as well as the import
and export of goods and technology.
Dini & Lulio, LDA, domiciled in Sintra (Portugal), is engaged in
the marketing, import and export of water treatment
equipment, swimming-pools and chemical products, pumps
and dosage systems, domestic and industrial waste water
treatment systems, environmental consultancy, machine
repairs, marketing of beauty and spa products and beauty
services.
Ecohídrica, Tecnologias da Agua LDA, domiciled in Sintra
(Portugal), is engaged in the trading of equipment, accessories
and products for irrigation and swimming-pools and water
treatment and structures relating to the use of this
equipment, including technical assistance, maintenance,
training and other complementary businesses.
Fabtronics Australia, Pty Ltd, established in Braeside,
Australia, has as its object the design and sale of electronic
components.
Fluidra Adriatic D.O.O., domiciled in Zagreb (Croatia), is
mainly engaged in the purchase, sale and distribution of
machinery, equipment, materials, products and special
equipment for pool and water system maintenance.
Fluidra Balkans JSC, domiciled in Plovdiv (Bulgaria), is mainly
engaged in the purchase, sale and distribution of machinery,
equipment, materials, products and special equipment for
pool and water system maintenance.
Fluidra Belgique, S.R.L., domiciled in Wavre (Belgium), is
engaged in the manufacture, purchase and
sale, distribution, marketing, export and import of all types of
swimming-pool products.
Fluidra BH D.O.O. Bijeljina, domiciled in Bijeljina (Bosnia and
Herzegovina), is mainly engaged in selling swimming-pool
products.
Fluidra Brasil Indústria e Comércio LTDA, domiciled in Itajaí
(Brazil), is mainly engaged in the marketing, import, export
and distribution of equipment, products and services for fluid
handling, irrigation, swimming-pools and water treatment, as
either partner or shareholder in other companies. Rendering
2024 Annual Financial Report        59
of technical assistance services for machines, filters and
industrial and electrical and electronic equipment and rental
of machines and industrial and/or electrical and electronic
equipment.
Fluidra Chile, S.A., domiciled in Santiago de Chile (Chile), is
mainly engaged in the purchase and sale, assembly,
distribution and marketing of swimming-pool, irrigation and
water treatment and purification machinery, equipment and
products.
Fluidra Colombia, S.A.S., domiciled in Funza (Colombia), is
engaged in the purchase and
sale, distribution, marketing, import, export of all types of
machinery, equipment, components and machinery
parts, tools, accessories and products for swimming-
pools, irrigation and water treatment and purification in
general, built with both metal materials and any type of plastic
materials and plastic derivatives.
Fluidra Comercial España, S.A.U., domiciled in Sant Cugat
del Vallés (Barcelona, Spain), is engaged in the manufacture,
purchase, sale and distribution of all kinds of machinery,
filters, instruments, accessories and specific products for
swimming-pools, as well as for the treatment and purification
of water in general, irrigation and fluid conduction, made of
both metallic materials and all kinds of plastic materials and
their transformation; as well as the construction and
manufacture of all kinds of elements and products that can be
manufactured with fibreglass, metal, vacuum thermoformed
materials or injected materials.
Fluidra Comercial Portugal Unipessoal, Lda., domiciled in
São Domingos da Rana (Portugal), is engaged in the
manufacture, purchase and
sale, distribution, marketing, export and import of all types of
swimming-pool products.
Fluidra Commercial France, S.A.S., domiciled in Perpignan
(France), is mainly engaged in the commercialisation of rotary
and centrifugal pumps, electric motors and accessories, and
the commercialisation of equipment for swimming-pools and
water treatment.
Fluidra Commercial, S.A.U., (absorbing company of Fluidra
Finco, S.L.U.) domiciled in Sant Cugat de Vallés (Barcelona,
Spain), is engaged in the holding and use of equity shares and
securities, and advising, managing and administering the
companies in which it holds an ownership interest, among
other activities.
Fluidra Commerciale Italia, S.P.A., domiciled in Bedizzole
(Italy), is engaged in the manufacture, purchase and sale,
distribution, marketing, export and import of all types of
swimming-pool products.
Fluidra Deutschland, GmbH (absorbing company of
Meranus Haan and Meranus Lauchhammer), domiciled in
Großostheim (Germany), is engaged in the distribution and
sale of pool-related products and accessories.
Fluidra Egypt, Egyptian Limited Liability Company,
domiciled in Cairo (Egypt), is mainly engaged in the marketing
of swimming-pool accessories.
Fluidra Export, S.A.U., domiciled in Sant Cugat de Vallés
(Barcelona, Spain), is engaged in both domestic and foreign
marketing of all types of products and goods, mainly in the
marketing of pool-related products, basically acquired from
related parties.
Fluidra Global Distribution, S.L.U. (absorbing company of
Unistral Recambios S.A.U.), domiciled in Sant Cugat del Vallés
(Barcelona, Spain), is engaged in the manufacture, purchase
and sale and distribution of all types of
machinery, equipment, components and machinery
parts, tools, accessories and products for swimming-
pools, irrigation and water treatment and purification in
general, built with both metal and any type of plastic materials
and plastic derivatives.
Fluidra Group Australia, Pty Ltd, domiciled in Smithfield
(Australia), is mainly engaged in the manufacture, assembly
and distribution of pool equipment and other related
products.
Fluidra Hellas, S.A. domiciled in Aspropyrgos (Greece), is
mainly engaged in the distribution of pool-related products.
Fluidra Holdings Australia, Pty Ltd, domiciled in Smithfield
(Australia), is engaged in the holding and use of equity shares
and securities, and advising, managing and administering the
companies in which it holds an ownership interest.
Fluidra Holdings South Africa Pty Ltd, domiciled in
Johannesburg (South Africa), is engaged in the holding and
use of equity shares and securities, and advising, managing
and administering the companies in which it holds an
ownership interest.
Fluidra India Private Limited, domiciled in Chennai (India), is
mainly engaged in the marketing of pool materials and
chemical water, spa and irrigation treatments.
Fluidra Indonesia, PT, domiciled in Jakarta (Indonesia), has as
its corporate purpose the import and distribution of products
and equipment for swimming-pools, as well as chemical
products and accessories.
Fluidra Industry France, S.A.S., with registered offices in
Perpignan (France), is mainly engaged in the manufacture of
automatic covers for swimming-pools of all types, as well as
the purchase and sale of materials, accessories and products
for swimming*pools.
Fluidra Kazakhstan Limited Liability Company, domiciled
in Almaty City (Kazakhstan), is engaged in the purchase of
swimming-pool material for subsequent sale in the domestic
market.
2024 Annual Financial Report        60
Fluidra Latam Export, LLC, domiciled in Wilmington (US), is
mainly engaged in distributing pool materials in the Latin
American market.
Fluidra Magyarország, Kft, domiciled in Budapest (Hungary),
is mainly engaged in the marketing and assembly of
machinery and accessories for swimming-pools, irrigation and
water treatment and purification.
Fluidra Malaysia SDN.BHD, domiciled in Selangor
(Malaysia), is mainly engaged in the marketing of swimming-
pool materials.
Fluidra Maroc, S.A.R.L., domiciled in Casablanca (Morocco), is
engaged in the import, export, manufacture, marketing, sale
and distribution of spare parts for swimming-pools, irrigation
and water treatment.
Fluidra México, S.A. DE CV, domiciled in Mexico
City (Mexico), is engaged in the purchase and sale, import,
export, storage, manufacture and, in
general, marketing of all types of goods, equipment,
components, machinery, accessories and chemical specialties
for swimming-pools, irrigation and
water treatment.
Fluidra Middle East Fze, domiciled in Jebel Ali (Dubai), is
engaged in the commercialisation of sand, gravel, stones, tiles,
flooring materials, swimming-pools, swimming-pool and water
treatment equipment and related accessories, water cooling
and heating equipment, electronic instruments, pumps,
motors, valves and spare parts, as well as fibreglass products.
Fluidra Montenegro DOO, domiciled in Podgorica
(Montenegro), is mainly engaged in the purchase, sale and
distribution of machinery, equipment, materials, accessories,
products and special equipment for pool and water system
and irrigation maintenance.
Fluidra (N.Z.) Limited, domiciled in North Shore City (New
Zealand), is engaged in the distribution and sale of pool
material.
Fluidra Nordic AB, domiciled in Källered (Sweden), is mainly
engaged in the purchase, sale, import, export of product
categories and products relating to swimming-pools, water
treatment and irrigation.
Fluidra North Amercia LLC (previously called Zodiac Pool
Solutions, LLC), domiciled in Carlsbad (USA) is engaged in the
holding and use of equity shares and securities, and
advising, managing and administering the companies in which
it holds an ownership interest.
Fluidra Österreich GmbH “SSA”, domiciled in Grödig
(Austria), is mainly engaged in the marketing of swimming-
pool and wellness products.
Fluidra Polska, SP. Z.O.O., domiciled in Wroclaw (Poland), is
mainly engaged in the marketing of pool accessories.
Fluidra Romania S.A., domiciled in Bucharest (Romania), is
mainly engaged in the purchase, sale and distribution of
machinery, equipment, materials, accessories, products and
special equipment for pool and water system and irrigation
maintenance.
Fluidra Serbica, D.O.O. Beograd, domiciled in Belgrade
(Serbia), is mainly engaged in the marketing of swimming-pool
material.
Fluidra SI D.O.O., domiciled in Ljubljana (Slovenia), is mainly
engaged in marketing pool-related goods, products and
materials.
Fluidra Singapore, PTE LTD, domiciled in Singapore
(Singapore), is mainly engaged in the marketing of pool-
related accessories.
Fluidra Switzerland, S.A., domiciled in Bedano (Switzerland),
is mainly engaged in the marketing of pool material.
Fluidra Tr Su Ve Havuz Ekipmanlari AS, domiciled in Tuzla
(Turkey), is engaged in the import of equipment, chemical
products and other secondary materials necessary for
swimming-pools, and their subsequent distribution.
Fluidra Tunisie, S.A.R.L., with its registered office in El Manar
(Tunisia), has as its main purpose the provision of
manufacturing services and related activities aimed at
promoting and strengthening the Fluidra Group's activity in
Tunisia.
Fluidra USA, LLC, domiciled in Jacksonville (USA), is engaged
in the marketing of pool-related products and accessories.
Fluidra Vietnam LTD, domiciled in Ho Chi Minh City
(Vietnam), is engaged in advising, allocating and installing pool
filtering systems and water applications, as well as the import,
export and distribution of wholesale and retail products.
Fluidra Waterlinx Pty, Ltd, domiciled in Johannesburg (South
Africa), is mainly engaged in the manufacture and distribution
of swimming-pools, equipment and
spa and garden accessories.
I.D. Electroquímica, S.L.U., domiciled in Alicante (Alicante,
Spain), is engaged in the sale of all types of process
development machines and eletrochemical reactors.
Innodrip, S.L.U., domiciled in Sant Cugat del Vallés
(Barcelona, Spain), is engaged in the rendering of services
aimed at the sustainable use of water.
Inquide, S.A.U., domiciled in Polinyà (Barcelona, Spain), is
mainly engaged in the manufacture of chemical products and
specialties in general, excluding pharmaceutical products.
Kreative Techk, LDA, domiciled in Sintra (Portugal), is
engaged in providing marketing and IT consultancy services,
including business strategy services, market research,
promotion, advertising, sales post-sales and marketing for IT
and software equipment.
2024 Annual Financial Report        61
Manufacturas Gre, S.A.U., domiciled in Munguia
(Vizcaya, Spain), is engaged in the manufacture and marketing
of products, accessories and materials for swimming-
pools, irrigation and water treatment and purification in
general.
NCWG, Sistemas de Gestão de Água, LDA, domiciled in
Sintra (Portugal), is engaged in the sale, maintenance,
representation and distribution of equipment parts for
swimming-pools and water treatment, including the import
and export of chemicals for water treatment and
environmental protection, disinfection systems, fluid handling
and pumps.
Ningbo Dongchuan Swimming Pool Equipment Co., LTD,
domiciled in Ningbo (China), is engaged in the production and
installation of swimming-pool equipment, brushes, plastic and
aluminium products, industrial thermometer, water
disinfection equipment and water testing equipment. Import
and export of technology for own use or as an agent.
Piscines Techniques 2000, S.A.S., domiciled in Perpignan
(France), is engaged in the sale of
spare parts for swimming-pools; the purchase and sale of
swimming-pool equipment and used water systems; the
sale, distribution, marketing, repair and maintenance
of swimming-pool equipment, gardening, irrigation and water
treatment; and technical advice to swimming-pool and water
professionals.
Poolweb, SAS, domiciled in Chassieu (France),
is engaged in the purchase and sale of equipment for pools
and other business areas relating to water and relaxation, in
providing technical assistance to professionals in this industry
and to creating and selling IT programmes used in the
aforementioned activities.
SR Smith, LLC, domiciled in Canby, Oregon (United States),
has as its corporate purpose to engage in any lawful act or
activity that limited liability companies may engage in under
Delaware law, including consulting, brokering, commissions or
investments in other companies.
Sacopa, S.A.U. (absorbing company of Poltank,
S.A.U.), domiciled in Sant Jaume de Llierca (Girona, Spain), is
mainly engaged in the processing, marketing and sale of
plastic materials, as well as the
manufacture, assembly, processing, purchase and sale and
distribution of all types of lighting and
decoration devices and tools. Foreign and domestic trading
activities of all types of goods and products directly and
indirectly related to the above products, their purchase and
sale and distribution. Representation of domestic and foreign
brands and commercial and industrial
enterprises engaged in the manufacture of the
aforementioned products.
SIBO Fluidra Netherlands B.V., domiciled in Veghel (the
Netherlands), has as its corporate purpose to act as a
wholesale technician and to carry out all activities directly or
indirectly related thereto; as well as to incorporate, participate
in and direct the management, to have financial interests in
other companies; and to provide administrative services. It
owns 100% of the share capital of the German company SIBO
Gmbh.
SRS Australia , Pty LTD, domiciled in Brisbane, Queensland
(Australia), is principally engaged in the sale of swimming-pool
cover equipment and materials to both residential and
commercial retail and wholesale customers.
Sunbather Pty LTD, domiciled in Hastings, Victoria (Australia),
is principally engaged in the manufacture and distribution of
swimming-pool heating equipment and thermal pool covers..
Swim & Fun Scandinavia ApS, domiciled in Roskilde
(Denmark), is principally engaged in wholesale trade
transactions relating to swimming-pools and water treatment.
Talleres del Agua, S.L.U., domiciled in Los Corrales de Buelna
(Cantabria, Spain), is engaged in the
building, sale, installation, air-conditioning and maintenance
of swimming-pools, as well as the manufacture, purchase and
sale, import and export of all types of swimming-pool tools.
Taylor Water Technologies LLC, domiciled in Sparks,
Maryland (USA), is principally engaged in the manufacture and
distribution of water testing solutions, testing stations and
test strips for swimming-pools and plastic bottles.
Trace Logistics North, B.V., domiciled in Veghel (Holland), is
engaged in receiving third-party goods in consignment in its
warehouses or premises for their storage, control and
distribution to third parties at the request of its
depositors; performing storage, depositing, loading and
unloading duties and any other function required for
managing the distribution of these goods in accordance with
the instructions of the depositors and arranging and
managing transport.
Trace Logistics, S.A.U., domiciled in Maçanet de
la Selva (Girona, Spain), is engaged in receiving third-party
goods
in consignment in its warehouses or premises for
their storage, control and distribution to third parties at the
request of its depositors; performing storage, loading and
unloading duties and other supplementary activities that are
necessary for managing the distribution of these goods in
accordance with the instructions of the depositors
and arranging and managing transport.
Veico. Com. Br Indústria e Comércio LTDA, domiciled in
Ciudad de Itají, Estado de Santa Catarina (Brazil), has as its
corporate purpose the provision of administrative support,
digitalisation of texts, electronic templates and forms in
general, professional and managerial development courses
and training, as well as the sale of machines and equipment.
Wit Egypt, Egyptian Limited Liability Company, domiciled
in Cairo (Egypt), is mainly engaged in the marketing of
swimming-pool accessories.
2024 Annual Financial Report        62
Ya Shi Tu Swimming Pool Equipment (Shanghai) Co, Ltd,
domiciled in Shanghai (China), is mainly engaged in the
marketing of swimming-pool products.
Zodiac Pool Care Europe, S.A.S. (absorbing company of
Zodiac International, S.A.S.), domiciled in Belberaud (France),
is engaged in the distribution and sale of pool-related
products and accessories.
Zodiac Pool Systems Canada, INC, domiciled in Vancouver
(Canada), is engaged in the distribution and sale of pool-
related products and accessories.
Zodiac Pool Systems, LLC, domiciled in Carlsbad (USA), is
mainly engaged in the manufacture and distribution of several
Group brands relating to pool equipment.
Zodiac Swimming Pool Equipment (Shenzen) Co, Ltd,
domiciled in Shenzen (China), is mainly engaged in the
rendering of technical services for
pool and spa equipment; the distribution, sale, import and
export of pool and
spa products and elements and post-sales services.
ZPES Holdings, S.A.S., domiciled in Belberaud (France), is
engaged in the holding and use of equity shares and
securities, and advising, managing and administering the
companies in which it holds an ownership interest.
Associates consolidated using
the equity method
Astral Nigeria, Ltd., domiciled in Surulere-Lagos (Nigeria), is
engaged in the marketing of swimming-pool products.
Aspire Polymers Pty. LTD, domiciled in Mornington,
Victoria (Australia), is principally engaged in the
manufacture and distribution of a wide range of rubber
rollers.
Blue Factory S.R.L., domiciled in Milan (Italy), has as its
corporate purpose the provision of consultancy services to
both public and private entities related to project design and
implementation, the development, implementation and
marketing of innovative solutions and high-value
technological services. In particular, designing new models of
inclusive sport, leisure and recreational infrastructures, either
ex novo, or through the remodelling of existing facilities and
structures, characterised by environmental sustainability by
achieving a positive social impact and inclusion through the
involvement of families and different social classes; the
execution of the developed projects; the provision of services
related to the management, operation and maintenance of
the developed infrastructures and all related services.
Directors'
Report 2024
Leading today, shaping tomorrow
2024 Annual Financial Report        64
Contents         
2024 Annual Financial Report        65
1. GENERAL BUSINESS OUTLOOK
1. General business outlook
1.1. Outlook and results
Revenue decreased by €37,195 thousand with respect to the
corresponding prior year period. This decrease is a result of
fewer dividends received this year from Fluidra Commercial,
S.A.U. (formerly Finco, S.L.U.), the only Group company that
Fluidra, S.A. has a direct stake in at 31 December 2024
(see note 7). €179,346 thousand have been received.
There has been an increase in Other operating expenses of
€18,251 thousand compared to the previous year.
Due to the main changes mentioned above, operating results
for the year go from €197 million in 2023 to a €139 million in
2024.
If we analyse the balance sheet at 31 December 2024 compared
to the balance sheet at 31 December 2023, there are no
significant changes other than the investment in own shares
reflected under Own shares and equity holdings (which went
from €-42,155 thousand in 2023 to €-50,407 thousand in 2024).
The bank borrowings heading has a zero balance, due to the
liquidity generated by the Group (€24.7 million in 2023), (MARF)
(see note 12).
The average supplier payment period is 56 days.
1.2. General description of risk policy
In terms of managing the risk policy, the Company has not
modified its management of financial market risks (exchange
rate and interest rate), maintaining the same hedging policies.
1.3. Treasury shares
During 2023. the Company has carried out several purchase and
sale transactions of treasury shares (5,007,687 shares
purchased and 5,030,840 sold). At year end, the Company
owned 2,285,612 treasury shares, which account for 1.17% of
share capital, at a cost of €50,407 thousand.
1.4. Research, development and
technological innovation
No investments have been made in research, development and
technological innovation during 2024.
1.5. Environment
At 31 December 2024 there are no significant assets for the
protection or improvement of the environment and the
Company has not incurred any major expenses of an
environmental nature during either year.
1.6. Personnel
The number of employees and directors at year end has
increased by 98 compared to 2023.
1.7. Non-financial information and
diversity - Act 11/2018
This information required by Act 11/2018 is included in the
consolidated directors’ report which forms part of the
Consolidated Annual Report. The individual directors’ report is
exempt from reporting requirements.
1.8. Subsequent events
Annual Corporate
Governance Report
2024 Annual Financial Report        67
Issuer Identification Particulars
Year-end date:
31/12/2023
Tax Identification Code:
A-17728593
Registered name:
FLUIDRA, S.A.
Registered office:
AVENIDA ALCALDE BARNILS, 69 (SANT CUGAT DEL VALLÈS) BARCELONA
2024 Annual Financial Report        68
A. Ownership structure
A.1. Complete the following table regarding the share
capital and attached voting rights, including any rights
corresponding to loyalty shares, at the year-end:
Indicate whether the Company’s Articles of Association
provide for double votes for loyalty:
☐ Yes
☑ No
Date of last
change
Share capital €
Number of
shares
Number of
voting rights
14/12/2022
192,129,070.00
192,129,070.00
192,129,070.00
The share capital of Fluidra S.A. (hereinafter “Fluidra” or the
“Company”) was decreased by € 3,500,000 on 14th December
2022, through the redemption of 3,500,000 shares with a par
value of €1 each. The current share capital is € 192,129,070
divided into 192,129,070 shares with a par value of €1 each.
The corresponding capital decrease deed was granted on 15th
December 2022 before the Notary Public of Barcelona Mr
Ramón García-Torrent Carballo, under number 7440 of his
protocol, and was filed with the Mercantile Registry on that
same date. It was registered in the Mercantile Registry of
Barcelona on 10th January 2023, with effects on the date of the
filing entry, i.e. 15th December 2022.
Indicate whether there are different classes of shares with
different rights attaching thereto:
☐ Yes
☑ No
A.2. List the direct and indirect holders of significant
shareholdings in the Company at the end of the year,
including members of the board of directors who have a
significant shareholding:
Name of shareholder
% voting rights
attached to shares
% voting rights
through financial instruments
% of total voting
rights
Direct
Indirect
Direct
Indirect
RHÔNE CAPITAL LLC
0.00
11.67
0
0
11.67
Mr JUAN PLANES VILA
0,03
7.33
0
0
7.36
EDREM, S.L
0,31
6.62
0
0
6.93
BOYSER, S.L.
1,17
6.63
0
0
7.8
CONCERTED ACTION
0
25.45
0
0
28.29
Mr MANUEL PUIG ROCHA
0
7.00
0
0
7.41
G3T, S.L.
5.73
0
0
0
5.73
BLACKROCK EUROPEAN MASTER HEDGE
FUND LIMITED
0
0
0
3.02
3.02
BLACKROCK INC.
0
1.2
0
5
6.2
PISCINE LUXEMBOURG HOLDINGS 1, S.A.R.L.
11.67
0
0
0
11.67
DISPUR, S.L.
0.73
6.6
0
0
7.33
PIUMOC INVERSIONS, S.L.U.
5.6
0
0
0
5.6
ANIOL, S.L.
0.63
5.6
0
0
6.23
MARATHON ASSET MANAGEMENT LIMITED
0
3.02
0
0
3.02
Mr ROBERT GARRIGOS RUIZ
0
6.23
0
0
6.23
CAPITAL RESEARCH AND MANAGEMENT
COMPANY
0
5.31
0
0
5.31
All the percentage shareholdings mentioned above have been
recalculated on the basis of the share capital following the
capital decrease on 14th December 2022: € 192,129,070. Some
of the percentages indicated on the website of the Spanish
National Securities Market Commission (Comisión Nacional del
Mercado de Valores – CNMV) have been calculated on the basis of
the previous share capital of €195,629,070.
2024 Annual Financial Report        69
Breakdown of the indirect shareholdings:
Name of indirect shareholder
Name of direct shareholder
% voting rights
attached to
shares
% voting rights
through financial
instruments
% of total voting
rights
RHÔNE CAPITAL LLC
PISCINE LUXEMBOURG HOLDINGS 1, S.A.R.L.
11.67
0
11.67
Mr JUAN PLANES VILA
DISPUR, S.L.
0.73
0
0.73
Mr JUAN PLANES VILA
DISPUR POOL, S.L.
6.6
0
6.6
Mr MANUEL PUIG ROCHA
SCHWARZSEE 2018, S.L.
7.41
0
7.41
BOYSER, S.L.
BOYSER CORPORATE PORTFOLIO, S.L.
6.63
0
6.63
EDREM, S.L.
EDREMCARTERA, S.L.U.
6.62
0
6.62
CONCERTED ACTION
DISPUR POOL, S.L.
6.6
0
6.6
CONCERTED ACTION
PIUMOC INVERSIONS, S.L.U.
5.6
0
5.6
CONCERTED ACTION
EDREMCARTERA, S.L.U.
6.62
0
6.62
CONCERTED ACTION
BOYSER CORPORATE PORTFOLIO, S.L.
6.63
0
6.63
ANIOL, S.L.
ANIOL, S.L.
0.63
0
0.63
ANIOL, S.L.
PIUMOC INVERSIONS, S.L.U.
5.6
0
5.6
CONCERTED ACTION
DISPUR, S.L.
0.73
0
0.73
CONCERTED ACTION
ANIOL, S.L.
0.63
0
0.63
CONCERTED ACTION
EDREM, S.L.
0.31
0
0.31
CONCERTED ACTION
BOYSER, S.L.
1.17
0
1.17
State the most significant movements in the shareholding
structure that have occurred during the year:
Most significant movements
On 14th February 2024, T. ROWE PRICE ASSOCIATES, INC.
reduced its shareholding, specifically to 2.98%, and is therefore
now below the threshold of 3% of the Company’s capital.
A.3. Disclose the shareholding, irrespective of the
percentage, at the end of the year held by members of
the board of directors who hold voting rights attached
to shares in the Company or through financial
instruments, excluding directors identified in section A.2
above:
Name of director
% voting rights attached to
shares (including loyalty
votes)
% voting rights through
financial instruments
% of total
voting rights
Of the total % voting rights
attributed to shares,
indicate where applicable
the % of additional votes
attributed to
Direct
Indirect
Direct
Indirect
Direct
Indirect
Mr ELOY PLANES CORTS
0.25
0
0
0
0.25
0
0
Mr BRUCE WALKER BROOKS
0.21
0
0
0
0.21
0
0
Mr BRIAN MCDONALD
0
0
0
0
0
0
0
Mr BERNARDO CORBERA SERRA
0.11
0.15
0
0
0.26
0
0
Mr OSCAR SERRA DUFFO
0.03
0
0
0
0.03
0
0
Mr BERNAT GARRIGOS
0
0
0
0
0
0
0
% of total voting rights held by members of the Board of Directors
8.16
2024 Annual Financial Report        70
Breakdown of the indirect shareholding:
Name of director
Name of direct
shareholder
% voting rights
attached to shares
(including loyalty
votes)
% voting rights
through financial
instruments
% of total
voting rights
Of the total % voting
rights attached to
shares, indicate where
applicable the % of
additional votes
attributed to loyalty
shares
Mr BERNARDO CORBERA SERRA
BERAN CARTERA S.L.U
0.15
0
0.15
0
Breakdown of the total percentage of voting rights represented on the Board:
Total % voting rights represented on the board of directors
53.85
The shareholder Piscine Luxembourg Holdings 1, S.A.R.L., a
wholly owned subsidiary of Rhône Capital LLC, which has a
shareholding of 11.67% in the Company’s share capital, is
represented on the Board of Directors of the Company
through the proprietary directors Mr José Manuel Vargas
Gómez and Mr Michael Steven Langman.
The shareholder Boyser, S.L., which has a total shareholding,
direct and indirect, of 7.80% in the Company’s share capital, is
represented on the Board of Directors of the Company
through the proprietary director Mr Óscar Serra Duffo.
The shareholder Edrem, S.L., which has a total shareholding,
direct and indirect, of 6.93% in the Company’s share capital, is
represented on the Board of Directors of the Company
through the proprietary director Mr Bernardo Corbera Serra.
The shareholder Dispur, S.L., which has a total shareholding,
direct and indirect, of 7.33% in the Company’s share capital, is
represented on the Board of Directors of the Company
through the executive director Mr Eloy Planes Corts.
The shareholder Aniol, S.L., which has a total shareholding,
direct and indirect, of 6.23% in the Company’s share capital, is
represented on the Board of Directors of the Company
through the proprietary director Mr Bernat Garrigós Castro.
The shareholders Schwarzsee 2018, S.L. (controlled by Mr
Manuel Puig Rocha) and G3T, S.L. which have a total combined
direct and indirect shareholding of 13.14% in the Company’s
share capital, are represented on the Board of Directors of the
Company through the proprietary director Mr Manuel Puig
Rocha.
A.4. State any family, commercial, contractual or
corporate relationships between owners of significant
shareholdings, insofar as they are known to the
Company, except where they are immaterial or derive
from ordinary commercial transactions, except those
reported in section A.6:
Name of related parties
Type of relationship
Brief description
No data
A.5. State any commercial, contractual or corporate
relationships between owners of significant
shareholdings and the Company and/or the group,
except where they are immaterial or derive from
ordinary commercial transactions of the Company:
Name of related parties
Type of relationship
Brief description
No data
A.6. Describe any relationships, unless insignificant for
both parties, between significant shareholders or
shareholders represented on the board and directors, or
their representatives in the case of board members that
are legal persons.
Explain, as the case may be, how significant shareholders are
represented. Specifically, state those directors who have been
appointed to represent significant shareholders, those whose
appointments were proposed by significant shareholders, or
are related to significant shareholders and/or companies in
their group, specifying the nature of such ties. In particular,
mention the existence, identity and post of members of the
board, or representatives of directors, of the listed Company
who are in turn members of the board or their
representatives in companies that hold significant
shareholdings in the listed Company or in group companies of
these significant shareholders:
2024 Annual Financial Report        71
Name of related director
or representative
Name of related significant
shareholder
Name of the group
Company of the
significant shareholder
Description of relationship/post
Mr JOSÉ MANUEL VARGAS
GÓMEZ
PISCINE LUXEMBOURG
HOLDINGS 1, S.A.R.L.
RHÔNE CAPITAL LLC
José Manuel Vargas Gómez is General Director of
Rhône Group
Mr MANUEL PUIG ROCHA
G3T, S.L.
G3T, S.L.
Manuel Puig Rocha was appointed at the proposal
of the shareholder G3T, S.L. (together with
Schwarzsee, 2018, S.L.) through a shareholders’
agreement between the two companies dated 5th
May 2023.
Mr MANUEL PUIG ROCHA
SCHWARZSEE 2018, S.L.
MAVEOR, S.L.
Manuel Puig Rocha is Sole Director of Maveor, S.L.
Mr BERNARDO CORBERA SERRA
EDREM, S.L.
EDREM, S.L.
Bernardo Corbera Serra is CEO of Edrem, S.L.
Mr ÓSCAR SERRA DUFFO
BOYSER, S.L.
BOYSER, S.L.
Óscar Serra Duffo is chairman of the Board of
Directors of Boyser, S.L.
Mr ELOY PLANES CORTS
DISPUR, S.L.
DISPUR, S.L.
Eloy Planes Corts is a director of Dispur, S.L.
Mr BERNAT GARRIGÓS CASTRO
PIUMOC INVERSIONS, S.L.U.
ANIOL, S.L.
Bernat Garrigós Castro is CEO of Aniol, S.L.
Mr BRUCE WALKER BROOKS
PISCINE LUXEMBOURG
HOLDINGS 1, S.A.R.L.
RHÔNE CAPITAL LLC
The appointment of Bruce Walker Brooks as a
director was proposed by Rhône Group
Mr MICHAEL STEVEN LANGMAN
PISCINE LUXEMBOURG
HOLDINGS 1, S.A.R.L.
RHÔNE CAPITAL LLC
Michael Steven Langman is General Director of
Rhône Group
A.7. State whether the Company has been notified of
any shareholders’ agreements affecting the Company
pursuant to the provisions of articles 530 and 531 of the
Companies Act (Ley de Sociedades de Capital). If so,
briefly describe these agreements and list the
shareholders bound by them:
☑ Yes
☐ No
2024 Annual Financial Report        72
Parties to the
shareholders’ agreement
% share capital
affected
Brief description of the agreement
Date of expiration of the
agreement, if any
PISCINE LUXEMBOURG
HOLDINGS 1, S.A.R.L., PIUMOC
INVERSIONS, S.L.U., ANIOL, S.L.,
EDREM, S.L., DISPUR, S.L.,
BOYSER, S.L., EDREM CARTERA,
S.L.U., DISPUR POOL, S.L., BOYSER
CORPORATE PORTFOLIO, S.L.
39.96
On 03/11/2017 a shareholders’ agreement was
formalized by the same shareholders of Fluidra
who are parties to the shareholders’ agreement
initially formalized on 05/09/2007 and Piscine
Luxembourg Holdings 1, S.à.r.l. (controlled by
Rhône Capital LLC), reported through Relevant
Event no. 258222. This shareholders’ agreement
came into effect on 02/07/2018, which is the date
of effects of the cross-border merger by
absorption by Fluidra, S.A. (transferee) of Piscine
Luxembourg Holdings 2 S.à.r.l. (transferor)
reported by the Company through Relevant Event
no. 258221.
Regulated in Clause 20 of the
Agreement, available on
www.fluidra.com, Shareholders
and Investors, Corporate
Governance, Shareholders’
Agreements.
G3T, S.L., SCHWARZSEE 2018, 3.L.
13.14
On 05/05/2023, an agreement was formalized
between the shareholders Schwarzsee 2018, S.L.
(formerly Banelana, S.L.) and G3T, S.L. The purpose
of this agreement is to regulate the terms and
conditions under which Schwarzsee 2018, S.L. And
G3T, S.L. proposed to Fluidra the appointment of a
proprietary director (Mr Manuel Puig Rocha)
representing both shareholders, and how their
rights as shareholders of Fluidra will be exercised
for the implementation and management of the
proposal made.
Regulated in Clause 3 of the
Agreement, available
Shareholders and Investors,
Corporate
Governance, Shareholders’ Agree
ments.
PIUMOC INVERSIONS, S.L.U.,
ANIOL, S.L., EDREM, S.L., DISPUR,
S.L., BOYSER, S.L., EDREM
CARTERA, S.L.U., DISPUR POOL,
S.L., BOYSER CORPORATE
PORTFOLIO, S.L.
28.29
On 05/09/2007 a shareholders’ agreement was
formalized by certain shareholders in Fluidra, S.A.
which was reported as a Relevant Event to the
CNMV on 02/01/2008 with no. 87808 (the
“Syndication Agreement”). The Syndication
Agreement has been modified on 7 occasions (First
novation: 10/10/2007; Second novation:
01/12/2010, Relevant Event no. 134239; Third
novation: 30/07/2015, Relevant Event no.
227028; including supplementary agreement of
30/09/2015, Relevant Event no. 229114; Fourth
novation: 27/07/2017 Relevant Event no. 255114;
Fifth novation 03/11/2017, Relevant Event
no. 258223, modified on 25/04/2018, Relevant
Event no. 264650, subrogations on 23/05/2018
Relevant Event no. 266060, and supplementary
agreement to the Fifth Novation on 27/07/2018,
Relevant Event no. 268610; Sixth novation
22/12/2020, Notice of Other Relevant Information
no. 6355; Seventh novation 07/05/2024, Notice of
Other Relevant Information no. 28491).
Regulated in Clause One, Clause
Two, Clause Eight and Clause
Nine of the Syndication
Agreement, available on
www.fluidra.com, Shareholders
and Investors, Corporate
Governance, Shareholders’
Agreements.
State whether the Company is aware of the existence of
concerted actions among its shareholders. If so, briefly
describe them:
☑ Yes
☐ No
Parties to the concerted action
% share capital
affected
Brief description of the concerted action
Date of expiration, if any
PIUMOC INVERSIONS, S.L.U.,
ANIOL, S.L., EDREM, S.L., DISPUR,
S.L., BOYSER, S.L., EDREM
CARTERA, S.L.U., DISPUR POOL,
S.L., BOYSER CORPORATE
PORTFOLIO, S.L.,
28.29
The Syndication Agreement establishes that the
parties bound by it, in relation to the shares
referred to in it, undertake to exercise their voting
rights at General Meetings of Fluidra as indicated in
the Syndication Agreement.
Regulated in Clause One and
Clause Seven of the Agreement,
available on www.fluidra.com,
Shareholders and Investors,
Corporate Governance,
Shareholders’ Agreement.
2024 Annual Financial Report        73
Expressly state whether any of such agreements,
arrangements or concerted actions have been modified or
terminated during the financial year:
On 07/05/2024, the seventh novation of the Fluidra Vote and
Share Syndication Agreement between the current syndicated
family shareholders of the Company, initially formalized on 5th
September 2007 and subsequently modified on 10th October
2007, 1st December 2010, 30th July and 30th September 2015, 27th
July and 3rd November 2017, 25th April and 27th July 2018 and
22nd December 2020. This new Vote and Share Syndication
Agreement sets out the intention of the current syndicated
family shareholders in the Company to extend the term of the
syndication, modify the scope of the shares in Fluidra covered
by the syndication and modify the regime for transfer of shares
in Fluidra, among others. 
A.8. State whether there is any individual or Company
that exercises or could exercise control over the
Company in accordance with article 5 of the Securities
Market Act (Ley del Mercado de Valores). If so, identify
the party in question:
☐ Yes
☑ No
A.9. Complete the following tables regarding the
Company’s own shares:
At year end:
Number of direct
shares
Number of indirect
shares (*)
Total % of share
capital
2,285,612
1.19
(*) Through:
Name of direct shareholder
Number of direct
shares
No data
Explain any significant variations occurring during the year:
Explain significant variations
The Company implemented a temporary own share repurchase
programme on 17th July 2023, following approval by the Board of
Directors on 11th July 2023 and subsequent publication through a
communication of Other Relevant Information dated 12th July
2023 under registration number 23562. The repurchase
programme was executed for the purpose of implementing the
Fluidra incentivized global share repurchase programme for
employees of the Fluidra Group approved by the Company’s
Ordinary General Shareholders’ Meeting held on 10th May 2023,
as item ten of the agenda (the “Global Plan”).
This repurchase programme should initially have ended on 16th
December 2024. However, at its meeting held on 29th October
2024, the Board of Directors resolved to extend the temporary
own share repurchase programme associated to the Global Plan,
under the provisions of and within the limits of the authorization
granted by the General Shareholders’ Meeting of 5th May 2022.
This repurchase programme has been extended for the purpose
of continuing with the Global Plan.
In accordance with the Global Plan, which will be extended from
January 2025 to December 2026, the maximum number of shares
to be acquired under the repurchase programme continues to be
set at 500,000 Fluidra shares, representing approximately 0.26%
of the Company’s share capital on the date the resolution was
passed, and the maximum amount assigned to the repurchase
programme continues to be 12.5 million euros, in the same terms
and conditions as are set out in the repurchase programme.
In the framework of the Global Plan, the Company acquired
40,183 own shares in 2023, which were immediately handed over
to the employees who had subscribed to the Global Plan. In turn,
the Company acquired 51,249 own shares in 2024, which were
immediately handed over to the employees who had subscribed
to the Global Plan.
A.10. Describe the terms and conditions and the
duration of the powers currently in force given by the
shareholders to the board of directors in order to issue,
repurchase or transfer own shares of the Company:
At the Ordinary General Shareholders’ Meeting held on 5th May
2022, it was resolved to (i) authorize the Company to proceed
with the derivative acquisition of own shares, directly or through
group companies, and with the express power to reduce the
share capital to redeem own shares, delegating to the Board of
Directors the necessary powers to execute the resolutions
passed by the General Meeting in this regard, rendering the
previous authorization without effect, and (ii) authorize it to
apply the portfolio of own shares, as the case may be, to the
execution or coverage of remuneration systems. The
authorization granted is valid for a term of five (5) years as of
the date the resolution is passed, i.e. until 5th May 2027.
At the Board meeting of 14th December 2022, it was resolved, in
the context of this authorization granted to the Board of
Directors, to authorize the Chairman/CEO and the Co-CEO,
jointly and severally and indistinctly, to proceed with the
derivative acquisition and disposal of own shares up to a
maximum number of shares not exceeding five per cent (5%) of
the Company’s share capital. This authorization was approved to
be valid until 31st December 2023.
In addition, at the Board meeting held on 13th December 2023,
it was resolved, in the context of this authorization granted to
the Board of Directors, to authorize the Chairman/CEO and the
Co-CEO, jointly and severally and indistinctly, to proceed with
the derivative acquisition and disposal of own shares up to a
maximum number of shares not exceeding five per cent (5%) of
the Company’s share capital. This authorization was approved to
be valid until 31st December 2024.
Finally, at the Board meeting held on 12th December 2024, it was
resolved, in the context of the authorization granted to the
2024 Annual Financial Report        74
Board of Directors, to authorize the Chairman/CEO and the Co-
CEO, jointly and severally and indistinctly, to proceed with the
derivative acquisition and disposal of own shares up to a
maximum number of shares not exceeding five per cent (5%) of
the Company’s share capital. This authorization is valid until 31st
December 2025.
A.11. Estimated free float:
%
Estimated free float
27.41
To calculate the free float, the percentage shareholders included
in section A.2, among others, including both the voting rights
attached to shares and voting rights through financial
instruments, have been discounted, in accordance with the
provisions established in CNMV Circular 3/2021, of 28th
September.
A.12. State whether there are any restrictions (under the
Articles of Association, legislative or of any other nature)
on the transfer of securities and/or any restrictions on
voting rights. In particular, disclose the existence of any
restrictions that might hinder a takeover of the
Company through the acquisition of its shares on the
market, and any prior authorization or communication
arrangements in respect of acquisitions or transfers of
the Company’s financial instruments that are applicable
to it by virtue of sector-specific regulation.
☑ Yes
☐ No
Description of the restrictions
The redrafted text of the vote and share syndication agreement
formalized on 7th May 2024 establishes that the syndicated
shares may be freely acquired by shareholders or by third
parties with no limitations other than those established by
applicable legislation. In any case, any syndicated shareholder
who wishes, when he or she deems appropriate within the term
of the syndication, to transfer all or part of his/her syndicated
shares, provided that the aforesaid transfer affects syndicated
shares that represent 0.5% or more of
Fluidra’s share capital at that time, must notify each and every
one of the group leading companies that shareholder does not
belong to of his/her intention to transfer syndicated shares, at
least thirty (30) calendar days prior to the date on which the
transfer is to take effect, using any written means that assures
reception thereof, stating the n umber of syndicated shares the
shareholder wishes to transfer. The term of the syndication
refers to the period between the date on which the Fluidra
shares were admitted for trading (i.e. 31st October 2007) and the
first of the following dates: (i) 30 th June 2027, (ii) the date on
which the obligation may arise to submit a takeover bid for all
the securities of Fluidra, in accordance with the provisions of
Royal Decree 1066/2007, of 27th July, on the regime of takeover
bids. The agreement also establishes the mechanism for
syndicating the votes attached to the syndicated shares.
In turn, the shareholders’ agreement formalized on 3rd
November 2017 between certain shareholders of Fluidra (the
“Current Shareholders”) and Piscine Luxembourg Holdings 1,
S.à.r.l. (a Company controlled by Rhône Capital LLC) (the “SHA”)
establishes a series of rules and commitments, including a pre-
emption right, for transfers by Piscine Luxembourg Holdings 1,
S.à.r.l. after 24 months, provided that a series of circumstances
and shareholding thresholds are met. In relation to the above,
on 26th June 2019 Piscine Luxembourg Holdings 1, S.à.r.l. carried
out a private placement, having received prior authorization
from the Current Shareholders, through the accelerated
placement addressed exclusively to eligible investors of
7,850,000 shares representing approximately 4% of the
Company’s share capital. Subsequently, on 18th November 2020,
Piscine Luxembourg Holdings 1, S.à.r.l completed a second
private placement, through an accelerated placement aimed
exclusively at qualifying investors, of 12,121,212 shares
representing approximately 6.2% of the Company’s share
capital. In 2021, Piscine Luxembourg Holdings 1, S.a.r.l. carried
out three private placements, through accelerated placements
aimed exclusively at qualifying investors, for a total of
40,600,000 shares representing approximately 20.71% of the
Company’s share capital. Following these accelerated
placements, Piscine Luxembourg Holdings 1, S.à.r.l. held
22,428,788 shares in the Company, representing approximately
11.47% of the capital, which after the capital decrease carried
out by the Company on 14th December 2022 by redeeming
3,500,000 own shares, represented 11.67% of the Company’s
share capital.
A.13. State whether the general shareholders’ meeting
has approved the adoption of anti-takeover measures
pursuant to the provisions of Act 6/2007.
☐ Yes
☑ No
If so, describe the measures approved and the terms on which
the restrictions will become ineffective:
A.14. State whether the Company has issued securities
that are not traded on a regulated market in the
European Union.
☐ Yes
☑ No
If applicable, specify the different classes of shares and the
rights and obligations attaching to each class of shares:
2024 Annual Financial Report        75
B. General Shareholders’ Meeting
B.1. State and, if applicable, describe whether there are
differences with respect to the minimum requirements
set out in the Companies Act in connection with the
quorum needed to hold a valid general shareholders’
meeting:
☐ Yes
☑ No
B.2. State and, if applicable, describe any differences
from the rules set out in the Companies Act for the
adoption of corporate resolutions:
☐ Yes
☑ No
B.3. State the rules applicable to the amendment of the
Company’s Articles of Association. In particular, disclose
the majorities provided for amending the Articles of
Association, and any rules provided for the protection of
shareholders’ rights in the amendment of the Articles of
Association.
The procedure for amending the Articles of Association must
conform to the provisions of article 285 and following of the
Companies Act, which require approval by the General
Shareholders’ Meeting, with the quorum and majorities
established in articles 194 and 201 of the aforesaid Act, as well
as the requirement to draw up and make available to the
shareholders a mandatory report by the directors justifying the
amendment. Article 27 of the Articles of Association and article
15 of the General Meeting Regulations set out the principle
contained in article 194 of the Companies Act and establish that
in order for an ordinary or extraordinary General Meeting to
resolve validly on any amendment of the Articles of Association,
the attendance, in person or through a representative, of
shareholders holding at least fifty per cent of the share capital
with voting rights is required on the first call.
On the second call, twenty-five per cent of the aforesaid capital
will be sufficient. Article 24 of the General Meeting Regulations
regulates the procedure for voting on proposed resolutions of
the General Shareholders’ Meeting, establishing, in the case of
amendments to the Articles of Association, that each article or
group of articles of sufficient entity is to be voted on separately.
B.4. State data on attendance at general shareholders’
meetings held during the year this report refers to and
for the two previous years:
Attendance
% remote voting
Date of general meeting
% shareholders
present in person
% represented
Electronic voting
Other
Total
5/5/2022
3.32
83.28
0
0.41
87.01
Of which floating capital
0.07
33.84
0
0.41
34.32
10/5/2023
8.67
77.33
0
0.45
86.45
Of which floating capital
0.17
32.25
0
0.45
32.87
8/5/2024
14.34
70.6
0
0.41
85.35
Of which floating capital
0.10
30.7
0
0.41
31.21
B.5. State whether any item on the agenda of the
general shareholders’ meetings held during the year has
not been approved by the shareholders for any reason:
☐ Yes
☑ No
B.6. State whether there are any restrictions in the
Articles of Association requiring a minimum number of
shares in order to attend the general meeting, or to vote
remotely:
☐ Yes
☑ No
B.7. State whether it has been established that certain
decisions, other than those established by law, involving
an acquisition, disposal, or contribution to another
Company of essential assets or similar corporate
operations must be submitted for approval to the
general shareholders’ meeting:
☐ Yes
☑ No
2024 Annual Financial Report        76
B.8. State the address and method for accessing the
Company’s website to access information on corporate
governance and other information on general
shareholders’ meetings that must be made available to
shareholders through the Company’s website:
Following the route to SHAREHOLDERS AND INVESTORS
the following will appear:
STOCK EXCHANGE INFORMATION
REPORTING CENTER
RELEVANT EVENTS
CORPORATE
GOVERNANCE CONTACT
2024 Annual Financial Report        77
C. Company management structure
C.1. Board of Directors
C.1.1. Maximum and minimum number of directors
established in the Articles of Association and the number set
by the general shareholders’ meeting:
Maximum number of directors
14
Minimum number of directors
14
Number of directors established by the General Meeting
14
There are no observations in this regard.
C.1.2. Complete the following table on members of the board:
Name of director
Representative
Type of
director
Position on the
board
Date of first
appointment
Date of last
appointment
Selection procedure
Mr JOSÉ MANUEL VARGAS
GÓMEZ
Proprietary
DIRECTOR
2/7/2018
5/5/2022
GENERAL MEETING
RESOLUTION
Ms ESTHER BERROZPE
GALINDO
Independent
DIRECTOR
6/9/2019
8/5/2024
GENERAL MEETING
RESOLUTION
Mr MANUEL PUIG ROCHA
Proprietary
DIRECTOR
10/5/2023
10/5/2023
GENERAL MEETING
RESOLUTION
Mr BERNARDO CORBERA
SERRA
Proprietary
DIRECTOR
5/9/2007
6/5/2021
GENERAL MEETING
RESOLUTION
Mr ÓSCAR SERRA DUFFO
Proprietary
VICE-CHAIRMAN
5/9/2007
6/5/2021
GENERAL MEETING
RESOLUTION
Mr JORGE VALENTÍN
CONSTANS FERNÁNDEZ
Independent
LEAD INDEPENDENT
DIRECTOR
5/5/2015
10/5/2023
GENERAL MEETING
RESOLUTION
Mr ELOY PLANES CORTS
Executive
CHAIRMAN
31/10/2006
6/5/2021
GENERAL MEETING
RESOLUTION
Mr BERNAT GARRIGÓS
CASTRO
Proprietary
DIRECTOR
5/5/2022
5/5/2022
GENERAL MEETING
RESOLUTION
Ms AEDHMAR HYNES
Independent
DIRECTOR
10/5/2023
10/5/2023
GENERAL MEETING
RESOLUTION
Mr BRUCE WALKER BROOKS
Other External
DIRECTOR
2/7/2018
5/5/2022
GENERAL MEETING
RESOLUTION
Mr MICHAEL STEVEN
LANGMAN
Proprietary
DIRECTOR
2/7/2018
5/5/2022
GENERAL MEETING
RESOLUTION
Mr BRIAN MC DONALD
Independent
DIRECTOR
6/9/2019
8/5/2024
GENERAL MEETING
RESOLUTION
Ms BÁRBARA BORRA
Independent
DIRECTOR
30/12/2021
5/5/2022
GENERAL MEETING
RESOLUTION
Ms OLATZ URROZ GARCIA
Independent
DIRECTOR
8/5/2024
8/5/2024
GENERAL MEETING
RESOLUTION
Total number of directors
14
State any directors that have left the board, either through
resignation or by a resolution of the General Meeting, during the
reporting period:
Name of director
Type of director at
time of leaving
Date of last
appointment
Date director left
Specialized committees on
which director served
State whether director left
before end of term
No data
2024 Annual Financial Report        78
C.1.3.Complete the following tables concerning board
members and their categories:
Executive Directors
Name of director
Position within
the Company’s
structure
Profile
Mr ELOY PLANES
CORTS
Executive Chairman
- CEO
Born in 1969, Eloy Planes Corts holds a Degree in Industrial Engineering from the Polytechnic
University of Catalonia (UPC) and a Master’s Degree in Business Management from EADA. A
member of the second generation of one of the founding families, Eloy joined Fluidra (then
“Astral”) as R&D Manager in 1994 and in 1998 was appointed as Logistics Manager and then as
General Manager of AstralPool España, leading the mergers of different commercial companies
in Spain and gaining in-depth knowledge of the business. In 2000, Eloy took on the General
Management of AstralPool, continuing with the expansion of the business in international
markets. In 2002, the family group took a decisive step: under the leadership of Eloy as General
Manager, the Fluidra group was created (under the name of “Aquaria”), bringing together the
pool production and distribution companies. Banco Sabadell acquired 20% of the share capital
and joined the four owner families. Eloy led the change in logistical model. In 2006, Fluidra
reached its current size with the incorporation of four previously independent partners. In the
same year, Eloy was appointed CEO of the Fluidra group, leading the company to significant
milestones: its flotation in 2007, its restructuring in 2008/09, accompanied by an acceleration of
the internationalization process in the commercial aspect and the application of lean
management in the industrial part of the group. In 2016, Eloy took on the role of Executive
Chairman of Fluidra. In that same year he created the Fluidra Foundation. In 2017 a major
transformational corporate operation led by Eloy was announced: the merger with US company
Zodiac, which was completed in July 2018. In 2021, Fluidra was included in the IBEX-35 index and
closed the year with historic turnover of more than 2 billion euros.
Eloy is Executive Chairman of the Board of Directors of Fluidra. He is also the President of the
Barcelona International Pool Trade Show and of the Catalunya Cultura Foundation and a director
of Dispur, S.L., and he natural person who acts as the representative of Dispur, S.L. as Chairman
and Director of Fixe Climbing, S.L. Since September 2023, Eloy Planes has also been First Vice-
President of the Chamber of Commerce of Barcelona.
Total number of executive directors
1
% of total board
7.14
There are no observations.
2024 Annual Financial Report        79
External Propietary Directors
Name of director
Name of significant
shareholder
represented by the
director or that
proposed the director’s
appointment
Profile
Mr JOSÉ MANUEL
VARGAS GÓMEZ
RHÔNE CAPITAL LLC
Born in 1970, José Manuel Vargas joined Rhône in 2007 as a senior advisor and became
managing director in 2017. In April 2021, Mr Vargas temporarily stepped aside from the
post of managing director of Rhône and returned to his role as senior advisor to dedicate
his efforts to Maxam, a company in Rhône’s investment portfolio, as he had undertaken the
post of Executive Chairman and CEO of Maxam in May 2020. With effect from 1st January
2024, Mr Vargas resumed his role as managing director of Rhône, and has taken on
oversight responsibilities for Rhône’s European operations from the firm’s London office.
For this reason he resigned as CEO of Maxam and continues to be the Chairman of the
multinational as part of Rhône’s ongoing supervision of its investment. Previously he had
been Chairman and CEO of Aena SME, S.A., and led the restructuring process, partial
privatization and IPO of the company in 2015. Before joining Aena, he held senior
management posts in Vocento, S.A. where he was Financial Director until he was promoted
to CEO and was also CEO of ABC. Prior to his time in the communication industry, he had
been financial director and general secretary of JOTSA (of the Philipp Holzmann group). In
addition to his role as Chairman of Maxam, Mr Vargas is also part of the Board of Directors
of Fluidra, S.A. Throughout his career, Mr Vargas has also served on the Board of Directors
of other companies, such as Aena, Vocento, the newspaper ABC, the COPE radio station,
Net TV, the newspaper El Correo and Wellbore Integrity Solutions.
In early 2024 he was also appointed as a director of two companies: ASK Chemicals, which
is part of Rhône’s portfolio, and Petra Diamonds, and was appointed Chairman of the latter
in November 2024. In 2015 he won the prize for Best Executive of the Year awarded by the
Spanish Executives Association (Asociación Española de Directivos - AED) and was named
Person of the Year in the economic and financial field by Spanish economic newspaper El
Economista. Mr Vargas has a degree in Economic and Business Sciences from the
Complutense University of Madrid and holds a Law Degree from UNED. He is also a
chartered accountant.
Mr MANUEL PUIG
ROCHA
G3T, S.L.
Born in 1961, Manuel Puig Rocha qualified as an Industrial Engineer from the Polytechnic
University of Catalonia (UPC). Manuel Puig has held several executive posts in Puig for more
than 35 years. During his career at Puig, he was responsible for managing several of its
brands and in the last ten years he has participated very actively in the important
acquisition processes that have brought about the inorganic growth of Puig. Since 2007,
Manuel has been Vice-Chairman of Puig, a member of its Board of Directors and, since
February 2021, Chairman of the ESG Commission of the Board of Directors of Puig. He is
also a member of the Boards of Directors of Exea Empresarial, Isdin, Flamagas, Colonial and
RACC.
Mr BERNARDO
CORBERA SERRA
EDREM, S.L.
Born in 1965, Bernardo Corbera Serra holds a Degree in Business Science from E.S.E.I. and
has completed the IESE Senior Executive Programme. In the past he has held several posts
in the Fluidra Group, although he does not currently provide any services to it. In particular,
he started his career at Astral Export, S.A. where he was responsible for expansion in Africa,
the Middle East and Central America. In 1993, he moved to the USA where he took on the
market study and subsequent implementation of Astral Products and Poltank in that
country. In 1999, he joined Astral Grup with responsibility for North America and Mexico
and was appointed as a member of the Executive Committee. In 2000 he was appointed to
the Board of Directors of Fluidra, and CEO of Edrem, S.L., a family investment company. In
addition, he manages and is a member of the board of Beran Cartera, S.L.
Mr ÓSCAR SERRA
DUFFO
BOYSER, S.L.
Born in 1962, Óscar Serra Duffo obtained a Degree in Business Administration from
Management School in 1981. He started his career in the marketing area of several family
businesses, notably La Casera and Schweppes. In 1989 he joined the commercial
department of Plasteral, taking responsibility for the Spas division. Throughout his career
he has worked in the areas of marketing and communication. At present, he does not
provide services for the Fluidra Group, focusing his professional activity on the
management of several family companies. He is the chairman of the Board of Directors of
Boyser, S.L. and holds directorships in various Boyser group companies.
2024 Annual Financial Report        80
External Propietary Directors
Name of director
Name of significant
shareholder
represented by the
director or that
proposed the director’s
appointment
Profile
Mr BERNAT
GARRIGÓS CASTRO
ANIOL, S.L.
Born in 1967, Bernat Garrigós Castro obtained a Degree in Biology from the University of
Barcelona in 1991, and later, in 1994, studied for a Master’s Degree in Environmental
Management at Duke University and an Executive Development Programme organized by
IESE Business School. Since 2004, he has managed Aniol, S.L. His career in the Fluidra Group
has included posts in several companies. From 1995 to 1998 he was Product Manager at
Astral Grup and subsequently, until 2002, held the post of Production Manager at Servaqua,
S.A. He currently does not provide services for the Fluidra group. Bernat Garrigós Castro is
CEO of Aniol, S.L. and of Piumoc Inversions, S.L.U. He is also president of the Alive
Foundation and sole director of Constralsa, S.R.L., and Chairman of ADBE Partners, S.L.
Mr MICHAEL STEVEN
LANGMAN
RHÔNE CAPITAL, LLC
Born in 1961, Michael Steven Langman co-founded Rhône in 1996 and has been
responsible for the day-to-day management of the company since its inception. Rhône is an
alternative asset management company specializing in private equity. He is a Member and
Managing Director of Rhône. Before founding Rhône, Mr Langman was a Managing Director
at Lazard Frères, where he specialized in mergers and acquisitions. Before joining Lazard
Frères, he worked in the mergers and acquisitions department of Goldman Sachs. He has
over thirty years of experience in finance, analysis and investments in public and private
companies. In addition to Fluidra, S.A., Mr Langman currently serves on the Boards of
Directors of several companies in Rhône’s investment portfolio, including Hudson's Bay
Company, Lummus Technology L.L.C., Vista Global Holdings and Wellbore Integrity
Solutions LLC. He graduated with honours from the University of North Carolina at Chapel
Hill and holds a master's degree from the London School of Economics.
Total number de proprietary directors
6
% of total board
42.86
There are no observations.
External independent directors
Name of director
Profile
Ms ESTHER BERROZPE GALINDO
Born in 1970, Esther Berrozpe has extensive international experience having worked for
more than three decades in consumer goods companies for three decades, where she has
held posts of responsibility both in Europe and North America. She has considerable
experience in the commerce, industry and logistics sectors, in talent and cultural change
management, as well as in mergers and acquisitions. Esther currently holds the posts of
President, CEO and director of Attindas Hygiene Partners, world leader in the personal
hygiene sector. Before joining Attindas, Esther was CEO of Ontex, a leading international
group in personal hygiene listed on Euronext Brussels. Before Ontex, Esther worked for 19
years at Whirlpool Corporation, world leader in the household electrical goods sector,
where she held several executive posts, the last of which as president for Europe, the
Middle East and Africa and as executive vice-president. Previously, Esther worked for
Pagliere, Sara Lee and the Wella Group. She was a senior advisor at American Industrial
Partners (AIP) and an independent director of Pernod Ricard, Ontex Group and Roca
Corporación. Esther holds a degree in Economics and Business Science from Deusto
University in San Sebastián (Spain), and studied Economics and International Business at
the University of Bergamo (Italy).
Mr JORGE VALENTÍN CONSTANS FERNÁNDEZ
Born in 1964, Jorge Constans holds a degree in Economics from the University of
Barcelona, the General Management Programme of IESE and Business Management from
ESADE. In a career spanning 22 years at Danone, he held several positions in sales,
marketing, general management in Spain and was later Chairman and CEO of Danone
France. He was then responsible for the Europe region, and responsibility for the USA was
later added. During the last two years in the company, he was chairman of the dairy
product division, with turnover of 12 B€ and present in more than 50 countries. At Louis
Vuitton he held the position of Chairman and CEO. He currently serves on the Boards of
Puig, Punto Fa (Mango) and Fluidra.
2024 Annual Financial Report        81
External independent directors
Ms AEDHMAR HYNES
Born in 1966, Aedhmar Hynes has developed her career in the communication and
marketing industry over more than three decades, leading and supporting many of the
most influential brands in the world through digital transformation and technological
disruption (advising technological powerhouses such as Adobe, Cisco, Harmon, IBM,
Lenove and Xerox). For more than 25 years, Aedhmar has held several executive posts in
Text100, one of the leading digital communication agencies in the world, with 22 offices
and more than 600 consultants in Europe, North America and Asia. From 1997 to 2000 she
was President of the Operations division in North America, participating in the foundation
of the first Text100 office in Silicon Valley and the establishment of offices in the US market
(New York, Boston, Rochester and San Francisco) and from 2000 to 2018 she held the post
of Global CEO, making the agency a world leader in the digital marketing sector.
Throughout her career, she has held the post of director at Rosetta Stone (RST) and
Tupperware TUP (both traded on the New York Stock Exchange). Aedhmar is currently a
member of the Board of Directors of IP Group plc IPO.L (which is traded on the London
Stock Exchange) and Jackson Family Wines. She also participates actively in non-profit
organizations, as a member of the Board of Directors of Technoserve, a member of the
Board of Trustees of Connecticut Public Broadcasting Network and as a member and
former president of the Board of Trustees of The Page Society. Aedhmar has been
distinguished with some of the most significant awards in the digital communication sector
(specifically, in recent years she has been included among the 50 most influential
communications professionals in the world and in 2019 she was included in the PRWeek
Hall of Fame).
Mr BRIAN MCDONALD
Born in 1963, Brian McDonald was CEO of RGIS from 2014 to 2017. RGIS was the world’s
leading inventory management company, a 680-million-dollar business with 53,000
associates in 30 countries around the world. Before joining RGIS, Brian was executive vice-
president and operations director at Tyco International, where he had direct responsibility
for its fire and security installation and services division valued at 7.8 billion dollars. Brian
worked at Tyco for more than 10 years in different roles, including Sales Director, Vice-
President of Field Operations, Vice-President of Southern Operations and Managing
Director of ADT United Kingdom/Ireland. Before joining Tyco, Brian held several executive
positions with the UTC Power and Otis Elevator units of United Technologies. He is
currently an executive of BLM Advisors LLC, having held this post since January 2018. In
September 2021, he joined the board of directors of KPI Solutions, a US company that
provides integration services in the warehouse automatization sector. He has a Degree in
Physics from the US Naval Academy and MBA in Operations management from the
University of Virginia Darden Graduate School of Business. On graduating from the Naval
Academy, Brian served for 5 years as a lieutenant and division officer aboard a US Navy
aircraft carrier, overseeing its nuclear systems. He is a trustee of the US Naval Academy
Foundation Athletics and Scholarship Programs.
Ms BÁRBARA BORRA
Born in 1960, Barbara Borra has been President and CEO of the home solutions division of
the Franke Group since January 2019. Barbara has extensive international experience,
having lived in 9 countries and 11 cities in Europe, the USA and China. Before joining
Franke, Barbara worked at Whirlpool for 10 years, holding different senior management
posts, most recently as Vice-President of operations in China. Previously, Barbara held a
number of international posts in different countries during her time at Rhodia and General
Electric. Barbara has a degree in Chemical Engineering from Turin Polytechnic and an MBA
from INSEAD.
Ms OLATZ URROZ GARCIA
Born in 1973, Ms Olatz Urroz Garcia started her career at General Electric (BE), where she
performed a range of diverse roles in different areas (industrial, energy, financial services)
and geographies (including the United Kingdom and Italy) until 2010, when she became
Chief Financial Officer for the EMEA region of GE Energy. In 2013 she joined Brand
Infrastructure Services as Vice-President of Finance for international business (all except
the USA). That company had the backing of the private equity firm CD&R. In 2017, Ms Urroz
moved to Vodafone PLC (HQS) as the Chief Financial Officer for Technology and Common
Functions. In the summer of 2019, she joined Amazon.com as Vice President of Finance,
Global Customer Fulfillment, Customer Service, Robotics, Sustainability, Real Estate, Health
and Safety and Product and Customer Assurance. In late 2022 she took on the role of CFO
of PagoNxt, a stand-alone fintech company of Banco Santander, where she was
responsible for the end-to- end CFO role leading around 500 people across multiple
geographies. In September 2024, Ms Urroz joined Banco Santander as Chief of Staff and
Strategy.
Total number of independent directors
6
% of total board
42.86
There are no observations.
2024 Annual Financial Report        82
State whether any director classified as independent receives
from the Company or its group any amount or benefit for
items other than director remuneration, or maintains or has
maintained during the last year a business relationship with
the Company or with any Company of its group, whether in
the director’s own name or as a significant shareholder,
director, or senior manager of an entity that maintains or has
maintained such a relationship.
If applicable, include a reasoned statement from the board
regarding the reasons why it considers that the director in
question can carry out his/her duties as an independent
director.
Name of director
Description of relationship
Reasoned statement
No data
Other External Directors
Identify the other external directors and describe the reasons
why they cannot be considered proprietary or independent
directors, as well as their ties whether with the company, its
management or its shareholders:
Name of director
Reasons
Company, director or
shareholder with which
the director has ties
Profile
Mr BRUCE WALKER
BROOKS
Bruce W. Brooks held the
post of Co- CEO of Fluidra
until September 2024.
Specifically, the Board of
Directors of the Company
resolved to accept Bruce’s
resignation as Co-CEO of the
Company, with effect from
1st September
2024. However, Bruce has
continued to hold the post
as director of Fluidra for the
duration of his tenure, under
the category of “Other
External” director.
---
Born in 1964, Bruce W. Brooks holds a Degree in Marketing
from the University of Virginia. Bruce has significant
experience in international management, after more than 20
years at Black & Decker Corporation. In 1986, shortly after
obtaining his degree, he started his career at that company,
where he held a number of different posts over the years,
including group vice-president, president of the consumer
product group, president of construction tools and vice-
president for Latin America. In 2011, he joined Zodiac Pool
Solutions where he held the post of CEO. During his time at
Zodiac, Bruce led the company to an approach focused on
the residential pool market, thus leading the company’s
financial resurgence after 2011. In 2016, Bruce oversaw the
successful transition of ownership from the Carlyle Group to
Rhône Group and in 2018 he played a decisive role in the
plan to integrate with Fluidra. Throughout his career, Bruce
has shown great skill in the management and development
of existing companies as well as in their expansion into new
markets, at both domestic and international level and is
highly valued for his strategic reasoning and his capacity to
develop and execute systems and processes with the
successful attainment of short and long-term goals. Bruce
held the post of co-CEO of Fluidra until September 2024 and
is currently a member of the Board of Directors of Fluidra.
Total number of other directors
1
% of total board
7.14
State the changes, if any, in the category of each director
during the period:
Name of director
Date of change
Former category
Current category
Mr BRUCE WALKER BROOKS
1/9/2024
Executive
Other External
2024 Annual Financial Report        83
C.1.4. Complete the following table with information
regarding the number of female directors for the last 4 years,
as well as the category of such directors:
Number of female directors
% of total directors of each category
2024
2023
2022
2021
2024
2023
2022
2021
Executive
0.00
0.00
0.00
0.00
Proprietary
0.00
0.00
0.00
0.00
Independent
4
3
2
2
66.67
60.00
40.00
40.00
Other External
0.00
0.00
0.00
0.00
Total
4
3
2
2
28.57
23.08
16.67
16.67
C.1.5. State whether the Company has diversity policies in
relation to the board of directors of the Company on such
matters as age, gender, disability, or professional training and
experience. Small and medium-sized enterprises, as defined
in the Auditing Act, must disclose at least the policy they have
implemented in relation to gender diversity.
☑ Yes
☐ No
☐ Partial policies
If such diversity policies exist, describe them, their goals, the
measures and the way in which they have been applied and
the results obtained during the year. Also state the specific
measures adopted by the board of directors and the
appointments and remuneration committee to achieve a
balanced and diverse presence of directors.
If the company does not apply a diversity policy, explain the
reasons why it does not do so.
Description of policies, measures and how they have been
applied, as well as the results obtained
The Appointments and Remuneration Committee (“ARC”)
Regulations establish that this Committee is responsible for
evaluating the necessary skills, knowledge and experience on
the Board, defining as a result the functions and aptitudes
required in the candidates to fill vacancies, evaluating the time
and dedication required for them to fulfil their duties. For this
purpose:
a) it will draw up a skills matrix;
b) it will evaluate the time and dedication required for them to
fulfil their duties effectively; and
c) it will promote programmes to update directors’ knowledge,
when necessary. The ARC should also set representation
targets for the least-represented sex on the Board, drawing
up guidelines on how to reach this target and reporting to the
Board on matters of gender diversity and qualifications of
directors (see the Annual Report on the activities of the ARC
in 2024 for further information).
The selection policy for candidates to hold positions on the
Board of Fluidra (“Selection Policy”), which is published on the
Company’s website under “Shareholders and Investors,
Corporate Governance, Policies”, is aimed at favouring an
appropriate composition of the Board of Directors. In
accordance with the Good Governance Code for Listed
Companies, the Selection Policy ensures that the proposed
appointments of Company directors are based on a prior
analysis of the needs of the Board of Directors, and favours
diversity of knowledge, experience and gender within the Board
of Directors, so that they do not suffer from implicit bias that
could lead to any kind of discrimination and, in particular, could
hinder the selection of female candidates, promoting an
increase in their presence in light of best corporate governance
practice, subject at all times to the fundamental principle of
merit and suitability of the candidate in line with the analysis of
the Company’s needs carried out by the Board of Directors.
The Selection Policy assures compliance with applicable
legislation on diversity in the composition of the Board of
Directors and ensures that selection processes favour diversity
(not just of gender but also of nationalities, countries of origin,
cultural roots and experience and knowledge) so that they do
not suffer from implicit bias that could lead to any kind of
discrimination and, in particular, that could hinder the selection
of female candidates. It also includes a rule that establishes that
the second re-election of independent directors cannot be
proposed for a term of re-election of more than 2 years, to give
more flexibility to the incorporation of directors if necessary for
the Company.
Among other activities, the ARC and the Board of Directors of
the Company have continued working to increase gender
diversity on the Board of Directors in accordance with the
provisions of Article 529 bis of the Spanish Companies Act, with
the aim of reaching the percentage established at the 2025
General Shareholders' Meeting.
In the selection processes, our starting point is an analysis of the
Board’s skills map to determine the needs to be covered, and
gender diversity is taken into consideration, balanced alongside
other criteria of the desired profile, such as knowledge,
nationality, experience and technical capabilities, subject at all
times to the fundamental principle of merit and suitability of the
candidate.
This target will be achieved with the selection of new candidates
to cover vacancies on the Board of Directors, or in the event that
2024 Annual Financial Report        84
a resolution is passed to increase the number of members of
the Board of Directors.
In any case, we can state that the measures adopted in relation
to director selection are working, and proof of this is the fact
that four of the last give appointments of independent directors
have been covered by women: Ms Esther Berrozpe, Ms Bárbara
Borra, Ms Aedhmar Hynes and Ms Olatz Urroz.
Furthermore, following the end of the tenure of two proprietary
directors, the appointment of two women has been proposed.
With these appointments, the percentage of women on the
Board would be 42.86%, and therefore in 2025 the Company will
exceed the percentage of representation of the least-
represented sex on the Board.
C.1.6. Explain any measures approved by the Appointments
Committee in order for selection procedures to be free of any
implicit bias that hinders the selection of female directors,
and in order for the Company to search deliberately for
women who meet the professional profile that is sought and
include them among potential candidates and reach a
balanced presence of men and women. Also state whether
these measures include measures to foster the presence of a
significant number of female senior executives:
Explanation of measures
In its Director selection and appointment criteria approved by
the Board of Directors, Fluidra establishes that, in choosing
directors, the Company will take into consideration the Board
skills map to determine the needs to be covered and gender
diversity, with the object of ensuring equality of opportunity as
indicated in the Equality Act, the Code of Commerce, the
Companies Act and the Auditing Act, with regard to non-financial
and diversity reporting. Similarly, Fluidra will strive to achieve in
relation to its Board of Directors, not only gender diversity, but
also diversity of nationalities, countries of origin, cultural roots,
age and professional experience and knowledge. Accordingly, in
director selection processes, candidates will be evaluated under
criteria of equality and objectivity, avoiding implicit bias that
could lead to any kind of discrimination and, in particular, hinder
the selection of female directors. In addition to the measures
included in the Selection Policy to foster diversity, described in
section C.1.5 above, one of the principles of which is to avoid, in
the selection of candidates, any kind of bias that could lead to
discrimination and, in particular, hinder the selection of persons
of either sex, the ESG (Environmental, Social and Governance)
Policy determines that all persons, irrespective of their race,
gender, religion or ideology, have the same opportunities of
access to the organization and personal treatment, to develop
their professional potential, following the group’s principles and
values. Furthermore, in accordance with the ESG Policy, the
Company must foster a business culture based on equality of
treatment and opportunities between men and women.
Finally, it should be noted that the selection processes have
deliberately sought to increase the Board with female
candidates, with the aim of achieving a gender balance on the
Board (see the Annual Report on the Activities of the
Appointments and Remuneration Committee in 2024 for further
details).
The Company is also working to increase the number of female
senior executives in its Management Committee (“MAC”). In this
regard, in the first quarter of 2024 a new female executive
joined the MAC, which is now made up of 11 members, 2 of
which are women (18.18%).
If there are few or no female directors or senior managers
despite any measures adopted, describe the reasons for this:
Explanation of measures
One of the goals of the Appointments and Remuneration
Committee in relation to the director and senior management
selection policy is to favour diversity in terms of professional
background, knowledge, nationality and, especially, gender. In
2025 the Company will comply with the requirement established
in the Companies Act concerning the presence of the least-
represented sex on the Board of Directors, reaching 42.86%. The
Board also has a good cultural balance and in terms of
geographic origin.
In this regard, the Appointments and Remuneration Committee
continues to work so that future selection processes will
continue to favour gender diversity not only on the Board of
Directors but also in Senior Management, in order to comply
with the Good Governance recommendation on this matter.
C.1.7. Explain the conclusions of the appointments committee
regarding verification of compliance with the policy aimed at
favouring an appropriate composition of the Board of
directors.
The Appointments and Remuneration Committee oversees
compliance with the director Selection Policy for the purpose of
ensuring that selection processes take into consideration
gender diversity balanced with other criteria of the profile being
sought such as knowledge, nationality, experience and solvency
of the candidates. In this regard, the most recent decisions of
the Appointments and Remuneration Committee in relation to
the appointment of the new members of the Board of Directors
reflect effective compliance with the policy aimed at favouring
an appropriate composition of the Board of Directors. The
Appointments and Remuneration Committee and the Board of
Directors of Fluidra are aware of that established in article 529
bis of the Companies Act on gender diversity and proof of this is
the fact that with the appointment by the General Shareholders’
Meeting of proprietary directors in June 2025, the target of a
presence of more than 40% of the least-represented sex on the
Board will have been reached.
2024 Annual Financial Report        85
C.1.8. Explain, if applicable, the reasons why proprietary
directors have been appointed at the proposal of
shareholders whose shareholding is less than 3% of share
capital:
Name of shareholder
Justification
No data
State whether there has been no answer to formal petitions
for presence on the Board received from shareholders whose
shareholding is equal to or greater than that of others at
whose proposal proprietary directors have been appointed.
If applicable, describe the reasons why such petitions have
not been answered:
☐ Yes
☑ No
C.1.9. State any powers and faculties delegated by the Board
of Directors, including powers relating to the possibility of
issuing or repurchasing shares, to CEOs or committees of the
board:
Name of director or committee
Brief description
ELOY PLANES CORTS
The Board of Directors has delegated on a permanent basis all the faculties permitted by law to
Mr Eloy Planes, CEO of the Company.
C.1.10. Identify any members of the board who are directors,
representatives of directors or officers of other companies
that form part of the listed Company’s group:
Name of director
Name of group Company
Position
Does he/she have
executive duties?
Mr ELOY PLANES CORTS
ASTRAL NIGERIA, LTD
DIRECTOR
NO
Mr ELOY PLANES CORTS
FLUIDRA COMMERCIAL, S.A.U.
JOINT CEO
YES
Mr ELOY PLANES CORTS
INNODRIP, S.L.
DIRECTOR
NO
C.1.11. Identify the posts of director or representative of
director held in other companies, whether or not they are
listed companies, by directors of your Company or
representatives of directors:
Identification of director or representative
Name of Company, listed or not
Position
Mr BERNARDO CORBERA SERRA
Beran Cartera, S.L.
SOLE DIRECTOR
Mr BERNARDO CORBERA SERRA
Edrem, S.L.
CEO
Mr BERNARDO CORBERA SERRA
Edrem Cartera, S.L.U.
CHAIRMAN
Mr BERNARDO CORBERA SERRA
Adbe Partners, S.L.
VICE-CHAIRMAN
Mr JOSÉ MANUEL VARGAS GÓMEZ
MaxamCorp Holding, S.L. (Rhône portfolio)
CHAIRMAN
Mr JOSÉ MANUEL VARGAS GÓMEZ
ASK Chemicals International Holding, GmbH
DIRECTOR
Mr JOSÉ MANUEL VARGAS GÓMEZ
Petra Diamonds
CHAIRMAN
Mr ÓSCAR SERRA DUFFO
Boyser Corporate Portfolio, S.L.U.
DIRECTOR
Mr ÓSCAR SERRA DUFFO
Boyser, S.L.
CHAIRMAN
Mr ÓSCAR SERRA DUFFO
Pentamar, S.A.
SOLE DIRECTOR
Mr ÓSCAR SERRA DUFFO
Boyser Solar, S.L.U.
CHAIRMAN
Mr ÓSCAR SERRA DUFFO
Adbe Partners, S.L.
DIRECTOR
Mr JORGE VALENTIN CONSTANS FERNANDEZ
Puig Brands, S.A.
DIRECTOR
Mr JORGE VALENTIN CONSTANS FERNANDEZ
Punto Fa, S.L. (Mango)
DIRECTOR
Mr ELOY PLANES CORTS
Barcelona International Pool Trade Show
PRESIDENT
Mr ELOY PLANES CORTS
Catalunya Cultura Foundation
PRESIDENT
Mr ELOY PLANES CORTS
Barcelona Chamber of Commerce
1st VICE-PRESIDENT
Mr ELOY PLANES CORTS
Family Business Institute
TRUSTEE
Mr ELOY PLANES CORTS
Business and Climate Foundation
TRUSTEE
Mr ELOY PLANES CORTS
Fixe Climbing, S.L.
REPRESENTATIVE OF DIRECTOR
Mr ELOY PLANES CORTS
AI Lerele Inversions, S.L.
CHAIRMAN
Mr ELOY PLANES CORTS
Adbe Partners, S.L.
REPRESENTATIVE OF DIRECTOR
Mr BERNAT GARRIGÓS CASTRO
Aniol, S.L.
CEO
Mr BERNAT GARRIGÓS CASTRO
Piumoc Inversions, S.L.U.
CEO
2024 Annual Financial Report        86
Identification of director or representative
Name of Company, listed or not
Position
Mr BERNAT GARRIGÓS CASTRO
Constralsa, S.L.
SOLE DIRECTOR
Mr BERNAT GARRIGÓS CASTRO
Alive Foundation
PRESIDENT
Mr BERNAT GARRIGÓS CASTRO
Adbe Partners, S.L.
CHAIRMAN
Mr MICHAEL STEVEN LANGMAN
Rhône Group LLC and affiliated entities
CEO
Mr MICHAEL STEVEN LANGMAN
Hudson’s Bay Company (Rhône portfolio)
DIRECTOR
Mr MICHAEL STEVEN LANGMAN
Lummus Technology LLC (Rhône portfolio)
DIRECTOR
Mr MICHAEL STEVEN LANGMAN
Vista Global Holding Limited (Rhône portfolio)
DIRECTOR
Mr MICHAEL STEVEN LANGMAN
Wellbore Integrity Solutions LLC (Rhône portfolio)
DIRECTOR
Mr MICHAEL STEVEN LANGMAN
Hospital for Joint Disease Musculoskeletal, NYU
Langone Medical Center
DIRECTOR
Mr BRIAN MCDONALD
BLM Advisors LLC
SOLE DIRECTOR
Mr MICHAEL STEVEN LANGMAN
KPI Integrated Solutions
DIRECTOR
Mr BRIAN MCDONALD
Modigent, Inc.
DIRECTOR
Mr BRIAN MCDONALD
US Naval Academy Athletics and Scholarship
Foundation
TRUSTEE
Ms BÁRBARA BORRA
Franke Home Solutions
PRESIDENT-CEO
Ms BÁRBARA BORRA
Franke S.p.A.
PRESIDENT
Ms BÁRBARA BORRA
Franke France SAS
PRESIDENT
Ms BÁRBARA BORRA
Franke Kitchen Systems Egypt S.A.E.
PRESIDENT
Ms BÁRBARA BORRA
Franke UK Ltd.
CEO
Ms BÁRBARA BORRA
Franke (China) Kitchen System Co. Ltd.
PRESIDENT
Ms BÁRBARA BORRA
Franke Mexico S.A. de C.V.
PRESIDENT
Ms BÁRBARA BORRA
Franke Mutfak ve Banyo Sistemieri Sanayi ve Tic. A.
PRESIDENT
Ms BÁRBARA BORRA
Franke Faber India Pvt. Ltd.
DIRECTOR
Ms BÁRBARA BORRA
Industrias Spar San Luis S.A.
DIRECTOR
Ms BÁRBARA BORRA
Franke Australia Pty Ltd.
PRESIDENT
Ms BÁRBARA BORRA
Franke New Zealand
PRESIDENT
Ms ESTHER BERROZPE GALINDO
Journey Personal Care Holdings Ltd. (UK)
CEO
Ms ESTHER BERROZPE GALINDO
Attends Healthcare Products Inc. (US)
PRESIDENT
Ms ESTHER BERROZPE GALINDO
Associated Hygiene Products LLC (US)
PRESIDENT
Ms ESTHER BERROZPE GALINDO
Laboratorios Indas, S.A.U. (Spain)
SOLE DIRECTOR
Ms ESTHER BERROZPE GALINDO
Attindas Hygiene Partners, Inc.
CEO
Ms ESTHER BERROZPE GALINDO
Journey DPC Corp.
PRESIDENT
Ms ESTHER BERROZPE GALINDO
Journey DPC Holdings Corp.
PRESIDENT
Ms ESTHER BERROZPE GALINDO
Journey Personal Care Corp
PRESIDENT
Ms ESTHER BERROZPE GALINDO
Journey Personal Care Holdings Corp.
PRESIDENT
Ms ESTHER BERROZPE GALINDO
Journey Personal Care Holdings LLC
PRESIDENT
Ms ESTHER BERROZPE GALINDO
PCG Holding LLC (US)
PRESIDENT
Mr MANUEL PUIG ROCHA
Lyskamm 1861, S.L.
JOINT AND SEVERAL DIRECTOR
Mr MANUEL PUIG ROCHA
Schwarzsee 2018, S.L.
JOINT AND SEVERAL DIRECTOR
Mr MANUEL PUIG ROCHA
Exea Empresarial, S.L.
REPRESENTATIVE OF DIRECTOR
Mr MANUEL PUIG ROCHA
Inmo, S.L.
JOINT AND SEVERAL DIRECTOR
Mr MANUEL PUIG ROCHA
Whymper 1865, S.C.R., S.A.
CHAIRMAN
Mr MANUEL PUIG ROCHA
Inmocol Torre Europa, S.A.
CHAIRMAN
Mr MANUEL PUIG ROCHA
Torre Puig LH 4648, S.L.
JOINT AND SEVERAL DIRECTOR
Mr MANUEL PUIG ROCHA
Quaestor Investments, S.A.
CHAIRMAN
Mr MANUEL PUIG ROCHA
Puig, S.L.
REPRESENTATIVE OF DIRECTOR
Mr MANUEL PUIG ROCHA
Puig Brands, S.A.
VICE-CHAIRMAN
Mr MANUEL PUIG ROCHA
Maveinn Inversiones Inmobiliarias, S.L.
JOINT AND SEVERAL DIRECTOR
Mr MANUEL PUIG ROCHA
Sociedad Textil Lonia, S.A.
DIRECTOR
Mr MANUEL PUIG ROCHA
Transiluxs, S.L.
JOINT DIRECTOR
Mr MANUEL PUIG ROCHA
Casa Fiesta Formentera y Asociados, S.L.
JOINT DIRECTOR
Mr MANUEL PUIG ROCHA
Charlotte Tilbury Limited
DIRECTOR
Mr MANUEL PUIG ROCHA
Beijing Yitian Shidai Trading Co., LLC
DIRECTOR
2024 Annual Financial Report        87
Identification of director or representative
Name of Company, listed or not
Position
Mr MANUEL PUIG ROCHA
Cosmetika SAS
DIRECTOR
Mr MANUEL PUIG ROCHA
Ponteland Distribuiçao SA
DIRECTOR
Mr MANUEL PUIG ROCHA
Puig North America, INC
DIRECTOR
Mr MANUEL PUIG ROCHA
Quaestor Holdings SA
VICE-CHAIRMAN
Mr MANUEL PUIG ROCHA
Inmo USA INC
JOINT AND SEVERAL DIRECTOR
Mr MANUEL PUIG ROCHA
Flamasats, S.L.
DIRECTOR
Mr MANUEL PUIG ROCHA
Isdin, S.A.
DIRECTOR
Mr MANUEL PUIG ROCHA
Inmobiliaria Colonial, SOCIMI, S.A.
DIRECTOR
Mr MANUEL PUIG ROCHA
Exea Capital, SCR, S.A.
CHAIRMAN
Mr MANUEL PUIG ROCHA
Real Automóvil Club de Cataluña, S.L.
OTHER
Mr MANUEL PUIG ROCHA
Exea Ventures, S.L.U.
REPRESENTATIVE OF DIRECTOR
Ms AEDHMAR HYNES
IP Group Plc
DIRECTOR
Ms AEDHMAR HYNES
Jackson Family Wines
DIRECTOR
Ms AEDHMAR HYNES
Technoserve (Non-profit organization)
DIRECTOR
Ms AEDHMAR HYNES
Connecticut Public Broadcasting Network
TRUSTEE
Ms AEDHMAR HYNES
The Page Society
TRUSTEE
Ms OLATZ URROZ GARCÍA
SMPS MERCHANT PLATFORM SOLUTIONS MEXICO,
S.A. DE C.V.
PRESIDENT
State any other remunerated activities of directors or
representatives of directors, irrespective of their nature,
other than those indicated above:
Identification of director or representative
Other remunerated activities
Mr JORGE VALENTÍN CONSTANS FERNÁNDEZ
He has provided business consultancy services for which he has received
remuneration.
Mr BRIAN MC DONALD
He has provided consultancy services as an expert in the sector in relation to the
acquisition of companies for which he has received remuneration.
Ms OLATZ URROZ GARCIA
Chief of Staff and Strategy at Banco Santander
Bernat Garrigós Castro receives remuneration for his posts as
CEO of Aniol, S.L. and as CEO of Piumoc Inversions, S.L.U. Oscar
Serra Duffo receives remuneration for his post as executive
chairman of Boyser, S.L.
Bernardo Corbera Serra receives remuneration for his post as
sole director of Beran Cartera, S.L. Barbara Borra receives
remuneration for her post as President and CEO of Franke
Home Solutions.
Jorge Valentín Constans Fernández receives remuneration for
his posts as director of Puig Brands, S.A. and Punto Fa, S.L.
(Mango). Steven Langman receives remuneration for his post as
managing director of Rhône Group LLC.
Brian McDonald receives remuneration for his posts as director
of KPI Integrated Solutions and Modigent Inc. Aedhmar Hynes
receives remuneration for her posts as director of IP Group Plc
and of Jackson Family Wines.
Manuel Puig Rocha receives remuneration for his post as
director of Lyskamm 1861, S.L. and for his posts as director on
the boards of Puig Brands, S.A., Quaestor Holdings, S.A.,
Inmobiliaria Colonial, SOCIMI, S.A. and Real Club Automóvil de
Cataluña, S.L.
Esther Berrozpe Galindo receives remuneration for her post as
CEO of the Attindas Hygiene Partners Group: all the companies
mentioned above in which Esther Berrozpe Galindo holds a post
are part of the Attindas Hygiene Partners Group.
José Manuel Vargas Gomez receives remuneration for his post
as managing director of Rhône Group LLC, as well as for his post
as chairman in MaxamCorp Holding, S.L. and also as chairman
of Petra Diamonds.
C.1.12. State and, if applicable, explain whether the Company
has established rules on the maximum number of boards on
which directors may serve, identifying, where appropriate,
where this is regulated:
☑ Yes
☐ No
Explanation of the rules and identification of the regulating
document
In the Board of Directors Regulations, the Company establishes
in article 25 that anyone who belongs to more than four (4)
Boards of Directors of listed companies other than the Company
may not be appointed as a director of the Company.
2024 Annual Financial Report        88
C.1.13. State the following items relating to the total
remuneration of the board of directors:
Remuneration of the board of directors accrued in the year (thousand euros)
4,876
Amount of funds accumulated by present directors under long-term saving systems with vested economic rights (thousand euros)
704
Amount of funds accumulated by present directors under long-term saving systems with non-vested economic rights (thousand euros)
Amount of funds accumulated by former directors under long-term saving systems (thousand euros)
Of the amount of vested pension rights accrued by the current
directors, as detailed in the attached table, €29,000 was accrued
in the 2024 financial year.
The accrued remuneration includes the vesting of the incentive
corresponding to the 1st cycle 2022-2024, which entails the
delivery of 3,765 shares to Mr. Eloy Planes and 4,518 shares to
Mr. Bruce Brooks on June 25, 2025. Considering the share price
as of December 31, 2024 (€23.52 per share), this would amount
to a value of €89,000 for Mr. Eloy Planes and €106,000 for Mr.
Bruce Brooks.
C.1.14. Identify the members of the Company’s senior
management who are not executive directors and state the
total remuneration accruing to them during the year:
Name
Position
Mr KEITH MCQUEEN
CHIEF TECHNOLOGY OFFICER (CTO)
Mr CARLOS FRANQUESA CASTRILLO
GENERAL BUSINESS MANAGER – Southern Europe, Australia and New Zealand
Mr JAVIER TINTORÉ SEGURA
CHIEF FINANCIAL & SUSTAINABILITY OFFICER (CFSO)
Mr MARTI GIRALT ADROHER
CHIEF PRODUCT OFFICER (CPO)
Mr NICOLÁS MARTÍNEZ FERNÁNDEZ
GLOBAL INTERNAL AUDIT AND COMPLIANCE DIRECTOR
Ms SANDRA SOFIA TAVARES DA SILVA
GLOBAL HEAD OF HUMAN RESOURCES AND TRANSFORMATION (CHRO&T)
Ms CLARA VALERA JAQUES
STRATEGY, INVESTOR RELATIONS AND M&A SENIOR DIRECTOR
Mr JAIME ALBERTO RAMIREZ ALZATE
CHIEF EXECUTIVE OFFICER (Co-CEO)
Mr JONATHAN VINER
GENERAL BUSINESS MANAGER – North America
Mr JORGE ALBERTO MAYTORENA MONAÑO
CHIEF OPERATIONS OFFICER (COO)
Mr DAVID MENDEZ RODRIGUEZ
GENERAL BUSINESS MANAGER – Central-Northern Europe and emerging markets
Number of women in senior management
2
Percentage of total members of senior management
18.18
Total senior management remuneration (in thousand euros)
7,705
C.1.15. State whether the board regulations have been
amended during the year
☑ Yes
☐ No
Description of amendments
The Board of Directors resolved, at its meeting of 19th March
2024, to approve an amendment of the Board of Directors
Regulations, with effect from 8th May 2024, for the purpose of
increasing the number of members of the Company’s Board of
Directors from thirteen (13) to fourteen (14) members. The
increase in the number of members of the Board of Directors
seeks to achieve a greater number of perspectives and interests
represented, with the aim of complying with best practice in
good governance in the composition of the Board of Directors,
while permitting a greater presence of women on the Board of
Directors and thus continue with the trend the Company has
been showing of progressively incorporating a greater presence
of women in its governing bodies, in line with corporate
governance best practice and the applicable legislation. In this
regard, article 7 (quantitative composition) of the Board
Regulations was amended.
C.1.16. State the procedures for the selection, appointment,
re-election and removal of directors. Describe the competent
bodies, the procedures to be followed and the criteria applied
in each procedure.
Article 17.1 of the Board Regulations establishes that directors
will be appointed at the proposal of the Appointments and
Remuneration Committee, in the case of independent directors,
and following a prior report by the Appointments and
Remuneration Committee in the case of all other directors, by
the General Shareholders’ Meeting or by the Board of Directors.
The proposal for appointment or re- election must be
accompanied by a justificatory report from the Board assessing
the competence, experience and merits of the proposed
candidate, which will be attached to the minutes of the General
Shareholders’ Meeting or Board meeting.
2024 Annual Financial Report        89
In relation to external directors, article 18 of the Board
Regulations establishes that the Board of Directors will strive to
ensure that the elected candidates are persons of
acknowledged solvency, competence and experience, and must
exercise particular rigour in relation to those persons who are
called upon to fill the positions of independent director
established in article 6 of the Board Regulations.
In accordance with the provisions of the Appointments and
Remuneration Committee Regulations, the Appointments and
Remuneration Committee will evaluate the necessary skills,
knowledge and experience in the Board and will define,
consequently, the functions and aptitudes necessary in the
candidates who are to fill each vacancy and will evaluate the
time and dedication required for them to carry out their duties
properly. For this purpose, it will, among others: (a) draw up a
matrix of necessary skills of the Board of Directors to help the
Appointments and Remuneration Committee to analyse the
skills, knowledge and experience of the directors who are
members of the Board and to define the functions and
aptitudes of the candidates who are to cover any vacancies
arising and (b) evaluate the time and dedication required for
them to fulfil their duties effectively.
Removal of Directors: Article 21.1 of the Board Regulations
establishes that directors will be removed from their post when
the period for which they were appointed has ended and when
the General Meeting so decides making use of the faculties
conferred on it by law or the Articles of Association. Reference
should therefore be made to the situations established in the
Companies Act, specifically in article 223 and following.
The Board may only propose the removal of an independent
director before the end of the term established in the Articles of
Association when there is due cause, observed by the Board
following a report by the Appointments and Remuneration
Committee. In particular, due cause will be deemed to exist
when the director has failed to comply with the inherent duties
of the position or has incurred in the course of the term of office
in any of the circumstances of impediment described in the
definition of independent director established in the Companies
Act.
In accordance with the Selection Policy, the selection of
candidates is based on a prior analysis of the needs of the
Company, the group and the Board. The Board must ensure that
the procedures for selecting its members favour diversity of
gender, nationalities, countries of origin, cultural roots,
experience and knowledge, so that they do not suffer from
implicit bias that could lead to any kind of discrimination and, in
particular, could hinder the selection of female candidates,
promoting an increase in their presence in light of best
corporate governance practice, subject at all times to the
fundamental principle of merit and suitability of the candidate in
line with the analysis of the Company’s needs carried out by the
Board of Directors. When a vacancy arises, the Board of
Directors will instruct the Appointments and Remuneration
Committee to draw up a report setting out the evaluation of the
skills, knowledge and experience, and also the diversity that are
necessary in the Board of Directors and define, consequently,
the required functions and aptitudes of the candidates to fill
each vacancy. Based on this report, the Board of Directors will
carry out an analysis of the needs of the Company and the
group, which is to serve as the starting point for the director
selection process. The Company may make use of the services
of external advisors for the prior analysis of the Company’s
needs, the search for or evaluation of candidates to the post of
director or the evaluation of their performance.
The candidate selection process must, in any case, avoid any
kind of bias that could lead to discrimination and, in particular,
could hinder the selection of persons of either sex.
Any director may ask the Appointments and Remuneration
Committee to take potential candidates into consideration to
cover vacancies on the Board, provided that they meet the
requisites established in this Policy, for the Committee to decide
whether it considers them suitable.
When the re-election of any director is being considered, the re-
election proposal submitted to the General Meeting by the
Board must be preceded by a report issued by the
Appointments and Remuneration Committee. This report will
evaluate, especially, the director’s performance during his or her
term of office and his or her capacity to continuing performing
duties satisfactorily. In particular, in the case of independent
directors, particular consideration will be given to the analysis of
the Company’s needs in order to determine whether the
candidate for re-election can perform the functions and has the
skills required by the Board, and for the second re-election, as
the case may be, of an independent director, the Board of
Directors may not propose to the General Meeting the re-
election for a term of more than two (2) years.
C.1.17. Explain the extent to which the annual evaluation of
the board has given rise to significant changes in its internal
organization and to the procedures applicable to its activities:
Description of changes
In accordance with the provisions of the Appointments and
Remuneration Committee Regulations, the Appointments and
Remuneration Committee will evaluate the necessary skills,
knowledge and experience on the Board of Directors and will
define the necessary duties and aptitudes of the candidates to
fill each vacancy accordingly, and will evaluate the time and
dedication required in order to discharge the duties well. For
this purpose: (a) it will draw up a matrix of necessary skills of the
Board of Directors to help the Appointments and Remuneration
Committee to analyse the skills, knowledge and experience of
the directors who are members of the Board and to define the
functions and aptitudes of the candidates who are to cover any
vacancies arising; (b) it will evaluate the time and dedication
required for them to fulfil their duties effectively; and (c) it will
promote programmes to update directors’ knowledge, when
necessary.
The Appointments and Remuneration Committee will also
promote and co-ordinate the annual performance evaluation
2024 Annual Financial Report        90
process of the Board of Directors, the Chairman of the Board, its
Committees, their members and of executive directors.
Fluidra regularly (once every three years at most) conducts
evaluations of the operation and composition of the Board of
Directors and its Committees, with the assistance of an external
consultant. The last two such evaluations were carried out in
2021 and 2024, by the external consultant Seeliger y Conde.
The conclusion of the evaluation of the Board’s functioning and
composition has been positive, highlighting the following
aspects: Composition of the Board: The Board has great
professional capacity, with sound and committed members, and
a balanced combination of knowledge. There is mutual respect
among members.
Healthy group dynamics: The Board fosters a culture of co-
operation and empathy, seeking consensus in debates and
decisions. Relations are honest and respectful.
Positive results: The Company’s business performance has
created a positive climate of trust in the management team,
with alignment in the Boards’ role between advisory and
supervisory functions.
Effective committees: The Audit Committee is excellently
managed and contributes at the expected level, and the
Appointments and Remuneration Committee is operating well.
The opportunities for improvement are related to ongoing
measures to foster efficiency in the decision-making process
and more focus and time dedicated to constructive strategic
debates.
The results of the evaluation of the Board of Directors carried
out in 2024 were reviewed and approved by the Appointments
and Remuneration Committee. The summary of conclusions
reflected the healthy state of Fluidra’s Board of Directors and its
Committees, and made suggestions to improve the Board of
Directors and continue advancing in the continuous
improvement of Fluidra’s governance bodies. Although the
annual Board evaluation has not given rise to important
changes in its internal organization or in the procedures
applicable to its activities, action plans have been defined aimed
at continuing to improve the effectiveness, efficiency and
strategic alignment of the Board of Directors, fostering an active,
integrated and forward-looking leadership structure.
Describe the evaluation process and the areas evaluated by
the board of directors, assisted, as the case may be, by an
external consultant, regarding the operation and composition
of the board and its committees and any other area or aspect
that has been evaluated.
Description of evaluation process and areas evaluated
The evaluation of the Board of Directors was carried out in 2024
with the participation of an external consultant, taking into
account the recommendations of the Good Governance Code
for Listed Companies and international best practice in
corporate governance.
The purpose of the evaluation is to evaluate the Board’s
composition, operation and performance and provide a
framework for self- assessment of its skills and competences by
responding to a series of questions and statements. The
questionnaire is organized in four parts: the first analyses the
mechanics, the organization, the structure and the performance
of the Board, the second is a self-assessment of skills which
examines the capabilities of each of its members, the third part
concerns training needs and the last part asks for suggestions to
improve the general functioning of the Board.
In 2025, the results and conclusions of the evaluation carried
out in December 2024 by the external consultant were
submitted to the Chair of the Appointments and Remuneration
Committee.
C.1.18.In years when the evaluation has involved the
assistance of an external advisor, detail any business
relationship that the consultant or any Company of its group
have with the Company or any of the group companies.
In 2024, the evaluation of the Board of Directors was assisted by
the external consultant Seeliger y Conde, which has not
provided any other service to the Company during the year. In
previous years, Seeliger y Conde has provided certain advisory
services to the Company, mainly consisting of support in
selection processes, which in no case represent a conflict with
the Company.
C.1.19.State the circumstances in which the resignation of
directors is mandatory.
In accordance with article 21.2 of the Board Regulations,
directors must offer their resignation to the Board of Directors,
formalizing their resignation if the Board so decides, in the
following cases: 
a) When they cease to hold the executive position to which their
appointment as director was associated.
b) When they incur in any of the situations of incompatibility or
prohibition established by law.
c) When they are severely reprimanded by the Board of
Directors because of breaching their obligations as directors.
d) When their continued presence on the Board could
jeopardize or damage the Company’s interests, credit or
reputation or when the reasons for which they were
appointed no longer exist (for example, when a proprietary
director disposes of its shareholding in the Company). In
particular, directors will be required to inform the Board of
Directors and, as the case may be, resign when situations
affecting them arise, whether or not they are related to their
performance in the Company, that could damage the
Company’s credit and reputation, and particularly in relation
to any criminal case in which they are named as investigated
persons. The Board of Directors will examine the case and
decide, following a report from the Appointments and
Remuneration Committee, whether or not it should take any
measure, such as commencing an internal investigation,
2024 Annual Financial Report        91
requesting the director’s resignation or proposing his or her
removal.
e) In the case of independent directors, they may not remain in
their position as such for a continued period of more than 12
years, and therefore at the end of that term they must offer
their resignation to the Board of Directors.
f) In the case of proprietary directors (i) when the shareholder
they represent sells the shareholding in full and; furthermore
(ii) in respect of the corresponding number, when the
aforesaid shareholder reduces its shareholding to a level that
requires a reduction in the number of proprietary directors.
Article 21.3 also establishes that, in the event that a director
ceases to hold his or her position before the end of the term of
office, due to resignation or any other reason, the aforesaid
director must explain the reasons in a letter which will be sent
to all members of the Board. 
C.1.20. Are qualified majorities, different from the statutory
majorities, required to adopt any type of decision?
☐ Yes
☑ No
If so, describe the differences.
C.1.21. Explain whether there are specific requirements, other
than the requirements relating to directors, in order to be
appointed chairman of the board of directors:
☑ Yes
☐ No
Description of requirements
In accordance with the provisions of article 8 of the Board
Regulations, the Chairman of the Board of directors will be
elected out of the Board members with the favourable vote of at
least nine (9) Board members, as established in the Company’s
Articles of Association, following a report from the
Appointments and Remuneration Committee. The removal of
the Chairman of the Board will require that the corresponding
resolution be passed with the favourable vote of at least nine (9)
members of the Board of Directors.
C.1.22. State whether the Articles of Association or the Board
regulations establish any age limit for directors:
☐ Yes
☑ No
C.1.23. State whether the Articles of Association or the Board
regulations establish any limit on the term of office or other
stricter requisites in addition to those established by law for
independent directors, that is different from the term
established by regulatory provisions:
☐ Yes
☑ No
C.1.24.State whether the Articles of Association or the Board
regulations establish specific rules for proxy voting at Board
meetings through other directors, the manner of doing so
and, in particular, the maximum number of delegations that a
director may hold, as well as whether any restriction has been
established regarding the categories of directors who may be
delegated, beyond the restrictions imposed by legislation. If
so, briefly describe such rules.
As established in article 16 of the Board Regulations, Directors
shall make every effort to attend all Board meetings and when it
is impossible for them to attend in person for justified reasons,
they will grant representation in writing, on a special basis for
each meeting, appointing another member of the Board as
proxy with the pertinent instructions and notifying the Chairman
of the Board of Directors of this. Non-executive directors may
only delegate another non-executive director to represent them.
C.1.25. State the number of meetings that the board of
directors has held during the year. In addition, specify the
number of times the board has met, if any, at which the
chairman was not in attendance. Proxies granted with specific
instructions shall be counted as attendance. .
Number of meetings of the board
8
Number of board meetings at which the Chairman was
not in attendance
0
State the number of meetings held by the lead independent
director with the other directors, at which no executive
director was present or represented:
Number of meetings
2
State the number of meetings held by the different
committees of the board during the year:
Number of meetings of the Audit Committee
7
Number of meetings of the Executive, Strategy and
ESG Committee
1
Number of meetings of the Appointments and
Remuneration Committee
9
2024 Annual Financial Report        92
C.1.26. State the number of meetings that the board of
directors has held during the year and data on attendance of
its members:
Number of meetings at which at least 80% of the
directors were present in person
8
% of personal attendance with respect to total votes
during the year
100
Number of meetings at which all directors were
present in person or represented by proxies
with specific instructions
8
% of votes cast by directors present in person or
represented by proxies with specific instructions
compared to total votes during the year
100
The attendance of each of the members of the Board of
Directors at Board meetings held in 2024 is detailed below:
1
Mr Eloy Planes Corts:
100%
2
Ms Esther Berrozpe Galindo:
100%
3
Ms Bárbara Borra:
100%
4
Mr Bruce W. Brooks
100%
5
Mr Jorge Constans Fernández
100%
6
Mr Bernardo Corbera Serra:
100%
7
Mr Bernat Garrigós Castro
100%
8
Ms Aedhmar Hynes:
100%
9
Mr Michael Steven Langman
(Delegated Mr José Manuel Vargas Gomez to
represent him at one meeting).
87.5%
10
Mr Brian McDonald:
100%
11
Mr Manuel Puig Rocha:
100%
12
Mr Óscar Serra Duffo
100%
13
Ms Olatz Urroz Garcia:
100%
14
Mr José Manuel Vargas Gómez:
100%
Furthermore, the attendance of each of the members of the
Board of Directors at the meetings of committees held in 2024 is
detailed below:
Executive, Strategy and ESG Committee:
 
1
Mr Eloy Planes Corts:
100%
2
Ms Bárbara Borra:
100%
3
Mr Bruce W. Brooks
100%
4
Mr Jorge Constans Fernández
100%
5
Ms Aedhmar Hynes:
100%
6
Mr Manuel Puig Rocha
100%
7
Mr Óscar Serra Duffo:
100%
8
Mr José Manuel Vargas Gómez:
100%
Appointments and Remuneration Committee: 
 
1
Ms Esther Berrozpe Galindo:
100%
2
Mr Jorge Constans Fernandez:
100%
3
Mr Bernardo Corbera Serra (Delegated Mr Jorge
Constans Fernandez to represent him on one
occasions and Mr Esther Berrozpe Galindo on
another)
77.8%
4
Mr Michael Steven Langman (Delegated Ms Esther
Berrozpe Galindo to represent him at one meeting).
88.9%
Audit Committee:
1
Mr Brian McDonald:
100%
2
Ms Esther Berrozpe Galindo  (Delegated Mr Brian
McDonald to represent her at one meeting):
85.7%
3
Mr Bernat Garrigós Castro (Delegated Mr Briand
McDonald to represent him at one meeting):
85.7%
4
Ms Aedhma Hynes:
100%
5
Ms Olatz Urroz Garcia:
6
Mr Jose Manuel Vargas Gomez:
100%
For each of the absences, the Directors sent apologies for their
absence for duly justified causes and delegated another director
to represent them with specific voting instructions.
C.1.27. State whether the individual and consolidated annual
accounts that are submitted to the board are previously
certified:
☐ Yes
☑ No
Identify, if applicable, the person/persons that has/have
certified the individual and consolidated annual accounts of
the Company for preparation by the board:
C.1.28. Explain the mechanisms, if any, established by the
board of directors so that the annual accounts that the board
of directors submits to the general shareholders’ meeting are
drawn up in accordance with accounting legislation.
As established in article 38.3 of the Board Regulations, the
Board of Directors will strive to draw up the accounts definitively
in such a way that they are prepared in accordance with
accounting legislation. In exceptional cases in which there are
qualifications, both the Chairman of the Audit Committee and
the external auditors will explain clearly to the shareholders at
the General Meeting the Audit Committee’s opinion on their
content and scope. However, when the Board considers that it
should uphold its criteria, it will explain publicly the content and
scope of the discrepancy, making a summary of that opinion
available to shareholders at the time of publishing the notice of
the General Meeting.
C.1.29. Is the secretary of the board a director?
☐ Yes
☑ No
If the secretary is not a director, complete the following table:
Name of secretary
Representante
Mr ALBERT COLLADO ARMENGOL
2024 Annual Financial Report        93
C.1.30. State the specific mechanisms established by the
Company to preserve the independence of the external
auditors and the mechanisms, if any, to preserve the
independence of financial analysts, investment banks and
rating agencies, including how legal provisions have been
implemented in practice.
To preserve the independence of the external auditors: 
Article 8 of the Audit Committee Regulations establishes that the
committee will exercise the following powers in relation to the
external auditor or audit firm:
Submit to the Board proposals for the selection, appointment,
re-election and replacement of the external auditor or audit
firm, and their contract conditions, according to the criteria
indicated in the same Regulations (resources, experience and
geographical coverage of the audit firm; availability of
personnel with the necessary skills, technical resources,
independence of the audit firm, non-discrimination and
quality and effectiveness of the service);
Meet with the external auditor or audit firm and receive
regular information on the progress and results of the audit
programme, and verify that the management team acts in
accordance with their recommendations (meetings that will
discuss, among other matters, the suitability of the scope of
the consolidation, significant changes in policy or significant
weaknesses in internal control).
Ensure the independence of the auditor or audit firm in
carrying out its duties (in this regard, the Audit Committee will
issue a report each year, before the audit report on the
accounts is issued, in which it will express an opinion on the
independence of the auditors);
Favour that the auditor of the group undertake responsibility
for the audits of the companies that make up the group.
Guarantee fluid and permanent communication with the
auditor, requesting information on the audit plan, its
effectiveness and any other matter related to the audit
process. These communications must be made together with
the duties and obligations of each party to assure the external
auditor’s independence. These communications will be made
at annual meetings, most of which will be held without the
presence of Company management.
In turn, article 54 of the Company’s Articles of Association
establishes that the auditors are to be appointed by the General
Meeting before the end of the financial year that is to be
audited, for an initial term, which may not be less than three
years nor more than nine years, as of the date on which the first
financial year to be audited commences, notwithstanding the
provisions established in the legislation regulating the audit
activity with regard to the possibility of an extension.
The General Meeting may appoint one or several natural or legal
persons who will act jointly.
When the persons appointed are natural persons, the General
Meeting must appoint as many alternates as principal auditors.
The General Meeting may not revoke the auditors’ appointment
before the end of the term for which they were appointed,
unless there is due cause.
The Audit Committee will refrain from proposing to the Board of
Directors, and the latter in turn will refrain from submitting to
the General Meeting, the appointment as auditor of the
Company’s accounts of any firm that incurs in a cause of
incompatibility under legislation on auditing as well as any firms
in which the fees to be paid to them by the Company, for all
services, are more than five per cent of their total revenues
during the last financial year.
To preserve the independence of financial analysts, investment
banks and rating agencies:
The Company maintains relations with financial analysts and
investment banks in which it ensures the transparency, non-
discrimination, veracity and reliability of the information
provided. Corporate Financial Management, through Investor
Relations Management, is responsible for co-ordinating relations
with and handling requests for information from institutional or
private investors. The mandates to investment banks are
granted by Corporate Financial Management while Analysis and
Planning Management handles the work with such banks.
In 2018 the Company obtained credit ratings from Moody's and
Standard & Poor’s, which are published on the Company’s
website and were originally reported to the market through
Relevant Event notices number 261590 and number 268995.
These credit ratings from Moody’s and Standard & Poor’s were
updated and confirmed respectively on 18th March and 28th
August 2024.
The independence of financial analysts is protected by the
existence of Investor Relations Management which is specifically
dedicated to dealing with them, guaranteeing objective,
equitable and non-discriminatory treatment among investors.
To guarantee the principles of transparency and non-
discrimination, and complying at all times with the regulations
on the Securities Market, the Company has several
communication channels:
Personalized attention to analysts and investors
Publication of information on quarterly, half-yearly and annual
results, communications of privileged information and other
relevant information. Publication of press releases.
E-mail on the website (investor_relations@fluidra.com,
accionistas@fluidra.com). Shareholder information telephone
service (34 937243900)
Presentations, both in person and by telephone. Visits to the
Company’s premises.
All this information is accessible through the Company’s website
2024 Annual Financial Report        94
C.1.31. State whether the Company has changed the external
auditor during the year. If so, identify the incoming and
outgoing auditor:
☐ Yes
☑ No
If there has been any disagreement with the outgoing auditor,
explain the content of such disagreements:
☐ Yes
☑ No
C.1.32. State whether the audit firm performs other non-audit
work for the Company and/or its group. If so, state the
amount of the fees received for such work and the percentage
this amount represents of the fees billed to the Company
and/or its group for audit work:
☑ Yes
☐ No
Company
Group
companies
Total
Amount of other non-audit
work (thousand euros)
146
12
158
Amount of non-audit
work / Amount of audit
work (%)
104.6
0.85
10.4
Regarding the amount of non-audit services, the Audit
Committee Report on the external auditor's independence
(published on the Company's website on this same date) can be
consulted, which details that these services correspond to other
accounting verification services related to the audit.
C.1.33. State whether the audit report on the annual accounts
for the previous year has qualifications. If so, state the
reasons given to the shareholders at the General Meeting by
the chairman of the audit committee to explain the content
and scope of such qualifications.
☐ Yes
☑ No
C.1.34. State the number of years for which the current audit
firm has been auditing the Company’s individual and/or
consolidated annual accounts without interruption. Also state
the percentage that the number of years audited by the
current audit firm represents with respect to the total
number of years in which the annual accounts have been
audited:
Individuals
Consolidated
Number of years without a break
9
9
Individuals
Consolidated
No. of years audited by current
audit firm / No. of years the
Company or its group has been
audited (%)
42.90
39.10
C.1.35. State whether there is a procedure to ensure directors
have the necessary information to prepare meetings of
management bodies sufficiently in advance and, if so,
describe it:
☑ Yes
☐ No
Description of the procedure
Fluidra adopts the necessary measures so that directors receive,
whenever possible, sufficiently in advance the necessary
information, specifically drawn up and oriented in order to
prepare the meetings of the Board and its Committees.
In this regard, in accordance with article 15 of the Board
Regulations, notice of the meetings of the Board of Directors is
to be issued at least five days in advance and will always include
the agenda for the meeting and the information necessary to
deliberate on and pass resolutions on the matters to be
discussed included in the agenda, unless the meeting of the
Board of Directors has been held or convened exceptionally for
reasons of urgency. The Chairman, as the person responsible
for the efficient operation of the Board, with the Secretary’s
collaboration, will ensure that directors receive such information
adequately. The Chairman of the Board of Directors may
convene extraordinary meetings of the Board when in his
opinion the circumstances so require, and in such cases the
term of advance notice and other requisites indicated above do
not apply. However, every effort will be made to ensure that any
documentation that is to be provided to the Directors is
delivered sufficiently in advance. Furthermore, Board meetings
will be deemed valid without the need to have been previously
convened if all the members are present or represented and
agree unanimously to hold a meeting.
The Board and its Committees also have an action plan that
details and schedules the activities to be carried out each year,
according to the competences and tasks assigned to them.
To provide all the information and clarifications necessary in
relation to the matters discussed, the principal senior managers
of the Group regularly attend the meetings of the Board and its
Committees, to provide information on matters within their area
of competence.
2024 Annual Financial Report        95
Furthermore, article 22 of the Board Regulations establishes as
follows:
1. Any director may request information on any matter that
falls under the competence of the Board and, in this regard,
examine its books, records, documents and other
documentation. The right to information extends to
companies in which a stake is held, whenever possible.
2. The request for information should be addressed to the
Secretary of the Board of Directors, who will convey it to the
Chairman of the Board of Directors and the appropriate
person in the Company.
3. The Secretary will inform the director of the confidential
nature of the information he or she requests and receives
and of the duty of confidentiality in accordance with the
Board Regulations.
C.1.36. State whether the company has established any rules
requiring directors to inform the Company and, as the case
may be, resign, when situations affecting them occur,
whether or not they are related to their actions in the
Company, that could be damaging to the Company’s credit
and reputation, and, if so, provide a detailed description:
☑ Yes
☐ No
Explain the rules
Article 32.2 of the Board Regulations establishes the obligation
for directors to inform the Company in any situations that might
damage the Company’s credit or reputation and, in particular, to
inform the Board of any criminal investigations in which they are
involved as investigated persons, as well as the subsequent
procedural phases, any disqualification procedures initiated
against them, any near- insolvency economic situations of any
trading companies in which they hold stakes or which they
represent or, as the case may be, the commencement of
insolvency proceedings against such companies.
This same article also establishes that in the event that a
director is prosecuted or a court order is issued against a
director for the commencement of a trial for any of the criminal
offences listed in article 213 of the Companies Act, the Board
will examine the case as soon as possible and, in light of its
specific circumstances, will decide whether or not the director is
to remain in office. 
C.1.37. State whether the board has been informed or is
otherwise aware of any situation affecting a member of the
board, whether or not it is related to that member’s actions in
the Company, that could be damaging to the Company’s credit
or reputation, unless there are special circumstances that
have been duly noted in the minutes:
☐ Yes
☑ No
C.1.38. Describe the significant agreements entered into by
the Company that come into effect, are amended, or
terminate in the event of a change in control at the Company
as a result of a takeover bid, and the effects thereof.
Not applicable.
C.1.39. Identify individually, when directors are involved, and
on an aggregate basis in all other cases, and provide a
detailed description of the agreements between the Company
and its management level and decision-making positions or
employees that provide for indemnities, guarantee or “golden
parachute” clauses upon resignation or unfair dismissal, or if
the contractual relationship is terminated as a result of a
takeover bid or other type of transaction.
2024 Annual Financial Report        96
Number of beneficiaries
10
Type of beneficiary
Description of the agreement
Executive Chairman /Co-
CEO / Senior Managers
The Executive Chairman’s contract establishes compensation in the event of termination of his contract by
Fluidra for any reason, except in the event of serious and culpable or negligent breach of his obligations as an
executive director, for an amount equal to two years’ salary, based on the gross fixed annual salary received in
the year termination occurs and the gross variable annual salary received. He will also be entitled to receive
this compensation if he decides to end the contract by choice, provided that this is for any of the following
causes: serious breach by the Company of the obligations acquired relating to his post; reduction and
substantial limitation of his duties or powers; substantial modification of the conditions agreed in the contract;
change of ownership of the share capital of Fluidra, whether or not there is any variation in the Company’s
governing bodies. The amount of this compensation includes the legal compensation that he would be entitled
to receive for termination of his previous employment relationship, of sixteen years and seven months, which
was suspended by his appointment as a director. The contract includes a post-contractual non-compete clause
for a term of two years after the end of provision of services. The economic compensation established for the
obligation undertaken by virtue of the non-compete clause is two years’ fixed gross annual salary at the time
of termination of the contract.
Senior managers:
Non-compete and non-solicitation:
One senior manager has a post-contractual non-compete clause for a term of 18 months with no additional
compensation.
One senior manager has a post-contractual non-compete and non-solicitation clause for a term of 24
months with no additional compensation.
One senior manager has post-contractual clause for a term of 12 months with no additional compensation. ·
One senior manager has a post-contractual non-compete clause for a term of 18 months, and 15% of his
fixed remuneration comprises the remuneration of the non-compete obligation.
One senior manager has a post-contractual non-compete and non-solicitation clause for a term of 18
months, and 15% of his fixed remuneration services to remunerate the non- compete obligation, and the
amount received in this respect must be at least equal to 1.5 times his fixed remuneration on the date of
termination, otherwise the difference must be paid.
Two senior managers have a post-contractual non-compete and non-solicitation clause for a term of 12
months, with 15% of their fixed remuneration being the remuneration for the non-compete obligation.Two
senior managers have a post-contractual non-compete clause for a term of 12 months, and 15% of their
fixed remuneration serves to remunerate this obligation. For one of them the amount received in this
respect must be at least equal to 1 times his fixed remuneration on the date of termination, otherwise he
must be paid the difference.
Guarantee clauses in the event of termination:
One senior manager is entitled to receive compensation in the event of termination of his contract by
Fluidra for any reason, except in the event of fair dismissal, the amount of which is equal to one year’s fixed
gross annual salary at the time of termination and payment of medical insurance for 12 months.
Two senior managers are entitled to receive compensation in the event of termination of their contract by
the Group for no cause or by the senior manager with cause, for an amount equal to one year’s gross fixed
salary, the higher of the annual variable target and the last annual variable remuneration received, payment
of medical insurance for 12 months in the case of one senior manager and for a term or not more than six
months in the case of the other, and payment of an outplacement service in the case of one of them.
One senior manager is entitled to receive compensation in the event of termination of his contract as a
result of a change in control, for an amount equal to one year’s gross fixed salary, payment of medical
insurance for a term of not more than 6 months and payment of an outplacement service for a maximum of
two months.
One senior manager is entitled to receive compensation in the event of termination of his contract by
Fluidra for any reason, except in the event of fair dismissal, the amount of which is equal to equal to one
year’s fixed gross annual salary at the time of termination.
State whether, beyond the cases established by law, such
contracts have to be reported to and/or approved by the
decision-making bodies of the Company or its group. If so,
specify the procedures, cases envisaged and the nature of the
bodies responsible for approval or reporting them:
Board of Directors
General Meeting
Body that authorizes the clauses
Yes
No
Is the General Meeting informed of the clauses?
2024 Annual Financial Report        97
C.2. Committees of the board of directors
C.2.1.Describe all the committees of the board of directors,
their members and the proportion of executive, proprietary,
independent and other external directors of which they are
comprised:
Executive, Strategy and ESG Committee
Name
Position
Category
Mr JOSE MANUEL VARGAS GOMEZ
MEMBER
Proprietary
Mr OSCAR SERRA DUFFO
MEMBER
Proprietary
Mr JORGE VALENTÍN CONSTANS
FERNÁNDEZ
MEMBER
Independent
Mr ELOY PLANES CORTS
CHAIRMAN
Executive
Ms AEDHMAR HYNES
MEMBER
Independent
Mr BRUCE WALKER BROOKS
MEMBER
Other External
Ms BARBARA BORRA
MEMBER
Independent
Mr MANUEL PUIG ROCHA
MEMBER
Proprietary
% executive directors
12.50
% proprietary directors
37.50
% independent directors
37.50
% other external directors
12.50
Explain the duties delegated or assigned to this committee
other than those already described in section C.1.9, and
describe the procedures and rules of organization and
operation thereof. For each of these duties, state the most
important actions carried out during the year and how each
of the duties assigned to it, either by law or the Articles of
Association or in other corporate resolutions, has been
exercised in practice.
The duties of the Executive, Strategy and ESG Committee, and its
procedures and rules of organization and operation, are set out
in article 12 of the Board of Directors Regulations:
i) To advise and propose to the Board of Directors actions of
strategic relevance on the Company’s growth, development,
diversification, business transformation and technology.
ii) To advise the Board of Directors on the Company’s long-term
strategy, identifying new value creation opportunities and
submitting corporate strategy proposals to the Board of
Directors in relation to new investment or divestment
opportunities, financial operations with a material accounting
impact and relevant technological or structural organizational
transformations.
To study and propose to the Board of Directors
recommendations and improvements concerning strategic
plans and any updates thereto from time to time that are to be
approved by the Board of Directors.
iii) To advise the Board of Directors on ESG, including the
following functions:
1. To advise on and propose the ESG strategy, and to propose
the Company’s sustainability and environmental policies.
2. To ensure that ESG is part of the Company’s strategic
business plans, acknowledging the strategic component that
ESG represents for the Company.
3. To report to the Board of Directors on possible amendments
and periodic updates of the ESG strategy, including the
Company’s strategy in relation to social action, the policies
on diversity and integration, human rights, equal
opportunities and work-life balance, regularly evaluating its
degree of compliance and submitting to the Board of
Directors proposals for improvement which it considers to
be in the Company’s best interest.
The Executive, Strategy and ESG Committee will not under any
circumstances undertake oversight and control duties in relation
to ESG, as these are attributed, in accordance with the
provisions of their respective regulations, to the Audit
Committee and the Appointments and Remuneration
Committee, as the case may be.
iv) The Board may ask the Committee to draw up reports on
matters that come under its sphere of action.
The Executive, Strategy and ESG Committee will make proposals
and recommendations to the Board of Directors on the actions
it considers appropriate in the sphere of competences
described in paragraphs (i) to (iv) above, but it will not have
powers to make any decision on the Company’s behalf, as the
ultimate decision-making powers on such matters correspond
to the Board of Directors and, where appropriate under the
applicable regulations, the General Meeting.
Appointments and Remuneration Committee
Name
Position
Category
Ms ESTHER BERROZPE GALINDO
CHAIR
Independent
Mr BERNARDO CORBERA SERRA
MEMBER
Proprietary
Mr JORGE VALENTÍN CONSTANS
FERNÁNDEZ
MEMBER
Independent
Mr MICHAEL STEVEN LANGMAN
MEMBER
Proprietary
% executive directors
0.00
% proprietary directors
50.00
% independent directors
50.00
% other external directors
0.00
Explain the duties assigned to this committee, including, if
appropriate, those that are in addition to the duties
established by law, and describe the procedures and rules of
organization and operation thereof. For each of these duties,
state the most important actions carried out during the year
and how each of the duties assigned to it, either by law or the
Articles of Association or in corporate resolutions, has been
exercised in practice.
The duties of the Appointments and Remuneration Committee,
and its procedures and rules of organization and operation, are
set out in article 14 of the Board of Directors Regulations, and in
the Appointments and Remuneration Committee Regulations. In
this regard, the duties assigned to this Committee correspond
2024 Annual Financial Report        98
mainly to those established by law and duties deriving from
good governance recommendations and the Appointments and
Remuneration Committee Technical Guide.
The most relevant activities carried out by this Committee in
2024 are detailed in the annual report of the activities of the
Appointments and Remuneration Committee for 2024, available
Audit Committee
Name
Position
Category
Mr JOSÉ MANUEL VARGAS GÓMEZ
MEMBER
Proprietary
Ms ESTHER BERROZPE GALINDO
MEMBER
Independent
Mr BERNAT GARRIGÓS CASTRO
MEMBER
Proprietary
Mr BRIAN MCDONALD
CHAIRMAN
Independent
Ms OLATZ URROZ GARCIA
MEMBER
Independent
% de consejeros ejecutivos
0.00
% de consejeros dominicales
40.00
% de consejeros independientes
60.00
% de consejeros otros externos
0.00
Explain the duties assigned to this committee, including, if
appropriate, those that are in addition to the duties
established by law, and describe the procedures and rules of
organization and operation thereof. For each of these duties,
state the most important actions carried out during the year
and how each of the duties assigned to it, either by law or the
Articles of Association or in corporate resolutions, has been
exercised in practice.
The functions of the Audit Committee, and its procedures and
rules of organization and operation, are set out in article 13 of
the Board of Directors Regulations, and in the Audit Committee
Regulations. In this regard, the duties assigned to this
Committee correspond mainly to those established by law and
duties deriving from good governance recommendations and
the Audit Committee Technical Guide.
Certain additional duties are included in article 10 of the Audit
Committee Regulations, principally with regard to compliance.
The most relevant activities carried out by this Committee in
2024 are detailed in the annual report on the activities of the
Audit Committee for 2024, available at www.fluidra.com.
Identify the directors who are members of the audit
committee and who have been appointed taking into account
their knowledge and experience in the areas of accounting,
auditing, or both, and report the date of appointment of the
chairman of this committee.
Name of directors with
experience
Mr JOSÉ MANUEL VARGAS GÓMEZ / Ms
ESTHER BERROZPE GALINDO / Mr
BERNAT GARRIGOS CASTRO / Mr BRIAN
MC DONALD / Ms OLATZ URROZ GARCIA
Date of appointment of
chairman to that post
8/5/2024
C.2.2 Complete the following table with information regarding
the number of female directors on the committees of the
board of directors at the end of the last four years:
Number of female directors
2.024
2.023
2.022
2.024
Number
%
Number
%
Number
%
Number
%
Executive, Strategy and ESG
Committee
2
25
2
28.57
1
16.67
0
0
Appointments and
Remuneration Committee
1
25
1
25
1
25
0
0
Audit Committee
2
40
1
20
0
0
1
25
C.2.3. State, if applicable, the existence of regulations of the
board committees, where such regulations may be consulted,
and any amendments made during the year. Also state
whether any annual report on the activities of each
committee has been prepared voluntarily.
Appointments and Remuneration Committee
The Committee is regulated in the Board of Directors
Regulations (article 14), and in the Appointments and
Remuneration Committee’s own Regulations. Both Regulations
are published on the Company’s website. The Company draws
up an annual report on the activity of the Appointments and
Remuneration Committee, the contents of which are published
together with the informative documentation for shareholders
in relation to the Ordinary General Shareholders’ Meeting.
Audit Committee
The Committee is regulated in the Board of Directors
Regulations (article 13) and in the Internal Rules of Conduct, and
also in the Audit Committee’s own Regulations. All three
Regulations are published on the Company’s website. The
Company draws up an annual report on the activity of the Audit
Committee, the contents of which are published together with
the informative documentation for shareholders in relation to
the Ordinary General Shareholders’ Meeting.
Executive, Strategy and ESG Committee
The Committee is regulated in the Board of Directors
Regulations (article 12), which are published on the Company’s
website.
2024 Annual Financial Report        99
D. Related-Party transactions
and intragroup transactions
D.1. Explain any procedure and the competent bodies for
the approval of related-party and intragroup
transactions,
indicating the Company’s general internal criteria and
rules regulating the obligations of affected directors or
shareholders to abstain and detailing the internal
reporting and periodic control procedures established
by the Company in relation to related-party transactions
the approval of which has been delegated by the Board
of Directors.
In accordance with the provisions of article 33 of the Fluidra
Board Regulations, any transaction carried out by the Company
or its subsidiaries with its Directors, shareholders holding 10%
or more of the voting rights or shareholders with representation
on the Board or with any other persons to be considered related
parties in the terms established by law, provided that, under
ruling legislation, they are deemed to be related-party
transactions and unless approval corresponds to the General
Meeting, will be submitted for authorization by the Board of
Directors, subject to a favourable prior report from the Audit
Committee. This authority may not be delegated except in the
cases and under the terms established by law.
On one hand, when a related-party transaction has to be
approved by the General Shareholders’ Meeting, the proposed
resolution for approval adopted by the Board of Directors must
be submitted to the General Meeting indicating in that proposal
whether it has been approved by the Board of Directors with or
without a vote against it by a majority of the Independent
Directors.
On the other hand, when the Board of Directors delegates the
approval of related-party transactions in accordance with the
provisions of the law, it will establish in relation to such
transactions an internal reporting and periodic control
procedure, which will involve the Audit Committee, to verify the
equity and transparency of such transactions and, as the case
may be, compliance with the applicable legal criteria. These
transactions will not require a prior report by the Audit
Committee. The Board of Directors approved an internal policy
for the approval of delegated related-party transactions, the
date of effects of which is 7th May 2024.
In relation to the obligations of affected directors or
shareholders to abstain, article 33.2 of the Board Regulations
establishes that the directors affected by one of these
transactions, approval of which corresponds to the Board of
Directors and has not been delegated, must refrain from
participating in the deliberation and vote on the resolution in
question, as established by law, and therefore the number of
affected directors will be subtracted for the purposes of
determining the quorum and voting majority in relation to the
matter in question.
D.2. Disclose individually any transactions that are
significant due to their amount or subject-matter
carried out between the Company or its subsidiaries and
shareholders holding 10% or more of the voting rights or
represented on the Company’s Board of Directors,
stating what body was competent for approving them
and whether any affected shareholder or director has
abstained. If competence lay with the General Meeting,
state whether the proposed resolution has been passed
by the Board without a majority of the independent
directors voting against it:
Name of
shareholder or
any of its
subsidiaries
% shareholding
Name of
subsidiary
Amount
(thousand euros)
Body that
approved the
transaction
Identification
of significant
shareholder or
director that
abstained
Proposal to General
Meeting, if applicable, was
passed by the Board without
vote against of majority of
independent directors
No data
Name of shareholder or any of its
subsidiaries
Nature of the relationship
Type of transaction and other information
necessary to evaluate it
No data
2024 Annual Financial Report        100
D.3. Disclose individually any transactions that are
significant due to their amount or subject-matter
carried out between the Company or its subsidiaries and
the Company’s directors or senior managers, including
transactions with entities which the director or senior
manager controls or controls jointly, and stating what
body was competent for approving them and whether
any affected shareholder or director has abstained. If
competence lay with the General Meeting, state
whether the proposed resolution has been passed by the
Board without a majority of the independent directors
voting against it:
Name of directors
or senior managers
or their controlled
entities or under
joint control
Name of
subsidiary
Relationship
Amount
(thousand
euros)
Body that
approved the
transaction
Identification of
significant
shareholder or
director that
abstained
Proposal to General Meeting, if
applicable, was passed by the
Board without vote against of
majority of independent
directors
No data
Name of directors or senior managers or their controlled entities or under
joint control
Nature of the transaction and other information necessary
to evaluate it
No data
D.4. Report individually any transactions that are
significant due to their amount or subject-matter
carried out by the Company with its parent Company or
with other companies belonging to the same group as
the parent Company, including the listed Company’s
own subsidiaries, unless no other related party of the
listed Company has an interest in these subsidiaries or
they are wholly owned, directory or indirectly, by the
listed Company.
In any case, report any intragroup transaction with
entities established in countries or territories
considered to be tax havens:
Name of the group
Company
Brief description of
the transaction and
other information
necessary to
evaluate it
Amount
(thousand euros)
No data
D.5. Disclose individually any transactions that are
significant due to their amount or subject-matter
carried out by the Company or its subsidiaries with
other related parties so considered in accordance with
the International Accounting Standards adopted by the
EU that have not been reported under previous
headings:
Name of the related
party
Brief description of
the transaction and
other information
necessary to
evaluate it
Amount
(thousand euros)
IBERSPA, S.L.
Purchase of goods by
FLUIDRA group from
IBERSPA.
7,114
D.6. Describe the mechanisms established to detect,
determine and resolve potential conflicts of interest
between the Company and/or its group, and its
directors, senior managers, significant shareholders or
other related parties. 
In accordance with the provisions of the Fluidra Board of
Directors Regulations, a Board member must inform the Board
of Directors of the existence of any conflicts of interest and
refrain from attending and intervening in the deliberations that
affect matters in which that member is subject to a conflict of
interest, unless the applicable legislation authorizes him/her to
do so. A conflict of interest of the Board member is also
considered to exist when the matter affects any of the following
persons: the spouse or person with a similar relationship;
ascendants, descendants and siblings and their respective
spouses or persons with a similar relationship; ascendants,
descendants and siblings of the spouse or person with a similar
relationship; companies or entities in which the Board member
has, directly or indirectly, including through a proxy, a
shareholding that gives him or her a significant influence or the
Board member carries out in them or in their parent Company a
post in the governing body or in senior management; for these
purposes, any shareholding of 10% or more in the share capital
or the voting rights or by virtue of which it has been possible to
obtain, in fact or in law, representation on the Company’s
governing body, is presumed to grant significant influence: and,
in the case of proprietary directors, the shareholder or
shareholders who proposed their appointment or appointed
them or persons related directly or indirectly to them.
In any case, Board members may not use the Company’s name
or cite their status as Board members in order to carry out
transactions on their own account or on the account of persons
related to them. Board members may not carry out, directly or
indirectly, professional or commercial transactions with the
Company unless authorized by the Board in the terms
established by law, in the Articles of Association and in the
Board Regulations.
2024 Annual Financial Report        101
Board members must report any direct or indirect stake that
they or their related persons hold in the capital of a Company
with the same, a similar or complementary kind of activity to
that which constitutes the corporate object. Furthermore, Board
members may not engage, on their own account or on the
account of another, in the same, a similar or complementary
kind of activity to that which constitutes the corporate object
and may not hold the post of Board member or senior manager
in companies that are competitors of the Company, except for
any posts they may hold, as the case may be, in group
companies, unless they obtain the express authorization of the
General Meeting and notwithstanding the provisions of the
Companies Act.
Situations of conflict of interest of the Board members will be
disclosed in the annual report.
Furthermore, article 10 of the Company’s Internal Rules of
Conduct establishes as follows in relation to conflicts of interest:
Subject Persons in a situation of conflict of interest must
observe the following general principles of conduct:
Independence: Subject Persons must act at all times with
freedom of judgement, with loyalty to the Company and its
shareholders and independently of their own interests or those
of any other party. Consequently, they will refrain from
favouring their own interests to the expense of the Company’s
interests.
Abstention: They must refrain from acting or influencing
decision-making that could affect the persons or entities with
which there is a conflict and from accessing Confidential
Information affecting such a conflict.
Communication: Subject Persons must inform the Company’s
Internal Audit and Compliance Director of any possible conflicts
of interest in which they may find themselves.
A conflict of interest is considered to be any situation in which
the Company’s interests or those of any of the companies of the
Fluidra group clash with the personal interest of the Subject
Person. A personal interest of the Subject Person will exist when
the matter affects him /her or Persons Closely Related to him/
her.
Notwithstanding the provisions of Fluidra’s Internal Rules of
Conduct, the Company’s Board members will be governed with
regard to this matter by the provisions of the Company’s Board
of Directors Regulations.
Finally, in accordance with the provisions of article 33 of the
Board Regulations, the execution by the Company of any
transaction with Board members and with significant
shareholders or with shareholders who are represented on the
Board or with persons related to them, unless approval of such
transactions correspond to the General Meeting, will be
submitted to the Board of Directors for authorization, subject to
the prior favourable report of the Audit Committee. However,
the Board’s authorization will not be deemed necessary in
related-party transactions that comply simultaneously with the
following three conditions: (i) they are carried out by virtue of
contracts with standard terms and conditions applicable en
masse to a large number of customers; (ii) they are carried out
at prices or rates established on a general basis by the party
acting as supplier of the goods or services in question; and (iii)
the amount thereof does not exceed 1% of the Company’s
annual revenues.
Board members affected by one of such transactions will not
exercise or delegate their vote and will leave the room during
the Board meeting while the Board is deliberating on the matter,
and will be subtracted from the number of members of the
Board for the purposes of determining quorum and majorities
in relation to the matter in question.
D.7. State whether the Company is controlled, in the
sense of article 42 of the Code of Commerce, by another
Company, listed or not, and has business relations,
directly or through its subsidiaries, with that Company
or any of its subsidiaries (other than those of the listed
Company) or carries on activities related to the activities
of any of them.
☐ Yes
☑ No
2024 Annual Financial Report        102
E. Risk management and control systems
E.1. Explain the scope of the Company’s financial and
non-financial Risk Management and Control System,
including the system for managing tax risks:
Fluidra’s risk management system is designed to mitigate all the
risks to which the Company may be exposed on account of its
activity. The risk management structure is based on three
pillars.
Common management systems, designed specifically to
mitigate business risks.
Internal control procedures aimed at mitigating the risks
deriving from drawing up financial information and improving
the reliability of such information, which have been designed
in accordance with Internal Control over Financial Reporting
(ICFR).
The risk map, which is the methodology used by Fluidra to
identify, understand and assess the risks that affect the
Company. The aim is to obtain an overall view of risks,
designing a system of efficient responses aligned with the
business objectives.
The Risk Management and Control System works in an
integrated and continuous way to permit effective management
of the risks and the controls that mitigate them at all levels of
the organization. It is a global and dynamic system that
encompasses the entire organization and its environment,
including all subsidiaries and geographical areas. Compliance
with the system is mandatory for all employees of the Group, in
particular by managers and directors of the Company.
E.2. Identify the decision-making bodies of the Company
responsible for preparing and implementing the
financial and non- financial Risk Management and
Control System, including the system for managing tax
risks:
Fluidra’s Risk and Opportunity Management System (“ROMS”) is
structured according to 3 lines of defence: the regional
businesses and their transactional support functions; the
corporate functions of oversight and control of the group’s
operations and Internal Audit.
Oversight of the Group’s ROMS is the responsibility of the Audit
Committee, as the delegated consultation body of the Board of
Directors for these matters. The risk management functions of
the Audit Committee include, among others:
Periodic review of the results obtained in the ROMS;
Evaluation of the effectiveness of the internal control and
management systems, as well as the measures established to
mitigate the risks identified;
Assurance of the process established to identify and reassess
financial and non-financial risks;
Identification and understanding of emerging risks, and their
alert mechanisms; and
Assurance that risks are maintained and managed within the
tolerance levels established by the Board.
In turn, the role of the MAC is to identify the different types of
risks and opportunities, including among the financial and
economic risks any contingent liabilities and other off-balance-
sheet risks; identify the measures that are necessary to mitigate
the impact of the risks identified, in the event that they
materialize; identify the internal control and reporting systems
that will be used to control and manage the risks. Within the
MAC, the CFSO is responsible for management of the system
and the risk management function through the ERM
department. ERM is responsible for: supervising risks according
to the methodology and tools defined in the Policy; coordinating
the first and second lines of defence; promoting a sound risk
culture throughout the organization. Finally, the Internal Audit
department carries out independent oversight of the risk
management system, and of the internal control systems,
contributing with its recommendations to reducing the potential
impact of the risks on the organization to reasonable levels, and
to improving the risk management and control processes.
The objectives of the Audit Committee are:
To report to the General Shareholders’ Meeting on any
matters arising within its sphere of competence.
To propose to the Board of Directors, for submission to the
General Shareholders’ Meeting, the appointment of auditors
or audit firms as referred to in article 264 of the Companies
Act, and their contract conditions, the scope of their
professional engagement and, as the case may be, their
revocation or non-renewal.
To supervise the effectiveness of the Company’s internal
control and Internal Control over Financial Reporting, internal
audit and the risk management systems, and to discuss with
the auditors or audit firms any significant internal control
weaknesses detected in the course of the audit.
To supervise the process of drawing up and presenting
statutory financial information.
To review the Company’s accounts, ensure compliance with
legal requirements and correct application of generally
accepted accounting principles, for which purpose it has the
direct collaboration of the external and internal auditors.
2024 Annual Financial Report        103
To handle and oversee relations with the external auditors or
audit firms in order to receive information on any matters that
could compromise their independence and any other matters
related to the auditing process, as well as any other
communications established in auditing legislation and
auditing standards.
To supervise performance of the audit contract, ensuring that
the opinion on the Annual Accounts and the main contents of
the audit report are expressed clearly and precisely, and to
evaluate the results of each audit.
To supervise compliance with legislation on related-party
transactions. In particular, it will ensure that such transactions
are reported to the market (Order 3050/2004, of the Ministry
of Economy and Treasury, of 15th September 2004).
To issue annually, prior to the issue of the audit report, a
report expressing an opinion on the independence of the
auditors or audit firms, as well as disclosing the provision of
any additional services.
To examine compliance with the Internal Rules of Conduct,
the Audit Committee Regulations and the Company’s rules of
good governance and to make the necessary proposals for
improvement.
To receive information and issue a report on any disciplinary
measures sought to be imposed on members of the
Company’s senior management team.
With regard to tax, the tax strategy approved by the Board is
governed by the following principles: compliance with the
applicable tax obligations in the territories where it does
business, promote a relationship of collaboration with the Tax
Authorities with which it relates, and protect sustainable value
generation for the Company’s different stakeholders. Tax
Management of the Group reports, at least once a year, to the
Board on the management of and compliance with tax
obligations as well as tax risk control and management aspects.
E.3. Point out the main financial and non-financial risks,
including tax risks and to the extent that they are
significant the risks deriving from corruption (with the
scope indicated in Royal Decree Act 18/2017), that could
affect the achievement of business goals:
After the process of identifying and assessing corporate risks, a
total of 34 risks have been identified in 2024. Below, we detail
the 10 most significant risks: 
Financial Risks:
a) Increase in raw material prices.
b) Exchange rate fluctuations.
Non-Financial Risks:
a) Cybersecurity incidents.
b) Competitor strategy changes that may impact market
dynamics.
c) Loss of competitiveness due to lack of adaptation to new
technologies.
d) Quality incidents in production processes.
e) Water crisis.
f) Business interruption due to issues in information systems.
g) Compliance: Taxes, tariffs, transfer pricing, and other
regulations that may impact the Group’s operations.
h) Impacts resulting from catastrophic events in production or
logistics plants.
E.4. Identify whether the Company has risk tolerance
levels, including one for tax risk:
Fluidra defined its risk tolerance (maximum acceptable value of
unexpected losses that the Company can handle). Based on the
values that were calculated, impact scales have been defined
that the group uses in its risk matrix.
The various risks are identified and assessed on the basis of an
analysis of the possible events that could give rise to such risks.
The assessment is carried out using metrics that measure
likelihood and impact. The controls in place to mitigate them are
determined as well as the additional action plans necessary if
such controls are considered insufficient.
This process, performed annually, lets the Company’s Risk Map
be obtained. The most relevant risks are taken from this map
and, together with the main variations compared to the
previous year, are submitted to the Audit Committee for
discussion and approval. The definition of the scale of gravity
and the scale of likelihood is carried out based on qualitative
and quantitative criteria.
Once the critical risks have been identified and re-assessed,
Company Management establishes specific actions, determining
the person responsible and timing, to mitigate the impact and
likelihood of such risks and at the same time reviews the current
controls over these risks. The analysis of risks, controls and
actions to mitigate their impact and likelihood is presented
annually to the Audit Committee, for supervision and approval.
The Audit Committee subsequently reports to the Board of
Directors.
E.5. State what financial and non-financial risks,
including tax risks, have materialized during the year:
In 2024, the Company had a fire in two of its warehouses
located in France. The fires in these warehouses affected the
Company’s activity as the result of the materialization of the risk
of a catastrophic event in a production/distribution plant. The
assessment of the impact of these events is currently being
completed, as there are a number of variables that are
influencing the economic impact, minimized to a considerable
extent by insurance coverage.
In addition, and as a result of an incident related to the quality
process for one of our products, the Company has devised a
2024 Annual Financial Report        104
process for the recall of the product in question, both from our
customers’ premises and from end user, issuing the pertinent
communications to carry out the recall of the product.
E.6. Explain the plans for responding to and supervising
the Company’s main risks, including tax risks, as well as
the procedures followed by the Company to ensure that
the board of directors responds to the new challenges
that appear:
In addition to what is explained in sections E.3 and E.5, Fluidra
also manages the following risks:
Strategic risks:
Continuing analysis of sales of new strategic products and
comparison with competitors based on market research
monitoring to estatistical database analysis by type of market
and product. Comparative studies are performed that let us
measure the figures against the competition and update
product valuations with the information obtained.
Customers with a greater awareness of sustainability: a study
is planned that will identify risks and opportunities in market
trends from the ESG standpoint.
Analysis of new lines of business: advising from external
consultants specializing in development processes.
Operational risks:
Protection of technology and R&D: given the activities carried
out by the different business units, this is an essential
milestone in order to maintain its competitive edge. Fluidra
has development criteria, policies and legal protocols to
assure this protection, encompassing information security
and cybersecurity.
Action plans to ensure that production capacities are adapted
to the demand levels for new products.
Expansion through the acquisition of companies in the sector:
integration processes in all areas so that the companies are
integrated efficiently.
Impacts of climate change on operations: monitoring to
prevent alterations in the Group’s supply chain.
Financial risks:
Corporate Management Control Department: detection and
rapid eradication of any irregularity in subsidiaries to
standardize the consolidation of financial and non-financial
statements; analysis of procedures and internal controls of
the subsidiaries successively checked by the Internal Audit
Department and reviewed by external auditors.
Plan for implementation and update of the subsidiaries’
computer systems.
Continuous monitoring of exposure to exchange rate risk or
interest rate risk and proposing corrective measures.
Continuous monitoring of credit risk: analysing the financial
health and the profits obtained from customers that
represent a higher risk in relation to the fixed costs borne by
Fluidra.
Regulatory and compliance risks:
Procedure for identification and assessment of legal/tax risks
applied periodically: identify any conflicts/litigation that could
have an impact on the Company’s assets, or any differences of
opinion that might arise due to different interpretations of the
law with respect to a specific tax. Accounting provisions to
cover the risks are analysed and recorded.
Providing annual information on environmental performance
and management: Fluidra works to guarantee the reliability
and integrity of the information provided on energy use,
waste generation and greenhouse gas emissions through
external verification of its Non- Financial Statement.
Environmental risks:
Effect of climate change on the business: calculation of the
financial impact as a result of the possibility of a reduction in
sales of seasonal products and of potential property damage
and interruptions of its activity. This risk is offset with the
group’s geographical diversification, the increase in the
portfolio of products for adverse climate conditions and the
R&D of products with low water, energy and chemical product
consumption, as well as products and services that enable
efficient utilization of pools in any climate situation. The ESG
department performs a qualitative analysis of the physical
and transition risks. It has been determined that acute
physical risks on the business infrastructures and the costs
associated to prevention, adaptation and mitigation are the
most likely in the medium term and those that could have
greater impact.
Environmental legislation: the subsidiaries/regions are
responsible for compliance with legislation and have the
support of the corporate ESG and HSE departments.
Human Resources risks:
Talent management: people management to reduce
workplace conflicts and not affect the Company’s
performance: policy of bonuses linked to the Company’s
results and personal targets; identifying and rewarding the
best professionals to attract and retain talent; individual and
collective development plans; succession plans that guarantee
the continuity of the Company.
Occupational health and safety: investments are made in the
factories periodically and training is given to prevent
workplace accidents.
Confidential Channel: managed by the Ethics Committee, for
reporting any issue considered appropriate.
Respect for internationally recognized Human Rights: efforts
are made to prevent and mitigate any potential risk that could
arise from the Company’s activities and/or commercial
relations. All employees and suppliers undertake to respect
2024 Annual Financial Report        105
the principles contained in the Universal Declaration of
Human Rights by accepting Fluidra’s respective Ethics Codes.
Reputational risks:
Transparency in communications with stakeholders:
comparison with different international benchmarks and
external agency ratings to ensure compliance and plan future
improvements; publication of Annual Integrated Report.
United Nations Global Compact and principles of the ILO.
Fluidra carries on its activity in some of the countries that
have not signed up to the Global Compact and ILO principles.
Supplier assessments and audits are performed and training
is given to them on the human rights commitments contained
in the Ethics Code. 
2024 Annual Financial Report        106
F. Internal Control and Risk Management
Systems on Financial Reporting (ICFR)
Describe the mechanisms that make up the control and risk
management systems in relation to the Company’s financial
reporting (ICFR).
F.1. Control environment in the Company.
Indicate, specifying their main features, at least the following:
F.1.1.What bodies and/or functions are responsible for: (i) the
existence and maintenance of an adequate and effective ICFR;
(ii) the implementation of this system; and (iii) supervision of
the system.
Fluidra S.A. and its subsidiaries formally define the
responsibilities for the adequate and effective existence of ICFR
in the Board of Directors Regulations.
The Board of Directors has designated Corporate Financial
Management of Fluidra as responsible for the implementation
and maintenance of ICFR.
As regards responsibility for supervising ICFR, articles 6 and 7 of
the Audit Committee Regulations explicitly include the
responsibility of the Audit Committee in relation to supervision
of the ICFR, as well as the responsibility for supervising the
process of drawing up and presenting statutory financial
information.
The Audit Committee has the support of Internal Audit and
Regulatory Compliance management in fulfilling its
responsibilities and this is reflected in the charter for that
management area.
F.1.2. Whether any of the following are in place, particularly
with regard to the process of preparing financial information:
Departments and/or mechanisms in charge of: (i) the design
and review of the organizational structure; (ii) clearly
defining the lines of responsibility and authority, with an
appropriate distribution of tasks and duties; and (iii)
ensuring that there are sufficient procedures for the proper
dissemination of these in the Company:
Fluidra has internal processes that establish the authorization
levels necessary to modify the organizational structure. Defining
the structure and reviewing it are ultimately responsibilities of
the Executive Chairman and CEO, with the support of the
Appointments and Remuneration Committee. The
Appointments and Remuneration Committee is made up of 4
directors from the Board of Directors, of whom 2 are
proprietary directors and 2 are independent.
Fluidra has an internal organization chart available on the
corporate intranet which covers the main business areas and
ranges from the position of Executive Chairman through the
CEO to the level of General Management of each business.
This organization chart specifies the areas and departments
(including the departments involved in the preparation, analysis
and supervision of the financial information), and details the
hierarchical dependencies.
For the purposes of preparing statutory financial information,
the Group Accounting Manual (GAM) sets out the basic lines of
responsibility existing in the process, policies, documentation
necessary and timing. 
Code of conduct, body that approves it, degree of
dissemination and instruction, principles and values
included (indicating whether the recording of operations
and the preparation of financial information are specifically
mentioned), body in charge of analysing breaches and
proposing corrective actions and penalties:
Fluidra’s commitments include focusing its efforts on ensuring
that operations are carried out in an environment of ethical
professional practice. This is carried out through the
implementation of mechanisms aimed at preventing and
detecting fraud committed by employees, or inappropriate
practice that could lead to sanctions, fines or damage the
Group’s image, and also by reinforcing the importance of ethical
values and integrity among its professionals.
Fluidra has a Code of Conduct (hereinafter Ethics Code), the first
version of which was approved by the Board of Directors at a
meeting held on 16th December 2008 and the latest version at
the Board meeting held on 7th May 2024.
The Ethics Code must be observed by all employees of the
Group and is accessible to all employees through the corporate
website in 18 languages and the “myfluidra” Intranet. All
employees, when they join Fluidra, receive a copy of the Ethics
Code which they have to sign as evidence of their agreement to
comply with Fluidra’s internal policies.
The main values included in the Ethics Code are those of
bringing maximum transparency to Fluidra’s business, creating
an environment of trust for its customers, suppliers,
shareholders, employees, public and private institutions and for
society in general. The Ethics Code is based on the ten principles
declared in the UN Global Compact and seeks to be the guide
that sets out the most relevant ethical principles and behaviour
to be observed in internal and external relations, including and
2024 Annual Financial Report        107
updating all conduct that is not permitted from a legal
approach.
The general ethical principles considered in the Fluidra Ethics
Code are specified in terms of the ICFR (Internal Control over
Financial Reporting), in values associated to professional
integrity and responsibility, guidelines for action related to a
greater or lesser extent to the reliability of the financial
information and compliance with applicable legislation.
Updates and amendments of the Ethics Code are proposed and
promoted by the Audit Committee. The modifications that have
been made to the Ethics Code are indicated below:
On 28th February 2012, the Audit Committee approved the
review of the Ethics Code with the aim of incorporating
modifications that reflected the evolution of the legal
framework to which it is subject, especially with regard to the
responsibilities of the Board of Directors and the Audit
Committee.
During 2015, Fluidra reviewed the Ethics Code again, with the
aim of bringing it into line with new legislative changes,
updating it once again in 2016 to the latest changes in
regulations.
In addition to the Ethics Code, Fluidra also has other features
that seek to achieve an environment of ethical professional
practice.
During 2017, the Compliance Coordination Committee was
consolidated, made up of the corporate areas of Human
Resources, Internal Audit, Legal Advising and by the CFSO. As
established in its Rules of application, its main functions are as
follows:
Promoting, disseminating and applying the Ethics Code
throughout the Group.
Ensuring that the criminal offence prevention and control
model is developed correctly in the Group.
Encouraging the creation of internal policies, rules and
procedures.
In 2019, the Board of Directors of Fluidra published a new
Ethics Code, resulting from the merger of the two codes of
conduct of the former Fluidra and the former Zodiac. Group
Management prepared a compulsory online course for all
employees aimed at helping them to know and understand
the principles and commitments of the organization. The
course consisted of three parts: an information video of the
Chairman of the Group, an online course on the New Ethics
Code, and finally acceptance of the Fluidra Ethics Code.
At the end of 2019, the Audit Committee opted to coordinate
Compliance Management and the position of compliance officer
in Internal Audit management under the leadership of the
Global Internal Audit Director. As part of this change, the
Compliance Coordination Committee undertook advisory
functions to the Global Internal Audit and Compliance Director.
In 2022 the Ethics Code was revised to bring the contents
relating to the Confidential Channel into line with the changes
that had taken place in that mechanism in order to comply with
Directive 2019/1937. Furthermore, on the occasion of that
change, the Code became the responsibility of HR & ESG
Management.
In 2023, following the movement of the ESG Department from
the former HR & ESG Management to Financial Management, it
was agreed that the Code would become the responsibility of
the ESG Department.
In 2024, certain changes have been made to the Ethics Code to
adapt it to the new legislation (Corporate Sustainability Due
Diligence Directive or “CSDDD”) and cover the requirements of
the ESG ratings.
Whistleblowing channel that makes it possible to report any
irregularities of a financial or accounting nature to the audit
committee, as well as any possible breach of the code of
conduct and irregular activities in the organization,
specifying, if appropriate, whether it is confidential and
whether it provides the possibility of reporting
anonymously respecting the rights of the whistleblower and
the person reported:
Fluidra has an internal whistleblowing channel (“Confidential
Channel”) through which all employees, board members,
customers, suppliers, contractors or subcontractors and
shareholders can raise their queries and concerns. A
communication channel has been enabled to send them which,
from October 2022, has been outsourced so as to ensure
confidentiality and anonymity. Access to this channel can be
obtained from the corporate website. Fluidra also has an Ethics
Committee, whose role is to deal with the queries and
complaints received through the Confidential Channel. Its
objective is to carry out monitoring and control of compliance
with the principles established in the Ethics Code.
The Ethics Committee reports annually to the Audit Committee
the breaches of the Ethics Code identified and the corrective
actions and disciplinary measures proposed, if necessary. All
communications between the Ethics Committee and the
employees of Fluidra are totally confidential, respecting the
limitations established in applicable personal data protection
legislation. In this regard, all members of the Ethics Committee
are authorized to know the combined information of all queries
and notifications received from the group through the query
and notification procedure.
The Confidential Channel is the Internal Reporting System that
Fluidra makes available so that any person can report breaches
(or risks of breaches) of the applicable legislation or of the Ethics
Code that have occurred in the context of Fluidra’s activities, in
compliance with the provisions of Act 2/2023, of 20th February,
regulating the protection of whistleblowers and combatting
corruption, and of all the requirements deriving from it, as well
as any applicable local legislation.
2024 Annual Financial Report        108
Regular training and update programmes for personnel
involved in the preparation and review of financial
information, as well as in the evaluation of ICFR, covering at
least accounting policies, auditing, internal control and risk
management:
With the aim of promoting training and development, Fluidra
has the Fluidra MyCampus platform. The aim of MyCampus is to
consolidate an offering of corporate training on multidisciplinary
and business contents to promote the transmission of internal
knowledge and also the acquisition of new knowledge by
offering external content.
Bolstering internal training in Fluidra, by offering courses in the
main functional and business areas given by internal trainers,
whenever possible, is considered key in order to take full
advantage of Fluidra’s knowledge and foster interrelation
among Fluidra’s professionals. Since 2021, we have had the
contents of LinkedIn Learning including financial content
available to our employees on demand.
For aspects related to the preparation of financial information,
Fluidra invests in training on accounting and financial skills by
giving training to the employees involved in the subsidiaries
through in-person visits, or online, which goes over the
reporting statements, the different information needs for
central services or criteria for obsolescence or insolvency,
among others.
F.2. Financial reporting risk assessment
Indicate at least the following: 
What are the main features of the risk identification process,
including the process of identifying the risks of error or fraud,
with respect to:
Whether the process exists and is documented:
The process followed by Fluidra to identify risks of error in the
financial information is systematic and well documented. Fluidra
places special emphasis on the identification of risks of material
error or fraud, by determining financial reporting control
objectives for each of the risks identified. This risk identification
process is carried out and documented by Financial
Management of Fluidra and is supervised by the Audit
Committee, with the support of Internal Audit.
Whether the process covers all the financial reporting
objectives (existence and occurrence; completeness;
valuation; presentation, breakdown and comparability, and
rights and obligations), whether it is updated, and how
often:
The process is structured so that, on a regular basis, the areas
that can have a material effect on the financial statements are
analysed based on a range of criteria that include quantitative
and qualitative factors, identifying relevant areas/locations at
transaction level, to the extent that they are affected by
transactions with a material impact on the financial statements.
The scope of the areas identified is reviewed by Corporate
Financial Management of Fluidra and is ultimately supervised by
the Audit Committee. If in the course of the year (i),
circumstances not previously identified that show possible
errors in the financial information or (ii), substantial changes in
Fluidra’s operations come to light, Financial Management
assesses the existence of the risks that should be added to the
risks that have already been identified 
The existence of a process for the identification of the
consolidation perimeter, taking into account, among other
matters, the possible existence of complex corporate
structures, holding entities, or special purpose entities:
Through meetings with General Management of the divisions
and the Legal Department, Financial Management regularly
updates the corporate structure defining the consolidation
perimeter for accounting and tax purposes. In addition, at least
once a year the consolidation perimeter is supervised and
approved by the Audit Committee.
The Company has a tax policy that sets out the guidelines for
the group’s legal structure, seeking to attain the business goals
while avoiding complex instrumental structures.
Whether the process takes into account the effects of other
types of risks (operational, technological, financial, legal,
tax, reputational, environmental, etc.) to the extent that
they affect the financial statements:
The process takes into account other types of risks to the extent
that they affect the financial statements.
What governance body of the Company supervises the
process:
As indicated in the Board of Directors Regulations, the Audit
Committee is responsible for reviewing the internal control and
risk management systems periodically, so that the main risks
are identified, managed and reported adequately.
F.3. Control activities.
Indicate whether at least the following are in place and
describe their main features:
F.3.1.Procedures for review and authorization of financial
information, and description of the ICFR to be published in
the securities market, indicating the persons or divisions
responsible for them, as well as documentation describing the
flows of activities and controls (including those relating to risk
of fraud) of the various types of transactions that could
materially affect the financial statements, including the
closing process and the specific review of significant
judgements, estimates, valuations, and projections.
Fluidra has a range of procedures to validate the accounting
closing and the preparation of financial information for all areas.
The control activities identified and formally documented focus
on activities related directly to balances and transactions that
could have a material effect on the financial statements and also
seek to mitigate the risk of fraud.
2024 Annual Financial Report        109
As regards the closing procedure and the procedure for the
review and authorization of the financial information published
on the market, it commences with the establishment of a
detailed calendar of closing activities duly distributed to all the
divisions through the GAM. Thereafter, each subsidiary reports
its financial data using a standard format determined by
Financial Management using the Hyperion tool. Financial
Management is then responsible for the consolidation process,
and prepares the Consolidated Annual Accounts, which are
validated by the CFSO for subsequent presentation to and
supervision by the Executive Chairman, CEO, Internal Audit
management, the Audit Committee and the Board of Directors.
Fluidra also has a series of procedures through which Financial
Management reviews ICFR, mainly consisting of:
Existence of an ICFR management policy that articulates the
scope, responsibilities, procedure for evaluating the
effectiveness of the model, supervision of the model,
establishment of action plans and their follow up, and
supervision by the Audit Committee.
System for evaluating the internal control model through Self-
Evaluation questionnaires: Financial Management of Fluidra,
based on the process of identifying and assessing risks and
controls, defines self-evaluation questionnaires which must be
completed by the Divisions considering the minimum
requisites to guarantee reasonable assurance as to the
reliability of the financial information. Internal Audit
supervises the effectiveness of the model in accordance with
the provisions of the internal audit plan.
In relation to the specific review of relevant judgements,
estimates, valuations and projections, this takes place initially in
the existing control activities either in the routine transactions of
Fluidra, or through the control mechanisms in place in the
process of preparing the financial information detailed in the
GAM. Depending on the degree of judgement and estimation
applied and the potential impact on the financial statements,
there is a subsequent scale of discussion and review involving
General and Financial Management of the Division, Corporate
Financial Management, the CEO, the Executive Chairman, the
Audit Committee and the Board of Directors, in that order, in
cases of substantially relevant aspects in the preparation of
financial information.
When third-party experts are involved in areas subject to
judgement, estimate, valuation and projections, they discuss
and present their results to Financial Management, after having
applied a series of control and supervision procedures to the
work carried out by these experts, and depending on their
materiality they are submitted to the Audit Committee.
In particular, the main judgements and estimates addressed
during the year are those indicated in the notes to the
Consolidated Annual Accounts for the year.
F.3.2. Internal control policies and procedures on information
systems (including, among others, secure access, change
control, operation of the systems, operational continuity, and
segregation of duties) that provide support for the Company’s
relevant processes in drawing up and publishing financial
information.
Fluidra uses information systems to carry out and maintain
adequate recording and control of its operations. As part of the
process of identifying risks of error in the financial information,
Fluidra identifies, through Financial Management, the systems
and applications that are relevant in preparing it. The systems
and applications identified include both those directly used in
preparing the financial information and the interfaces with this
system, notably in relation to sales/accounts receivable and
purchases/accounts payable.
The policies and procedures concerning Fluidra’s information
systems cover both hardware and software security with regard
to access (ensuring segregation of functions through adequate
restriction of access), procedures to check the design of new
systems or modifications to existing systems, the operation of
the systems and continuity in their operation (or start-up of
alternative systems and applications) in the event of incidents
that affect their operation. These policies seek, among others, to
guarantee the following aspects:
Secure access both to data and applications.
Control over changes in the applications.
Correct operation of the applications.
Availability of data and continuity of the applications
Adequate segregation of functions
Raising awareness of individual participation in computer
security
a) Secure access:
A series of measures at different levels have been defined to
prevent unauthorized access both to data and to the
applications.
At software, operating system and database level, the user-
password combination is used as a preventive control. At data
level, profiles have been defined which limit access to data and
on which a segregation of functions matrix is being developed
that will ensure the compatibility of the user’s functions
according to his/her responsibilities.
b) Change control: 
A change management methodology has been developed and
implemented which establishes the safeguards and validations
necessary to limit the risk in this process. Since 2012 a new
methodology called “change request” has been in use. The main
aspects featured include the following:
2024 Annual Financial Report        110
Approval by the business area
Testing prior to production
Specific environments for development and test tasks
Reverse procedures
Segregation of functions as the development team does not
have access to production.
c) Operation:
To ensure that operations are carried out correctly, the
interfaces between the systems involved in preparing financial
information are monitored. There is also an internal “Help Desk”
services for end users in the event of detecting any kind of
incident, query or request for training and which controls the
efficiency of the operation of the information systems.
d) Availability and continuity:
At is head offices, the Company has two Data-Processing
Centres (main and backup) that enable it to ensure the
availability of the information system in a contingency. All of this
is supported, furthermore, by a Disaster Recovery Plan with the
tasks and steps to be carried out to restore the systems in such
an event. This DRP is tested in real conditions once a year. In
addition, daily backups are made of the data and applications,
which are kept at a secure location temporarily. To recover such
data there is a specific procedure although integral tests are not
carried out regularly. Partial information recovery processes are
however carried out regularly. Specific on-premise applications
for Fluidra’s North American companies are kept at two
outsourced data centres, located in Atlanta and implemented in
the fourth quarter of 2024, which have enhanced redundancy
and security systems. Daily backups between the data centres
are also performed. Testing of the Disaster Recovery Plan is
expected to be completed in January 2025. In Australia, the data
of the main applications are stored at the head offices in
Smithfield, and have a daily backup in a secondary in-house
data centre, located in Keysborough. Both data centre
incorporate software security improvements implemented in
2024. Data recovery testing processes are performed routinely
in order to verify the integrity of the system.
e) Segregation of functions:
A series of profiles have been defined describing the
functionalities to which a user should have access in the
Information Systems. These profiles are used to prevent a user
from having more privileges than are strictly necessary. The
definition of these profiles is currently under review.
f) Awareness raising:
Fluidra has implemented a Cybersecurity Awareness Program
that includes phishing simulations and training courses for all
employees with digital identity
F.3.3. Internal control policies and procedures designed to
supervise management of activities outsourced to third
parties, as well as the aspects of assessment, calculation or
valuation entrusted to independent experts, which may
materially affect the financial statements.
If a service has to be outsourced or an independent expert has
to be involved in assessments, calculations and valuations with a
significant impact on the financial information, Financial
Management of Fluidra leads the decision-making process.
F.4. Information and communication.
Indicate whether at least the following are in place and
describe their main features:
F.4.1.A specific function charged with defining and updating
accounting policies (accounting policy area or department)
and with resolving questions or conflicts arising from their
interpretation, maintaining fluid communications with those
responsible for operations at the organization, as well as an
updated accounting policy manual that has been
communicated to the units through which the entity
operates.
Among other functions, Financial Management is responsible
for keeping the accounting policies applicable to the group up to
date. In this regard, it is responsible for updating the GAM,
which includes the group’s accounting policies and chart of
accounts, as well as an analysis of any regulatory and
accounting changes that could have an impact on Fluidra’s
financial reporting.
The GAM is updated periodically, or when a significant new
development so requires, and was last updated in May 2023.
The updates review both accounting policies based on changes
in applicable EU-IFRS and the group’s accounting structure,
ensuring traceability between individual charts of accounts of
the group subsidiaries and the Fluidra chart of accounts which is
used as the basis for drawing up the different reporting
packages to be provided to external bodies. Changes and
updates to the GAM are communicated to all responsible
financial personnel by e-mail. The latest version of the GAM is
always available on the group’s intranet under the heading
“policies and procedures”.
Financial Management is also responsible for clearing up any
doubts about the accounting treatment of certain transactions
raised by the personnel responsible for preparing the financial
information of Fluidra.
To add greater convenience and efficiency to the responsibility
of keeping the GAM up-to-date, and to identify any incidents and
weaknesses that have to be remedied, there is a working group
on accounting procedures, made up of a member of Corporate
Financial Management, the Internal Audit Director and the
person responsible for updating the GAM, the aim of which is to
update the GAM based on the incidents detected by internal
audit in the course of its duties, which are not contemplated in
the Group’s current policies. This working group meets once a
quarter and records minutes of the meetings.
2024 Annual Financial Report        111
F.4.2. Mechanisms to capture and prepare financial
information using standardized formats, to be applied and
used by all units of the Company or group, supporting the
main financial statements and the notes, as well as the
information provided on ICFR.
All the companies that form part of the Consolidated Group at
the end of 2024 use a single standardized reporting format.
Most of them (approximately 70% of turnover), have one of the
two Corporate Systems for accounting in terms of capture and
preparation of financial information. For the remaining 30%,
which have not implemented that Information System at
present, Fluidra ensures that standardized formats are used in
preparing the financial information through mechanisms that
reflect those used in the integrated tool. The financial
information reported by all the subsidiaries covers the
composition of the main Financial Statements and the notes.
The Financial Management department of Fluidra is responsible
for obtaining data from all the subsidiaries, and with this
information makes the necessary consolidation adjustments to
obtain the consolidated figures and complements the financial
information with the reserved notes to Consolidated Financial
Statements.
In 2024, new reporting and consolidation software was
implemented and has been fully active in the closing for the
current year.
To ensure the reliability of the information reported by the
subsidiaries, they must report a range of data to allow an
analysis of variations in asset and liability items and results
obtained with respect to the monthly budget and the previous
year, in which the various balance sheet and income statement
items are interrelated, permitting greater knowledge in detail of
the operations reported at local level.
The Company has also implemented ICFR management
software based on the Company’s processes, where the most
relevant subsidiaries report compliance with a series of controls,
both over the financial information report and other controls
associated to processes with a relevant impact on the financial
statements. These controls are suitably supervised by the
responsible financial personnel of the corresponding division,
creating action plans if considered necessary. Internal audit
carries out supervision of the effectiveness of the controls twice
a year, in accordance with the annual audit plan, reporting the
results to the Audit Committee.
F.5. Supervision of operation of the system.
Indicate and describe the main features of at least the
following:
F.5.1. The ICFR supervision activities carried out by the audit
committee as well as whether the entity has an internal audit
function whose duties include providing support to the
committee in its work of supervising the internal control
system, including ICFR. Information is also to be provided
concerning the scope of the evaluation of ICFR performed
during the year and on the procedure whereby the person or
division charged with performing the evaluation reports the
results thereof, whether the entity has an action plan in place
describing possible corrective measures, and whether the
impact thereof on the financial information has been
considered.
The duties of the Audit Committee in relation to the supervision
of ICFR are established in articles 6 and 7 of the Audit
Committee Regulations and, among others, are focused on:
Supervising the effectiveness of the Company’s internal
control, especially Internal Control on Financial Reporting,
internal audit, as the case may be, and the risk management
systems, and discussing with the auditors or audit firms any
significant internal control weaknesses detected in the course
of the audit.
Supervising the process of drawing up and presenting
statutory financial information.
Reviewing the Company’s accounts, ensuring compliance with
legal requirements and correct application of generally
accepted accounting principles, for which purpose it has the
direct collaboration of the external and internal auditors. In
particular, the Audit Committee ensures that, in cases in
which the auditor has included any qualification in the audit
report, the Chairman of the Audit Committee explains clearly
to the General Meeting the Audit Committee’s opinion on the
content and scope of the qualification, making a summary of
that opinion available to the shareholders when notice of the
Meeting is published, together with the other proposals and
reports of the Board.
In relation to the information systems and internal control:
Supervising and evaluating the process of drawing up and
the integrity of the financial and non-financial information
presented, and the financial and non-financial risk
management and control systems relating to the Company
and, as the case may be, the group, reviewing compliance
with regulatory requisites, adequate definition of the
consolidation perimeter and correct application of
accounting policies.
Reviewing the internal control and risk management
systems periodically, so that the main risks are identified,
managed and reported adequately.
2024 Annual Financial Report        112
Ensuring the independence and effectiveness of the internal
audit function; proposing the selection, appointment, re-
election and removal of the person responsible for internal
audit; proposing the budget for the department; approving
or proposing to the Board of Directors the approval of the
internal audit orientation and annual work plan, ensuring
that its activity is focused mainly on the relevant risks
(including reputational risks), receiving periodic information
on its activities; and verifying that senior management takes
into account the conclusions and recommendations of its
reports.
Establishing and supervising a mechanism that allows
employees and other persons related to the Company, such
as directors, shareholders, suppliers, customers,
contractors or subcontractors to report any irregularities of
potential relevance, including financial and accounting or
any other irregularities related to Fluidra that they observe
in the Company or the group. This mechanism should
guarantee confidentiality and, in any case, provide for
situations in which these matters may be reported
anonymously, respecting the rights of the whistleblower
and the reported person.
Internal Audit Management is located within the Group’s
organizational structure, and depends on the Audit Committee,
so that its independence is assured as well as the performance
of the assigned functions. All the actions carried out by Internal
Audit Management that require approval are approved by the
Board of Directors at the proposal of the Audit Committee.
Internal Audit prepares and presents an Annual Internal Audit
Plan which is reviewed and approved by the Audit Committee. In
2024, Internal Audit met with the Audit Committee in the
months of January, February, March, May, July, October and
December to present the results and evolution of its work. At
these meetings, Internal Audit reported the weaknesses
identified in the design of the internal control model, proposing
the corresponding action plans and the dates of implementation
of these plans. In turn, Internal Audit supervises the correct
implementation of the corrective actions.
In the months of May, June, October and December 2024, the
Audit Committee, through Internal Audit Management,
supervised the correct review of the effectiveness of the
controls conducted by Financial Management. A small number
of weaknesses were detected, corresponding to the Australian
subsidiary, which have been duly corrected. The weaknesses
detected are reported to the heads of the Divisions and the
corresponding action plans are designed, with a follow-up of
their implementation.
F.5.2. Whether it has a discussion procedure whereby the
auditor (as provided in the Technical Auditing Standards), the
internal audit function, and other experts can inform senior
management and the audit committee or the directors of the
entity of the significant internal control weaknesses detected
during the review of the annual accounts or such other
reviews as may have been entrusted to them. Information
shall also be provided on whether there is an action plan to
attempt to correct or mitigate the weaknesses found.
The Audit Committee meets at least four times a year, with the
aim of obtaining and analysing the necessary information to
fulfil the tasks with which it has been entrusted by the Board of
Directors.
Special attention is given to the review of the Company’s
quarterly financial information, which is presented by General
Financial Management. In order to carry out this process, the
Audit Committee is assisted by Internal Audit, General Financial
Management (responsible for preparing the financial
information) and the Auditor, with the aim of ensuring the
correct application of ruling accounting policies and the
reliability of the financial information, and in order to be able to
report significant control weaknesses identified, if there are any,
and the corresponding action plans.
Prior to the reports issued by the Audit Committee, Internal
Audit Management discusses the results of its work with local
management, Financial Management and Corporate General
Management, thus ensuring fluid and efficient communication
among all parties.
In relation to the External Auditors, they present annually the
scope, timing and areas of emphasis of their audit work on the
annual accounts, in accordance with the applicable auditing
standards. They also meet with the Audit Committee to present
the conclusions of their work and areas for improvement. The
weaknesses reported are communicated to Internal Audit
Management for inclusion in the implementation plan. It should
be noted that the External Auditors have stated that no
significant internal control weaknesses have come to light
during the audit performed in 2024.
F.6. Other relevant information.
F.7. External audit report.
Report on:
F.7.1. Whether the information on ICFR sent to the markets
has been reviewed by the external auditor, in which case the
entity should include the corresponding report as an
appendix. Otherwise, the reasons for this should be provided.
Fluidra has submitted the information on ICFR sent to the
markets for 2024 to be reviewed by the External Auditor. The
favourable report issued by the External Auditor is attached as
an appendix to this document.
2024 Annual Financial Report        113
G. Degree to which corporate governance
recommendations are followed
State the Company’s degree of compliance with the
recommendations of the Good Governance Code of
Listed Companies.
If the Company does not comply with any
recommendation or follows it partially, a detailed
explanation of the reasons must be given, providing
shareholders, investors, and the market in general with
sufficient information to assess the Company’s course of
action. Generalized explanations will not be acceptable.
1. The Articles of Association of listed companies should not
place an upper limit on the votes that can be cast by a single
shareholder or impose other obstacles to the takeover of the
Company by means of share purchases on the market..
Complies ☒Explain ☐
2. When the listed Company is controlled, in the sense of
article 42 of the Code of Commerce, by another Company,
listed or not, and has business relations, directly or through
its subsidiaries, with that other Company or any of its
subsidiaries (other than those of the listed Company) or
carries on activities related to those of any of such companies,
it should provide detailed disclosure on:
a) The respective business activity and any business dealings
between the listed Company or its subsidiaries, on the one
hand, and the parent Company or its subsidiaries, on the
other hand.
b) The mechanisms in place to resolve possible conflicts of
interest.
Complies ☐Complies partially ☐Explain ☐
Not applicable ☒
3. During the ordinary general meeting, the chairman of the
board should verbally inform shareholders in sufficient detail
of the most relevant aspects of the Company’s corporate
governance, supplementing the written information
circulated in the annual corporate governance report. In
particular:
a) Changes taking place since the previous ordinary general
meeting.
b) The specific reasons for the Company not following a given
Good Governance Code recommendation, and any
alternative rules followed instead.
Complies ☒Complies partially ☐Explain ☐
4. The Company should draw up and promote a policy relating
to communication and contacts with shareholders and
institutional investors in the framework of their involvement
with the Company, and with proxy advisors, that complies in
full with market abuse regulations and gives equitable
treatment to shareholders in the same position. This policy
should be published on the Company’s website, complete with
details of how it has been put into practice and the identities
of the relevant spokespersons or those charged with its
implementation.
And, notwithstanding the legal obligations on the
dissemination of privileged information and other statutory
information, the Company should also have a general policy
relating to the communication of economic and financial, non-
financial and corporate information through the channels it
considers appropriate (traditional media, social media or
other channels) that contributes to maximizing the
dissemination and quality of the information available to the
market, investors and other stakeholders.
Complies ☒Complies partially ☐Explain ☐
5. The board of directors should not make a proposal to the
general meeting for the delegation of powers to issue shares
or convertible securities without a preferential subscription
right for an amount exceeding 20% of capital at the time of
such delegation.
When the board approves any issue of shares or convertible
securities without preferential subscription rights, the
Company should immediately post on its website the reports
explaining the exclusion referred to in mercantile legislation.
Complies ☒Complies partially ☐Explain ☐
6. Listed companies that draw up the following reports on a
voluntary or compulsory basis should publish them on their
website sufficiently in advance of the ordinary general
meeting, even if their distribution is not mandatory:
a) Report on auditor’s independence.
b) Reports on the activities of the audit committee and the
appointments and remuneration committee.
c) Report of the audit committee on related-party
transactions.
Complies ☒Complies partially ☐Explain ☐
2024 Annual Financial Report        114
7. The Company should livestream its general shareholders
meetings on the corporate website.
The Company should also have mechanisms that permit the
delegation and exercise of vote through remote means and, in
the case of large cap companies and to the extent that it is
proportionate, even attendance at and active participation in
the General Meeting.
Complies ☒Complies partially ☐Explain ☐
8. The audit committee should strive to ensure that the
annual accounts the board of directors presents to the
general shareholders’ meeting are drawn up in accordance
with accounting legislation. In cases in which the auditor has
included a qualification in the audit report, the chairman of
the audit committee should give a clear account at the
general meeting of the audit committee’s opinion on its
content and scope, and a summary of that opinion should be
made available to the shareholders at the time of publishing
the notice convening the meeting, together with the
remaining proposals and reports of the board.
Complies ☒Complies partially ☐Explain ☐
9. The Company should publish permanently on its website
the requisites and procedures it will accept as evidence of
ownership of shares, the right to attend general meetings and
the exercise or delegation of voting rights.
Such requisites and procedures should encourage
shareholders to attend and exercise their rights and be
applied in a non - discriminatory manner.
Complies ☒Complies partially ☐Explain ☐
10. When a shareholder entitled to do so exercises the right to
supplement the agenda or submit new proposals prior to the
general meeting, the Company should:
a) Immediately circulate these supplementary items and new
proposals for resolutions.
b) Publish the model of attendance card or proxy
appointment or remote voting form duly modified so that
new agenda items and alternative proposals can be voted
on in the same terms as those submitted by the board of
directors.
c) Put all these items or alternative proposals to the vote
applying the same voting rules as for those submitted by
the board of directors, with particular regard to
presumptions or inferences about votes.
d) After the general meeting, disclose the breakdown of votes
on such supplementary items or alternative proposals.
Complies ☒Complies partially ☐Explain ☐
Not applicable ☐
11. In the event that the Company plans to pay for attendance
at the general meeting, it should first establish a general,
long-term policy in this respect.
Complies ☐Complies partially ☐Explain ☐
Not applicable  ☒
12. The board of directors should perform its duties with unity
of purpose and independent judgement, according the same
treatment to all shareholders in the same position. It should
be guided at all times by the Company’s best interest,
understood as the attainment of a profitable business that is
sustainable in the long term, promoting its continuity and
maximizing its economic value.
In pursuing the corporate interest, it should not only abide by
laws and regulations and conduct based on good faith, ethics
and respect for commonly accepted customs and good
practice, but also strive to reconcile the Company’s interests
with the legitimate interests of its employees, suppliers,
customers and other stakeholders, as well as with the impact
of its activities on the broader community and the
environment.
Complies ☒Complies partially ☐Explain ☐
13. The board of directors should have an optimal size to
promote its efficient functioning and maximize participation.
The recommended range is accordingly between five and
fifteen members.
Complies ☒Explain ☐
14. The board of directors should approve a policy aimed at
favouring an appropriate composition of the board of
directors and that:
a) Is concrete and verifiable.
b) Ensures that appointment or re-election proposals are
based on a prior analysis of the skills required by the board
of directors; and
c) Favours a diversity of knowledge, experience, age and
gender. For these purposes, measures that foster a
significant number of female senior managers are deemed
to favour gender diversity.
The results of the prior analysis of the skills required by the
board should be reflected in the appointments committee’s
report, to be published when the general meeting is convened
that is to resolve on the ratification, appointment or re-
election of each director.
The appointments committee should perform an annual
check on compliance with this policy and set out its findings in
the annual corporate governance report. 
Complies ☒Complies partially ☐Explain ☐
2024 Annual Financial Report        115
15. Proprietary and independent directors should constitute
an ample majority on the board of directors, and the number
of executive directors should be the minimum necessary
bearing in mind the complexity of the corporate group and
the percentage shareholding of the executive directors in the
Company’s capital.
The number of female directors should represent at least 40%
of the members of the board of directors by the end of 2022
and thereafter, and prior to that should not be less than 30%.
Complies ☐Complies partially ☒Explain ☐
At 31st December 2024, of the total of 14 members of the Board
of Directors of Fluidra, 13 are non-executive directors, therefore
complying with the recommendation on this matter.
With regard to the recommendation that 40% of the Board
members be women, this recommendation will be met with
effect from June 2025 with the appointment of two female
proprietary directors, which will bring the total number of
female directors to 6 out of 14 (42.86%).
16. The percentage of proprietary directors with respect to all
non-executive directors should be no greater than the
proportion between the capital of the Company represented
by such directors and the remainder of the Company’s capital
This criterion can be relaxed:
a) In large cap companies where few or no shareholdings
attain the legal threshold to be regarded as significant.
b) In companies with a plurality of shareholders represented
on the board but not otherwise related.
Complies ☒Explain ☐
17. Independent directors should represent at least half of all
board members.
However, when the Company does not have a large market
capitalisation, or when a large cap Company has shareholders
individually or concertedly controlling over 30% of share
capital, independent directors should occupy, at least, a third
of board places.
Complies ☐ Explain ☒
At 31st December 2024, of the total of 14 directors on the Board
of Directors of Fluidra, 6 are independent directors representing
42.86% of the total number of Board members. This proportion
corresponds to the particular features of the Company’s
shareholder structure and of the shareholders’ agreement, as
well as the concerted action of certain significant shareholders
described in section A.7 of this Report, all of which has resulted
in the Company having 6 proprietary directors and 1 executive
director and 1 other external director during the year, falling 1
independent director short of the number required to comply
with the recommendation, taking into account that the
Company is a large cap Company. In this regard, it should be
borne in mind that the percentage of independent directors
(42.86%) exceeds the floating capital (27.41%). Accordingly,
Fluidra considers that the proportions of each category are
adequate for the composition of its Board of Directors in light of
its shareholder composition and allow it to reach the necessary
levels of honourability, dedication, independence and suitability.
18. Companies should disclose the following information
about their directors on their websites and keep it regularly
updated:
a) Background and professional experience.
b) Directorships held in other companies, listed or otherwise,
and other paid activities they engage in, of whatever
nature.
c) Statement of the director category to which they belong, in
the case of proprietary directors indicating the shareholder
they represent or have links with.
d) Dates of their first appointment as a board member and
subsequent re-elections.
e) Shares held in the Company, and any options on such
shares.
Complies ☒Complies partially ☐Explain ☐
19. Following verification by the appointments committee, the
annual corporate governance report should disclose the
reasons for the appointment of proprietary directors at the
request of shareholders controlling less than 3 percent of
capital; and explain any rejection of a formal request for a
board place from shareholders whose equity stake is equal to
or greater than that of others applying successfully for a
proprietary directorship.
Complies ☐Complies partially ☐Explain ☐
Not applicable ☒
20. Proprietary directors should resign when the shareholders
they represent dispose of their shareholding in its entirety. If
such shareholders reduce their stakes, thereby losing some of
their entitlement to proprietary directors, the number of
proprietary shareholders should be reduced accordingly.
Complies ☒Complies partially ☐Explain ☐
Not applicable ☐
21. The board of directors should not propose the removal of
independent directors before the expiry of their term of office
established in the Articles of Association, except when there is
due cause, found to exist by the board of directors following a
report of the appointments committee. In particular, due
cause will be deemed to exist when directors take up new
posts or responsibilities that prevent them allocating
sufficient time to their duties as a board member, or are in
breach of the inherent duties of their post or come under one
of the disqualifying grounds for classification as an
independent director enumerated in the applicable
legislation.
2024 Annual Financial Report        116
The removal of independent directors may also be proposed
when a takeover bid, merger or similar corporate transaction
alters the Company’s capital structure, provided the changes
in board membership ensue from the proportionality criterion
set out in recommendation 16.
Complies ☒Explain ☐
22. Companies should establish rules obliging directors to
disclose and, as the case may be, to resign when situations
arise affecting them, whether or not they are related to their
actions in the Company, that might be damaging to the
Company’s credit and reputation, and, in particular, obliging
them to inform the board of any criminal cases in which they
are involved as investigated parties and the corresponding
judicial proceedings.
Once the board has been informed of or has otherwise
learned of the situations mentioned in the preceding
paragraph, it should examine the case as soon as possible
and, in light of the particular circumstances and following a
report of the appointments and remuneration committee,
decide whether or not it should take some kind of measure,
such as opening an internal investigation, requesting the
director’s resignation or proposing his or her removal from
office. This matter should be reported in the annual corporate
governance report, unless there are special circumstances
that justify its omission, which must be noted in the minutes.
The foregoing is notwithstanding the information which the
Company must publish, if applicable, at the time of taking the
corresponding measures.
Complies ☒Complies partially ☐Explain ☐
23. All directors should express their clear opposition when
they feel a proposal submitted for the board’s approval might
damage the corporate interest. In particular, independent
directors and other directors not subject to potential conflicts
of interest should strenuously challenge any decision that
could harm the interests of shareholders lacking board
representation.
When the board makes significant or reiterated decisions
about which a director has expressed serious reservations,
then he or she must draw the pertinent conclusions. Directors
resigning for such causes should set out their reasons in the
letter referred to in the next recommendation.
The terms of this recommendation also apply to the secretary
of the board, even if he or she is not a director.
Complies ☒Complies partially ☐Explain ☐
24. When a director, either by resignation or a resolution of
the general meeting, ceases to hold his or her post before
their tenure expires, he or she should explain sufficiently the
reasons for his or her resignation or, in the case of non-
executive directors, his or her opinion on the reasons for
removal by the meeting, in a letter to be sent to all members
of the board.
Notwithstanding that all the above may be reported in the
annual corporate governance report, to the extent that it is
relevant for investors the Company should publish the
resignation or removal as soon as possible, making sufficient
reference to the reasons or circumstances indicated by the
director.
Complies ☒Complies partially ☐Explain ☐
Not applicable ☐
25. The appointments committee should ensure that non-
executive directors have sufficient time available to discharge
their responsibilities effectively.
The board of directors regulations should lay down the
maximum number of Company boards on which directors can
serve:
Complies ☒Complies partially ☐Explain ☐
26. The board should meet with the necessary frequency to
properly perform its functions, and at least eight times a year,
in accordance with a calendar and agendas set at the start of
the year, to which each director may propose the addition of
initially unscheduled items.
Complies ☒Complies partially ☐Explain ☐
27. Director absences should be kept to a strict minimum and
quantified in the annual corporate governance report. In the
event of absence, directors should delegate another director
to represent them and issue appropriate instructions.
Complies ☒Complies partially ☐Explain ☐
28. When directors or the secretary express concerns about
some proposal or, in the case of directors, about the
Company’s performance, and such concerns are not resolved
at the meeting, they should be recorded in the minutes if the
person expressing them so requests.
Complies ☒Complies partially ☐Explain ☐
Not applicable ☐
29. The Company should establish suitable channels for
directors to obtain the advice they need to carry out their
duties including, if necessary, external advising at the
Company’s expense.
Complies ☒Complies partially ☐Explain ☐
30. Regardless of the knowledge directors must possess to
carry out their duties, they should also be offered refresher
programmes when circumstances so advise.
Complies ☒Complies partially ☐Explain ☐
2024 Annual Financial Report        117
31. The agendas of board meetings should clearly indicate the
items on which directors must arrive at a decision, so they can
study the matter beforehand or gather the material they
need.
When, exceptionally, for reasons of urgency, the chairman
wishes to present decisions or resolutions for board approval
that were not on the agenda, their inclusion will require the
express prior consent, duly recorded in the minutes, of the
majority of directors present.
Complies ☒Complies partially ☐Explain ☐
32. Directors should be regularly informed of movements in
share ownership and of the views of significant shareholders,
investors and rating agencies on the Company and its group.
Complies ☒Complies partially ☐Explain ☐
33. The chairman, as the person charged with the efficient
functioning of the board of directors, in addition to the
functions assigned by law and the Company’s Articles of
Association, should prepare and submit to the board a
schedule of meeting dates and agendas; organize and
coordinate regular evaluations of the board and, where
appropriate, the Company’s chief executive officer; exercise
leadership of the board and be accountable for its proper
functioning; ensure that sufficient time is given to the
discussion of strategic issues, and approve and review
refresher courses for each director, when circumstances so
advise.
Complies ☒Complies partially ☐Explain ☐
34. When a lead independent director has been appointed,
the Articles of Association or board of directors regulations
should grant him or her the following powers over and above
those conferred by law: chair the board of directors in the
absence of the chairman and vice-chairs, if any; give voice to
the concerns of non-executive directors; maintain contacts
with investors and shareholders to hear their views and
develop a balanced understanding of their concerns,
especially those to do with the Company’s corporate
governance; and coordinate the chairman succession plan.
Complies ☒Complies partially ☐Explain ☐
Not applicable ☐
35. The secretary of the board should make special efforts to
ensure that the board’s actions and decisions are informed by
the governance recommendations of the Good Governance
Code that are applicable to the Company.
Complies ☒Explain ☐
36. The board in full should conduct an annual evaluation,
adopting, where necessary, an action plan to correct
weaknesses detected in:
a) The quality and efficiency of the board’s operation.
b) The operation and composition of its committees.
c) The diversity in the composition and competences of the
board.
d) The performance of the chairman of the board of directors
and the Company’s chief executive.
e) The performance and contribution of each individual
director, with particular attention to the chairs of board
committees.
The evaluation of board committees should start with the
reports they send to the board of directors, while that of the
board itself should start with the report of the appointments
committee.
Every three years, the board of directors should engage an
external consultant to aid in the evaluation process. This
consultant’s independence should be verified by the
appointments committee.
Any business dealings that the consultant or any company in
its group has with the Company or with any Company in its
group should be detailed in the annual corporate governance
report.
The process followed and areas evaluated should be
described in the annual corporate governance report.
Complies ☒Complies partially ☐Explain ☐
37. Where there is an executive committee, at least two non-
executive directors should be on this committee, at least one
of whom is independent; and the secretary of the committee
should be the secretary of the board.
Complies ☒Complies partially ☐Explain ☐
Not applicable ☐
38. The board should be kept fully informed of the business
transacted and decisions made by the executive committee.
To this end, all board members should receive a copy of the
executive committee’s minutes.
Complies ☒Complies partially ☐Explain ☐
Not applicable ☐
39. The members of the audit committee, particularly its
chairman, should be appointed taking into account their
knowledge and experience in accounting, auditing and both
financial and non-financial risk management.
Complies ☒Complies partially ☐Explain ☐
40. Under the supervision of the audit committee, there
should be a unit in charge of the internal audit function to
oversee proper operation of reporting and internal control
systems. This unit should report functionally to the board’s
non- executive chairman or the chairman of the audit
committee.
Complies ☒Complies partially ☐Explain ☐
2024 Annual Financial Report        118
41. The head of the unit handling the internal audit function
should present an annual work programme to the audit
committee for approval by the committee or by the board,
inform it directly of the execution of this plan, including any
incidents and scope limitations arising during its
implementation, the results and monitoring of its
recommendations and submit a report on its activities at the
end of each year.
Complies ☒Complies partially ☐Explain ☐
Not applicable ☐
42. In addition to the functions established by law, the audit
committee should have the following functions:
1. In relation to internal control and reporting systems:
a) Supervise and evaluate the process of drawing up and the
integrity of the financial and non-financial information and
the control and management systems over the financial
and non-financial risks relating to the Company and, as the
case may be, the group - including operational,
technological, legal, social, environmental, political and
reputational or corruption-related risks - reviewing
compliance with regulatory requisites, adequate definition
of the consolidation perimeter and correct application of
accounting policies.
b) Ensure the independence of the unit that undertakes the
internal audit function; propose the selection, appointment
and removal of the person responsible for the internal
audit service; propose the budget for this service; approve
or propose approval by the board of the approach and the
annual internal audit work plan, ensuring that its activity is
focused mainly on the relevant risks of the Company
(including reputational risks); receive periodic information
on its activities; and verify that senior management takes
into account the conclusions and recommendations of its
reports.
c) Establish and supervise a mechanism that allows
employees and other persons related to the Company,
such as directors, shareholders, suppliers, contractors or
subcontractors, to report any irregularities of potential
relevance, including financial and accounting or any other
kind of irregularities that they observe in the Company or
the group. This mechanism should guarantee
confidentiality and, in any case, provide for cases in which
communications may be made anonymously, respecting
the rights of the whistleblower and the reported person.
d) Ensure in general that the policies and systems established
in relation to internal control are applied effectively in
practice.
2. In relation to the external auditor:
a) Investigate the circumstances giving rise to the resignation
of the external auditor, should this come about.
b) Ensure that the remuneration of the external auditor does
not compromise its quality or independence.
c) Ensure that the Company notifies any change of external
auditor through the CNMV, accompanied by a statement of
any disagreements arising with the outgoing auditor and
the reasons for the same.
d) Ensure that the external auditor has a yearly meeting with
the board in full to inform it of the work undertaken and
developments in the Company’s risk and accounting
positions.
e) Ensure that the Company and the external auditor adhere
to current regulations on the provision of non- audit
services, limits on the concentration of the auditor’s
business and, in general, other regulations on auditor
independence.
Complies ☒Complies partially ☐Explain ☐
43. The audit committee should be empowered to meet with
any Company employee or manager, even ordering their
appearance without the presence of another senior manager.
Complies ☒Complies partially ☐Explain ☐
44.The audit committee should be informed of any structural
and corporate modification operations the Company is
planning, so the committee can analyse and report to the
board beforehand on their economic conditions and
accounting impact, especially, when applicable, on the
proposed swap ratio.
Complies ☒Complies partially ☐Explain ☐
Not applicable ☐
45. The risk management and control policy should identify or
determine at least:
a) The different types of financial and non-financial risks the
Company is exposed to (including operational,
technological, legal, social, environmental, political and
reputational risks, including risks related to corruption),
with the inclusion under financial or economic risks of
contingent liabilities and other off- balance- sheet risks. .
b) A risk management and control model based on different
levels, a part of which will include a committee specialized
in risks when sectorial regulations so establish, or the
Company considers appropriate.
c) The risk level the Company sees as acceptable.
d) The measures devised to mitigate the impact of the risks
identified, should they materialize.
e) The internal control and reporting systems to be used to
control and manage the above risks, including contingent
liabilities and off-balance-sheet risks.
Complies ☒Complies partially ☐Explain ☐
2024 Annual Financial Report        119
46. Companies should establish an internal risk control and
management function to be exercised by one of the
Company’s internal department or units, under the direct
supervision of the audit committee or some other dedicated
board committee. This function should be expressly charged
with the following responsibilities:
a) Ensure that risk control and management systems are
functioning correctly and, specifically, that all the
significant risks the Company is exposed to are adequately
identified, managed and quantified.
b) Participate actively in the preparation of risk strategies and
in key decisions about their management.
c) Ensure that risk control and management systems are
mitigating risks adequately in the context of the policy
defined by the board of directors.
Complies ☒Complies partially ☐Explain ☐
47. Members of the appointments and remuneration
committee - or of the appointments committee and the
remuneration committee, if they are separate - should be
appointed ensuring that they have adequate knowledge, skills
and experience for the functions they are called on to
discharge. The majority of their members should be
independent directors.
Complies ☐Complies partially ☒Explain ☐
The members of the Appointments and Remuneration
Committee have been appointed taking into account their
knowledge, skills and experience as well as the mission of the
Committee. As far as the composition of the Committee is
concerned, it is made up of four non- executive directors, two of
whom are independent, while the other two are proprietary
directors. The Chair of the Committee is an independent
director.
The reason why the Company does not comply with this part of
the recommendation concerning composition is because clause
8.3.6 of the Shareholders’ Agreement formalized between
Rhône Capital and the founding families of Fluidra on 3rd
November 2017, on the occasion of the merger between Fluidra
and Zodiac, establishes that the Appointments and
Remuneration Committee is to be made up of four (4) members,
of whom two (2) will be independent directors (one of them the
Chair), one will be designated “at the proposal of the Current
Shareholders” (i.e. at the proposal of the four founding families
of the Company) and the other will be designated “at the
proposal of the Shareholder of Zodiac Holdco” (i.e. at the
proposal of the Rhône Capital fund). This Shareholders’
Agreement is published on the Company’s website
www.fluidra.com, under “Shareholders and Investors”
“Corporate Governance”, “Shareholders’ Agreements”, and on
the website of the CNMV and in the Mercantile Registry of
Barcelona.
Indeed, given the shareholder concentration of Fluidra, as
explained in section A.7 of the Annual Corporate Governance
Report, the Company understands that it was necessary that the
two blocks represented in the Shareholders’ Agreement
between Rhône Capital and the founding families of Fluidra
each had a representative on a body such as the Appointments
and Remuneration Committee, which was considered of great
importance for the operation of the Company. This Committee
was consequently composed of two proprietary directors and
two independent directors, the Chair being one of the
independent directors, who co-ordinates and personally
manages the work of this Committee.
48. Large cap companies should have separate appointments
and remuneration committees.
Complies ☐Explain ☒Not applicable ☐
Fluidra has not considered it necessary for the time being to
separate its current Appointments and Remuneration
Committee into two committees, as it understands that the
functions relating to appointments and those relating to
remuneration can be discharged objectively and independently
by the same committee. As a matter of fact, Fluidra considers
that is not efficient to separate the competencies in two
committees and that the existence of only one committee does
not limit in any way or compromise the exercise of the faculties
granted by law to the Appointments and Remuneration
Committee.
49.The appointments committee should consult with the
Company’s chairman and chief executive, especially on
matters relating to executive directors.
When there are vacancies on the board, any director should
be able to approach the appointments committee to propose
candidates for the committee to judge whether they might be
suitable.
Complies ☒Complies partially ☐Explain ☐
50. The remuneration committee should operate
independently and have the following functions in addition to
those assigned by law:
a) Propose to the board the standard conditions for senior
management contracts.
b) Monitor compliance with the remuneration policy set by
the Company.
c) Periodically review the remuneration policy for directors
and senior managers, including share-based remuneration
systems and their application, and ensure that their
individual remuneration is proportionate to the amounts
paid to other directors and senior managers in the
Company.
d) Ensure that conflicts of interest do not undermine the
independence of any external advice provided to the
committee.
2024 Annual Financial Report        120
e) Verify the information on director and senior manager
remuneration contained in corporate documents, including
the annual report on directors’ remuneration.
Complies  ☒Explain ☐ Not applicable ☐
51. The remuneration committee should consult with the
Company’s chairman and chief executive, especially on
matters relating to executive directors and senior managers. .
Complies  ☒Explain ☐ Not applicable ☐
52. The rules on the composition and operation of the
supervisory and control committees should be set out in the
board of directors’ regulations and should be consistent with
the rules applicable to legally mandatory committees in
accordance with the above recommendations, including the
following rules:
a) These committees should be formed exclusively by non-
executive directors, with a majority of independent
directors.
b) They should be chaired by independent directors.
c) The board of directors should appoint the members of
such committees with regard to the knowledge, skills and
experience of the directors and each committee’s terms of
reference; discuss their proposals and reports; and report
back on their activities and work at the first full board
meeting following each committee meeting.
d) The committees may engage external advice, when they
feel it necessary for the discharge of their functions.
e) Minutes of their meetings should be drawn up and made
available to all board members.
Complies  ☐Complies partially  ☐Explain ☐
Not applicable ☒
53. The task of supervising compliance with the Company’s
policies and rules on environmental, social and corporate
governance matters, as well as internal codes of conduct,
should be assigned to one board committee or split between
several committees of the board of directors, which could be
the audit committee, the appointments committee, a
committee specializing in sustainability or corporate social
responsibility or a dedicated committee established ad hoc by
the board under its powers of self-organization. This
committee should be made up exclusively of non-executive
directors, the majority of whom should be independent, and
should be specifically charged with the minimum functions
indicated in the following recommendation.
Complies  ☒Complies partially  ☐Explain ☐
54. The minimum functions referred to in the preceding
recommendation are as follows:
a) Oversee compliance with the Company’s corporate
governance rules and internal codes of conduct, also
ensuring that the corporate culture is aligned with its
mission and values.
b) Oversee application of the general policy relating to the
communication of economic and financial, non- financial
and corporate information and communication with
shareholders and investors, proxy advisors and other
stakeholders. The way in which the Company
communicates with and relates to its small and medium-
sized shareholders will also be monitored.
c) Periodically evaluate and review the Company’s corporate
governance system and its environmental and social policy,
to confirm that it is fulfilling its mission to promote the
corporate interest and catering, as appropriate, to the
legitimate interests of the other stakeholders.
d) Oversee the Company’s social and environmental practices
to ensure that they conform to the established strategy
and policies.
e) Oversee and evaluate processes in relation to the different
stakeholders.
Complies  ☒Complies partially  ☐Explain ☐
55. The environmental and social sustainability policies should
identify and include at least:
a) The principles, commitments, goals and strategy in relation
to shareholders, employees, customers, suppliers, social
matters, environment, diversity, fiscal responsibility,
respect for human rights and the prevention of corruption
and other illegal conduct.
b) The methods or systems to monitor compliance with the
policies, the associated risks and their management.
c) The mechanisms for supervising non-financial risk,
including the risk related to ethics and business conduct.
d) Channels for stakeholder communication, participation
and dialogue.
e) Responsible communication practices that prevent the
manipulation of information and protect honour and
integrity.
Complies  ☒Complies partially  ☐Explain ☐
56. Directors’ remuneration should be sufficient to attract and
retain individuals with the desired profile and compensate the
dedication, qualifications and responsibility that the post
demands, but not so high as to compromise the independent
judgement of non- executive directors.
Complies  ☒Explain ☐
2024 Annual Financial Report        121
57. Variable remuneration linked to the Company’s
performance and the director’s personal performance, and
remuneration in the form of awarding shares, options or
rights on shares or instruments linked to the share price and
long -term savings schemes such as pension plans, retirement
systems or other benefits should be confined to executive
directors.
Share-based remuneration of non-executive directors may be
considered when it is subject to the condition that the shares
must be kept until the end of their term of office. This
condition, however, will not apply to any shares that the
director must dispose of to defray costs related to their
acquisition.
Complies  ☒Complies partially  ☐Explain ☐
58. In the case of variable remuneration, remuneration
policies should include limits and technical safeguards to
ensure they reflect the professional performance of the
beneficiaries and not simply the general progress of the
markets or the Company’s sector, or other similar
circumstances.
In particular, variable remuneration components should meet
the following conditions:
a) They should be subject to predetermined and measurable
performance criteria that take into account the risk
assumed to obtain a given outcome.
b) They should promote the sustainability of the Company
and include non-financial criteria that are relevant for the
creation of value in the long term, such as compliance with
the Company’s internal rules and procedures and its risk
management and control policies.
c) They should be focused on achieving a balance between
the delivery of short, medium and long-term objectives,
such that performance-related pay rewards ongoing
achievement, maintained over sufficient time to appreciate
its contribution to long-term value creation. This will
ensure that performance measurement is not based solely
on one-off, occasional or extraordinary events.
Complies  ☒Complies partially  ☐Explain ☐
Not applicable ☐
59. Payment of variable remuneration components should be
subject to sufficient checks that predetermined performance
or other conditions have effectively been met. Companies will
include in the annual directors’ remuneration report the
criteria in terms of time required and methods to conduct
such a check in line with the nature and characteristics of
each variable component.
Additionally, companies should consider establishing a
reduction clause (“malus”) based on the deferral for a
sufficient length of time of payment of part of the variable
components that will lead to total or partial loss of such
components in the event that prior to the time of payment
any event occurs that renders this advisable.
Complies  ☒Complies partially  ☐Explain ☐
Not applicable ☐
60. Remuneration linked to Company earnings should bear in
mind any qualifications stated in the external auditor’s report
that reduce the amount of such earnings.
Complies  ☒Complies partially  ☐Explain ☐
Not applicable ☐
61. A major part of executive directors’ variable remuneration
should be linked to the award of shares or financial
instruments the value of which is linked to the share price.
Complies  ☒Complies partially  ☐Explain ☐
Not applicable ☐
62. Once shares, options or financial instruments have been
awarded as part of share-based remuneration, executive
directors should not be allowed to transfer ownership or
exercise them until a term of at least three years has elapsed.
This does not include cases in which a director has, at the
time of transfer or exercise, a net economic exposure to the
variation in the price of the shares for a market value equal to
at least twice his or her annual fixed remuneration by holding
shares, options or other financial instruments.
The above condition will not apply to any shares that the
director must dispose of to defray costs related to their
acquisition, or, following a favourable opinion by the
appointments and remuneration committee, to deal with any
supervening extraordinary situations that so require.
Complies  ☒Complies partially  ☐Explain ☐
Not applicable ☐
63. Contractual arrangements should include a clause that
allows the Company to reclaim variable components of
remuneration when payment was not in line with the
director’s actual performance or was based on data
subsequently found to be inaccurate.
Complies  ☒Complies partially  ☐Explain ☐
Not applicable ☐
2024 Annual Financial Report        122
64. Severance payments should not exceed an amount
equivalent to two years of the director’s total annual
remuneration and should not be paid until the Company
confirms that the director has met the predetermined criteria
or conditions.
For the purposes of this recommendation, severance payment
will be deemed to include any payments the accrual of which
or obligation to pay arises as a result of or on the occasion of
the termination of the contractual relationship between the
director and the Company, including amounts not previously
vested of long-term savings plans and any amounts paid by
virtue of post-contractual non-compete clauses.
Complies  ☐Complies partially  ☒Explain ☐
Not applicable ☐
In relation to the Executive Chairman, his contract establishes
compensation in cases of termination of the contract by
Fluidra’s decision or the Executive Chairman’s own decision for
the causes detailed in section C.1.39, for an amount equivalent
to two years of his remuneration, based on the gross annual
salary received in the year the termination of the contract takes
place and the variable gross annual salary for the preceding
year. This compensation includes the amount of the severance
pay which the Executive Chairman is entitled to receive for the
termination of his previous employment relationship of sixteen
years and seven months, which was suspended when he was
appointed to the Board.
Additionally, his contract includes a post-contractual non-
compete clause for a term of two years, with an economic
compensation of two years of his fixed gross annual
remuneration at the time of termination of his contract.
If, as a result of the termination of his contract, the Executive
Chairman were to receive, in addition to the non-competition
compensation, the severance compensation for termination of
his contract, the sum of the two amounts would exceed two
years’ salary. However, the Company understands that the
amount of the compensation for termination of the contract
(which was already reduced in 2015, from three to two years’
annual salary, as a result of the introduction of this
recommendation that year) should not be reduced, as it
includes the termination of his prior employment relationship of
sixteen years and seven months, which was suspended when he
was appointed as a director.
2024 Annual Financial Report        123
H. Other information of interest
1. If there are any significant aspects regarding corporate
governance in the Company or entities of the group that have
not been included in the other sections of this report, but
should be included in order to provide more complete and
well-reasoned information regarding the corporate
governance structure and practices in the entity or its group,
briefly describe them.
2. In this section, you may also include any other information,
clarification, or comment relating to the prior sections of this
report to the extent they are relevant and not repetitive.
Specifically, state whether the Company is subject to laws
other than Spanish laws regarding corporate governance and,
if applicable, include such information as the Company is
required to provide that is different from the information
required in this report.
3. The Company may also state whether it has voluntarily
adhered to other international, industrial, or other codes of
ethical principles or good practice. If so, identify the code in
question and the date of adherence thereto. In particular,
mention whether the Company has signed up to the Code of
Good Tax Practice, of 20th July 2010:
As reported through the disclosure of other relevant
information (ORI) on February 27, 2025, the Board of Directors
agreed on February 25, 2025, to appoint Ms. Olatz Urroz García
as Chair of the Audit Committee until the end of the term for
which she was appointed as a member of the Company's Board
of Directors, replacing Mr. Brian McDonald, who remains a
member of the Audit Committee.
This annual corporate governance report was approved by
the Board of Directors of the Company at its meeting held on:
25/03/2025
State whether any directors voted against or abstained in
relation to the approval of this Report.
☐ Yes
☑ No
SCIIF eng_Página_1.jpg
SCIIF eng_Página_2.jpg
SCIIF eng_Página_3.jpg
SCIIF eng_Página_4.jpg
Annual Report on
Remuneration of Directors
of listed Companies 2024
2024 Annual Financial Report        129
Issuer Identification
Year-end date:
31/12/2024
CIF:
A-17728593
Company Name:
FLUIDRA, S.A.
Registered address:
AVENIDA ALCALDE BARNILS, 69 (SANT CUGAT DEL VALLÉS) BARCELONA
2024 Annual Financial Report        130
A. Remuneration policy of the Company
for the current Fiscal Year
A.1.1 Explain the current director remuneration policy
applicable to the year in progress. To the extent that it is
relevant, certain information may be included in relation to
the remuneration policy approved by the General
Shareholders' Meeting, provided that these references are
clear, specific and concrete.
The specific assessments for the year in progress should be
described, both the remuneration of directors in their status
as such and as a result of their executive functions carried out
for the Board pursuant to the contracts signed with executive
directors and to the remuneration policy approved by the
General Shareholders' Meeting.
In any event, the following aspects should be reported:
a) Description of the procedures and bodies at the Company
involved in the determination and approval of the
remuneration policy and its terms and conditions
b) Indicate and, where applicable, explain whether
comparable companies have been taken into account in
order to establish the Company's remuneration policy.
c) Information on whether any external advisors took part in
this process and, if so, their identity
d) Procedures included in the current remuneration policy for
directors for making temporary exceptions to the policy,
the conditions under which such exceptions can be made
and the components that may be subject to exception
under the policy.
The 2024 Fluidra's General Shareholders' Meeting
("Shareholders' Meeting" or "Meeting") approved Fluidra's
Remuneration Policy for Directors (“2024-2027 Remuneration
Policy” or “2024-2027 Policy”), applicable from the approval date
through December 31, 2027.
However, the change in the make-up of the Board of Directors
through the appointment of a new chief executive officer
("CEO") at Fluidra, as tabled for approval together with this
Annual Report on Remuneration by the Shareholders' Meeting,
has made it necessary to adapt the Remuneration Policy, which
will enter into force on the date of its approval until 31
December 2028 ("2025–2028 Remuneration Policy" or "2025–
2028 Policy".
Following an analysis of the information received from
institutional investors and proxy advisors, and of the provisions
of the Code of Good Corporate Governance on the
remuneration of directors, the proposed 2025–2028
Remuneration Policy will follow along the same lines as the
2024–2027 Policy in terms of the principles, structure and
content of the remuneration package. The same principles and
foundations as the 2024–2027 Remuneration Policy are
maintained, namely, that remuneration should be reasonably
proportionate to the Company’s importance, its economic
situation and the market standards of comparable companies. It
should be geared towards promoting the creation of sustainable
long-term value, linking directors' remuneration to business
performance and shareholders’ interests and incorporating the
necessary safeguards to avoid excessive risk-taking and the
rewarding of poor results.
Additionally, Fluidra takes into account the economic
environment, the Company’s results, the strategy of the Fluidra
group, best market practices and Corporate Governance
recommendations in relation to remuneration. As was the case
in the 2024–2027 Policy, the 2025–2028 Remuneration Policy
establishes that Fluidra's Board of Directors, on the
recommendation of the Appointments and Remuneration
Committee ("ARC"), may approve temporary exceptions to the
Remuneration Policy under exceptional circumstances where it
is necessary to serve the long-term interests and sustainability
of Fluidra as a whole or to ensure its viability. The details of and
justification for temporary exceptions will be included in the
pertinent Annual Remuneration Report.
The key changes to the 2025–2028 Remuneration Policy are as
follows:
Adjustment of the remuneration of the Executive Directors to
match the remuneration of the new CEO (Mr. Jaime Ramírez),
whose appointment together with the 2025–2028  Policy will
be tabled for approval by the Meeting.
Insofar as the new CEO is concerned, this remuneration is
backed by a new comparative analysis with the aim of
matching his remuneration to that of executive directors in
comparable companies, based on Fluidra's size, sector, and
the domestic and international markets in which it operates,
as described below. The Executive Chairman's remuneration
has not undergone any changes in comparison with the
previous policy, except for the annual fixed adjustment in line
with the management team.
Description of the main characteristics of the long-term
incentive for the key and executive directors that is being
tabled for approval together with this Policy 2025–2029 Plan,
following the start of the third and last cycle of the 2022–2026
Plan in 2024. The structure of the 2025–2029 Plan will follow
along the same lines as the 2022–2023, as it is also made up
of 3 cycles that each last for 3 years.
2024 Annual Financial Report        131
Fluidra regularly requests benchmarks on the amount and
structure of Fluidra's remuneration packages for its senior
management team to ensure that it is aligned with market
standards. In 2024, Willis Towers and Watson, a firm specialized
in this matter, conducted a benchmarking study on the total
remuneration of Fluidra's Executive Directors and senior
management team.
This study used the following criteria to select the baseline
group: companies in the same industrial sector, including
companies that are competitors in in the pool sector and
companies considered to be competitors in terms of talent,
whose turnover and market capitalization is approximately
between 25 and 400% of that of Fluidra, and whose main HQ is
in Europe or the USA, in order to reflect Fluidra's geographical
context.
Based on where a director is geographically located, one of the
following two peer groups is used:
European Peer Group. Kone, Gestamp, Siemens - Mobility,
Acerinox, Kingspan, Hella, Nissan Motor – Europe, Schneider
Electric - Europe Operations, Schneider Electric - Energy
Management WE, Grifols, Alfa Laval, Konecranes, Siemens -
Portfolio Companies, Cellnex, Weir Group, DMG Mori, Somfy,
Almirall, Rovi.
US Peer Group. Pool Corp, Xylem, Rexnord Corporation,
Winnebago, Pentair, A.O. Smith Corp, Flowserve Corporation,
DoN/Aldson, ITT Inc., Viasat, Watts Water Technology, Leslie’s,
SPX Corporation, Hayward Holdings, Mueller Water Products,
Latham Pool.
The selection prioritized competitors by talent and the most
closely related sectors, i.e. industrial machinery and capital
goods, as a result of which a wide range had to be included in
terms of size in order to ensure that there was a comparison
group made up of a sufficient number of companies that made
it possible to obtain robust, representative results, to the extent
that the number of peers in terms of comparable size is very
small and only located in the USA. This makes it possible to
include companies that, although they differ in size, share a
business life cycle or strategic characteristics in a range aligned
with best market practices.
The remuneration of the new CEO for his executive functions is
backed by the aforementioned study, in which the US peer
group was taken into consideration, as the new CEO was
selected from candidates from this country and his operational
headquarters will also be in the United States. This is due to the
relevance of the American market, both in terms of the current
climate and of Fluidra's strategy for the future.
Insofar as the rest of the directors and the Executive Chairman
are concerned, the findings of the aforementioned study carried
out by Willis Towers and Watson were updated internally, as a
result of which it was confirmed that their remuneration was
aligned with market standards.
A.1.2 Relative importance of variable remuneration items vis-
à-vis fixed remuneration (remuneration mix) and the criteria
and objectives taken into consideration in their assessment
and to guarantee a suitable balance between the fixed and
variable components of remuneration.
In particular, indicate actions taken by the Company in
relation to the remuneration plan to reduce exposure to
excessive risk and adjust it to the Company's long-term
objectives, values and interests, including, where applicable, a
reference to the measures which are planned to guarantee
that the remuneration policy is consistent with the Company's
long-term results, the measures adopted in relation to
personnel whose professional performance has material
repercussions on the Company's risk profile and the
measures planned to avoid conflicts of interests, if any.
Furthermore, state whether the Company has established any
period for the accrual or vesting of certain variable
remuneration items, in cash, shares or other financial
instruments, any deferral period in the payment of amounts
or the handover of accrued and vested financial instruments,
or if any clause exists reducing the deferred remuneration or
that obliges a director to return remuneration received, when
such remuneration has been based on certain figures that
have clearly been shown to be inaccurate has been agreed.
According to the 2024–2027 Remuneration Policy, the 2024–
2028 Remuneration Policy (jointly, the "Remuneration Policy"),
only the Executive Directors receive short-term and long-term
variable remuneration. This is in compliance with CNMV
recommendation no. 57, according to which variable
remuneration linked to the Company’s performance and
personal performance, and that consisting of the award of
shares, options or rights over shares or instruments linked to
share value, must be confined to Executive Directors.
Notwithstanding the foregoing, directors who following the
termination of their executive functions still sit on the Board as
external directors may receive the variable remuneration that
they would have been paid during the period in which they
exercised their executive functions, but liquidated after ceasing
to exercise the aforementioned executive functions.
The remuneration system of Executive Directors reflects a
balanced and efficient relationship between fixed components
and variable annual or multi-year components. Variable
remuneration is set with a medium and long-term view, which
provides an incentive for performance in strategic terms in
addition to the achievement of short-term results, considering
the current situation and the Company’s outlook and objectives
with regard to sustainable growth, without the variable
remuneration threatening the Company’s ability to maintain its
solvency and financial situation.
The Remuneration Policy seeks to promote and favor the
achievement of the Company's strategic objectives by
incorporating long-term incentives, reinforcing continuity in the
Company's competitive development, fostering motivation,
loyalty and retention, whilst keeping remuneration in line with
best practices.
2024 Annual Financial Report        132
1. Annual variable remuneration ("AVR")
According to the Remuneration Policy, the AVR, weighted
according to the attainment scale, may not exceed 150% of the
fixed remuneration for executive functions once the level of
attainment of objectives is applied. The attainment scale for
economic objectives ranges from 0% of the incentive to a
maximum of 185% of the AVR target if the maximum values for
each indicator are achieved or exceeded.
The setting of the percentage represented by RVA in relation to
fixed remuneration for executive functions, the indicators, and
the evaluation of performance shall be determined annually by
the board of directors, upon a proposal by the ARC, which shall
subsequently determine the levels of achievement. In order to
receive the full amount of the annual bonus, the Executive
Director must still be associated with Fluidra on December 31 of
the year in which the bonus is to be paid. In the event of
termination of their relationship with Fluidra prior that date,
they shall receive the proportional part of the variable
remuneration to which they would have been entitled in the
event of continuing through to December 31 which corresponds
to the part of the year for which they have remained with
Fluidra.
2.  Long-term variable remuneration
The Executive Directors may participate in long-term incentive
plans based on Fluidra equity instruments, or linked to the value
of such instruments, established by the Company for its
executive personnel ("LTI").
The LTI will entitle its beneficiaries to receive, once a certain
period of time has elapsed, an amount in shares or other
instruments, or options over the same, or cash, subject to
fulfillment of the conditions and strategic objectives established
in the LTI. Those plans shall be of a recurring nature, their
specific conditions being set by the Board of Directors upon a
proposal by the ARC. They must be in alignment and compatible
with the principles of the Remuneration Policy and be approved
by the Fluidra Shareholders’ Meeting insofar as may be
required.
In 2025, the following LTIs are in place:
The 2022–2026 Plan approved by the General Shareholders'
Meeting in 2022.
In 2025, the first Cycle of the 2022–2026 Plan will be settled, in
the amounts accrued on 31 December 2024. The other two
cycles, the 2023–2025 Cycle and the 2024–2026 Cycle will be in
force in 2025.
The 2025–2029 Plan, which the Board of Directors, as tabled
by the ARC, submitted for approval by the Meeting in 2025,
together with the Annual Report on Remuneration. The first
Cycle of the 2025–2029 Plan, namely, the 2025–2027 Cycle, will
enter into force in 2025.
The remuneration mix in 2025 is as follows, depending on the
level of attainment linked to variable remuneration (the
calculation of the remuneration mix does not include in kind
remuneration or contributions to pension plans, since the
amount is negligible):
Variable Annual Remuneration (% of fixed
remuneration):
Executive Chairman: minimum: 0%, target: 100%;
maximum 185% 
CEO: minimum: 0%, target: 150%, maximum: 277.5%
Long-term incentive (on fixed remuneration) –
percentages for each of the three cycles – see
section A.1.6.
Executive Chairman: minimum: 0%, target: 250%;
maximum 430%
CEO: minimum: 0%, target: 345%, maximum: 593.4%
The two long-term incentive plans in place in 2025 (2022–2026
Plan and 2025–2029 Plan) have overlapping cycles, each of
which start every year and last for 3 years. The units in each of
the three cycles of the 2022–2029 Plan, of which the executive
directors are beneficiaries, in addition to the first cycle of the
2025–2029 Plan (the only cycle tabled for approval by the
Meeting together with this Annual Report on Remuneration),
have been calculated based on the same percentage of any
given beneficiary's remuneration is, namely, 250% in the case of
Mr. Planes and 345% in the case of Mr. Ramírez.
Given that a new cycle will start in 2025 and that the cycle
started 3 years before will accrue, the annualized percentage
taken was the LTI against fixed remuneration, the percentage on
fixed remuneration that, to calculate the number of units in the
cycle, has been allocated to each cycle, namely, 250% in the case
of Mr. Planes and 345% in the case of Mr. Ramírez.
The principles regulating the Company’s Director Remuneration
Policy take into account the shareholders’ interests and prudent
risk management. The remuneration system therefore seeks to
promote the Company’s long-term profitability and
sustainability and includes the necessary safeguards to prevent
excessive risk-taking and the rewarding of poor results.
The measures that the Company has established for deciding on
appropriate risk management and promoting the sustainability
of results are:
AVR:
There is no entitlement to receive a guaranteed variable
annual remuneration.
The maximum AVR may not exceed 150% of an Executive
Director’s fixed remuneration weighted by the level of
attainment scale (with a maximum of 277.5% of the fixed
remuneration in the event of overachievement of objectives).
The parameters of the AVR are defined annually, the
objectives being set by the Board upon a proposal by the ARC,
having regard to the variables which have been identified
within the Company’s risk map.
2024 Annual Financial Report        133
Defined scales of achievement for each objective based on the
Company's results are included. Any variation in the
Company's results will affect the degree of achievement of the
objectives and directly affect the amount of the AVR to which -
where appropriate - the Executive Directors may be entitled.
The AVR accrues annually and is paid annually in arrears,
within the first quarter of the calendar year following the year
of accrual, once the fulfillment of the associated objectives is
verified.
LTI:
There is no guaranteed right to receive the long-term
incentive.
Long-term remuneration is linked to specific financial and
ESG (“Environment, Social and Governance”) metrics, including
defined scales of achievement for each objective based on the
Company’s results.
Pursuant to the Remuneration Policy, the incentive to be
settled shall take into account any qualifications in the
external auditor's report that reduce the Company's earnings.
The payment of the long-term incentive must be deferred for
the minimum period of time necessary to verify that the pre-
established conditions to which it is linked have indeed been
met (malus clause).
The long-term remuneration system for Executive Directors
imposes on them the obligation to maintain the ownership of
a certain number of any shares they may receive under long-
term incentive plans.
The long-term remuneration corresponding to the Executive
Directors is subject to a clawback clause, which enables the
Company to demand reimbursement of the remuneration if it
becomes evident that the payment was made based wholly or
in part on information which has subsequently been proven
to be false or seriously inaccurate. The 2025-2029 Plan
submitted for approval by the General Meeting in 2025
imposed a new regulation whereby the clawback clause would
also apply to any Beneficiaries who have breached the
Group's internal rules and policies or if their negligent conduct
has resulted in significant losses for the Group.
Finally, insofar as the measures intended to avoid conflicts of
interest, as set forth in the Board Regulations, the directors
agree:
Not to directly or indirectly perform professional or
commercial transactions with the Company unless authorized
by the Company in the terms envisaged in the law, the Bylaws
and the Board Regulations.
To report the existence of conflicts of interest to the Board of
Directors.
To refrain from participating in debates and votes on
resolutions with respect to which they, or persons related to
them, have a direct or indirect conflict of interest, unless they
are authorized to do so by the applicable legislation. This will
not apply to resolutions or decisions affecting the Director in
his/her capacity as such, such as designation or removal from
his/her office on the managing body or similar.
Refraining from using the name of the Company or flaunting
their status as directors to carry out transactions on their own
behalf or on behalf of persons related to them.
Not to directly or indirectly perform professional or
commercial transactions with the Company unless authorized
by the Company in the terms envisaged in the law, the Bylaws
and the Board Regulations.
To adopt the necessary measures to avoid situations in which
their interests, for their own account or for the account of
others, may be in conflict with the corporate interest and with
their duties to the Company.
A.1.3. Amount and nature of fixed components that are due to
be accrued during the year by directors in their status as such.
The maximum annual remuneration Directors may earn for the
supervisory and collegiate decision-making functions inherent to
their status as such, approved at the 2024 General
Shareholders’ Meeting, is €2,200,000.
The aforementioned amount is, in any case, a maximum limit,
and it falls to the Board to propose how that amount will be
distributed amongst the different components and the
directors, in the form, at the time and in the proportions freely
determined by the Board in light of the functions and
responsibilities attributed to each one, their membership of and
positions held on the Board Committees, and any other
objective circumstances which may be deemed relevant. Of that
amount, the breakdown of the fixed remuneration per position
and responsibilities of the members of the Board that is
expected to accrue in fiscal year 2025 is as follows (the same as
in 2024):
€92,000 per annum for each member of the Board of
Directors
For the responsibility and dedication required of members of
the various Committees and that involved in the
Chairmanship and coordination of the Board:
An additional €20,000 per annum for each member of the 
ARC, except for the Committee chairman, who will receive an
additional €40,000.
An additional €20,000 per annum for each member of the
Audit Committee, except for the Committee chairman, who
will receive an additional €40,000.
An additional €12,000 for each member of the Delegate,
Strategy and ESG Committee.
An additional €50,000 per annum for the Chairman of the
Board of Directors.
2024 Annual Financial Report        134
An additional €25,000 per annum for the coordinator of the
Board of Directors.
However, the Executive Directors who are members of the
different Committees shall not receive any additional amount
for their membership thereof.
Allowances for attendance at Board or Committee meetings
are 8,000 per annum. The amount received by those Directors
who reside outside Europe, however, is 20,000 euros per
annum.
Finally, Directors will be reimbursed for duly justified expenses
incurred in the course of rendering their services to the
Company.
A.1.4. Amount and nature of fixed components that are due to
be accrued during the year for the performance of senior
management functions of executive directors.
The fixed cash remuneration to be paid to executive directors in
2025 is as follows:
Mr. Planes: €510,000.
Mr. Ramírez: $816.000, proportional to the time that he is an
Executive Director (the amount of the fixed remuneration as
an employee received before his appointment as Executive
Director was the same).
The Remuneration Policy anticipates an annual review of fixed
remuneration by the Board of Directors at the proposal of the
ARC for the years in which it is in force. It is not anticipated that
while the Remuneration Policy is in force that the variation will
rise above 30%. In any event, any variation in the fixed
remuneration must be reported in the Annual Report on
Remuneration for the year in question.
Part of Mr. Ramírez’ remuneration is paid by another Company
in the Fluidra Group.
In accordance with the provisions of the agreement signed by
Fluidra with the CEO, Mr. Ramírez, the remuneration that he
receives for his oversight and joint decision-making functions
inherent to his status as Director will reduce the total amount of
his remuneration that he should receive for his executive
functions.
A.1.5. Amount and nature of any component of in kind
remuneration that will accrue during the year, including, but
not limited to, insurance premiums paid in favor of the
director.
Executive Directors receive the following in kind remuneration:
In accordance with the Fluidra policy for executive personnel,
the Company makes available to its Executive Directors a
vehicle at an estimated cost for 2025 of €15,000 for Mr. Planes
and €12,000 for Mr. Ramírez.
The Company assumes the cost of a life insurance policy
covering the Executive Directors against the contingencies of
death and disability. As of the date of this Report, the
estimated annual premium for 2025 is €30,000 for Mr. Planes
and €18,000 for Mr. Ramírez.
Fluidra assumes the cost of a family medical insurance policy,
for which the annual premium for 2025 is approximately
€8,000 for Mr. Planes and €18,000 for Mr. Ramírez.
Part of Mr. Ramírez’ remuneration is paid by another Company
in the Fluidra Group.
A.1.6. Amount and nature of variable components,
differentiating between those established in the short and long
term. Amount and nature of variable components, which
differentiate between those established in the short- and long-
term. Financial and non-financial parameters, including social,
environmental and climate change parameters selected to
calculate variable remuneration in the year in progress,
explaining the extent to which these parameters are related to
performance, both of directors and the Company, together
with their risk profile, and the methodology, timetable and
techniques established to determine the degree of compliance
with the parameters used in the design of the variable
remuneration, explaining the applicable criteria and factors in
terms of the time required and the methods used to effectively
verify compliance, with the performance conditions or any
others to which the accrual is tied and the vesting of each
component of variable remuneration.
State the range, in monetary terms, of the different variable
components according to the degree of compliance with the
objectives and parameters established, and whether any
maximum monetary amounts exist in absolute terms.
The variable remuneration system for the Executive Directors
for 2025 includes two components: annual variable
remuneration (AVR) and a long-term incentive (LTI).
(i) AVR:
In accordance with the terms of their respective contracts, the
Executive Directors receive AVR linked to the achievement of
economic and management objectives related to the budget set
by the Board of Directors for each year. The objective criteria to
be used to calculate the AVR for 2025 are as follows:
The Executive Chairman’s AVR for 2025, prior to weighting
based on the achievement scale, is 100% of the fixed annual
remuneration for executive functions. The achievement scale
ranges from a payment of 40% of the variable amount, in the
event of achieving the minimum levels established for each
indicator (0% if the minimum levels are not achieved), up to
maximum payment of 185%, in the event of achieving or
exceeding the maximum levels established for each indicator.
The Executive Chairman’s AVR for 2025, prior to weighting
based on the achievement scale, is 150% of the fixed annual
remuneration for executive functions. The achievement scale
ranges from a payment of 40% of the variable amount, in the
event of achieving the minimum levels established for each
indicator (0% if the minimum levels are not achieved), up to
2024 Annual Financial Report        135
maximum payment of 185%, in the event of achieving or
exceeding the maximum levels established for each indicator.
The indicators for 2025:
(i) 85%, economic objectives:
Free cash-flow (25%), PF Cash EPS (25%), EBITDA (25%) and total
growth in sales (10%), and
(ii) 15% management objectives
within the management objectives, 5% are linked to attaining
the Company’s ESG objectives, such as the S&P score, the
carbon footprint, the global NPS and the overall sales of
sustainable products, in addition to all other strategic
management targets of the Company.
The achievement scale for the economic objectives in 2025 is as
follows:
Free cash flow: 80% of the objective for entitlement to
payment of 40% of the AVR linked to this objective, and 120%
for entitlement to 200%.
Cash Earning Per Share: 70% of the objective for entitlement
to payment of 40% of the AVR linked to this objective, and
130% for entitlement to 200%.
EBITDA: 80% for entitlement to payment of 40% of the AVR
linked to this objective, and 120% for entitlement to 200% of
the variable target. Total growth in sales: 50% of the objective
for entitlement to payment of 40% of the AVR linked to this
objective, and 150% for entitlement to 200%.
Total growth in sales: 50% of the objective for entitlement to
payment of 40% of the AVR linked to this objective, and 150%
for entitlement to 200%.
If the management objectives are achieved, the payout would be
100% of the target AVR linked to these objectives; otherwise it
would be 0%.
At the end of the fiscal year, upon receipt of the appropriate
supporting documentation, the Board of Directors, on the
recommendations of the ARC, will assess the degree of
compliance with the objectives set at the beginning of the fiscal
year and approve the amount of the AVR to be received by each
executive director based on the degree of compliance achieved.
Once the amount of the incentive is approved, it will be paid in
cash after Fluidra's annual accounts have been drafted, taking
into account, where applicable, any provisos in the external
auditor's report. The Annual Report on Remuneration for the
year in which the AVR is paid must include information related
to the targets set for each indicator and their degree of
attainment.
(ii) LTI:
In 2025, the Executive Directors are beneficiaries of the 2022–
2026 Plan:
2022–2026 Plan
The 2022–2026 Plan for key senior management and executive
directors of the Fluidra group was approved at the 2022 General
Shareholders’ Meeting.
The goal of the plan is to incentivize, motivate and build loyalty
among Fluidra's management team by linking part of their
remuneration to the value of the Company’s stock to align the
interests of the beneficiaries with those of shareholders by
offering them competitive remuneration that is in line with
market remuneration practices and the Fluidra group's new
organization and strategy.
The basic conditions of the 2022–2026 Plan are as follows:
Instrument: The 2022–2026 Plan is implemented through the
award of a certain number of units ("PSUs") which will then be
used as a reference in order to determine the final number of
Shares to be delivered to the Beneficiaries after a certain period
of time, as long as certain strategic objectives of the Fluidra
Group are fulfilled and the requirements provided for in the
Regulations are met.
Term: The 2022–2026 Plan has a term of five (5) years, running
from January 1, 2022, with effect from the date of approval of
the Plan by the Fluidra Shareholders’ Meeting  (the “Start Date”)
until December 31, 2026 (the “End Date”), without prejudice to
the effective settlement of the last cycle of the Plan, which will
take place in June 2027.
The Plan is divided into three (3) independent cycles (the
"Cycles") and has three award dates (the "Award Dates") for the
target incentive to be received in the event of achieving 100% of
the objectives to which it is linked ("Target Incentive"), each of
which took place in 2022, 2023 and 2024, respectively.
Each one of the Cycles has an objective measurement period of
three (3) years (the "Measurement Period"), starting on January
1 of the year in which the Cycle begins (the "Measurement
Period Start Date") and ending three (3) years after the
Measurement Period Start Date, that is, on December 31 of the
year the Measurement Period for the Cycle ends (the
"Measurement Period End Date").
Once the Measurement Period for each Cycle has ended, the
associated incentive to which each of the Beneficiaries will be
entitled will be determined according to the degree of
achievement of the objectives established for the Cycle in
question ("Degree of Achievement").
The settlement of the incentive during each Cycle of the Plan will
take place in the month of June of the fiscal year following the
End Date of the Measurement Period ("Settlement Date").
Beneficiaries: The beneficiaries of the 2022–2026 Plan (the
"Beneficiaries") will be the members of the management team
2024 Annual Financial Report        136
of Fluidra and of its subsidiaries making up the Fluidra Group, as
determined by the Board of Directors of Fluidra, at the proposal
of the ARC, who are expressly invited to participate in the Plan
via a letter of invitation (the "Letter of Invitation") and who
expressly accept such invitation.
For these purposes, the Fluidra Shareholders' Meeting
designated as Beneficiaries of the 2022–2026 Plan those
directors of Fluidra who, during the term of the Plan, were
attributed executive functions in the Fluidra Group ("Executive
Directors"), namely, Mr. Planes, Executive Chairman, and Mr.
Brooks, CEO.
Maximum number of Shares included in the Plan: The total
number of Shares which, in implementation of the Plan, will be
delivered to the Beneficiaries at the end of each Cycle will be
that resulting from dividing the maximum amount allocated to
each Cycle by the weighted average closing price of the Shares
for the trading sessions taking place in the thirty (30) days prior
to the Measurement Period Start Date of the Cycle in question
(the “Reference Value”). The maximum total amount allocated to
the Plan if 100% of the related objectives are met is €55 million.
The maximum amount to be allocated to each Cycle of the Plan,
if 100% of the objectives are met, will be determined by the
Board of Directors following a report from the ARC, but may not
exceed a total of €55 million for all three Cycles of the Plan.
In any event, if 100% of the objectives are met, the total number
of Shares to be delivered in implementation of the Plan to all of
the Beneficiaries in the three Cycles may not exceed 0.8% of the
share capital of Fluidra on the date of approval of the Plan, and
will be 1.3% in the event of reaching the maximum Degree of
Achievement of the objectives.
If the maximum number of Shares allocated to the Plan
authorized by the Shareholders' Meeting is insufficient to be
able to settle the incentive in Shares corresponding to the
Beneficiaries under each Cycle of the Plan, Fluidra will pay in
cash the amount of the incentive corresponding to the excess
which cannot be settled in Shares.
If 100% of the objectives of the Plan are met, the Executive
Directors of Fluidra will be entitled to receive, at the end of each
of the three Cycles, a number of Shares equal in value to 250%
of their Fixed Annual Remuneration in force on the award date
of the incentive corresponding to the Cycle in question, divided
by the Reference Value.
In any event, the number of Shares to be delivered will depend
on the number of PSUs assigned and on the degree of
achievement of the objectives to which the incentive is linked.
For the first Cycle of the Plan, if 100% of the Cycle objectives are
met, and taking into consideration the average weighted closing
price of the Share for the trading sessions taking place on the
thirty (30) days prior to January 1, 2022 and the Annual Fixed
Remuneration of the Executive Directors in force on the date of
approval of the Plan, 37,651 Shares would be delivered to the
Executive Chairman, Mr. Planes and 45,181 Shares would be
delivered to the CEO in 2024, Mr. Brooks. A breakdown of the
information related to the accrual and the vesting of the
incentive referred to in the first cycle of the Plan is given in
section B.7.
For the second Cycle of the Plan, if 100% of the Cycle objectives
are met, and taking into consideration the average weighted
closing price of the Share for the trading sessions taking place
on the thirty (30) days prior to 1 January 2023 and the Annual
Fixed Remuneration of the Executive Directors in force on the
date of Invitation Letter to the second Cycle of the Plan, 88,500
Shares would be delivered to the Executive Chairman, Mr. Eloy
Planes. In the event of reaching the maximum Degree of
Achievement of the objectives to which the second Cycle is
linked, the number of Shares to be delivered will be Accordingly,
the maximum number of Shares to be delivered would be
152,220 Shares in the case of Mr. Eloy Planes.
For the third Cycle of the Plan, if 100% of the Cycle objectives are
met, and taking into consideration the average weighted closing
price of the Share for the trading sessions taking place on the
thirty (30) days prior to 1 January 2024 and the Annual Fixed
Remuneration of the Executive Directors in force on the date of
Invitation Letter to the third Cycle of the Plan, 66,811 Shares
would be delivered to the Executive Chairman, Mr. Eloy Planes.
In the event of reaching the maximum Degree of Achievement
of the objectives to which the third Cycle is linked, the number
of Shares to be delivered will be 172% should 100% of the
targets be met. Accordingly, the maximum number of Shares to
be delivered would be 114,915 Shares in the case of Mr. Eloy
Planes.
After joining the Fluidra Group in 2024 as an employee, Mr.
Jaime Ramírez was made a beneficiary of just the third cycle of
the 2022–2026 Plan, whereby he was allocated 195,734 units,
which he continues to hold under the same condition, following
his appointment as CEO. The number of units allocated to him
in the third cycle was calculated on a pro rata basis in respect of
the number of units that would have fallen to him for the three
cycles of the 2022–2026 Plan, given the time that has elapsed
since the date he joined the Fluidra Group until the end date of
the 2022–2026 Plan, based on the percentage per cycle allotted
(345%) on the fixed remuneration. Therefore, the number of
Shares to be delivered to the CEO in the event that 100% of the
Cycle's targets had been met would be 195,734 Shares. In the
event of reaching the maximum Degree of Achievement of the
objectives to which the third Cycle is linked, the number of
Shares to be delivered will be 172% should 100% of the targets
be met. Accordingly, the maximum number of Shares to be
delivered would be 336,662 Shares in the case of Mr. Jaime
Ramírez.
Requirements for receiving the incentive: The requirements to
be met, on a cumulative basis, in order for a Beneficiary to vest
the right to receive the incentive corresponding to each Cycle of
the 2022–2026 Plan are as follows:
As regards the total PSUs awarded in relation to each Cycle,
the Beneficiaries must remain at the Fluidra Group until the
Measurement Period End Date of the Cycle, notwithstanding
the provisions envisaged for special leaving situation
2024 Annual Financial Report        137
established in the Regulations, which will also set out the
formula to be used for calculation of the PSUs vested as at the
leaving date. In respect of the foregoing, the termination of
Mr. Brooks' executive functions in 2024 by mutual agreement
meant that his consideration would remain in place for the
proportional part of the PSUs awarded in the second and
third cycles of the period from the start of the cycle to 31
December 2024. This means that the number of Shares to be
received should 100% of the targets in the Second and Third
Cycles have been attained would be 70,800 and 26,724,
respectively, whereby the maximum number of Shares would
be 121,776 and 45,965 respectively, should the maximum
degree of attainment of the targets be met. 
Meet the objectives established for each Cycle of the 2022–
2026 Plan in the terms and conditions described in this
agreement and the implementing Regulations.
In the case of Executive Directors, 100% of the PSUs awarded
in each Cycle must be linked to fulfillment of the objectives to
which the corresponding Cycle is linked.
Targets: The Degree of Achievement of the incentive
corresponding to one Cycle of the Plan, and therefore the
number of Shares to be delivered to the Beneficiaries in relation
to such Cycle, will depend on the degree of achievement of the
targets that the Board of Directors, at the proposal of the ARC,
has established for each Cycle of the 2022–2026 Plan, insofar as
relates to the percentage of PSUs awarded which is linked to
such achievement.
In the three Cycles of the Plan, the Incentive will be linked to
achievement of the following strategic objectives of the
Company:
(i) Objectives in terms of the creation of value for shareholders:
Evolution of Fluidra, S.A.'s Total Shareholder Return  (“TSR”), in
absolute terms;
(ii) Economic-financial objectives:
Evolution of the EBITDA of the Fluidra Group.
(iii) ESG targets: improved S&P rating,
hereinafter, the “Metrics”:
TSR, EBITDA and the ESG objectives will be calculated during the
Measurement Period of each Cycle that ends on 31 December
2024, 2025 and 2026, respectively.
The initial value considered for the purpose of measuring the
evolution of the TSR will be the weighted average listed price of
the Fluidra share at the close of trading for the trading sessions
taking place on the thirty (30) days preceding the  Measurement
Period Start Date of the corresponding Cycle, the final value
considered being the weighted average listed price of the
Fluidra share at the close of the trading sessions taking place on
the thirty (30) days preceding the Measurement Period End Date
of the corresponding Cycle.
The weighting percentages for the Incentive awarded to the
Executive Directors in the three Cycles will be 50% for the TSR
objective, 40% for the EBITDA objective, and 10% for the ESG
objective.
For the TSR and EBITDA objectives, a Degree of Achievement
associated with each objective will be established and this may
range between 0% and 180%. The Degree of Achievement
deriving from each of the above objectives will be calculated by
linear interpolation. In the case of the ESG objective, the Degree
of Achievement will be 0% or 100%. The maximum Degree of
Achievement for the Executive Directors will therefore be 172%.
Delivery and availability of shares: The Shares will be
delivered either by Fluidra, or by a third party, depending on the
coverage systems finally adopted by the Board of Directors.
Once the Shares have been awarded for a period of three
years after the End Date the Executive Directors and
members of the Executive Committee will not be able to sell
the Shares received under the Plan until they hold a number
of shares equivalent to at least their fixed annual
remuneration in the case of Executive Committee members
and twice their fixed annual remuneration in the case of
Executive Directors.
However, this will not apply in respect of shares that
Executive Directors or Executive Committee members need
to dispose of in order to cover the acquisition cost, including
taxes on the delivered Shares, or if a waiver is obtained from
the Board of Directors with a favorable report from the
Appointments and Remuneration Committee, in order to
deal with one-off events that may occur.
Malus and clawback clauses. The Plan will envisage the
corresponding malus and clawback clauses. The Board of
Directors will determine, where applicable, whether the
circumstances that trigger the application of these clauses
have occurred and the part of the Incentive which, where
appropriate, is to be reduced or recovered. In relation to the
clawback clause, Fluidra, S.A. may demand the return of the
Shares delivered under each Cycle of the 2022–2026 Plan, or
the cash equivalent thereof, or even offset the delivery made
against other remuneration of any type to which the
Beneficiary may be entitled if, during the two years following
the Settlement Date of each Cycle, it becomes evident that
the settlement in question was based wholly or in part on
information which has subsequently been clearly shown to
be false or to contain serious inaccuracies. The above will
apply to the Executive Directors in all cases and to
Beneficiaries who are responsible for such information.
Similarly, the incentive settled in favor of members of the
executive committee and the internal auditor, to whom the
clawback clause is not applicable, will in any event be
recalculated based on the correct information.
2024 Annual Financial Report        138
2025–2029 Plan:
To approve a long-term variable remuneration plan (“2025–2029
Performance Share Plan”, “2025–2029 Plan” or the “Plan”)
intended for the executive directors and the management team
of Fluidra, S.A. (“Fluidra” or the “Company”) and of the investee
companies that belong to the consolidated group (the “Fluidra
Group”) that includes the delivery of Fluidra shares.
The 2025–2029 Plan, which is linked to the Fluidra Group's
strategic plan, was passed based on the following basic terms
and conditions, which will be subject to input by Fluidra’s Board
of Directors to the regulations of the 2025–2029 Plan (the
“Regulations”.
Objective of the 2025–2029 Plan: The 2025–2029 Plan aims to
encourage, motivate and retain the management team by
linking the incentive to the fulfillment of Fluidra's medium- and
long-term strategic plan, which will make it possible to align the
interests of the Beneficiaries (as defined below) with those of
the shareholders by offering them competitive remuneration
that is in line with market remuneration practices, and the
organizational and strategic situation of the Fluidra Group.
The 2025–2029 Plan consists of the Beneficiaries being entitled
to receive a certain number of ordinary shares of the Company
(the "Shares") subject to the fulfillment of certain requirements.
Instrument: The 2025–2029 Plan is implemented through the
award of a certain number of units ("PSUs"), which will then be
used as a reference in order to calculate the final number of
Shares to be delivered to the Beneficiaries after a certain period
of time, as long as certain strategic objectives of the Fluidra
Group are fulfilled and the requirements provided for in the
Regulations are met.
Term: The 2025–2029 Plan has a term of five (5) years, running
from January 1, 2025, with effect from the date of approval of
the Plan by the Fluidra Shareholders' Meeting to which this
resolution is submitted for approval (the "Start Date") until
December 31, 2029 (the "End Date"), notwithstanding the
effective settlement of the last cycle of the Plan (as the term is
defined below), which will take place in June 2030.
The Plan is divided into three (3) independent cycles (the
"Cycles") and will have three award dates (the "Award Dates") for
the target incentive to be received in the event of achieving
100% of the objectives to which it is linked ("Target Incentive"),
each of which will take place in 2025, 2026 and 2027,
respectively.
Each of the Cycles will have an objective measurement period of
three (3) years (the "Measurement Period"), starting on January
1 of the year in which the Cycle begins (the "Measurement
Period Start Date") and ending three (3) years after the
Measurement Period Start Date, that is, on December 31 of the
year the Measurement Period for the Cycle ends (the
"Measurement Period End Date").
Once the Measurement Period for each Cycle has ended, the
associated incentive to which each of the Beneficiaries will be
entitled will be calculated according to the degree of
achievement of the objectives established for the Cycle in
question ("Degree of Achievement").
The incentive corresponding to each Cycle of the Plan will be
settled in the month of June of the year after the Measurement
Period End Date, following approval of the financial statements
for the year in which the Measurement Period of the Cycle in
question ends (the "Settlement Date").
Beneficiaries: The beneficiaries of the 2025–2029 Plan (the
"Beneficiaries") will be the members of the management team
of Fluidra and of its subsidiaries that make up the Fluidra Group,
as determined by the Board of Directors of Fluidra, at the
proposal of the Appointments and Remuneration Committee,
who are expressly invited to participate in the Plan via a letter of
invitation (the "Letter of Invitation") and who expressly accept
this invitation.
For these purposes, the Fluidra Shareholders' Meeting
designates as Beneficiaries of the 2025–2029 Plan those
directors of Fluidra who, during the term of the Plan, are
attributed executive functions in the Fluidra Group ("Executive
Directors"). At the date of approval of the Plan by the Fluidra
Shareholders' Meeting, the Executive Directors are Mr. Eloy
Planes, Executive Chairman, and Mr. Jaime Ramirez, CEO.
Maximum number of Shares included in the Plan: The total
number of Shares that, in the implementation of the Plan, will
be delivered to the Beneficiaries at the end of each Cycle, in the
event of achieving 100% of the objectives, will be that resulting
from dividing the maximum amount allocated to each Cycle by
the weighted average closing price of the Shares for the trading
sessions taking place on the thirty (30) days prior to the
Measurement Period Start Date of the Cycle in question (the
"Reference Value"). The maximum total amount allocated to the
three Cycles of the Plan if 100% of the related objectives are met
is established in the amount of sixty four million of euros,, and
being one hundred and seven million euros in case of reaching
the maximum degree of achievement.
The maximum total amount allocated to each Cycle of the Plan,
if 100% of the objectives are met, will be determined each year
by the Board of Directors, following a report by the
Appointments and Remuneration Committee, and may not
exceed, for all three Cycles of the Plan as a whole, the
aforementioned amount of sixty four million of euros (one
hundred and seven million euros in case of reaching the
maximum degree of achievement).
In any event, if 100% of the objectives are met, the total number
of Shares to be delivered in the implementation of the Plan to all
of the Beneficiaries in the three Cycles may not exceed 1.21% of
the share capital of Fluidra on the date of approval of the Plan,
and will be 2.03% in the event of reaching the maximum Degree
of Achievement of the objectives.
If the maximum number of Shares allocated to the Plan
authorized by the Shareholders' Meeting is insufficient to be
able to settle the incentive in Shares corresponding to the
2024 Annual Financial Report        139
Beneficiaries under each Cycle of the Plan, Fluidra will pay in
cash the amount of the incentive corresponding to the excess
that cannot be settled in Shares.
If 100% of the objectives of the Plan are met, the Executive
Directors of Fluidra will be entitled to receive, at the end of each
of the three Cycles, a number of Shares equal in value to 250%
in the case of the Executive Chairman and 345% in the case of
the CEO of their Fixed Annual Remuneration in force on the
award date of the incentive corresponding to the Cycle in
question, divided by the Reference Value.
In any event, the number of Shares to be delivered will depend
on the number of PSUs assigned and on the degree of
achievement of the objectives to which the incentive is linked.
For the first Cycle of the Plan, if 100% of the Cycle objectives are
met, based on the average weighted closing price of the Share
for the trading sessions taking place on the thirty (30) days prior
to January 1, 2025 and the Annual Fixed Remuneration of the
Executive Directors in force on the date of approval of the Plan,
51,590 Shares would be delivered to the Executive Chairman
Eloy Planes and 105,395 Shares would be delivered to the CEO
Jaime Ramirez. In the event of reaching the maximum Degree of
Achievement of the objectives to which the first Cycle is linked,
the number of Shares to be delivered will be 172% of the Shares
to be delivered in the event of achieving 100% of the objectives.
Accordingly, the maximum number of Shares to be delivered
would be 88,735 Shares in the case of Eloy Planes and 181,279
Shares in the case of Jaime Ramirez.
For each of the remaining Cycles, the Board of Directors,
following a report by the Appointments and Remuneration
Committee, will set the maximum amounts that will serve as a
basis in order to establish, according to the Reference Value of
the Cycle in question, the number of Shares that may be
delivered if 100% of the objectives are met and in the event of
reaching the maximum Degree of Achievement of the objectives
to which the corresponding Cycle is linked. The number of PSUs
assigned in each Cycle will be duly reported in the
corresponding Annual Report on Directors' Remuneration.
Requirements for receiving the incentive: The requirements
to be met, on a cumulative basis, in order for a Beneficiary to
vest the right to receive the incentive corresponding to each
Cycle of the 2025–2029 Plan are as follows:
As regards the total PSUs awarded in relation to each Cycle, the
Beneficiaries must remain at the Fluidra Group until the
Measurement Period End Date of the Cycle, notwithstanding the
provisions envisaged for special leaving situations established in
the Regulations, which will also set out the formula to be used
for calculation of the number of PSUs vested as at the leaving
date.
Beneficiaries must meet the objectives to which each Cycle of
the 2025–2029 Plan is linked, under the terms and conditions
described in this agreement and implemented in the
Regulations.
In the case of Executive Directors, 100% of the PSUs awarded in
each Cycle must be linked to the fulfillment of the objectives to
which the corresponding Cycle is linked.
Targets: The Degree of Achievement of the incentive
corresponding to one Cycle of the Plan and, therefore, the
number of Shares to be delivered to the Beneficiaries in relation
to such a Cycle, will depend on the degree of achievement of the
objectives that the Board of Directors, at the proposal of the
Appointments and Remuneration Committee, establishes for
each Cycle of the 2025–2025 Plan, insofar as relates to the
percentage of PSUs awarded that is linked to such achievement.
The objectives will be:
Objectives in terms of the creation of value for shareholders.
Economic-financial objectives.
Targets linked to environment, social and governance (ESG)
matters.
First Cycle: In the first Cycle of the Plan, the Incentive will be
linked to the achievement of the following strategic objectives of
the Company:
Objectives in terms of the creation of value for shareholders.
Evolution of Fluidra's Total Shareholder Return (“TSR”), in
absolute terms.
Economic-financial objectives. Evolution of the EBITDA of the
Fluidra Group.
ESG targets. S&P rating.
Hereinafter, the above will be referred to as the “Metrics”.
The TSR, EBITDA and ESG objectives will be set during the First
Cycle Measurement Period that ends on December 31, 2027.
The initial value considered for the purpose of measuring the
evolution of the TSR will be the weighted average listed price of
the Fluidra share at the close of trading for the trading sessions
taking place on the thirty (30) days preceding the First Cycle
Measurement Period Start Date, the final value considered
being the weighted average listed price of the Fluidra share at
the close of the trading sessions taking place on the thirty (30)
days preceding the First Cycle Measurement Period End Date.
The weighting percentages for the Incentive awarded to the
Executive Directors will be 50% for the TSR objective, 40% for the
EBITDA objective, and 10% for the ESG objective.
In the case of Beneficiaries who are not directors, the Board of
Directors will decide, upon a proposal by the Appointments and
Remuneration Committee, the part of the Shares whose delivery
will depend on achievement of the TSR, EBITDA and ESG
objectives.
For the TSR and EBITDA objectives, a Degree of Achievement
associated with each objective will be established, which may
range between 0% and 180%. The Degree of Achievement
2024 Annual Financial Report        140
deriving from each of the above objectives will be calculated by
linear interpolation. In the case of the ESG objective, the Degree
of Achievement will be 0% or 100%. The maximum Degree of
Achievement for the Executive Directors will therefore be 172%.
Second and Third Cycles: For the Second and Third Cycles of
the Plan, the Fluidra Board of Directors, upon a proposal by the
Appointments and Remuneration Committee, may decide to
continue with or change the Metrics, their relative weights, and
the Degree of Achievement established for the First Cycle of the
Plan. In the event of the Board of Directors making any change
in this respect, the pertinent information will be duly set out in
the corresponding Annual Report on Directors' Remuneration.
Delivery and availability of shares: The Shares will be
delivered either by Fluidra, or by a third party, depending on the
coverage systems finally adopted by the Board of Directors.
Once the Shares have been awarded, and until a period of three
years has elapsed as from the End Date, the Executive Directors
and members of the executive committee will not be able to
transfer ownership of the Shares they may have received under
the Plan until they come to own a number of shares equivalent,
at least, to their annual fixed remuneration multiplied by two, in
the case of the Executive Directors, and by one, for the
members of the executive committee. However, this will not
apply in respect of shares that Executive Directors or Executive
Committee members need to dispose of in order to cover the
acquisition cost, including taxes on the delivered Shares, or if a
waiver is obtained from the Board of Directors with a favorable
report from the ARC, in order to deal with one-off events that
may occur.
Malus and clawback clauses. The Plan will envisage the
corresponding malus and clawback clauses, which will be
included in the Regulations. The Board of Directors will
determine, where applicable, whether the circumstances that
trigger the application of these clauses have occurred and the
part of the Incentive which, where appropriate, is to be reduced
or recovered.
In relation to the clawback clause, Fluidra, S.A. may demand the
return of the Shares delivered under each Cycle of the 2025–
2029 Plan, or the cash equivalent thereof, or even offset the
delivery made against other remuneration of any type to which
the Beneficiary may be entitled if, during the two years following
the Settlement Date of each Cycle, it becomes evident that the
settlement in question was based wholly or in part on
information which has subsequently been clearly shown to be
false or to contain serious inaccuracies. The above will apply to
the Executive Directors in all cases and to Beneficiaries who are
responsible for such information or who breach internal policies
and regulations. The clawback clause will also apply to any
Beneficiaries who have breached any of the Group's internal
standards and policies or if their negligent conduct has entailed
significant losses for the Group. Similarly, the Incentive paid to
members of the executive committee and the internal auditor,
to whom the clawback clause is not applicable, will in any event
be recalculated based on the correct economic and financial
information.
Cases of early termination or modification of the 2025–2029
Plan: The Regulations may envisage early termination and
settlement or modification of the 2025–2029 Plan in the event of
an acquisition or change of control, or if the Shares of Fluidra
cease to be listed on an organized market, or in circumstances
which, in the view of the Board of Directors, have a material
impact on the 2025–2029 Plan.
Payout scheme: The system of coverage to be used for the
2025–2029 Plan will be established in due time and form by the
Board of Directors of the Company, for which purpose said body
is hereby expressly empowered. The Company may allocate
treasury shares currently held or which it may come to hold to
cover the needs of the Plan, or it may use the financial
instrument most suitable in each case.
A.1.7. Main characteristics of long-term savings systems.
Among other information, state the contingencies covered by
the system, whether through defined contributions or
benefits, the annual contribution that needs to be made to
the defined contribution system, the benefits directors are
entitled to in the event of defined benefit systems, the
conditions under which economic rights are vested for
directors and their compatibility with any other type of
payment or severance pay as a result of the early termination
or dismissal of a director, or arising from the termination of
the contractual relationship, under the terms provided for,
between the Company and the director in question.
State if the accrual or vesting of any of the long-term savings
plans is linked to achieving certain objectives or parameters
related to the short- or long-term performance of the director.
Fluidra has reached an arrangement with Mr. Planes fora  set
pension contribution commitment entailing the setting up of a
retirement pension fund through annual contributions in the
amount of €16,000 in 2025. He has vested rights.
Mr. Ramírez is an active participant in the 401(k) pension plan
sponsored by Fluidra's US subsidiary. The estimated cost of the
plan to the Fluidra group in 2025 was €13,000. Fluidra reserves
the right to finance these pension commitments using whatever
instrument it considers most suitable pursuant to the currently
applicable legislation.
This commitment is compatible with the severance to which
Executive Directors are entitled in the event of termination or
early removal in the terms envisaged and described in the
subsections below.
2024 Annual Financial Report        141
A.1.8. Any type of payment or severance pay for early
termination or dismissal of the director, or deriving from the
termination of the contractual relation, in the terms provided,
between the Company and the director, whether voluntary
resignation by the director or dismissal of the director by the
Company, as well as any type of agreement reached, such as
exclusivity, post-contractual non-competition, permanence or
loyalty, which entitle the director to any type of
remuneration.
The non-executive directors are not entitled to indemnities for
termination of their functions as director.
The contracts of the Executive Directors envisage the following
severance payments in the event of termination of the provision
of services agreement signed by the Company and the director.
Severance pay for termination of contract
The severance to which the Executive Directors will be entitled in
in the event of the termination of a contract by Fluidra on any
grounds, except in cases of serious and willful or negligent non-
fulfillment of their duties as Executive Directors of the Company,
will be:
Mr. Eloy Planes: an amount equivalent to twice his annual
remuneration, based on his gross annual fixed salary for the
year in which his contract is terminated and the gross annual
variable salary for the preceding year. This includes the legal
indemnity that Mr. Eloy Planes is entitled to receive for the
termination of his previous employment relationship of 16
years and 7 months, suspended on the occasion of his
appointment as a director.
Sr. Jaime Ramírez: an amount equivalent to two times his
annual remuneration, based on his gross annual fixed salary
for the year in which his contract is terminated and the last
gross annual variable salary received in the 12 months
preceding the termination's effective date, in addition to
reasonable costs for outplacement services.
The Executive Directors will be entitled to receive this severance
pay if they decide to terminate their contracts by their own
choice, if such termination is due to any of the following causes:
Serious breach by the Company of any of the contractual
obligations related to their position.
Reduction and substantial limitation of their duties or powers.
Substantial modification of their contractual conditions.
Change of ownership of Fluidra's share capital with or without
changing the Company's governing bodies. Exclusivity and y
confidentiality
The contracts of the Executive Directors establish clauses
regulating confidentiality and exclusive dedication, this being
without prejudice to any activities which have been expressly
authorized by the Company, provided they do not hinder the
fulfillment of the duties of diligence and loyalty inherent in their
post or entail a conflict of interest with the Company. Such
exclusivity clause does not entitle the Executive Directors to any
specific remuneration.
Post-contractual non-compete
and non-solicitation undertaking
Notwithstanding the Executive Directors’ undertaking not to
compete with the Company while the contracts are in force, the
following is established:
Mr. Eloy Planes: a post-contractual non-competition
agreement with a duration of two years from the conclusion
of the effective provision of services. The economic
compensation established for the commitment pursuant to
the post-contractual non-compete undertaking is two times
his gross annual fixed remuneration in force at the time of
termination of the contract.
Sr. Jaime Ramírez: a post-contractual non-compete and non-
solicitation undertaking with a term of two years as from the
date on which his services effectively come to an end. There is
no additional compensation for the non-compete and non-
solicitation prohibition accepted by Mr. Jaime Ramirez, which
is understood to be compensated by the fixed and variable
remuneration he receives during the term of his contract.
A.1.9. State the conditions that contracts should respect for
those exercising senior management functions as executive
directors. Among others, information should be provided on
the duration, limits on amounts of severance pay, minimum
contract term clauses, notice periods and payment in lieu of
these notice periods, and any other clauses relating to hiring
bonuses, remuneration and golden parachute clauses for
early termination of the contractual relationship between the
Company and an executive director.
Include, among others, the pacts or agreement on con-
competition, exclusivity, permanence and loyalty, and post-
contractual non-competition, unless these have been explained
in the previous section.
The contracts of the Executive Directors of the Company are
commercial contracts, and contain a clear description of the
functions and responsibilities to be assumed according to the
provisions of commercial legislation, the By-laws, the
Regulations applicable to the bodies of the Company and those
attributed by it Shareholders’ Meeting. Set out below are the
essential terms and conditions of the contracts of Executive
Directors which have been approved in accordance with the
provisions of articles 249 and 529.80 of the Capital Companies
Act.
2024 Annual Financial Report        142
1. Term
The Executive Directors have signed an indefinite-term
contract for services with the Company which will remain in
force for as long as the directors perform the executive
duties delegated to them by the Board of Directors
according to their post.
2. Exclusivity and y confidentiality
The contracts establish clauses regulating confidentiality and
exclusive dedication, without prejudice to the activities which
are expressly authorized, provided they do not hinder the
fulfillment of the duties of diligence and loyalty inherent in
their post or entail a conflict with the Company.
3. Minimum contract terms
The Executive Directors’ contracts do not include any
minimum term or loyalty clauses.
4. Advance notice period
The parties are required to give at least six months’ notice
before the effective date of termination of a contractual
relationship, except when this occurs by mutual agreement,
due to serious and willful or negligent non-fulfillment of the
Executive Director’s professional duties or a serious breach
by the Company of the obligations undertaken in relation to
the position of Executive Director. In the event of non-
fulfillment of the obligation to give notice, the performing
party shall be entitled to receive an amount equal to the
fixed remuneration pending payment during the period of
the breach.
5. Severance pay for termination of a contract
Breakdown of the severance payable for termination of a
contract are provided in subsection A.1.8 of this Report.
6. Post-contractual non-compete and non-solicitation
undertaking
Breakdown of the post-contractual non-competition and
non-solicitation undertaking are provided in subsection A.1.8
of this Report.
7. Other
The contract on executive functions signed between Fluidra
and Mr. Ramírez includes provisions whereby the
remuneration paid to Mr. Ramírez (i) by any other Group
Company or (ii) by the Company for the oversight and joint
decision-making functions inherent to his post as
director,will reduce his total remuneration that he should be
paid for his executive functions (including the remuneration
in cash and in kind, and/or any other payment for the
termination of his contract, as the case may be).
Finally, the Board of Directors will periodically review the
conditions of the contracts signed with the Executive Directors
in order to include in them any amendments necessary to adapt
them to the Remuneration Policy in force at any given time and
to the internal regulations of the Company that apply.
A.1.10. The nature and estimated amount of any other
supplementary remuneration accrued by directors in the year
in progress in consideration for services rendered other than
those inherent in the post.
The Remuneration Policy does not envisage any remuneration
for directors not already mentioned in the previous subsections.
A.1.11. Other remunerative items or by-products, as the case
may be, of the Company granting the director advance
payments, loans, guarantees or any other remuneration.
The Remuneration Policy does not envisage the possibility of
providing advances, loans and guarantees to the directors.
A.1.12.  The nature and estimated amount of any other
planned supplementary remuneration accrued by directors in
the year in progress that are not included in the previous
sections, whether payment is satisfied by the Company or
another group Company.
No remuneration payable by Group entities to any of the
members of the Board is envisaged for the current financial year
that has not been included in the preceding sections.
A.2. No remuneration payable by Group entities to any
of the members of the Board is envisaged for the
current financial year that has not been included in the
preceding sections.
a) A new policy or a modification of the policy already
approved by the General Meeting.
b) Significant changes in the specific assessments established
by the board for the current year regarding the
remuneration policy in force with respect to those applied
in the previous year.
c) Proposals that the board of directors has agreed to submit
to the general shareholders' meeting to which this annual
report will be submitted and which are proposed to be
applicable to the current year.
As mentioned in section A.1, along with the Annual Report on
Remuneration, on the recommendation of the Board of
Directors the General  Meeting is asked to approve: (i) the 2025–
2028 Remuneration Policy that will be valid from its date of
approval; and (ii) the general conditions of the 2025–2029 Plan
of which the Executive Directors are beneficiaries.
A.3. Identify the direct link to the document where the
current Company remuneration policy is posted, which
must be available on the Company’s website.
The following remuneration policies are in effect for the year
2025:
2024–2027 Policy, in force from 1 January 2025 until the data
of approval of the 2025–2028 Policy.
2025–2028 Policy, in force from its date of approval until 31
December 2028.
2024 Annual Financial Report        143
A.4. Explain, taking into account the data provided in
Section B.4, the outcome of voting, of a consultative
nature, by shareholders at the General Shareholders'
Meeting on the annual report on remuneration for the
previous year.
The resolution received the favorable vote of 99.27% of the
voting quorum, in the terms stated in section B.4 of this Report.
Similarly, the Remuneration Policy in force in the current year
was approved with the vote of 97.38% of the quorum with
voting rights, whilst the maximum amount paid in remuneration
to directors for discharging their functions received a vote in
favor of 99.97%
2024 Annual Financial Report        144
B. Overall summary of the application of
the remuneration policy during the fiscal
year just ended
B.1.1. Explain the process followed to apply the remuneration
policy and calculate the individual remuneration contained in
Section C of this report. This information will include the role
played by the remuneration committee, the decisions taken
by the Board of Directors and, if applicable, the identity and
the role of the external advisors whose services have been
used in the process to apply the remuneration policy in the
year ended.
The individual remuneration of the directors of Fluidra accrued
in fiscal year 2024 that is reflected in section C of this Report has
been calculated in accordance with the principles and criteria of
the Company's directors' remuneration policy in force in 2024.
Since its approval, the Company has implemented the
Remuneration Policy approved at the General Shareholders’
Meeting held on May 8, 2024, which is valid for fiscal year 2024
(from its date of approval) until the approval of the 2025–2028
Policy that is submitted for approval by the Meeting together
with this Annual Report on Remuneration.
The procedures, matters and decisions adopted by the ARC and
the Board of Directors, according to the powers described in
subsection A.1 of this Report related to the Remuneration Policy,
are as follows:
Evaluation of the degree of compliance with the 2023 AVR
metrics of the Executive Directors and Fluidra’s management
team and approval of the amount of the 2023 AVR to be
settled in 2024, based on the degree of compliance.
Analysis of the remuneration in 2024 of Fluidra's Executive
Directors and the rest of its senior management team, and a
proposal to review salaries, as the case may be.
The 2024 AVR of Fluidra’s Executive Directors and
management team: determination of the AVR metrics,
establishment of the threshold for entitlement to the RVA and
payout scale depending on the degree of compliance with the
objectives of each metric.
Analysis and issue of a favorable report on the third LTI 2022–
2026 cycle, the beneficiaries, the metrics and the targets for
each of them, their weighting by group of beneficiaries and
the allocation of the number of units to each beneficiary.
Proposal of the Annual Report on  Remuneration of directors
for 2023, to be submitted to a consultative vote at the
Shareholders' Meeting.
Proposal to submit certain parts of the Annual Report on
Remuneration of directors for 2023 to the Shareholders'
Meeting for approval.
Proposal of the new long-term incentive 2025–2029 Plan to be
submitted for approval by the 2025 Shareholders' Meeting.
B.1.2. Explain any deviation from the established procedure
for the application of the remuneration policy that occurred
during the fiscal year.
There were no deviations in the procedure for the application of
the Remuneration Policy..
B.1.3. State whether any temporary exceptions to the
remuneration policy were applied and, if so, explain the
exceptional circumstances that led to the application of these
exceptions, the specific components of the remuneration
policy affected and the reasons why the Company believes
these exceptions were necessary to serve the long-term
interests and sustainability of the Company as a whole or to
ensure its viability. Also quantify the impact which the
application of these exceptions has had on the remuneration
of each director in the fiscal year.
No temporary exceptions were applied.
B.2. Explain the different actions taken by the Company
in relation to the remuneration system and how they
have contributed to reducing exposure to excessive risks
and adapting them to the long-term objectives, values
and interests of the Company, including a reference to
the measures that have been adopted to guarantee that
the long-term results of the Company have been taken
into consideration in the remuneration accrued and that
a suitable balance has been attained between the fixed
and variable components of the remuneration, the
measures that have been adopted in relation to those
categories of staff whose professional activities have a
material repercussion on the Company's risk profile and
the measures that have been adopted to avoid conflicts
of interest, if any.
The remuneration of Executive Directors is a key issue for the
Board of Directors and the ARC. Therefore, the compensation
model is continuously reviewed, evaluated and updated by both
bodies. Fluidra has defined a competitive executive
remuneration program which motivates and rewards executives
for achieving financial and strategic objectives that generate
2024 Annual Financial Report        145
long-term value for shareholders, while providing rewards
commensurate with performance. This program applies to both
Executive Directors and other non-executive directors who are
considered critical to the Company as a way of incentivizing the
growth and sustainability of the Company. Fluidra regularly
requests benchmarks on the amount and structure of Fluidra's
remuneration packages for its senior management team,
including executive directors, to ensure that it is aligned with
market standards. Therefore:
Total remuneration is composed of a fixed portion, an annual
variable portion and a long-term variable portion.
The LTIs are linked to the achievement of Fluidra's long-term
objectives based on its strategic plan.
The LTIs are paid in shares, thus aligning the Executive
Directors’ interests with those of the shareholders, with the
obligation to retain the ownership of the net shares received
for three years from the acquisition date, until the beneficiary
owns a certain number of shares equivalent to 2 annual
payments of his/her fixed remuneration.
Variable remuneration is not guaranteed.
LTIs are subject to clawback and malus clauses as described in
the preceding sections, which allow the Company to request
the return of the incentive paid in certain cases.
Finally, the steps taken to avoid conflicts of interest are
explained in section A.1.6 above.
B.3. Explain how the remuneration accrued and vested in
the fiscal year complies with the current remuneration
policy and, in particular, how it contributes to the
Company’s long-term sustainable performance.
Furthermore, report on the relationship between the
remuneration obtained by the directors and the results
or other performance measures of the Company in the
short- and long-term, explaining, as the case may be, how
the variations in the performance of the Company have
influenced changes in the remuneration of directors and
how the latter contribute to the short- and long-term
results of the Company.
Section C of this Report includes the breakdown of the
remuneration accrued in 2024, for all items, due to the directors
of Fluidra, pursuant to the remuneration policies in force in the
year with respect to remuneration items and amounts.
Variable remuneration is aligned with the achievement of
objectives linked to Fluidra’s annual budget, so that variations in
the Company’s performance have a direct influence on the AVR
and, therefore, on the compensation of directors with executive
functions. The AVR linked to the achievement of financial and
non-financial and business objectives is arranged with a view to
the medium- and long-term that drives long-term performance
in strategic terms, in addition to the achievement of short-term
results, based on the current situation and the prospects and
objectives for Fluidra's sustainable growth.
Medium and long-term incentives are linked to strategic plans of
at least three years, which fosters the creation of sustainable
value for the Group. Multi-year variable remuneration is settled
in the form of shares, making it possible to align the interests of
the Executive Directors with those of shareholders.
B.4. Report on the result of the consultative vote at the
General Shareholders’ Meeting on the annual
remuneration report for the previous year, indicating
the number abstentions, blank votes and yea and nay
votes cast:
Number
% of total
Votes cast
161,699,273
84.16
Number
% of votes cast
Votes against
560,286
0.35
Votes in favor
160,521,250
99.27
Blank votes
0
0
Abstentions
617,737
0.38
Remarks
B.5. Explain how the fixed components accrued during
the year by the directors in their capacity as such are
calculated, the relative proportion for each director and
how they have changed compared to the year before.
The remuneration items accrued in 2024 in fixed salary,
allowances and totals are as follows:
Name
Fixed Salary
Allowances
Total
Eloy Planes
140,000
8,000
148,000
Bruce Brooks
90,000
8,000
98,000
Óscar Serra
102,000
8,000
110,000
José Manuel Varga
122,000
8,000
130,000
Bernat Corbera
110,000
8,000
118,000
Bernardo Garrigós
110,000
8,000
118,000
Steven Langman
110,000
20,000
130,000
Jordi Constans
154,043
8,000
162,043
Brian McDonald
130,000
20,000
150,000
Esther Berrozpe
150,000
20,000
170,000
Bárbara Borra
102,000
8,000
110,000
Aedhmar Hynes
102,000
20,000
122,000
Manuel Puig
97,774
8,000
105,774
Olatz Urroz
71,263
5,183
76,446
Total (€):
1,591,081
157,183
1,748,264
2024 Annual Financial Report        146
The remuneration items accrued in 2023 in fixed salary,
allowances and totals are as follows:
Name
Fixed Salary
Allowances
Total
Eloy Planes
140,000
8,000
148,000
Bruce Brooks
90,000
8,000
98,000
Óscar Serra
102,000
8,000
110,000
José Manuel Vargas
122,000
8,000
130,000
Bernat Corbera
110,000
8,000
118,000
Bernardo Garrigós
110,000
8,000
118,000
Steven Langman
110,000
20,000
130,000
Gabriel López
39,739
2,827
42,566
Jordi Constans
167,000
8,000
175,000
Brian McDonald
130,000
20,000
150,000
Esther Berrozpe
142,850
8,000
150,850
Bárbara Borra
102,000
8,000
110,000
Aedhmar Hynes
65,589
12,932
78,520
Manuel Puig
57,900
5,173
63,073
Total (€):
1,489,077
132,932
1,622,009
B.6. Explain how the salaries accrued by each one of the
executive directors over the past fiscal year for the
performance of management duties were determined,
and how they have changed with respect to the previous
year
The fixed cash remuneration accrued in 2024 by the Executive
Directors, in addition to that received for their status as such, is
as follows:
Mr. Planes: According to the Remuneration Policy, in 2024 Mr.
Planes received fixed remuneration of €500,000 for his
executive functions, namely, no increase over 2023 (0%
increase).
Mr. Brooks: According to the Remuneration Policy, in 2024 Mr.
Brooks received fixed remuneration of €600,000, namely, no
increase over 2023 (0% increase).
B.7. Explain the nature and the main characteristics of
the variable components of the remuneration systems
accrued in the year ended.
Specifically:
a) Identify each of the remuneration plans that have
determined the different types of variable
remuneration accrued by each of the directors in the
year ended, including information on their scope, their
date of approval, their date of incorporation, the
periods of accrual and validity, the criteria used to
evaluate performance and how this has affected the
establishment of the variable amount accrued, as well
as the measurement criteria used and the time needed
to be in a position to adequately measure all the
conditions and criteria, explaining in detail the criteria
and factors applied in terms of the time required and
methods for verifying that performance or other
conditions tied to the accrual and vesting of each
component of variable remuneration have been
effectively fulfilled.
b) In the case of stock options and other financial
instruments, the general characteristics of each plan
must include information on both the conditions to
acquire unconditional ownership (vesting) and to
exercise these options or financial instruments,
including the price and term to exercise them.
c) Each of the directors, together with their category
(executive directors, proprietary external directors,
independent external directors and other external
directors), who are beneficiaries of remunerations
systems or plans that include variable remuneration.
d) As the case may be, information is to be provided on
periods for the accrual or deferment of payment
applied and/or the periods for withholding/
unavailability of shares or other financial instruments,
should they exist.
Explain the short-term variable components of the
remuneration systems
As explained in section A.1 of this Report, according to the
Remuneration Policy, the variable remuneration only applies to
Executive Directors.
The variable remuneration system for the Executive Directors in
2024 includes two components: AVR and long-term
remuneration (LTI).
(1) AVR
In accordance with the terms of their respective contracts, in
2024 the Executive Directors earned gross annual variable
remuneration linked to the achievement of economic and
management objectives related to the budget set by the Board
of Directors for that year, which will be paid in 2025. The
objective criteria used to calculate the AVR for 2024 are as
follows:
The AVR for 2024 prior to weighting by the achievement scale is
100% of the fixed remuneration for executive functions, in the
case of Mr. Planes, and 150% in the case of Mr. Brooks. In 2024,
the indicators and weightings were as follows:
(i) 85%, economic objectives:
Free Cash-Flow (25%), PF cash EPS (25%), EBITDA (25%) and total
sales growth (10%)
(ii) by 15% of management objectives:
linked to the Company's ESG (carbon footprint, sustainable
product sales and NPS) and to strategic management objectives.
On 24 March 2025, the ARC verified the degree of achievement
of the objectives linked to the accrual of AVR in 2024 and
submitted it to the Board of Directors for approval.
2024 Annual Financial Report        147
The AVR financial targets for 2024 and the breakdown of the
degree of achievement of each indicator are as follows:
Free Cash-Flow, objective €228.7 million, % of achievement
104.9%; PF cash EPS objective 1.15%, % of achievement 105.2%;
EBITDA objective €461.3 million, % of achievement 103.5%; and
total growth of sales target 0.9%, % of achievement 332.1%.
Insofar as management targets are concerned, the degree of
attainment was77.8% for Eloy Planes and 84.4% for Bruce
Brooks, respectively. They both attained 83.3% of the 5% target
set for ESG targets.
The total weighted degree of attainment was 121.6% for Eloy
Planes and 122.5% Bruce Brooks, respectively. Based on this
degree of attainment, on March 25, 2025 the Board of Directors
approved the AVR amounts accrued in 2025 to be settled in
2025, which in the case of Mr. Planes amounted to €608,000 and
€1,103,000 in the case of Mr. Brooks.
(ii) LTI
First cycle of the 2022–2026 Plan
On 24 March 2025, the ARC verified the degree of achievement
of the objectives linked to the accrual of the first cycle of the
2022–2026 Plan and submitted it to the Board of Directors for
approval.
The financial targets of the indicators for the first cycle of the
Executive Directors’ 2022–2026 Plan of the and the breakdown
of their degree of attainment are as follows:
TSR: TSR target 50.3%, TSR obtained -19.2%, % vested
according to the degree of attainment of the TSR target 0%,
EBITDA: EBITDA target €714 million; EBITDA obtained €477
million; % vested according to the degree of attainment of the
EBITDA target, 0%
ESG (S&P rating): ESG target: 69; ESG obtained 69; % vested
according to the degree of attainment of the ESG target: 100%
The total weighted degree of attainment by the Executive
Directors was 10% (50% x 0% GCTSR + 40% x 0% GCEBITDA +
100% x 10% GCESG).
Based on this degree of attainment, on March 25, 2025 the
Board of Directors approved gross number of Shares to be
settled in June 2025 for the first Cycle of the 2022–2026 Plan,
which in the case of Mr. Planes amounted to 3,765 Shares and
4,518 Shares in the case of Mr. Brooks. The gross value of the
Shares to be settled, based on the Fluidra share price at 31
December 2024 (€23.52/share) amounts to €89,000 in the case
of Mr. Planes and €106,000 in the case of Mr. Brooks.
Explain the long-term variable components of the
remuneration systems
The Executive Directors were beneficiaries in 2024 of the three
cycles of the 2022–2026 Plan, the main features of which are
described in section A.1 of this Report.
B.8. Indicate whether certain variable components have
been reduced or clawed back when, in the case of the
former, the payment of unvested amounts has been
deferred, or in the case of the latter, the vested and paid
amounts were based on data that have subsequently
proved to be inaccurate. Describe the amounts reduced
or clawed back through the application of the reduction
or clawback clauses, why they were implemented and
the years to which they refer.
There were no reductions or claims for reimbursement in
respect of vested and paid or deferred variable remuneration
components which were based on data that has subsequently
been shown to be clearly inaccurate.
B.9. Explain the main characteristics of the long-term
savings systems where the amount or equivalent annual
cost appears in the tables in Section C, including
retirement and any other survivor benefit that are
financed, totally or partially, by the Company, whether
through internal or external contributions, indicating
the type of plan, whether it is a defined contribution or
benefit, the contingencies covered, the conditions to
vest economic rights for directors and their
compatibility with any type of indemnity due to the
early termination or the termination of the contractual
relationship between the Company and a director.
In 2024, the Company had taken on commitments for pensions
with its Executive Directors through contributions on a definite
basis that entailed setting up a pension fund, to which an annual
contribution of €16,000 would be made in the case of Mr.
Planes. He has vested rights.
Mr. Brooks is an active participant in the 401(k) pension plan
sponsored by the US subsidiary. The estimated cost of the plan
to the Fluidra group in 2024 was €13,000.
B.10. Explain, where appropriate, the severance pay or
any other type of payment deriving from early dismissal
or early resignation, or from the termination of the
contract in the terms provided for therein, accrued and/
or received by directors during the year ended.
Mr. Brooks' contract as executive director was terminated on 31
August 2024, following which he sat on the Board as an external
director until 31 December 2024. Mr. Brooks stepped down
from his executive functions on 1 September 2024, following
which his contract was amended to reflect this and to govern his
functions until 31 December 2024 to ensure a smooth handover
to Fluidra's new CEO, in which it was agreed:
i) to pay him the fixed remuneration until 31 December 2024;
ii) with regard to his variable remuneration:
a. his removal had no effect on the AVR to be paid in 2024,
b. in terms of the 2022–2026 Plan, the number of PSUs
awarded was reduced in proportion to the time that had
2024 Annual Financial Report        148
elapsed from the corresponding cycle's start date until 31
December 2024. He thus kept all of the PSUs from the
2022–2024 cycle and the number of PSUs awarded in the
2023–2025 cycle was reduced from 106,200 to 70,800 and
in the 2024–2026 from 80,173 to 26,724; and
iii) certain welfare benefits will continue to be covered until 31
December 2025, as the amount is negligible. Mr. Brooks is
subject to the non-compete clause in his contract for two
years, over which time he will not receive any additional
remuneration given that this consideration is included in the
remuneration he has already been paid. The termination of
Mr. Brooks' contract did not involve the accrual or payment
of any indemnity.
B.11. Indicate whether there have been any significant
changes in the contracts of persons exercising senior
management functions, such as executive directors,
and, where appropriate, explain such changes. In
addition, explain the main conditions of the new
contracts signed with executive directors during the
year, unless these have already been explained in
Section A.1.
As explained in the previous section, on May 19, 2024 Mr.
Brooks and Fluidra signed off an arrangement by mutual
agreement to terminate his executive functions as CEO of
Fluidra from 31 August 2024, as a result of which the terms and
conditions of his contract were amended from this date as
discussed in the previous section. In order to ensure a smooth
handover of the position of the Company's CEO, from August 1,
2024 to December 31, 2024 his functions would focus on
providing the new CEO with the business know-how and advice
related to Fluidra's business, for which he would remain
available to Fluidra for whatever was required of him. Mr.
Brooks was paid his fixed remuneration until 31 December
2024, as well as his AVR conditions, whereby he was considered
a good leaver in relation to the 2022–2026 Plan on the effective
date of December 31, 2024 in order to calculate the number of
PSUs from each cycle that he would hold following the
termination of his executive functions at Fluidra. Mr. Brooks has
not received any indemnity for the termination of his contract as
an executive.
B.12. Explain any supplementary remuneration accrued
by directors as consideration for services rendered
outside of their post.
No other supplementary remuneration was accrued by directors
in consideration for services provided rendered other than
those inherent to their posts.
B.13. Explain any remuneration deriving from advance
payments, loans or guarantees granted, indicating the
interest rate, their key characteristics and the amounts
eventually returned, as well as the obligations taken on
by way of guarantee or collateral.
There are advance payments, loans or guarantees granted by
the Company to its directors.
B.14. Itemize the remuneration in kind accrued by the
directors over the year, briefly explaining the nature of
the different salary components.
There follows a breakdown of the amount of the items of
remuneration in kind accrued in 2024 by the Executive
Directors, the nature of which is described in Section A.1 of this
Report.
Mr Eloy Planes received the following in kind remuneration
included in the Remuneration Policy:
Life insurance policy: €31,000.
Medical insurance policy: €7,000.
Use of a Company car: €10,000
Contribution to pension plan: €16,000.
Mr. Brooks received the following in kind remuneration included
in the Remuneration Policy:
Life insurance policy: €17,000.
Medical insurance policy: €16,000.
Use of a Company car: €12,000.
Contribution to pension plan: €13,000.
B.15. Explain the remuneration accrued by directors by
virtue of payments settled by the listed Company to a
third Company at which a director renders services
when these payments seek to remunerate the director's
services to the Company.
The Company made no payments to any third party entity
where the directors might render their services for the purpose
of compensating them for their services to the Company.
However, as explained in preceding sections, the group
Company Zodiac Pool Solutions LLC paid Mr. Brooks some of
the remuneration accrued in respect of the executive functions
he discharged in 2024, as broken down in the preceding
sections.
2024 Annual Financial Report        149
B.16. Explain and provide details of the amounts accrued
during the year for any remuneration item other than
the ones mentioned above, regardless of the type or the
group Company that pays it, including all benefits in any
form, such as those which are considered related-party
transactions and especially those which materially
affect the true image of the total remuneration paid to
the director. Explain the amount paid or pending
payment and the nature of the consideration received.
Where applicable, state reasons why it was not
considered remuneration paid to a director in his/her
capacity as such or in consideration for the performance
of his/her capacity as such or in consideration for the
performance of his/her executive functions, and
whether or not it is considered appropriate to include it
in the amounts shown under “other items" in section C.
In 2024, the directors did not earn any remuneration items
other than those already described in this Report.
2024 Annual Financial Report        150
C. Breakdown of remuneration paid
to each Director
Name
Category
Period of accrual in fiscal year 2024
Mr. ELOY PLANES CORTS
Executive Director
From 1/1/2024 to 31/12/2024
Mr. BRUCE W. BROOKS
Chief Executive Officer
From 1/1/2024 to 31/8/2024
Mr. BRUCE W. BROOKS
External Director
From 1/9/2024 to 31/12/2024
Ms. ESTHER BERROZPE GALINDO
Independent Director
From 1/1/2024 to 31/12/2024
Ms. BÁRBARA BORRA
Independent Director
From 1/1/2024 to 31/12/2024
Mr. JORGE CONSTANS FERNÁNDEZ
Independent Director
From 1/1/2024 to 31/12/2024
Mr. BERNARDO CORBERA SERRA 100
Nominee Director
From 1/1/2024 to 31/12/2024
Mr. BERNAT GARRIGÓS CASTRO
Nominee Director
From 1/1/2024 to 31/12/2024
Ms. AEDHMAR HYNES
Independent Director
From 1/1/2024 to 31/12/2024
Mr.  MICHAEL STEVEN LANGMAN
Nominee Director
From 1/1/2024 to 31/12/2024
Mr. BRIAN MCDONALD
Independent Director
From 1/1/2024 to 31/12/2024
Mr. MANUEL PUIG ROCHA
Nominee Director
From 1/1/2024 to 31/12/2024
Mr. ÓSCAR SERRA DUFFO
Nominee Director
From 1/1/2024 to 31/12/2024
Mr. JOSÉ MANUEL VARGAS GÓMEZ
Nominee Director
From 1/1/2024 to 31/12/2024
Ms. OLATZ URROZ
Independent Director
From 8/5/2024 to 31/12/2024
2024 Annual Financial Report        151
C.1. Complete the following tables regarding the
individual remuneration of each director (including the
salary received for performing executive duties) during
the year.
a) Remuneration from the reporting Company:
i) Remuneration in cash (in thousand €
Name
Fixed
remuneration
Expenses
Remunerati
on for sitting
on Board
committees
Salary
Short-term
variable
remuneration
Long-term
variable
remuneration
Indemnity
Other items
2024 Total
2023 Total
Mr. ELOY PLANES CORTS
140
8
500
608
1,256
1,088
Mr. BRUCE W. BROOKS
90
8
600
1,103
1,801
1,499
Ms. ESTHER BERROZPE GALINDO
90
20
60
170
151
Ms. BÁRBARA BORRA
90
8
12
110
110
Mr. JORGE CONSTANS FERNÁNDEZ
115
8
39
162
175
Mr. BERNARDO CORBERA SERRA
90
8
20
118
118
Mr. BERNAT GARRIGÓS CASTRO
90
8
20
118
118
Ms. AEDHMAR HYNES
90
20
12
122
0.079
Mr. MICHAEL STEVEN LANGMAN
90
20
20
130
130
Mr. BRIAN MCDONALD
90
20
40
150
150
Mr. MANUEL PUIG ROCHA
90
8
8
106
0.063
Mr. ÓSCAR SERRA DUFFO
90
8
12
110
110
Mr. JOSÉ MANUEL VARGAS GÓMEZ
90
8
32
130
130
Ms. OLATZ URROZ
58
5
13
76
0
Remarks
The information for 2023 on the remuneration received by
Directors was only included if they continued to hold their
post in 2024. The remuneration of the Director who stepped
down in 2023 amounted to €42,000.
2024 Annual Financial Report        152
(ii) Table of changes in share-based remuneration schemes
and gross profit from vested shares or financial instruments.
Name
Name of plan
Financial instruments at
start of 2024
Financial instruments
executed
in fiscal year 2024
Financial instruments vested during the year
Matured,
unredeemed
instruments
Financial instruments at
start of 2024
No.
instruments
No. equivalent
shares
No.
instruments
No. equivalent
shares
No.
instruments
No. of
equivalent/
vested
shares
Price of
vested
shares
Gross profit
from shares
handed over
or vested
financial
instruments
(thousand €)
No.
instruments
No.
instruments
Nº Acciones
equivalentes
Mr. ELOY PLANES CORTS
2022-2024 Plan
1st cycle
37,651
37,651
3,765
3,765
23.52
89
0
0
Mr. ELOY PLANES CORTS
2022-2024 Plan
2nd cycle
88,500
88,500
88,500
88,500
Mr. ELOY PLANES CORTS
2022-2024 Plan
3rd cycle
66,811
66,811
66,811
66,811
Mr. BRUCE W. BROOKS
2022-2024 Plan
1st cycle
45,181
45,181
4,518
4,518
23.52
106
0
0
Mr. BRUCE W. BROOKS
2022-2024 Plan
2nd cycle
106,200
106,200
70,800
70,800
Mr. BRUCE W. BROOKS
2022-2024 Plan
3rd cycle
80,173
80,173
26,724
26,724
Ms. ESTHER BERROZPE GALINDO
Ms. BÁRBARA BORRA
Mr. JORGE CONSTANS FERNÁNDEZ
Mr. BERNARDO CORBERA SERRA 100
Mr. BERNAT GARRIGÓS CASTRO
Ms. AEDHMAR HYNES
Mr. MICHAEL STEVEN LANGMAN
Mr. BRIAN MCDONALD
Mr. MANUEL PUIG ROCHA
Mr. ÓSCAR SERRA DUFFO
Mr. JOSÉ MANUEL VARGAS GÓMEZ
Mr. GABRIEL LÓPEZ ESCOBAR
Ms. OLATZ URROZ
2024 Annual Financial Report        153
Remarks
The first Cycle of the 2022–2026 Plan accrued on 31
December 2024, of which Mr. Planes and Mr. Brooks were
beneficiaries. Based on this degree of attainment, on March
25, 2025 the Board of Directors approved the gross number of
Shares to be settled in June 2025 for the first Cycle of the
2022–2026 Plan, which in the case of Mr. Planes amounted to
3,765 Shares and 4,518 Shares in the case of Mr. Brooks. The
gross value of the Shares to be settled, based on the Fluidra
share price at 31 December 2024 (€23.52/share) amounts to
€89,000 in the case of Mr. Planes and €106,000 in the case of
Mr. Brooks.
Due to the termination of the contact entered into between
Fluidra and Mr. Brooks for his functions as Executive Director
in 2024 as a good leaver, the number of PSUs awarded in the
second Cycle of the 2022–2026 Plan was reduced in
proportion to the time that had elapsed from the
corresponding cycle's start date until 31 December 2024.
iii) Long-term saving systems.
Name
Remuneration from vested rights in savings plans
Mr. ELOY PLANES CORTS
16
Mr. BRUCE W. BROOKS
13
Ms. ESTHER BERROZPE GALINDO
Ms. BÁRBARA BORRA
Mr. JORGE CONSTANS FERNÁNDEZ
Mr. BERNARDO CORBERA SERRA
Mr. BERNAT GARRIGÓS CASTRO
Ms. AEDHMAR HYNES
Mr. MICHAEL STEVEN LANGMAN
Mr. BRIAN MCDONALD
Mr. MANUEL PUIG ROCHA
Mr. ÓSCAR SERRA DUFFO
Mr. JOSÉ MANUEL VARGAS GÓMEZ
Mr. GABRIEL LÓPEZ ESCOBAR
Ms. OLATZ URROZ
2024 Annual Financial Report        154
Contributions made by Company during the year (thousand €)
Amount of accumulated funds (thousand €)
Name
Savings plans with unvested
economic rights
Savings plans with unvested
economic rights
Savings plans with unvested
economic rights
Savings plans with unvested
economic rights
2024 fiscal year
2023 fiscal year
2024 fiscal year
2023 fiscal year
2024 fiscal year
2023 fiscal year
2024 fiscal year
2023 fiscal year
Mr. ELOY PLANES CORTS
16
16
227
211
Mr. BRUCE W. BROOKS
13
8
477
464
Ms. ESTHER BERROZPE GALINDO
Ms. BÁRBARA BORRA
Mr.  JORGE CONSTANS FERNÁNDEZ
Mr. ELOY PLANES CORTS
Mr. BERNARDO CORBERA SERRA
Mr. ÓSCAR SERRA DUFFO
Mr. JORGE VALENTIN CONSTANS FERNÁNDEZ
Mr. JOSÉ MANUEL VARGAS GÓMEZ
Mr. BRIAN LOUIS MCDONALD
Mr. BERNAT GARRIGÓS CASTRO
Ms. ESTHER FATIMA BERROZPE GALINDO
Ms. OLATZ URROZ
Remarks
2024 Annual Financial Report        155
iv) Detail other items
Name
Item
Amount
Mr. ELOY PLANES CORTS
Vehicle
10
Mr. ELOY PLANES CORTS
Life insurance
31
Mr. ELOY PLANES CORTS
Health insurance
7
Mr. BRUCE W. BROOKS
Health insurance
16
Mr. BRUCE W. BROOKS
Life insurance
17
Mr. BRUCE W. BROOKS
Vehicle
12
Ms. ESTHER BERROZPE GALINDO
Item
Ms. BÁRBARA BORRA
Item
Mr. JORGE CONSTANS FERNÁNDEZ
Item
Mr. BERNARDO CORBERA SERRA
Item
Mr. BERNAT GARRIGÖS CASTRO
Item
Ms. AEDHMAR HYNES
Item
Mr. MICHAEL STEVEN LANGMAN
Item
Mr. BRIAN MCDONALD
Item
Mr. MANUEL PUIG ROCHA
Item
Mr. ÓSCAR SERRA DUFFO
Item
Mr. JOSÉ MANUEL VARGAS GÓMEZ
Item
Mr. GABRIEL LÓPEZ ESCOBAR
Item
Ms. OLATZ URROZ
Item
Remarks
2024 Annual Financial Report        156
b) Remuneration paid to Company directors for sitting on
the boards of subsidiaries:
iv) Remuneration in cash (in thousand €)
Name
Fixed
remuneration
Expenses
Remuneration
for sitting on
Board
committees
Salary
Short-term
variable
remuneration
Long-term
variable
remuneration
Indemnity
Other items
2024 Total
2023 Total
Mr. ELOY PLANES CORTS
Mr. BRUCE W. BROOKS
Ms. ESTHER BERROZPE GALINDO
Ms. BÁRBARA BORRA
Mr. JORGE CONSTANS FERNÁNDEZ
Mr. BERNARDO CORBERA SERRA
Mr. BERNAT GARRIGÓS CASTRO
Ms. AEDHMAR HYNES
Mr. MICHAEL STEVEN LANGMAN
Mr. BRIAN MCDONALD
Mr. MANUEL PUIG ROCHA
Mr. ÓSCAR SERRA DUFFO
Mr. JOSÉ MANUEL VARGAS GÓMEZ
Mr. GABRIEL LÓPEZ ESCOBAR
Ms. OLATZ URROZ
Remarks
2024 Annual Financial Report        157
v) Table of changes in share-based remuneration schemes
and gross profit from vested shares or financial
instruments.
Name
Name of plan
Financial instruments at
start of 2024
Financial instruments
executed
in fiscal year 2024
Financial instruments vested during the year
Matured,
unredeemed
instruments
Financial instruments at
start of 2024
No.
instruments
No.
equivalent
shares
No.
instruments
No.
equivalent
shares
No.
instruments
No. of
equivalent/
vested shares
Price of vested
shares
Gross profit from
shares handed
over or vested
financial
instruments
(thousand €)
No.
instruments
No.
instruments
No.
equivalent
shares
Mr. ELOY PLANES CORTS
Plan
0.00
Mr. BRUCE W. BROOKS
Plan
0.00
Ms. ESTHER BERROZPE GALINDO
Plan
0.00
Ms. BÁRBARA BORRA
Plan
0.00
Mr. JORGE CONSTANS FERNÁNDEZ
Plan
0.00
Mr. BERNARDO CORBERA SERRA
Plan
0.00
Mr. BERNAT GARRIGÓS CASTRO
Plan
0.00
Ms. AEDHMAR HYNES
Plan
0.00
Mr. MICHAEL STEVEN LANGMAN
Plan
0.00
Mr. BRIAN MCDONALD
Plan
0.00
Mr. MANUEL PUIG ROCHA
Plan
0.00
Mr. ÓSCAR SERRA DUFFO
Plan
0.00
Mr. JOSÉ MANUEL VARGAS GÓMEZ
Plan
0.00
Mr. GABRIEL LÓPEZ ESCOBAR
Plan
0.00
Ms. OLATZ URROZ
Plan
0.00
Remarks
2024 Annual Financial Report        158
vi) Long-term saving systems.
Name
Remuneration from vested rights in savings plans
Mr. ELOY PLANES CORTS
Mr. BRUCE W. BROOKS
Ms. ESTHER BERROZPE GALINDO
Ms. BARBARA BORRA
Mr. JORGE CONSTANS FERNANDEZ
Mr. BERNARDO CORBERA SERRA
Mr. BERNAT GARRIGOS CASTRO
Ms. AEDHMAR HYNES
Mr. MICHAEL STEVEN LANGMAN
Mr. BRIAN MCDONALD
Mr. MANUEL PUIG ROCHA
Mr. OSCAR SERRA DUFFO
Mr. JOSÉ MANUEL VARGAS GÓMEZ
Mr. GABRIEL LÓPEZ ESCOBAR
Ms. OLATZ URROZ
2024 Annual Financial Report        159
Contributions made by Company during the year (thousand €)
Amount of accumulated funds (thousand €)
Name
Savings plans with unvested
economic rights
Savings plans with unvested
economic rights
Savings plans with unvested
economic rights
Savings plans with unvested
economic rights
2024 fiscal year
2023 fiscal year
2024 fiscal year
2023 fiscal year
2024 fiscal year
2023 fiscal year
2024 fiscal year
2023 fiscal year
Mr. ELOY PLANES CORTS
Mr. BRUCE W. BROOKS
Ms. ESTHER BERROZPE GALINDO
Ms. BARBARA BORRA
Mr. JORGE CONSTANS FERNANDEZ
Mr. BERNARDO CORBERA SERRA
Mr. BERNAT GARRIGOS CASTRO
Ms. AEDHMAR HYNES
Mr. MICHAEL STEVEN LANGMAN
Mr. BRIAN MCDONALD
Mr. MANUEL PUIG ROCHA
Mr. OSCAR SERRA DUFFO
Mr. JOSÉ MANUEL VARGAS GÓMEZ
Mr. GABRIEL LÓPEZ ESCOBAR
Ms. OLATZ URROZ
Remarks
2024 Annual Financial Report        160
vii) Detail other items
Name
Item
Amount
Mr. ELOY PLANES CORTS
Item
Mr. BRUCE W. BROOKS
Item
Ms. ESTHER BERROZPE GALINDO
Item
Ms. BARBARA BORRA
Item
Mr. JORGE CONSTANS FERNANDEZ
Item
Mr. BERNARDO CORBERA SERRA
Item
Mr. BERNAT GARRIGOS CASTRO
Item
Ms. AEDHMAR HYNES
Item
Mr. MICHAEL STEVEN LANGMAN
Item
Mr. BRIAN MCDONALD
Item
Mr. MANUEL PUIG ROCHA
Item
Mr. OSCAR SERRA DUFFO
Item
Mr. JOSÉ MANUEL VARGAS GÓMEZ
Item
Mr. GABRIEL LÓPEZ ESCOBAR
Item
Ms. OLATZ URROZ
Item
Remarks
2024 Annual Financial Report        161
c) Summary remunerations (thousand €):
This should include a summary of the amounts
corresponding to all the remuneration items included in this
report that have accrued to each director, in thousands of
euros.
Remuneration earned at the Company
Remuneration earned in Group companies
Name
Total
remuneration
in cash
Gross profit
from shares
handed over
or vested
financial
instruments
Remuneration
from savings
systems
Remuneration
from other
items
Total paid in
2024 by
Company
Total
remuneration
in cash
Gross profit
from shares
handed over
or vested
financial
instruments
Remuneration
from savings
systems
Remuneration
from other
items
Total paid in
2024 by
group
Total paid in
2024 by
Company +
group
Mr. ELOI PLANES CORTS
1,256
89
16
48
1,409
1,409
Mr. BRUCE W. BROOKS
1,801
106
13
45
1,965
1,965
Ms. ESTHER BERROZPE GALINDO
170
170
170
Ms. BÁRBARA BORRA
110
110
110
Mr. JORGE CONSTANS
FERNÁNDEZ
162
162
162
Mr. BERNARDO CORBERA SERRA
118
118
118
Mr. BERNAT GARRIGÓS CASTRO
118
118
118
Ms. AEDHMAR HYNES
122
122
122
Mr. MICHAEL STEVEN LANGMAN
130
130
130
Mr. BRIAN MCDONALD
150
150
150
Mr. MANUEL PUIG ROCHA
106
106
106
Mr. ÓSCAR SERRA DUFFO
110
110
110
Mr. JOSÉ MANUEL VARGAS
GÓMEZ
130
130
130
Ms. OLATZ URROZ
76
76
76
TOTAL
4,559
195
29
93
4,876
4,876
Remarks
The gross number of Shares to be settled in June 2025 for the
first Cycle of the 2022–2026 Plan, which in the case of Mr.
Planes amounted to 3,765 Shares and 4,518 Shares in the
case of Mr. Brooks. The gross value of the Shares to be
settled, based on the Fluidra share price at 31 December 2024
(€23.52/share) amounts to €89,000 in the case of Mr. Planes
and €106,000 in the case of Mr. Brooks.
2024 Annual Financial Report        162
C.2. Describe the evolution over the last five years of
the variation - as an amount and a percentage - in the
remuneration accrued by each one of the listed
Company's directors during the year ,in the Company’s
consolidated results and in the average remuneration
on a full-time equivalent basis of the employees of the
Company and its subsidiaries who are not directors of
the listed Company.
Total amounts accrued and % year-on-year change
Executive Directors
2024 fiscal year
2024/ 2023
Variation %
2023 fiscal year
2023/ 2022
Variation %
2022 fiscal year
2022/ 2021
Variation %
2021 fiscal year
2021/ 2020
Variation %
2020 fiscal year
Mr. BRUCE WALKER BROOKS
1,965
26.4%
1,555
-80.55
7,994
376.68
1,677
3.45
1,621
Mr. ELOY PLANES CORTS
1,409
23.9%
1,137
-77.90
5,144
301.88
1,280
9.97
1,164
Consolidated Company results
142,057
21.6%
116,851
-28.92
164,403
-35.77
255,968
156.22
99,903
Average employee remuneration
46
6.9%
43
4.88
41
2.50
40
5.26
38
Remarks
Analysis of the changes:
2022 vs 2021: The increase in the executive directors’
remuneration is due to the fact that the remuneration of the
executive directors includes the LTI that vested in 2022 after
accruing from 2018 to 2022. Fluidra settled the 2018–2023
Plan on 17 January 2023. The value of the shares delivered to
executive directors on the vesting date was €4,443,000 in the
case of Mr. Planes Corts and €7,192,000 in the case of Mr.
Brooks. If the multi-year remuneration for the period 2018–
2022, which vested in 2022, were removed from the
calculation, the executive directors’ remuneration would have
decreased by 52.17% in the case of Bruce Brooks and by
45.23% in the case of Eloy Planes.
2023 vs 2022: The increase in the executive directors’
remuneration is due to the fact that the remuneration of the
executive directors includes the LTI that vested in 2022 after
accruing from 2018 to 2022, as discussed above. If the multi-
year remuneration for the period 2018–2022, which vested in
2022, were removed from the calculation, the executive
directors’ remuneration would have increased by 86.9% in the
case of Bruce Brooks and by 55.2% in the case of Eloy Planes,
respectively. This difference is directly related to the degree of
attainment of the financial targets to which their AVR is linked,
which in 2023 was 88% whilst in 2022 it was 0%.
2024 vs 2023: This increase is directly related to the increase
in the variable remuneration for having attained a higher
percentage than in the previous year (121% in 2024), in
addition to the vesting of the incentive for the first cycle (a
total of €89,000 in the case of Mr. Planes and €106,000 in the
case of Mr. Brooks).
2024 Annual Financial Report        163
D. Other information of interest
If there are any relevant issues relating to directors’
remuneration that you have not been able to address in the
previous sections of this report, but which are necessary to
provide more comprehensive and fully reasoned information
on the remuneration structure and practices of the Company
with regard to its directors, briefly list them.
N/A
This annual remuneration report has been approved by the
Board of Directors of the Company on:
25/03/2025
State whether any directors have voted against or have
abstained from voting the approval of this report.
[    ] Yes
[ √ ] No
2024 Annual Financial Report        164
Fluidra, S.A.
Individual Annual Accounts
2024
On 25 March 2025, the board of directors of Fluidra, S.A. authorised for issue the annual accounts in accordance with the Spanish
General Chart of Accounts approved by Royal Decree 1514/2007, which comprise the balance sheet, the income statement, the
statement of recognised income and expense, the statement of changes in equity, the cash flow statement, the notes to the annual
accounts and the directors' report for the year ended 31 December 2024, in accordance with the European Single Electronic Format
(ESEF) as established in Delegated Regulation (EU) 2019/815 under ID number:
93053C10B2B3C8B1F10CB3663DBB39D77057654FBE2506FD3328427F85461159 (*)
And in witness whereof, all directors sign below in compliance with article 253 of the Spanish Companies Act.
Mr. Eloy Planes Corts
Ms. Esther Berrozpe Galindo
Ms. Barbara Borra
Mr. Bruce Walker Brooks
Mr. Jorge Valentín Constans Fernández
Mr. Bernardo Corbera Serra
Mr. Bernat Garrigós Castro
Ms. Aedhmar Hynes
Mr. Michael Steven Langman
Mr. Brian McDonald
Mr. Manuel Puig Rocha
Mr. Oscar Serra Duffo
Ms. Olatz Urroz García
Mr. José Manuel Vargas Gómez
(*) ID number hash SHA256
2024 Annual Financial Report        165
Statement of responsibility by the directors of Fluidra, S.A.
on the contents of the 2024 Annual Financial Report
With regard the 2024 Annual Financial Report of Fluidra, S.A. containing the annual accounts and directors’ report, the members of
the board of directors state that:
To the best of their knowledge, the annual accounts prepared in accordance with applicable accounting principles give a true and fair
view of the equity, financial position and results of Fluidra, S.A. and that the directors’ report includes a faithful analysis of the
business outlook, results and position of Fluidra, S.A. together with a description of the main risks and uncertainties it faces.
Statement made for the authorisation for issue of the 2024 Annual Financial Report of Fluidra, S.A., by the board of directors on 25
March 2025.
Mr. Eloy Planes Corts
Ms. Esther Berrozpe Galindo
Ms. Barbara Borra
Mr. Bruce Walker Brooks
Mr. Jorge Valentín Constans Fernández
Mr. Bernardo Corbera Serra
Mr. Bernat Garrigós Castro
Ms. Aedhmar Hynes
Mr. Michael Steven Langman
Mr. Brian McDonald
Mr. Manuel Puig Rocha
Mr. Oscar Serra Duffo
Ms. Olatz Urroz García
Mr. José Manuel Vargas Gómez